data_2lc6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lc6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 109.96 -0.385 . . . . 44.33 109.96 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.13 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 74.42 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.54 111.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.21 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.15 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.42 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.23 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.24 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 75.2 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 73.23 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.51 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 75.33 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.14 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 75.01 109.71 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.24 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.34 108.652 -177.687 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo . . . . . 0 C--O 1.239 0.553 0 CA-C-O 121.155 0.398 . . . . 71.12 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.4 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.54 114.853 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.45 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.34 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.41 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.22 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.02 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.42 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 74.43 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 75.33 109.088 -178.573 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.717 -0.475 . . . . 73.02 109.717 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.42 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 72.01 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.42 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 75.11 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.41 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 73.33 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.21 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.31 108.878 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.24 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.04 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.33 111.997 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.01 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 72.11 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 72.34 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.3 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.31 112.323 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.44 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 73.35 109.709 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.01 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.2 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.32 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 73.41 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.621 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.13 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.22 110.199 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.3 110.032 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 75.25 110.751 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.4 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.13 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 37.09 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.11 106.61 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 73.44 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.51 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 75.5 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.13 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 61.43 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 72.12 109.024 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 73.2 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.1 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.32 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 74.24 111.187 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.11 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.4 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.34 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.55 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.3 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 65.14 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.53 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 75.2 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.23 110.545 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.41 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.24 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 70.04 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.511 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 72.55 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.2 109.207 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.21 107.361 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 71.21 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.621 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo . . . . . 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 63.31 111.073 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.418 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.51 111.087 -172.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.14 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.32 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.41 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.42 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 72.52 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.45 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.32 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.584 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.53 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.14 111.244 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.41 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 75.32 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.14 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.486 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.23 111.249 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-O 120.995 0.331 . . . . 75.1 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 71.44 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.32 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.44 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 75.51 107.018 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.41 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.23 109.753 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 50.54 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.1 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.1 107.359 178.552 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.202 -0.666 . . . . 75.34 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.41 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.22 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.51 106.596 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.23 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.34 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.22 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 75.33 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 72.0 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.21 108.601 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.41 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 73.41 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.33 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.23 112.576 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.23 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.01 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.42 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 75.23 110.49 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.41 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.12 112.449 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.22 109.994 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.44 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.32 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 73.51 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.35 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.43 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.41 109.495 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.462 HG23 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 60.44 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.53 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.407 HG13 ' SD ' ' A' ' 238' ' ' MET . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.13 108.604 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.413 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.43 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.33 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.4 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.1 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.22 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.4 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.21 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.2 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 64.44 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.13 110.369 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.21 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.24 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 238' ' ' MET . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.43 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.2 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.15 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.34 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.478 ' HE2' HG13 ' A' ' 234' ' ' VAL . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.15 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 71.54 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.41 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.21 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 74.13 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.43 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.41 108.858 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.413 HD13 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 75.43 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.22 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.33 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.02 108.864 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.1 108.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 74.31 108.833 173.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo . . . . . 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 53.13 111.777 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.878 -0.786 . . . . 61.4 108.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.12 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 63.3 111.514 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.43 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.45 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.54 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.571 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 65.24 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.44 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.45 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.551 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 75.3 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.23 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.23 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 74.21 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.53 108.779 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 73.23 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.04 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 75.13 108.691 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--O 1.243 0.774 0 N-CA-C 109.129 -1.143 . . . . 74.13 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 74.33 111.491 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.53 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 72.13 110.079 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.32 106.208 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 73.13 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 74.12 109.574 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.45 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 72.24 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.13 107.415 178.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.072 -1.084 . . . . 75.42 108.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.4 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.3 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.02 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 64.45 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.44 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.45 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 70.03 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 71.11 107.605 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.23 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.42 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.04 113.659 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 61.35 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.02 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.31 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 71.03 110.347 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.3 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.11 113.499 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 74.15 111.078 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.33 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 72.4 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.33 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 73.42 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.448 ' HA ' HG13 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.3 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.33 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.11 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.01 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.11 109.818 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.43 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.32 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.31 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 72.43 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 72.55 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG21 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.43 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.21 111.744 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.42 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 73.11 112.393 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.21 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 60.12 110.266 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.13 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 73.32 108.794 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.461 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 74.13 112.39 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.41 109.3 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 75.03 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.11 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 74.5 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.05 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.3 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.14 107.373 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.15 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 218' ' ' VAL . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.44 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.462 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 74.43 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.571 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo . . . . . 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 74.31 109.629 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 161' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 109.84 -0.43 . . . . 62.41 109.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 73.1 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 70.02 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.15 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.14 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 53.13 111.8 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.31 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.14 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.536 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.32 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.531 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.1 m170 -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 73.41 108.554 170.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 65.15 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 147' ' ' ALA . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.42 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.411 ' NH2' ' HB3' ' A' ' 164' ' ' CYS . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 74.43 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.22 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.411 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 75.43 112.285 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.251 1.148 0 CA-C-O 121.09 0.371 . . . . 73.44 112.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.1 107.947 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.52 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.45 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 75.52 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.05 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 72.13 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 73.41 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.3 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.04 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 65.13 106.373 176.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 108.528 -0.916 . . . . 71.1 108.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.54 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.45 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 72.24 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.2 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.21 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 74.45 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.4 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.05 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.33 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.13 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.42 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 64.3 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 71.41 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 75.22 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.21 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.45 111.105 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.43 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 73.33 111.653 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.04 107.901 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 70.52 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 62.1 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.41 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.35 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 73.43 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 71.22 109.467 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 63.22 110.446 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.43 110.865 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 74.15 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 62.23 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 74.3 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.52 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.11 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 71.01 111.301 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.54 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.42 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 72.21 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.33 109.541 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.05 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.44 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.23 112.078 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.42 111.337 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 62.12 110.879 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.11 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.04 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.33 112.666 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 73.12 109.267 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.12 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.44 111.004 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.3 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 73.31 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 62.12 108.411 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.45 110.416 -173.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 72.04 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.51 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.41 108.004 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 159' ' ' ARG . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.05 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 72.21 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 75.23 110.48 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 109.583 -0.525 . . . . 72.33 109.583 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.42 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 72.41 110.522 -175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.43 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 73.22 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.1 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.42 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 73.5 111.399 -173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.42 110.528 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 63.02 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.1 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.12 108.824 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 73.04 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 72.11 108.735 174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 73.32 108.939 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.52 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.12 107.346 175.908 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--O 1.247 0.969 0 CA-C-O 121.045 0.352 . . . . 74.12 112.758 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.04 110.975 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 37.95 114.924 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.41 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.41 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.33 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 74.11 107.937 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.15 109.975 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 73.11 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 74.11 111.964 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.411 ' HG ' ' CD ' ' A' ' 217' ' ' GLU . 42.2 t . . . . . 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.35 109.046 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.42 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.15 111.967 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.51 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 74.33 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.54 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 63.2 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 74.04 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.33 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.22 108.811 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.04 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.13 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 37.95 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 65.35 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.45 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.1 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.11 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 64.24 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 73.21 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 72.14 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 75.41 109.62 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.41 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.23 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.4 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.574 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.14 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.31 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 73.03 110.366 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.454 HG23 ' HG3' ' A' ' 220' ' ' GLU . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.05 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 71.44 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 54.44 110.812 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 53.55 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 61.11 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.33 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.33 114.275 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.3 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.4 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 74.14 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 74.22 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.45 111.517 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.443 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 61.11 111.073 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.03 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.13 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.33 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.14 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.42 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.42 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 72.3 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.05 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 71.43 107.325 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.1 113.778 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.54 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.23 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 71.45 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 63.43 108.104 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.21 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.24 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.45 108.704 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.44 106.624 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo . . . . . 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.31 111.574 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 120.759 0.314 . . . . 73.25 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.22 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.1 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.02 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.1 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.03 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.24 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.35 112.185 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.5 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 65.35 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.539 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.13 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.41 110.265 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.43 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 74.53 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 71.35 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.14 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 74.11 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--O 1.254 1.325 0 CA-C-O 120.839 0.266 . . . . 74.04 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 72.03 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.4 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.14 107.914 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 75.21 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.13 110.51 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 63.43 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.41 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.42 108.917 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 119.464 -0.303 . . . . 73.13 110.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.22 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.24 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.4 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.33 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.23 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.45 107.776 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.24 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 73.14 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 71.23 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.15 113.758 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 74.54 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 63.33 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.12 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.11 112.129 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 75.4 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.05 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 71.03 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.24 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.41 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.651 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.42 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.33 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 72.31 110.93 -177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.432 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 74.33 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.32 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 75.43 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 73.42 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.52 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 73.41 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 64.21 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 225' ' ' GLU 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.44 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.54 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.44 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 229' ' ' LYS . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.31 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.508 ' O ' HG21 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 75.34 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.12 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.14 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.33 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.3 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.21 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.21 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 72.12 109.176 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 221' ' ' VAL . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 75.12 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 74.54 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 62.23 110.049 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.23 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 65.3 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.41 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.24 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.22 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.23 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 64.44 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 74.22 108.562 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.432 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.13 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.651 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 73.41 111.964 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 161' ' ' VAL . . . . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 110.208 -0.293 . . . . 73.43 110.208 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.32 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 75.53 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 73.21 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 73.13 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.32 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.24 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 72.42 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.23 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.23 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 71.3 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.435 ' CE1' HG23 ' A' ' 219' ' ' ILE . 33.3 m170 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.53 110.017 172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 72.51 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.24 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 147' ' ' ALA . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.2 110.514 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.22 108.987 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 74.11 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 N-CA-C 108.372 -1.434 . . . . 75.31 108.372 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 172' ' ' LEU . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.45 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.21 115.206 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.13 108.955 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 72.44 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.3 111.23 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.54 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.42 107.953 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.53 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.12 111.164 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 60.41 106.984 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 CA--C 1.506 -0.727 0 CA-C-O 119.815 -0.136 . . . . 73.12 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.43 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 75.14 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 75.33 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.11 109.501 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 62.35 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.3 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 72.11 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 73.35 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.4 ' CG2' ' HA3' ' A' ' 204' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.41 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 65.51 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 37.1 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.4 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.31 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.21 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.32 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.44 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.42 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.24 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 63.35 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 73.12 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 63.1 108.443 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 72.42 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 61.2 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.32 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.131 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.43 110.673 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 158' ' ' HIS . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.24 109.979 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.34 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.22 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 63.55 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.12 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 71.13 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 227' ' ' ALA . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.43 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.44 114.375 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 65.14 109.186 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.13 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 72.22 107.638 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.12 109.585 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 72.04 110.326 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.33 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 62.41 111.864 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.43 111.656 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.41 110.519 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.02 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.11 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.442 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.12 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.24 109.09 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.14 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.41 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.2 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.04 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 72.31 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.13 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 72.13 107.529 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 74.3 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.45 109.386 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 62.05 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo . . . . . 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 108.423 -0.954 . . . . 65.33 108.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.13 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.32 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 73.02 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.13 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.32 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.21 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.31 112.347 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.14 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 74.53 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.34 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 73.4 108.139 170.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.14 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.43 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.51 108.446 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 75.31 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.51 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.33 111.921 175.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo . . . . . 0 C--O 1.247 0.96 0 CA-C-O 121.79 0.662 . . . . 73.34 112.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.52 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.43 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.52 110.787 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.22 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.42 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 71.21 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.01 109.303 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.22 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.12 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 53.2 108.17 -176.68 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.556 -0.905 . . . . 73.34 108.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.3 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.2 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 74.52 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 75.51 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 72.4 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 74.43 107.776 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.15 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.54 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.21 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.44 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.1 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 63.35 110.686 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.43 108.648 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.24 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 211' ' ' LEU . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.02 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.31 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 72.15 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 72.43 106.943 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.2 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.51 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 65.24 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.15 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.24 108.877 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.488 HG23 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 72.02 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.31 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.51 HG13 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.43 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.1 112.172 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.24 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.11 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.33 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.43 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.32 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.21 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 75.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 74.14 110.095 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 71.31 109.559 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.44 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.02 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.14 111.541 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.42 109.708 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.34 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.3 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.528 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 73.23 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.32 109.159 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 62.41 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 73.41 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.55 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 247' ' ' ILE . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.12 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 74.54 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.22 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.33 108.523 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 75.01 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo . . . . . 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.41 111.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.45 0.167 . . . . 71.31 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.622 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.32 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.41 109.798 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 75.31 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.42 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 63.33 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 74.43 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.41 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.24 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 54.5 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.45 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 71.55 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.622 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.53 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 74.13 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 74.41 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 75.2 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 243' ' ' SER . 36.6 t . . . . . 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.4 107.564 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.246 0.894 0 N-CA-C 110.506 -0.613 . . . . 72.52 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.446 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.12 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.35 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.54 109.332 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.55 106.666 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.425 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.14 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.14 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.35 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 71.22 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 110.28 -0.267 . . . . 73.52 110.28 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.24 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.01 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 75.44 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.4 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.34 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 72.21 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.11 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.52 109.71 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.43 107.753 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.23 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.33 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.03 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 163' ' ' LEU . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.24 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.11 110.426 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 74.44 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 71.4 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 73.02 111.393 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.34 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.21 107.321 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.21 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.31 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.11 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.445 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.23 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 73.11 110.94 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.02 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.39 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 71.21 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.49 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 74.35 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 72.54 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.24 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.3 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.32 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 74.14 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.34 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 72.22 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.43 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.21 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.02 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 65.21 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 74.52 110.404 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 72.55 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.12 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.458 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.22 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.32 109.683 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.2 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.31 111.767 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.04 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.14 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.43 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.42 110.885 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.14 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 75.53 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 61.12 107.688 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.445 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.51 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo . . . . . 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.33 111.427 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.018 -1.105 . . . . 61.14 108.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.33 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 65.12 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.12 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.11 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.32 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.4 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.535 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.43 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.05 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 72.2 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.666 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 70.13 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.14 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 74.23 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.55 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.45 108.01 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.34 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.52 108.936 172.407 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 N--CA 1.482 0.808 0 N-CA-C 110.391 -0.657 . . . . 74.3 110.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 73.21 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.24 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 75.24 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.432 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.43 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.34 111.752 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 75.0 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.33 108.779 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.33 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 73.13 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.41 109.123 -178.129 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.537 -0.171 . . . . 63.22 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.23 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.03 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 70.51 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 61.44 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.54 108.285 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.05 109.728 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 64.23 108.707 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 73.03 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.23 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.13 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.45 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.52 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.41 107.6 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.1 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 73.3 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 44.24 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.461 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 72.32 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.12 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.41 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.13 114.368 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.55 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.594 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.22 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.22 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.2 110.149 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.469 HG23 ' HG3' ' A' ' 220' ' ' GLU . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 74.25 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.04 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.34 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 64.53 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.43 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 227' ' ' ALA . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.51 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.45 112.493 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.414 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 65.1 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.12 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.22 109.72 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 74.14 110.164 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.32 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.1 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 74.35 111.195 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.22 110.843 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.33 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.24 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.446 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.3 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.54 109.642 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 72.21 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.05 110.8 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 71.42 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.4 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 70.4 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.23 109.3 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.33 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 72.45 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.44 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 72.43 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.54 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 75.52 110.855 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 120.537 0.208 . . . . 52.42 110.769 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.44 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 65.43 112.177 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.54 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.1 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.41 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.21 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.04 110.928 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.43 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.43 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.548 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.3 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.8 m170 -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.1 109.165 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HD2' HD13 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.31 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.51 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 74.11 106.685 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.11 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 74.21 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 65.34 106.766 174.27 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--O 1.249 1.029 0 CA-C-O 121.174 0.406 . . . . 74.42 113.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.42 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.21 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.34 112.118 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.14 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.53 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.43 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.03 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 61.41 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 62.13 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 52.1 107.839 177.274 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 75.32 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.33 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.41 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.54 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.41 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.04 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 71.12 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.2 111.936 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.44 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.55 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.12 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.21 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.452 ' O ' HG21 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.43 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.32 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 74.43 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 205' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.13 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 53.15 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.458 HD13 ' HD2' ' A' ' 159' ' ' ARG . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 75.14 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.42 110.44 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 72.52 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.35 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.12 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 71.13 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.43 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 74.1 110.769 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 219' ' ' ILE . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.34 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.35 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.579 ' OD1' HD13 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.32 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.31 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.2 110.256 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.34 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.41 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.21 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 75.33 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.42 110.105 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 64.43 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.51 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.33 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.23 111.721 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.13 110.775 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.12 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.33 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.48 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 71.14 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 72.4 109.141 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.3 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 72.03 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.11 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.55 109.168 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.44 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.579 HD13 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.1 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.42 107.067 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 72.24 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.23 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 75.4 109.054 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.14 108.39 172.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo . . . . . 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.21 110.783 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 120.818 0.342 . . . . 72.22 111.569 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.34 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 74.11 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.42 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.3 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.3 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 73.34 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.42 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 75.2 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 73.15 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.24 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.33 110.378 171.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.41 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 75.25 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.22 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.51 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.44 109.404 -174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.32 111.139 -175.763 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.252 1.209 0 N-CA-C 110.0 -0.808 . . . . 61.32 110.0 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.2 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.22 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.1 109.546 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.45 107.463 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.43 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 70.1 109.347 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.51 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.22 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 63.24 108.755 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 70.04 108.301 -179.126 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.168 0.032 . . . . 74.22 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.41 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.22 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.41 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 73.11 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 72.44 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.24 109.808 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.22 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 74.55 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.495 ' CG2' ' HA3' ' A' ' 204' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.03 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.4 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.11 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 60.15 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 74.24 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.44 111.835 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.53 109.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.24 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.22 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.43 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.12 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.424 ' CD2' ' HG2' ' A' ' 159' ' ' ARG . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 71.34 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.43 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 70.54 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.44 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.567 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.33 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.12 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 71.44 110.507 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 72.32 110.849 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 74.53 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 75.32 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.4 110.976 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.31 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.4 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 227' ' ' ALA . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 75.32 112.516 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 74.54 114.438 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.14 108.656 177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG21 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.05 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 75.34 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.42 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 72.04 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.24 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.01 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.55 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.04 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.511 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 72.04 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.11 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.33 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.941 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.42 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 74.23 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.425 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 64.13 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 75.22 110.897 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.21 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 71.14 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.03 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.13 109.002 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo . . . . . 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.4 112.629 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.704 0 N-CA-C 110.281 -0.266 . . . . 73.12 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.21 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.41 110.37 -173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.44 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 63.13 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.03 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 74.43 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 44.24 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.45 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.44 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.517 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 72.11 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.21 109.447 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.52 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 75.32 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.4 107.794 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.33 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.35 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.31 109.545 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo . . . . . 0 C--O 1.246 0.906 0 CA-C-O 120.899 0.291 . . . . 71.54 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.495 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 74.23 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 37.27 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.3 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 65.02 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.42 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.12 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 72.34 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.4 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.1 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.464 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.1 107.297 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 . . . . . 0 N--CA 1.436 -1.158 0 N-CA-C 108.665 -0.865 . . . . 74.54 108.665 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.22 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.04 106.86 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.42 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.51 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 72.3 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 65.4 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.52 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 75.11 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.22 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.24 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.54 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.44 114.08 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 65.11 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.23 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.24 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 74.53 109.916 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.53 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 70.22 109.257 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.12 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.45 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.24 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.35 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.44 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.433 ' O ' HG21 ' A' ' 226' ' ' VAL . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.41 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.45 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.44 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.476 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.12 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.04 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.31 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.43 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.45 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.35 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.4 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 73.42 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.52 109.55 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.3 109.964 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.51 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.42 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.42 110.952 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.41 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.03 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.33 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 74.5 112.803 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.14 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 73.14 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 70.14 106.746 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 73.21 113.2 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.44 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.03 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.476 HD13 ' OD1' ' A' ' 222' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 73.33 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 72.45 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.44 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 73.34 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 74.15 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.43 108.517 169.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo . . . . . 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.22 109.428 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.199 -1.408 . . . . 74.42 107.199 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.11 108.319 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.53 111.528 -165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.24 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 75.34 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.14 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.21 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.24 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 75.03 109.179 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.54 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 71.45 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.14 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.31 107.703 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.32 108.295 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 63.13 109.468 178.016 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.241 0.656 0 CA-C-O 120.912 0.297 . . . . 73.31 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.46 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 71.25 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.12 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.4 109.92 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.14 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.02 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.35 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.01 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 74.21 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.04 108.124 -179.248 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.51 -0.588 0 N-CA-C 108.741 -0.837 . . . . 74.15 108.741 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.52 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.31 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.43 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 74.24 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.33 108.557 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.44 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.11 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.11 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 62.11 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 72.03 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.42 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.13 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.14 113.29 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 212' ' ' LEU . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 50.02 111.819 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.44 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 72.45 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.13 111.202 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 206' ' ' ALA . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.52 110.977 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.43 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.01 115.413 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.23 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.01 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.42 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.55 110.667 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.32 110.585 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.47 HG13 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.22 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.515 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.12 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 70.14 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 75.32 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 75.14 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.42 113.783 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.01 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.04 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 74.23 108.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.23 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 73.12 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.01 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.42 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 74.4 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.44 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 71.04 110.472 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.35 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 73.2 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 221' ' ' VAL . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.44 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 73.21 109.687 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.35 110.336 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.51 111.073 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 60.2 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.4 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.04 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.515 HD13 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 64.22 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 75.4 106.882 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.43 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 62.51 107.432 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 75.45 109.822 171.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.8 Cg_endo . . . . . 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.4 112.735 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 120.729 0.3 . . . . 74.21 111.414 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 75.54 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.12 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.52 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 64.43 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.45 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.31 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.33 111.582 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.34 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.31 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.43 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.41 108.999 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 73.22 109.332 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HD3' ' O ' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 70.24 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.24 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.42 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 71.44 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 61.53 105.371 171.229 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 112.515 0.159 . . . . 73.12 112.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.31 109.926 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.11 114.528 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 74.22 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.32 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 73.1 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.25 108.605 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.51 110.075 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.23 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.44 108.174 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.34 107.9 179.002 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 110.421 -0.214 . . . . 74.44 110.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.54 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 70.02 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.54 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.44 109.202 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 65.31 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.23 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.04 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.3 109.915 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.52 106.895 173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.41 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.23 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.01 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.33 111.647 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.02 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.11 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 74.44 110.456 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.01 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 65.31 111.99 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.23 109.787 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 64.44 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.32 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.34 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 73.31 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.13 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.22 110.316 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.21 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.32 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.13 107.278 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.1 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.12 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.32 107.761 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.35 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.34 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.21 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.54 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.55 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.31 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.33 110.6 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 73.3 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.45 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.03 111.201 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.42 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.43 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.33 112.903 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.24 109.321 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 60.13 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.04 110.371 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.52 114.733 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.04 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.32 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.14 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.24 107.305 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 73.2 110.751 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 74.14 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 75.14 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.542 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo . . . . . 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.23 111.653 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.635 -0.876 . . . . 75.55 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.42 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 75.5 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.31 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.23 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 75.11 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 158' ' ' HIS . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.52 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.14 109.178 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.21 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.565 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 71.12 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.434 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 31.9 m170 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.34 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 72.44 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 71.12 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.31 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 64.31 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 71.31 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 52.1 107.61 -179.018 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.697 -1.309 . . . . 73.23 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.02 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.23 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.13 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.24 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 74.23 111.864 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.12 109.558 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.31 111.027 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 52.41 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.42 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.44 108.581 -177.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.887 -1.153 . . . . 74.33 107.887 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 73.34 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.54 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.44 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.53 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 75.12 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.2 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.13 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 72.45 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.34 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.2 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.54 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 62.14 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.01 113.471 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 61.23 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.23 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 60.31 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.422 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 72.21 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.51 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.24 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.51 108.99 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 72.11 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.11 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.34 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.528 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.13 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.24 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.12 110.334 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.53 110.01 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.44 111.687 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.403 HG13 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.13 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.467 ' OD1' HD13 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.55 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 53.45 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.41 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 74.5 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.31 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.463 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' HG3' ' A' ' 233' ' ' GLN . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 74.21 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.24 110.478 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.45 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.33 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 238' ' ' MET . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 63.11 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.22 110.955 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.55 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.43 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.49 ' HE2' HG13 ' A' ' 234' ' ' VAL . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 74.31 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.471 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.22 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 64.4 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.01 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.34 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.31 110.956 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.4 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 74.43 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.53 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.4 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.35 108.72 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 75.33 109.197 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo . . . . . 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.11 112.795 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 111.319 0.118 . . . . 74.55 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.43 107.354 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 53.14 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.42 112.435 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.32 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.42 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 74.24 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.21 112.032 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 64.35 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.52 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.501 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 73.1 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 75.02 111.546 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 73.22 106.741 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 74.51 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 74.01 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.469 ' NH1' ' HB3' ' A' ' 164' ' ' CYS . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.55 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 73.34 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.469 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.42 112.086 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.317 -1.07 . . . . 70.31 109.317 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 245' ' ' LEU . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 62.23 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.425 ' CA ' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 55.32 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 73.42 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.34 107.207 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 74.1 112.424 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.43 108.683 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 45.12 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 72.32 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.41 108.058 -179.173 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 109.882 -0.414 . . . . 60.33 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.55 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.32 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 75.14 107.218 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.14 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.24 111.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.44 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.14 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 72.25 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.42 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 73.13 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 73.23 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.32 113.623 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 74.24 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.04 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.14 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.492 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.2 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 72.31 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.12 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 72.24 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 65.22 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.53 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.1 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.43 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 74.2 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 73.25 109.432 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 73.21 110.544 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 74.02 111.246 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.23 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.582 ' OD1' HD13 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.21 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.25 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.35 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.3 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.43 111.0 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.4 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.02 109.206 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 75.44 110.802 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.14 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 72.23 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.43 111.252 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 73.45 109.061 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.424 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.05 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.31 109.643 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 74.1 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.11 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.54 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.13 110.178 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.582 HD13 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.11 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 70.01 107.944 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 74.14 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 73.32 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.45 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.24 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo . . . . . 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.11 110.427 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.262 0.077 . . . . 54.12 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 74.01 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.32 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.23 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.4 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.34 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.35 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 72.14 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 54.45 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.2 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.532 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.21 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.31 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 75.3 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.02 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.45 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 164' ' ' CYS . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.44 107.966 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.42 110.994 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.242 0.699 0 N-CA-C 111.601 -0.192 . . . . 64.43 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 71.11 109.908 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.22 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.46 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.43 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 71.41 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.43 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.571 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.1 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 73.25 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 71.32 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.405 ' HG ' ' CD ' ' A' ' 217' ' ' GLU . 33.6 t . . . . . 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 61.33 107.497 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.599 -1.26 . . . . 74.34 107.599 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.11 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.32 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.42 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 71.22 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.54 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 71.21 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.31 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.33 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.33 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.33 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 63.21 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 43.3 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 65.23 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 62.21 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.53 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.22 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.13 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 62.24 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 74.52 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.498 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.33 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 74.03 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.42 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.41 113.476 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.02 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.43 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.31 109.438 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.51 110.623 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.35 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.14 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.21 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.1 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 74.1 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.22 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.51 110.827 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 45.05 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.55 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.14 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 74.23 110.256 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 74.11 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.41 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.54 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.32 109.759 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 71.2 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 74.45 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 75.13 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 75.11 112.918 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 63.24 109.77 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.51 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 72.54 109.69 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.51 115.345 -170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.33 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.24 111.342 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.24 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 74.32 108.657 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.22 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 64.14 111.556 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 108.731 -0.84 . . . . 75.21 108.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.1 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.515 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.51 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.53 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.33 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.33 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.11 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.41 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.41 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.516 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 63.15 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 25.6 m170 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 71.22 110.644 176.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.44 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.32 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.34 109.33 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.33 109.196 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 205' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 74.33 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 74.22 110.042 -179.204 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 120.77 0.237 . . . . 65.21 111.636 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 71.12 111.904 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 72.52 114.312 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.2 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.44 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 72.31 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.24 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 75.13 108.774 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 37.72 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.44 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.3 107.883 179.656 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.286 -0.635 . . . . 61.31 109.286 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 74.35 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.21 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.04 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.52 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.43 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.33 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 74.23 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.45 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.41 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 65.32 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.34 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.21 111.679 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.43 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.34 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 73.14 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.44 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.405 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.24 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 72.13 107.524 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.51 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.2 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 74.3 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 71.34 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.45 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 71.22 111.038 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 250' ' ' LYS . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 74.31 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.1 111.231 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 73.44 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.34 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 63.31 107.89 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 73.52 107.072 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.55 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.32 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.44 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 71.51 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 73.23 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 73.34 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.13 110.617 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.33 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 72.41 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 71.2 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.45 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.54 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.407 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.23 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.33 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.04 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.14 111.055 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 65.44 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.11 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.14 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.43 110.504 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.21 106.881 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.32 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.42 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.11 107.894 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.34 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.557 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 72.14 111.32 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 111.641 0.237 . . . . 73.43 111.641 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 74.53 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.31 111.026 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.15 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.12 112.785 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.33 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.13 110.133 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.12 110.661 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.41 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.41 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 73.04 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 75.31 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 73.2 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 74.24 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 74.25 111.874 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 71.22 108.231 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.41 106.976 174.388 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo . . . . . 0 C--O 1.258 1.478 0 CA-C-O 121.019 0.341 . . . . 64.23 112.052 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.46 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 71.3 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.23 116.175 -174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.02 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 75.21 107.155 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.4 111.877 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.44 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 74.42 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.01 108.237 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 119.405 -0.331 . . . . 75.13 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.41 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.43 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.21 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 61.51 108.856 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 54.22 110.92 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.34 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.11 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.04 108.358 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.23 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 72.01 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 64.25 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 75.22 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.21 111.491 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.31 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.439 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.24 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.11 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.23 110.337 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.31 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.44 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.21 113.016 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.23 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.5 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.54 109.454 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.35 110.78 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.33 111.493 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.21 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.515 ' OD1' HD13 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.34 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.23 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.44 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.23 108.895 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.34 112.234 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.11 110.247 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 52.11 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.02 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 65.51 108.892 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.13 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.52 111.676 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.34 111.077 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.31 110.683 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.12 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.53 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.666 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 72.44 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.34 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.53 112.685 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.666 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.1 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.35 110.24 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.44 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.515 HD13 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.21 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.41 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 75.04 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.44 108.42 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.13 107.636 170.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 71.25 108.517 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.896 0 N-CA-C 110.183 -1.167 . . . . 72.31 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -97.63 105.9 18.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.393 0.596 . . . . 75.53 110.98 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 130' ' ' LYS . 71.8 mmtt -118.37 84.16 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 122.089 0.947 . . . . 74.25 111.473 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -96.86 146.67 24.72 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.91 -1.496 . . . . 65.1 108.819 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 132' ' ' LYS . 10.0 mptt -101.3 84.83 2.69 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.323 -1.362 . . . . 74.1 107.323 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.43 114.85 54.84 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.624 -0.716 . . . . 73.04 110.935 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.81 135.05 31.68 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.027 1.818 . . . . 73.22 110.773 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.9 p -77.67 87.16 3.95 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.596 0.713 . . . . 74.23 110.719 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 71.9 mt -84.03 112.57 21.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 114.996 -1.002 . . . . 75.34 111.365 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.1 t -93.01 118.18 30.89 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.314 -1.735 . . . . 62.34 106.314 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -95.34 130.73 31.45 Favored Pre-proline 0 N--CA 1.434 -1.271 0 C-N-CA 119.52 -0.872 . . . . 71.22 110.677 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.93 175.39 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.899 2.399 . . . . 52.25 109.976 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -83.85 86.79 7.11 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.788 0.804 . . . . 75.33 109.541 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -114.31 139.6 49.31 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.308 -1.315 . . . . 54.53 107.576 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.52 17.6 21.85 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.53 0.937 . . . . 73.14 113.53 -173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -126.33 125.52 42.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.935 -0.765 . . . . 75.13 108.935 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 70.3 m -127.78 144.05 51.1 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.689 -0.804 . . . . 74.15 111.79 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.58 135.09 26.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.685 -1.228 . . . . 75.41 107.685 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.3 p -80.77 116.33 20.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.163 -1.051 . . . . 75.24 108.163 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.07 157.84 26.1 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.452 -1.249 . . . . 44.33 109.96 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.13 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 74.42 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.54 111.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.21 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.15 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 72.43 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.42 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.23 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.24 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 75.2 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 73.23 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.51 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 75.33 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.14 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 75.01 109.71 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.24 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 36.5 t -124.61 149.15 47.39 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.34 108.652 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 9.3 mmpt? -79.83 143.68 34.17 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.837 0.827 . . . . 74.14 112.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -123.1 104.03 8.94 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.357 -1.292 . . . . 73.01 108.006 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -92.37 0.39 Allowed Glycine 0 C--N 1.312 -0.774 0 O-C-N 123.722 0.639 . . . . 60.32 112.274 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.5 t -111.92 168.56 9.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.357 -0.609 . . . . 72.43 109.357 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.18 85.87 6.73 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.023 0.916 . . . . 70.44 112.744 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.34 149.26 72.09 Favored Pre-proline 0 C--N 1.29 -1.982 0 CA-C-N 114.443 -1.253 . . . . 75.1 109.14 170.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -53.94 155.4 14.83 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.157 2.572 . . . . 71.12 112.452 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.4 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.54 114.853 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.45 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.34 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.41 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.22 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.02 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.42 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 74.43 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t -104.76 153.18 21.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 75.33 109.088 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.47 120.89 44.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.416 ' NH1' HG21 ' A' ' 185' ' ' THR . 1.4 tmt_? -108.03 124.51 50.29 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.8 -1.926 . . . . 73.41 105.8 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -95.44 129.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.785 -0.45 . . . . 73.44 109.785 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.416 HG21 ' NH1' ' A' ' 183' ' ' ARG . 44.3 p -130.3 -179.66 5.38 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.013 -0.736 . . . . 72.41 109.013 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.77 -16.12 61.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.266 0.555 . . . . 72.13 109.71 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.9 m -80.78 -24.68 38.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.478 -0.783 . . . . 71.45 109.349 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.19 -143.5 14.97 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.976 -0.63 . . . . 62.43 112.249 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.25 117.11 33.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 121.129 0.49 . . . . 74.14 110.448 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.49 146.48 48.03 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 115.668 -0.696 . . . . 74.3 110.364 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.76 143.92 30.35 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.913 -0.585 . . . . 75.24 110.22 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -136.0 151.65 74.16 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.717 -0.475 . . . . 73.02 109.717 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.42 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 72.01 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.42 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 75.11 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.41 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 73.33 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.21 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.31 108.878 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.24 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.04 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.33 111.997 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.01 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 72.11 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 72.34 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.3 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.31 112.323 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.44 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 73.35 109.709 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.01 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.2 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.32 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 73.41 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.621 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.13 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.22 110.199 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.3 110.032 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 75.25 110.751 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.4 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.13 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 37.09 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.11 106.61 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 73.44 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.51 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 75.5 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.13 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 61.43 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 72.12 109.024 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 73.2 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.1 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.32 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 74.24 111.187 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.11 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.4 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.34 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.432 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.55 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.3 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 65.14 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.53 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 75.2 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 165' ' ' LYS . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.23 110.545 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.41 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.24 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 70.04 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.511 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 72.55 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.2 109.207 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.21 107.361 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 71.21 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.621 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo -62.26 132.79 40.33 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 63.31 111.073 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -92.83 -8.42 43.6 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.239 -0.892 . . . . 71.01 109.789 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 56.75 37.95 29.16 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.824 0.821 . . . . 64.13 109.756 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 66.88 67.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.88 -1.509 . . . . 75.53 110.485 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.153 1.381 . . . . 74.11 108.965 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.784 -0.927 . . . . 70.02 110.784 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.4 m -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.969 0.385 . . . . 72.44 110.121 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.61 152.39 27.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.076 0.465 . . . . 63.14 110.624 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.7 m -156.51 145.96 20.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.481 -2.044 . . . . 72.12 105.481 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -67.77 141.44 56.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.538 0.608 . . . . 74.53 110.658 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.74 114.08 64.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 115.977 -0.556 . . . . 73.54 110.626 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.62 38.69 0.58 Allowed 'Trans proline' 0 C--O 1.208 -0.988 0 C-N-CA 123.144 2.563 . . . . 50.33 112.024 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.0 m -76.27 -5.54 47.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.895 0.379 . . . . 55.31 111.089 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.7 pt -129.36 154.76 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 116.111 -0.495 . . . . 74.11 110.512 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 m 72.51 15.14 5.13 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.159 0.983 . . . . 70.41 113.09 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.7 pt -111.97 139.23 22.11 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 110.256 -0.276 . . . . 73.15 110.256 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.91 -159.93 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.747 2.298 . . . . 70.14 110.19 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -74.03 87.05 1.84 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.032 -1.099 . . . . 74.24 108.032 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -93.09 145.33 24.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.042 -0.981 . . . . 61.23 111.151 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.27 4.84 27.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.282 -0.417 . . . . 74.31 111.622 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -88.58 148.05 24.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.353 -0.61 . . . . 75.12 109.353 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.52 129.33 55.57 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.526 -0.916 . . . . 75.15 108.526 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.3 122.14 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.325 0 CA-C-N 115.556 -0.747 . . . . 74.3 109.893 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.3 p -80.14 119.74 23.33 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.356 -1.35 . . . . 50.41 107.356 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.55 154.64 42.4 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.51 111.087 -172.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.14 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.32 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.41 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.42 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 72.52 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.45 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.32 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.584 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.53 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.14 111.244 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.41 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 75.32 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.14 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.486 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p -143.4 142.28 31.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.23 111.249 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -135.25 143.81 46.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.185 -0.672 . . . . 72.01 109.185 171.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -94.82 137.73 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.985 0.421 . . . . 74.42 110.532 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.21 -28.85 12.16 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.381 -0.827 . . . . 52.44 111.359 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.2 m 66.28 160.89 0.14 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.773 0.829 . . . . 74.04 112.474 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 74.76 8.99 4.2 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.612 0.968 . . . . 73.33 113.612 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.0 148.1 37.28 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 107.565 -1.272 . . . . 72.33 107.565 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.69 157.83 30.92 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.391 2.727 . . . . 75.1 111.824 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 71.44 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.32 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.44 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 75.51 107.018 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.41 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.23 109.753 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 50.54 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.1 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t -102.33 143.31 32.24 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.1 107.359 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.49 123.58 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 121.58 0.705 . . . . 64.04 111.119 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -109.61 114.25 27.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.468 -0.938 . . . . 75.45 108.468 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -91.09 121.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.857 -0.424 . . . . 73.0 109.857 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 44.4 p -126.46 176.45 7.15 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.986 -0.552 . . . . 75.13 109.636 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.3 -15.74 63.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.22 0.533 . . . . 73.11 110.591 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 m -89.41 -12.48 40.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.04 -0.527 . . . . 75.4 110.301 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.62 -158.13 21.17 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.644 -0.982 . . . . 72.22 110.644 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.426 ' O ' HD13 ' A' ' 189' ' ' LEU . 3.2 pp -100.13 143.68 30.05 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.297 0.549 . . . . 74.4 112.02 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -115.19 132.82 56.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.738 -0.665 . . . . 61.11 109.384 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.51 125.69 50.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.962 -1.125 . . . . 75.31 107.962 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -131.11 154.02 81.89 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 109.202 -0.666 . . . . 75.34 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.41 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.22 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.51 106.596 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.23 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.34 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.22 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 75.33 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 72.0 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.21 108.601 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.41 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 73.41 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.33 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.23 112.576 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.23 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.01 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.42 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 75.23 110.49 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.41 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.12 112.449 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.22 109.994 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.44 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.32 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 73.51 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.35 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.43 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.41 109.495 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.462 HG23 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 60.44 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.53 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG13 ' SD ' ' A' ' 238' ' ' MET . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.13 108.604 174.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.413 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.43 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.33 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.4 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.1 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.22 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.4 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.21 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.2 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.485 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 64.44 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.13 110.369 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.21 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.485 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.24 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 238' ' ' MET . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.43 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.2 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.15 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.34 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.478 ' HE2' HG13 ' A' ' 234' ' ' VAL . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.15 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 71.54 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.41 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.21 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 74.13 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.43 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.41 108.858 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.413 HD13 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 75.43 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.22 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.33 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.02 108.864 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.1 108.651 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 74.31 108.833 173.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo -59.62 134.31 57.05 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 53.13 111.777 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.72 47.5 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.502 -0.772 . . . . 70.11 109.345 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.93 88.56 0.07 Allowed 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.213 0.945 . . . . 73.4 112.019 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.0 93.32 4.44 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.496 -0.927 . . . . 73.45 108.496 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 . . . . . 0 C--N 1.287 -2.138 0 CA-C-N 114.759 -1.11 . . . . 74.4 110.98 -175.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 111.196 -0.762 . . . . 74.4 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t 71.09 8.47 6.48 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.308 1.043 . . . . 73.5 112.655 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.02 -60.21 1.99 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.096 0.474 . . . . 72.3 110.714 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.4 m -81.39 93.92 6.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.844 -0.616 . . . . 75.14 110.179 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.81 153.84 43.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.386 -0.825 . . . . 74.32 108.792 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.39 112.29 65.39 Favored Pre-proline 0 C--N 1.29 -1.986 0 N-CA-C 107.514 -1.291 . . . . 73.2 107.514 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 108.98 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.315 2.677 . . . . 75.21 112.3 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -151.07 -45.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.224 -0.898 . . . . 74.1 110.867 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt 67.06 98.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.808 -1.087 . . . . 71.44 109.684 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.7 m -77.42 80.32 3.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.603 -0.726 . . . . 74.52 112.563 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.7 pt -114.91 132.09 23.15 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.161 -0.927 . . . . 75.3 109.773 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -92.12 -167.48 0.2 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 122.559 2.173 . . . . 73.14 110.682 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -84.91 77.28 10.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.991 -1.485 . . . . 73.53 106.991 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -144.0 82.66 1.72 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.416 -0.811 . . . . 75.34 109.405 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 63.4 m-85 -135.57 -24.92 1.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.914 0.709 . . . . 64.32 112.914 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -86.55 112.99 22.09 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.341 -1.726 . . . . 75.43 106.341 170.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 66.2 m -110.59 135.63 50.94 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 115.026 1.491 . . . . 74.03 115.026 -167.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.44 139.74 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 73.52 104.833 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 17.6 m -83.84 119.13 24.48 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 117.694 -1.603 . . . . 71.32 109.893 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.34 143.67 26.2 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.31 -1.314 . . . . 61.4 108.878 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.12 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 63.3 111.514 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.43 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.45 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.54 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.571 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 65.24 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.44 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.45 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.551 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 75.3 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.23 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.23 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 74.21 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 146' ' ' SER . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.53 108.779 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 73.23 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.04 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t -122.25 166.55 14.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 75.13 108.691 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 243' ' ' SER . 7.4 ptpp? -127.19 143.22 51.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.086 0.469 . . . . 75.42 112.12 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -108.12 101.23 10.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.296 -0.411 . . . . 74.43 110.964 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.88 -55.32 3.04 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-O 121.613 0.563 . . . . 60.43 112.372 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.7 m -135.69 -178.4 5.11 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.058 -1.46 . . . . 65.41 107.058 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.3 -60.56 2.17 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.516 -0.474 . . . . 75.4 110.918 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 59.92 167.52 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 123.902 0.751 . . . . 74.33 112.339 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.81 155.19 61.25 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.657 1.571 . . . . 74.13 109.129 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 74.33 111.491 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.53 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 72.13 110.079 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.32 106.208 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 73.13 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 74.12 109.574 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.45 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 72.24 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t -103.69 144.18 31.79 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.13 107.415 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.37 115.36 32.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 106.513 -1.662 . . . . 74.11 106.513 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -106.84 131.8 53.53 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 108.092 -1.077 . . . . 75.03 108.092 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.3 113.8 31.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.65 -0.87 . . . . 73.44 108.65 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.8 p -120.84 -178.22 3.68 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.239 -0.652 . . . . 74.15 109.239 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.66 -15.46 60.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.06 -0.719 . . . . 61.45 109.06 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -84.99 -8.59 58.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.335 -0.848 . . . . 62.51 109.365 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.55 -140.89 16.64 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.069 -0.514 . . . . 36.96 112.831 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.17 124.55 45.72 Favored 'General case' 0 CA--C 1.476 -1.884 0 CA-C-O 120.882 0.372 . . . . 74.32 110.583 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.65 136.32 37.35 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.408 -0.815 . . . . 61.23 110.297 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -104.19 127.11 51.77 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.367 -0.533 . . . . 74.21 110.831 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -132.91 156.67 79.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.072 -1.084 . . . . 75.42 108.072 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.4 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.3 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.02 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 64.45 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.44 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.45 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 70.03 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 71.11 107.605 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.23 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.42 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.437 ' HG ' ' OG ' ' A' ' 146' ' ' SER . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.04 113.659 -174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 61.35 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.02 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.31 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 71.03 110.347 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.3 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.11 113.499 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 74.15 111.078 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.33 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 72.4 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.571 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.33 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 73.42 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.448 ' HA ' HG13 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.3 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.33 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.11 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.01 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.11 109.818 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.43 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.32 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.31 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 72.43 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 72.55 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG21 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.43 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.21 111.744 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.42 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 73.11 112.393 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.21 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 60.12 110.266 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.13 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 73.32 108.794 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.461 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 74.13 112.39 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.41 109.3 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 75.03 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.11 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 74.5 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.499 ' HA ' ' HE2' ' A' ' 165' ' ' LYS . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.253 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.05 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.3 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.14 107.373 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.15 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 218' ' ' VAL . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.44 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.462 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 74.43 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.571 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo -61.95 135.69 56.94 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 74.31 109.629 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -34.59 71.36 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.707 -0.679 . . . . 75.23 110.929 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 65.6 11.26 7.35 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.871 0.844 . . . . 70.51 110.308 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -134.06 86.38 2.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.085 -1.82 . . . . 75.55 106.085 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 107.388 -1.338 . . . . 73.2 107.388 -176.197 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.153 0 N-CA-C 110.619 -0.992 . . . . 63.34 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.5 m -79.63 94.83 5.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.196 0.498 . . . . 75.22 110.667 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -120.68 -60.21 1.68 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.738 -0.665 . . . . 72.33 109.378 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.2 m 51.45 72.21 0.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.192 0.933 . . . . 55.33 110.775 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -103.02 137.39 41.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.279 -0.873 . . . . 74.35 111.019 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.13 108.29 54.02 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.67 -1.233 . . . . 75.21 107.67 174.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.28 170.36 14.89 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.499 2.133 . . . . 70.41 111.455 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.9 m -77.13 -22.46 52.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.231 -1.026 . . . . 74.33 108.231 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.7 mt 72.6 114.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 114.372 -1.285 . . . . 70.2 111.757 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 t -80.98 97.16 7.35 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.861 -0.792 . . . . 72.13 108.861 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.58 143.32 67.71 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.452 -0.794 . . . . 72.41 110.155 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.92 113.77 0.65 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.81 3.007 . . . . 74.1 113.53 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -146.07 23.1 1.37 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.907 -0.775 . . . . 73.34 108.907 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.7 ' HB3' ' O ' ' A' ' 143' ' ' ARG . 18.8 m-20 -83.82 133.38 34.75 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.796 -1.093 . . . . 64.3 111.802 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -92.16 -20.04 21.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.593 -1.262 . . . . 70.51 107.593 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.7 ' O ' ' HB3' ' A' ' 141' ' ' ASP . 40.5 ttm180 -120.31 142.57 48.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.251 -2.129 . . . . 72.53 105.251 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.0 t -106.74 128.91 54.61 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.962 -0.755 . . . . 72.23 108.962 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.0 139.11 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 115.052 -0.976 . . . . 71.52 110.758 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -81.45 139.64 35.1 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.815 -1.084 . . . . 73.24 109.594 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 161' ' ' VAL . . . -140.54 153.69 46.25 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 116.242 -0.435 . . . . 62.41 109.84 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 73.1 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 70.02 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.15 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.14 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 53.13 111.8 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.31 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.14 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.536 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.32 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.531 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.1 m170 -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 73.41 108.554 170.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 65.15 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 147' ' ' ALA . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.42 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.411 ' NH2' ' HB3' ' A' ' 164' ' ' CYS . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 74.43 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.22 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.411 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p -116.71 161.03 19.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 75.43 112.285 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.516 ' NZ ' ' HA ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -104.76 144.68 31.41 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 123.411 0.685 . . . . 73.45 109.839 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 168' ' ' SER . 59.2 t-80 -118.26 101.88 8.54 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.832 -0.622 . . . . 63.1 110.163 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -43.52 0.53 Allowed Glycine 0 N--CA 1.467 0.762 0 O-C-N 124.32 1.012 . . . . 63.24 114.398 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 166' ' ' HIS . 53.2 p -142.91 160.5 40.22 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.251 -1.018 . . . . 63.24 108.251 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 1.5 p30 -53.49 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.327 1.017 . . . . 72.04 112.355 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 59.95 161.46 0.1 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 123.318 0.647 . . . . 73.54 111.875 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.85 155.97 64.67 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 122.397 2.065 . . . . 73.44 112.56 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.1 107.947 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.52 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.45 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 75.52 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.05 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 72.13 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 73.41 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.3 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.04 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t -107.51 149.3 28.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 65.13 106.373 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.36 127.32 49.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 119.666 -0.814 . . . . 75.22 111.7 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -110.82 136.0 50.53 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.877 -1.157 . . . . 75.44 107.877 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.6 t -106.68 113.94 44.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.162 -0.615 . . . . 74.12 109.9 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.5 p -110.52 -174.7 2.54 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.076 -0.511 . . . . 74.44 110.497 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.31 71.5 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.899 0.381 . . . . 74.22 111.848 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 p -80.26 -23.52 40.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.038 -0.528 . . . . 73.24 110.517 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.21 -153.65 22.47 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.436 -0.888 . . . . 61.11 111.826 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.47 135.54 34.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.878 -0.415 . . . . 75.12 109.878 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -137.34 146.1 44.17 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.635 -0.876 . . . . 72.53 108.635 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -101.19 125.78 47.84 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.275 -0.57 . . . . 75.41 111.179 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.01 166.05 11.5 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.184 -0.917 . . . . 71.1 108.528 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.54 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.45 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 72.24 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.2 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.21 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 74.45 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.4 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.05 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.33 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.13 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.42 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 64.3 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 71.41 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 75.22 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.21 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.45 111.105 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.43 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 73.33 111.653 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.04 107.901 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 70.52 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 62.1 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.41 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.35 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 73.43 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 71.22 109.467 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 63.22 110.446 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.43 110.865 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 74.15 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 62.23 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 74.3 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.52 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.11 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 71.01 111.301 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.54 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.42 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 72.21 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.33 109.541 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.05 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.44 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.23 112.078 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.42 111.337 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 62.12 110.879 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.11 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.04 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.33 112.666 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 73.12 109.267 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.12 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.44 111.004 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.3 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 73.31 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 62.12 108.411 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.45 110.416 -173.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 72.04 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.51 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.41 108.004 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 159' ' ' ARG . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.05 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 72.21 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo -59.81 134.6 58.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 75.23 110.48 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.75 -0.25 57.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.624 0.726 . . . . 70.33 109.585 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.51 66.72 0.76 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.468 -1.242 . . . . 73.32 108.3 -176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 69.38 -37.83 0.38 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.002 1.321 . . . . 75.13 114.48 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.304 -1.38 0 C-N-CA 122.85 0.46 . . . . 75.2 111.21 -178.176 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.935 -0.866 . . . . 61.13 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.9 m -109.97 -25.3 10.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.484 -0.486 . . . . 72.42 110.525 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 44.48 82.02 0.03 OUTLIER 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.27 1.028 . . . . 75.42 112.33 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -147.15 119.17 8.19 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.308 0.575 . . . . 71.54 112.118 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 127.4 18.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.532 -1.655 . . . . 74.13 106.532 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 109.03 58.68 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 120.123 -0.631 . . . . 73.3 111.335 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.46 -27.66 9.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.779 1.653 . . . . 74.2 109.404 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 m -86.71 84.74 7.32 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.855 -1.066 . . . . 60.44 110.232 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.59 -15.94 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.853 -1.166 . . . . 72.34 107.853 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -45.14 111.09 0.29 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.949 1.7 . . . . 74.22 111.943 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.7 pt -92.66 144.23 28.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.766 -0.652 . . . . 61.34 110.633 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.77 179.01 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.679 1.586 . . . . 74.23 109.351 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -74.94 -22.75 58.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.518 -0.873 . . . . 75.11 109.045 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.0 98.75 8.08 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.744 -1.206 . . . . 73.42 107.744 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -97.83 98.22 9.64 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.141 -0.689 . . . . 74.11 109.141 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -126.77 108.1 10.74 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.923 -1.14 . . . . 62.11 107.923 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.6 p -110.52 143.93 40.13 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.634 -0.506 . . . . 73.22 109.634 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.43 141.2 41.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.351 -0.386 . . . . 72.21 111.689 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 p -71.43 138.19 48.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.141 0.496 . . . . 71.51 110.532 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.6 158.25 43.8 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.522 -0.763 . . . . 72.33 109.583 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.42 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 72.41 110.522 -175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.43 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 73.22 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.1 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.42 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 73.5 111.399 -173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.42 110.528 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 63.02 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.1 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.12 108.824 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 73.04 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 72.11 108.735 174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 73.32 108.939 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.52 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p -118.54 167.97 11.12 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.12 107.346 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -77.91 121.83 24.68 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.212 0.53 . . . . 75.14 111.904 -171.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -136.39 149.93 48.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.967 -1.123 . . . . 74.51 107.967 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 66.68 12.49 59.38 Favored Glycine 0 CA--C 1.519 0.295 0 O-C-N 123.661 0.601 . . . . 74.45 113.815 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m 67.17 -68.81 0.14 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 124.319 1.048 . . . . 72.33 112.595 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -133.4 5.8 3.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 121.536 -0.728 . . . . 73.25 111.867 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -62.83 143.27 97.13 Favored Pre-proline 0 C--O 1.245 0.865 0 CA-C-N 116.536 -0.302 . . . . 75.43 111.443 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.89 156.15 16.2 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 123.652 2.901 . . . . 74.12 112.758 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.04 110.975 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 37.95 114.924 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.41 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.41 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.33 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 74.11 107.937 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.15 109.975 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 73.11 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.534 ' HB ' ' NZ ' ' A' ' 191' ' ' LYS . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 74.11 111.964 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.411 ' HG ' ' CD ' ' A' ' 217' ' ' GLU . 42.2 t -102.52 154.25 19.29 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.35 109.046 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.78 114.5 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.428 -0.952 . . . . 73.14 108.428 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.404 ' HB3' ' HG3' ' A' ' 190' ' ' GLU . 17.0 tpp180 -108.53 125.72 52.13 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.259 -1.015 . . . . 74.34 108.259 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.03 113.82 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.523 -0.547 . . . . 72.4 109.523 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.7 p -115.3 -178.33 3.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.19 -0.459 . . . . 65.55 110.461 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.89 66.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.754 0.312 . . . . 73.04 111.378 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.0 m -83.5 -16.63 44.84 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.883 0.373 . . . . 73.02 110.785 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.02 -154.51 21.93 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.125 -0.79 . . . . 44.2 111.125 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.91 143.58 27.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.584 -0.895 . . . . 63.11 108.584 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.404 ' HG3' ' HB3' ' A' ' 183' ' ' ARG . 10.8 pt-20 -134.14 144.23 48.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.63 -0.508 . . . . 74.35 109.63 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.534 ' NZ ' ' HB ' ' A' ' 180' ' ' THR . 2.0 mmmp? -105.51 126.88 52.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.573 -0.529 . . . . 73.34 109.573 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -134.48 162.44 57.67 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.42 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.15 111.967 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.51 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 74.33 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.54 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 63.2 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 74.04 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.33 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.22 108.811 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.04 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.13 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 37.95 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 65.35 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.45 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.1 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.11 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 64.24 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 73.21 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 72.14 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 75.41 109.62 -176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.41 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.23 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.4 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.574 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.14 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.31 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 73.03 110.366 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.454 HG23 ' HG3' ' A' ' 220' ' ' GLU . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.05 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 71.44 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 54.44 110.812 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 53.55 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 61.11 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.33 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.33 114.275 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.3 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.4 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 74.14 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 74.22 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.45 111.517 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.443 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 61.11 111.073 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.03 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.13 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.33 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.14 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.42 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.42 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 72.3 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.05 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 71.43 107.325 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.536 ' HB3' ' HZ1' ' A' ' 165' ' ' LYS . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.1 113.778 -168.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.54 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.23 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 71.45 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 63.43 108.104 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.21 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.24 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.45 108.704 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.44 106.624 171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo -61.78 134.71 51.85 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.31 111.574 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.77 -9.79 58.9 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.652 -0.87 . . . . 74.11 108.652 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 50.1 t30 70.29 75.8 0.21 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.837 -1.529 . . . . 74.53 111.77 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -89.79 107.69 19.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.024 -1.102 . . . . 74.44 108.024 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 107.738 -1.208 . . . . 65.13 107.738 -177.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 112.328 -0.309 . . . . 74.41 112.328 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -74.3 121.03 20.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.927 -0.768 . . . . 74.41 108.927 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.78 95.95 0.06 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.793 0.806 . . . . 74.41 111.601 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -129.65 157.58 41.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.992 -1.004 . . . . 75.23 108.34 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.62 128.92 33.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.748 -0.381 . . . . 74.03 110.149 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.34 110.47 64.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.785 -0.821 . . . . 55.51 108.785 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.52 -47.22 24.98 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.722 2.282 . . . . 70.4 112.083 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.4 m 55.98 86.38 0.06 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.297 1.039 . . . . 72.03 112.688 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.86 94.27 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.328 -0.99 . . . . 44.43 108.328 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.9 p -151.64 157.14 41.73 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.211 -0.904 . . . . 74.33 110.242 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -95.12 142.74 25.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 109.867 -0.42 . . . . 73.15 109.867 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.15 102.39 0.92 Allowed 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.091 1.86 . . . . 74.4 111.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -85.38 149.26 25.56 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.277 -0.874 . . . . 65.3 109.831 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -136.94 93.84 2.89 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.601 0.715 . . . . 74.32 110.768 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.09 -70.74 0.68 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.423 -1.325 . . . . 72.53 107.423 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -144.75 127.54 16.29 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.523 -0.762 . . . . 73.24 109.907 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 166' ' ' HIS . 27.2 p -115.51 146.45 41.68 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.078 -1.082 . . . . 61.42 108.078 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.71 135.33 35.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.362 0.601 . . . . 74.12 112.027 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.1 p -87.94 119.87 28.71 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.569 -1.271 . . . . 71.31 107.569 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.5 156.64 47.34 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.895 -0.593 . . . . 73.25 111.112 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.22 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.1 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.02 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.1 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.03 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.24 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.35 112.185 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.5 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 65.35 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.539 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.13 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.41 110.265 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.43 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 74.53 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 71.35 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.14 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 74.11 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.69 148.73 40.78 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.8 OUTLIER -89.65 127.94 35.99 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.036 -1.468 . . . . 75.21 107.036 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 168' ' ' SER . 19.5 t-80 -141.93 131.65 24.15 Favored 'General case' 0 CA--C 1.484 -1.58 0 O-C-N 123.0 0.187 . . . . 71.33 110.929 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.77 -47.28 3.48 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.018 -0.833 . . . . 61.01 111.018 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 166' ' ' HIS . 24.5 t 174.41 -175.28 0.08 Allowed 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.426 -1.324 . . . . 72.21 107.426 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.12 83.75 6.7 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.964 0.888 . . . . 61.24 111.127 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.94 156.52 55.11 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.586 -1.188 . . . . 74.53 109.151 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.13 157.16 55.01 Favored 'Trans proline' 0 C--O 1.254 1.325 0 C-N-CA 123.345 2.697 . . . . 74.04 111.692 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 72.03 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.4 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.14 107.914 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 75.21 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.13 110.51 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 63.43 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.41 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t -109.61 149.24 29.98 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.42 108.917 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.94 113.81 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 106.56 -1.644 . . . . 62.12 106.56 174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -108.23 133.32 52.63 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 116.077 -0.511 . . . . 74.5 110.302 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 119.02 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 115.449 -0.796 . . . . 70.32 109.751 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 64.0 p -119.07 -174.8 2.78 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.969 -0.752 . . . . 72.11 108.969 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.257 0.551 . . . . 64.13 109.596 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.6 m -91.02 -17.84 25.6 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.935 -0.575 . . . . 74.54 111.005 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.68 -153.67 20.57 Favored Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 120.286 -0.959 . . . . 74.1 112.457 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.91 134.1 36.64 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 120.815 0.34 . . . . 52.1 110.601 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.32 146.99 45.27 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.631 -0.713 . . . . 64.21 110.571 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.07 125.78 44.65 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.407 -1.331 . . . . 71.41 107.407 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -143.7 150.52 50.7 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 122.175 -0.328 . . . . 73.13 110.471 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.22 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.24 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.4 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.33 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.23 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.45 107.776 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.24 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 73.14 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 71.23 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.15 113.758 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 74.54 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 63.33 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.12 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.11 112.129 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 75.4 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.05 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 71.03 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.24 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.41 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.651 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.42 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.33 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 72.31 110.93 -177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.432 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 74.33 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.32 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 75.43 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 73.42 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.52 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 73.41 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 64.21 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 225' ' ' GLU 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.44 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.54 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.44 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 229' ' ' LYS . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.31 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.508 ' O ' HG21 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 75.34 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.12 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.14 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.33 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.3 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.21 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.21 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 72.12 109.176 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 221' ' ' VAL . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 75.12 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 74.54 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 62.23 110.049 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.23 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 65.3 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.41 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.24 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.22 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.23 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 64.44 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 74.22 108.562 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.432 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.13 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.651 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo -61.16 133.56 47.56 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 73.41 111.964 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -98.39 8.37 44.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.234 0.54 . . . . 72.44 110.091 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -78.66 86.79 4.61 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.736 -1.209 . . . . 73.14 107.736 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.25 116.67 14.06 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.297 -0.865 . . . . 71.15 112.066 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 . . . . . 0 C--N 1.306 -1.301 0 CA-C-N 115.391 -0.822 . . . . 74.31 110.458 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.885 -0.886 . . . . 54.14 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 t -77.09 105.61 8.27 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.168 0.509 . . . . 73.21 109.697 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.74 44.31 2.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.058 0.932 . . . . 71.1 109.05 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 m -62.65 -23.49 67.12 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.824 -1.535 . . . . 72.12 109.346 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.85 123.43 21.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.236 -0.893 . . . . 72.12 109.201 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.42 108.39 61.67 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 109.967 -0.383 . . . . 74.34 109.967 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.27 -2.75 9.42 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.453 2.102 . . . . 71.31 111.109 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m 67.8 18.81 9.7 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.221 1.008 . . . . 63.31 111.883 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.91 -16.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.467 0.651 . . . . 63.24 110.506 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.2 t -107.02 142.87 35.96 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 107.882 -1.155 . . . . 62.33 107.882 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.0 mm -84.43 133.58 44.36 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.121 -1.066 . . . . 75.21 108.121 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -67.69 76.61 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.511 2.141 . . . . 74.12 111.424 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -162.14 24.23 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.017 -2.216 . . . . 72.11 105.017 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.748 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 10.0 t70 -70.5 142.93 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 113.496 -1.684 . . . . 75.51 109.685 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.97 1.14 52.61 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 114.774 1.398 . . . . 65.31 114.774 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.748 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 19.2 ptt180 -91.92 117.02 29.41 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.337 -1.345 . . . . 75.45 110.55 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 40.5 t -110.32 129.43 55.75 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.751 -1.203 . . . . 71.55 107.751 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.74 135.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.043 0.449 . . . . 71.42 111.081 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.2 p -82.15 137.77 34.88 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.803 -0.814 . . . . 72.12 108.803 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 161' ' ' VAL . . . -152.71 154.77 35.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 110.208 -0.293 . . . . 73.43 110.208 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.32 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.517 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 75.53 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 73.21 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 73.13 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.32 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.24 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 72.42 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.23 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.23 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 71.3 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.435 ' CE1' HG23 ' A' ' 219' ' ' ILE . 33.3 m170 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.53 110.017 172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 72.51 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.24 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 147' ' ' ALA . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.2 110.514 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.22 108.987 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 74.11 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 5.6 p -143.24 165.23 28.04 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 168' ' ' SER . 0.1 OUTLIER -108.31 142.36 38.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 120.05 -0.66 . . . . 72.31 110.246 176.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -97.36 98.25 9.81 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.612 -0.722 . . . . 72.41 110.795 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.05 -39.32 2.04 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 121.284 -0.484 . . . . 73.42 113.691 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 165' ' ' LYS . 33.9 m -142.38 151.14 41.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.054 -0.674 . . . . 72.52 111.104 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.99 89.77 1.12 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.864 0.84 . . . . 75.31 112.141 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -80.8 156.63 72.54 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.174 -0.921 . . . . 63.55 109.739 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.51 156.24 61.8 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.635 2.223 . . . . 75.31 108.372 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 172' ' ' LEU . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.45 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.21 115.206 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.13 108.955 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 72.44 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.3 111.23 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.54 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.42 107.953 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.53 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.12 111.164 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t -103.52 142.0 35.04 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 60.41 106.984 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.35 114.58 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.179 -1.415 . . . . 73.54 107.179 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -107.98 118.95 38.09 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.679 -1.146 . . . . 73.32 109.322 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.36 113.42 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 106.763 -1.569 . . . . 54.23 106.763 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -109.42 171.82 7.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 108.941 -0.763 . . . . 71.45 108.941 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.85 63.74 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.106 0.479 . . . . 74.24 109.928 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 m -98.06 -0.69 44.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.689 -0.687 . . . . 64.42 111.143 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.92 -143.97 17.12 Favored Glycine 0 CA--C 1.498 -1.023 0 C-N-CA 120.516 -0.85 . . . . 75.34 112.04 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.66 128.63 39.94 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.567 0.699 . . . . 72.23 112.316 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.75 146.72 49.05 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 114.29 -1.323 . . . . 75.31 108.929 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 191' ' ' LYS . 0.0 OUTLIER -114.71 125.31 53.58 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.623 -1.621 . . . . 75.32 106.623 175.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -136.75 149.87 68.26 Favored Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 120.528 -0.469 . . . . 73.12 110.683 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.43 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 75.14 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 75.33 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.11 109.501 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 62.35 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.3 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 72.11 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 73.35 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.4 ' CG2' ' HA3' ' A' ' 204' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.41 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 65.51 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 37.1 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.4 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.31 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.21 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.32 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.44 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.42 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.24 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 63.35 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 73.12 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 63.1 108.443 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 72.42 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 61.2 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.32 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.131 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.43 110.673 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 158' ' ' HIS . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.24 109.979 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.34 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.22 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 63.55 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.12 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 71.13 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 227' ' ' ALA . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.43 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.44 114.375 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 65.14 109.186 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.13 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 72.22 107.638 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.12 109.585 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 72.04 110.326 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.33 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 62.41 111.864 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.43 111.656 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.41 110.519 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.02 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.11 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.442 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.12 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.24 109.09 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.14 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.41 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.2 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.04 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 72.31 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.13 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 72.13 107.529 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 74.3 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.45 109.386 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 62.05 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo -59.98 134.43 56.52 Favored 'Trans proline' 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.79 -38.04 66.81 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.407 -0.815 . . . . 63.12 112.181 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 t30 49.21 81.35 0.05 Allowed 'General case' 0 C--N 1.347 0.484 0 O-C-N 124.349 1.03 . . . . 72.15 109.328 -171.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.34 -56.79 17.58 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.025 -0.988 . . . . 73.34 111.65 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 123.579 0.751 . . . . 74.22 109.384 176.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.411 0 N-CA-C 110.311 -1.115 . . . . 73.2 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 p -93.38 141.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.949 0.404 . . . . 63.34 112.084 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.71 100.46 3.43 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.695 1.198 . . . . 73.25 107.836 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.2 m -81.11 107.12 13.64 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.25 -0.432 . . . . 73.34 111.041 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 128.99 44.48 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.661 -0.496 . . . . 72.32 109.661 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.21 108.78 57.01 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.745 -0.465 . . . . 64.45 109.745 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.37 115.15 2.24 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.83 2.353 . . . . 74.41 110.761 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -83.71 84.91 7.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.312 0.577 . . . . 64.51 109.666 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.8 138.12 44.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.344 -1.354 . . . . 71.22 107.344 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.9 m -74.19 97.39 2.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.417 0.627 . . . . 74.34 110.569 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 144.01 68.52 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.451 -0.795 . . . . 73.31 110.203 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.85 146.2 93.98 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.461 2.107 . . . . 70.01 111.462 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -95.26 103.24 15.09 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 116.429 -0.351 . . . . 74.03 110.295 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.67 133.2 34.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.705 -0.85 . . . . 73.51 108.705 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -87.22 3.82 45.02 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.192 0.52 . . . . 72.54 110.32 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -75.18 149.0 39.1 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.364 -1.347 . . . . 71.42 107.364 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.5 t -108.43 127.29 53.77 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.819 -1.152 . . . . 75.43 108.662 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.55 141.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.249 -1.389 . . . . 75.45 107.249 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.616 ' OG ' ' HB ' ' A' ' 161' ' ' VAL . 7.7 t -84.92 136.33 33.68 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 107.859 -1.163 . . . . 55.31 107.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.79 147.64 39.52 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.423 -0.954 . . . . 65.33 108.423 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.13 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.32 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 73.02 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.13 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.32 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.21 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.31 112.347 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.14 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 74.53 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.34 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 73.4 108.139 170.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.14 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.43 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.616 ' HB ' ' OG ' ' A' ' 146' ' ' SER . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.51 108.446 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 75.31 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.51 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.02 134.81 52.42 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.33 111.921 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' A' ' 170' ' ' LYS . 68.1 mttm -135.27 143.46 46.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.758 -0.46 . . . . 71.42 109.758 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.48 95.52 5.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.217 0.451 . . . . 75.01 112.217 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.85 -27.94 2.56 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 115.001 0.761 . . . . 71.32 115.001 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.0 t -104.05 133.96 48.13 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.088 0.471 . . . . 74.12 111.488 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.01 80.7 3.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.72 0.771 . . . . 64.3 109.739 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 63.8 mttp -101.23 163.09 18.6 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.286 -0.87 . . . . 73.04 111.144 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.99 156.6 15.26 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 123.058 2.505 . . . . 73.34 112.486 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.52 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.43 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.52 110.787 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.22 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.42 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 71.21 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.01 109.303 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.22 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.12 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t -100.81 145.94 27.91 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 53.2 108.17 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.0 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.771 -0.65 . . . . 62.21 109.699 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -109.97 112.0 23.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.273 -1.01 . . . . 74.31 108.273 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.33 113.7 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.642 -0.503 . . . . 72.35 109.642 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 26.4 p -124.32 -174.32 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.716 -0.674 . . . . 60.24 111.882 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.29 70.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.595 -0.73 . . . . 63.34 111.81 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.3 p -80.7 -24.13 39.07 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.513 . . . . 52.41 110.272 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.77 -145.1 15.62 Favored Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.313 -1.515 . . . . 61.34 109.313 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 189' ' ' LEU . 3.4 pp -92.48 140.27 29.74 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.139 -1.024 . . . . 65.31 109.42 176.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.96 139.2 52.06 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.85 -0.426 . . . . 74.43 109.85 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -99.89 125.38 45.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.054 -1.091 . . . . 73.32 108.054 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 152.25 79.2 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.556 -0.905 . . . . 73.34 108.556 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.3 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.2 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 74.52 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 75.51 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 72.4 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 74.43 107.776 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 74.44 108.853 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.15 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.54 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.21 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.44 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.1 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 63.35 110.686 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.43 108.648 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.24 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 211' ' ' LEU . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.02 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.31 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 72.15 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 72.43 106.943 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.2 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.51 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 65.24 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.15 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.24 108.877 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.488 HG23 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 72.02 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.31 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.51 HG13 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.43 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.1 112.172 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.24 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.11 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.33 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.43 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.32 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.21 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 75.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 74.14 110.095 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 71.31 109.559 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.44 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.02 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.14 111.541 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.42 109.708 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.34 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.3 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.528 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 73.23 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.32 109.159 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 62.41 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 73.41 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.55 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 247' ' ' ILE . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.12 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 74.54 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.22 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.33 108.523 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 75.01 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo -56.35 135.08 68.21 Favored 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.41 111.829 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.5 -27.42 66.98 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.021 -0.991 . . . . 72.22 109.263 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.9 t30 58.7 96.09 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.497 1.123 . . . . 74.41 110.564 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -76.72 101.07 5.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.316 0.579 . . . . 72.11 110.344 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 106.468 -1.678 . . . . 72.03 106.468 -178.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.606 0 N-CA-C 111.162 -0.775 . . . . 74.31 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.6 m -86.32 125.46 33.64 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.2 -0.296 . . . . 72.44 110.2 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -131.4 142.09 49.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.207 -0.664 . . . . 74.55 109.207 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.4 m -91.62 118.69 30.85 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.802 -0.814 . . . . 64.33 108.802 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.19 99.38 7.77 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.519 -0.919 . . . . 74.54 108.519 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 134' ' ' PRO . . . -84.2 112.37 40.73 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 109.049 -0.723 . . . . 70.33 109.049 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 133' ' ' ALA . 9.8 Cg_endo -52.96 113.42 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.767 2.312 . . . . 75.43 111.222 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.5 m -95.54 92.4 6.63 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.302 -0.999 . . . . 71.33 108.302 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -112.73 106.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 115.311 -0.859 . . . . 74.12 110.242 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.2 m -75.82 110.8 10.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.437 -1.32 . . . . 64.14 107.437 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 34.0 pt -80.21 124.68 82.55 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 116.636 -0.256 . . . . 74.41 111.391 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 11.4 Cg_exo -73.54 179.23 5.77 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.715 2.277 . . . . 72.32 112.055 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.56 82.02 7.0 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.77 0.795 . . . . 63.41 111.132 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -167.0 161.43 14.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.395 -2.076 . . . . 74.14 105.395 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.45 87.82 2.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 115.942 1.83 . . . . 73.14 115.942 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 103.01 12.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.203 -2.147 . . . . 72.12 105.203 162.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 58.6 m -113.66 138.15 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.854 -0.739 . . . . 72.12 111.343 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.62 139.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 108.068 -1.086 . . . . 74.41 108.068 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.4 m -92.51 134.69 34.72 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.001 -1.111 . . . . 62.02 108.001 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.71 156.51 46.76 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.454 -0.339 . . . . 71.31 110.794 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.622 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.32 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.41 109.798 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 75.31 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.42 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 63.33 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 74.43 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.41 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.24 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 54.5 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.45 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 71.55 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.622 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.53 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 74.13 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 74.41 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 75.2 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 243' ' ' SER . 36.6 t -132.55 166.72 21.43 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.4 107.564 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.0 OUTLIER -78.0 138.66 38.94 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.638 -1.245 . . . . 74.15 107.638 -176.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -131.75 110.5 10.91 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.114 -0.366 . . . . 74.51 111.976 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.84 -63.89 4.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.39 -0.368 . . . . 64.21 112.985 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.1 t -150.13 -178.79 6.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.614 -1.624 . . . . 75.11 106.614 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.9 82.09 4.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.922 0.868 . . . . 73.53 110.557 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.13 154.35 43.22 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.455 -1.248 . . . . 65.12 110.96 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.99 158.06 56.36 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 123.828 3.019 . . . . 72.52 110.506 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.12 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.35 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.54 109.332 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.55 106.666 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.425 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.14 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.14 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.35 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 71.22 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -103.12 150.08 23.99 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.11 114.71 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.497 -1.297 . . . . 74.1 107.497 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.318 -0.623 . . . . 74.33 109.318 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.12 113.72 30.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.491 -0.559 . . . . 73.52 109.491 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 52.1 p -113.3 -174.15 2.4 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.999 -1.112 . . . . 70.54 107.999 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.02 60.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.187 0.518 . . . . 71.43 109.722 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -84.23 -25.13 29.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.378 0.609 . . . . 65.43 109.712 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.05 -167.96 27.14 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 110.593 -1.003 . . . . 45.44 110.593 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.9 pp -100.54 138.3 37.78 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.442 -0.577 . . . . 75.32 109.442 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.17 146.25 50.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.623 -0.431 . . . . 70.1 110.243 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.75 135.37 38.8 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.319 -1.363 . . . . 53.54 107.319 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.06 155.48 58.62 Favored Pre-proline 0 C--N 1.286 -2.154 0 C-N-CA 120.393 -0.523 . . . . 73.52 110.28 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.24 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.01 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 75.44 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.4 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.34 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 72.21 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.11 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.52 109.71 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.43 107.753 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.23 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.33 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.03 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.419 HD21 ' HG ' ' A' ' 163' ' ' LEU . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.24 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.11 110.426 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 74.44 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 71.4 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 73.02 111.393 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.34 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.21 107.321 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.21 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.31 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.11 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.445 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.23 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 73.11 110.94 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.02 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.39 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 71.21 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.49 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 74.35 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 72.54 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.24 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.3 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.32 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 74.14 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.34 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 72.22 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.43 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.21 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.02 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 65.21 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 74.52 110.404 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 72.55 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.12 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.458 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.22 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.32 109.683 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.2 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.31 111.767 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.04 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.14 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.43 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.42 110.885 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.14 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 75.53 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 61.12 107.688 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.445 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.51 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo -58.28 133.84 57.72 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.33 111.427 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.81 -6.88 57.92 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.214 -0.903 . . . . 72.33 110.352 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 59.91 33.66 21.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.358 1.075 . . . . 70.35 108.637 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.38 89.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.9 -1.5 . . . . 73.4 112.518 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.105 1.762 . . . . 74.21 110.112 176.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 111.208 -0.757 . . . . 75.43 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.1 m -73.43 130.81 40.92 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.751 0.421 . . . . 61.0 109.942 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 11.6 mptt -80.96 78.25 7.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.059 0.933 . . . . 74.05 111.358 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.7 m -162.02 -62.97 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.72 -1.585 . . . . 65.42 106.72 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 56.79 86.33 0.07 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.537 1.135 . . . . 70.04 113.373 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 118.47 60.07 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.462 -0.79 . . . . 71.13 109.726 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.8 -179.27 4.07 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.588 2.192 . . . . 73.25 111.134 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.7 m 68.95 108.77 0.05 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.687 0.795 . . . . 74.44 110.284 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -73.55 94.76 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.542 0.687 . . . . 73.24 110.195 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.6 p -101.35 115.08 29.68 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 115.323 -0.853 . . . . 64.4 110.456 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 142.75 26.28 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 109.094 -0.706 . . . . 64.22 109.094 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.01 117.22 4.05 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.825 2.35 . . . . 65.21 112.796 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -100.9 73.95 1.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.705 -1.22 . . . . 74.32 107.705 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 28.9 t70 -135.42 -168.4 2.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.501 -1.296 . . . . 65.22 107.501 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.489 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 85.0 t80 -83.16 -34.81 25.93 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 119.092 0.86 . . . . 71.43 109.775 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -121.74 148.98 43.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.984 -0.553 . . . . 74.34 110.904 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 32.4 m -125.04 150.44 46.77 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.014 -1.476 . . . . 71.14 107.014 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.81 140.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.522 -0.548 . . . . 62.13 109.522 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.6 t -88.45 138.83 31.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.278 0.561 . . . . 72.52 109.613 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.12 44.66 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.018 -1.105 . . . . 61.14 108.018 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.33 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 65.12 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.12 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.11 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.32 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.4 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.535 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.43 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.05 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 72.2 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.666 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 70.13 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.14 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 74.23 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.55 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.45 108.01 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.34 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.53 129.4 19.44 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.52 108.936 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -138.94 145.14 39.44 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.515 1.126 . . . . 73.44 111.677 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 82.2 m-70 -135.87 160.2 39.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 110.092 -0.336 . . . . 74.24 110.092 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.81 -68.94 2.17 Favored Glycine 0 CA--C 1.509 -0.338 0 O-C-N 123.585 0.553 . . . . 74.14 112.262 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 m -117.74 128.33 54.78 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.198 -1.038 . . . . 75.52 108.198 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -93.97 89.59 6.13 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.557 0.694 . . . . 63.33 111.768 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.26 135.51 94.95 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 75.11 107.696 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.52 156.75 13.5 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.16 2.573 . . . . 74.3 110.391 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 73.21 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.24 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 75.24 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.432 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.43 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.34 111.752 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 75.0 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.33 108.779 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.33 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 73.13 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -103.2 141.86 35.15 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.41 109.123 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -94.11 114.04 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 107.799 -1.186 . . . . 74.14 107.799 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -108.51 120.08 41.38 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.49 -0.777 . . . . 75.0 110.004 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.91 126.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.168 -0.678 . . . . 64.03 109.168 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.5 p -128.47 179.0 5.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.673 -0.862 . . . . 70.02 108.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.36 61.16 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.317 0.58 . . . . 75.22 110.132 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.9 m -87.57 -9.77 53.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.852 -0.613 . . . . 75.32 110.346 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.79 -152.85 17.65 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 109.776 -1.329 . . . . 72.35 109.776 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.35 135.25 42.08 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.174 0.987 . . . . 64.43 111.682 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.99 142.92 49.33 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.915 -1.143 . . . . 73.5 107.915 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -111.86 135.74 52.08 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.5 -0.48 . . . . 73.54 109.707 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.65 156.25 56.32 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.853 -0.612 . . . . 63.22 110.537 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.23 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.03 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 70.51 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 61.44 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.54 108.285 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.05 109.728 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 64.23 108.707 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 73.03 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.23 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.13 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.45 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.52 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.41 107.6 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.1 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 73.3 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 44.24 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.461 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 72.32 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.12 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.41 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.13 114.368 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.55 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.594 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.22 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.22 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.2 110.149 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.469 HG23 ' HG3' ' A' ' 220' ' ' GLU . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 74.25 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.04 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.34 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 64.53 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.43 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 227' ' ' ALA . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.51 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.45 112.493 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.414 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 65.1 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.12 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.22 109.72 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 74.14 110.164 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.32 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.1 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 74.35 111.195 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.22 110.843 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.33 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.24 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.446 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.3 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.54 109.642 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 72.21 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.05 110.8 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 71.42 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.4 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 70.4 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.23 109.3 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.33 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 72.45 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.44 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.448 ' CG2' HD21 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 72.43 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.54 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo -60.75 134.8 56.03 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 75.52 110.855 176.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.84 59.62 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.979 -0.555 . . . . 73.12 110.233 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 54.5 t30 66.63 -177.06 0.2 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 124.275 0.984 . . . . 62.3 108.73 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -80.91 88.8 5.86 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.739 -0.837 . . . . 61.31 108.739 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.213 -1.403 . . . . 73.45 107.213 -178.472 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.469 ' H1 ' ' CD ' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.491 -1.424 0 N-CA-C 110.097 -1.201 . . . . 73.43 110.097 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.7 m -79.22 81.85 5.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 120.536 0.207 . . . . 72.41 111.365 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -175.78 92.97 0.06 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.423 0.689 . . . . 73.32 109.766 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -74.11 107.03 6.06 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.215 -0.448 . . . . 75.3 110.759 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -114.38 145.93 41.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.092 0.472 . . . . 74.44 111.909 -177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.64 108.43 58.11 Favored Pre-proline 0 N--CA 1.422 -1.827 0 N-CA-C 105.538 -2.023 . . . . 61.3 105.538 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.98 -5.96 18.14 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.426 2.084 . . . . 64.01 112.881 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.8 m 57.35 75.35 0.37 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.014 0.912 . . . . 73.52 109.923 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.2 mt -91.49 104.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.82 -1.082 . . . . 75.04 109.554 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 p -70.65 102.04 2.19 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 61.03 110.215 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.5 pt -94.38 137.99 22.55 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.976 -0.556 . . . . 74.41 109.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.65 137.67 65.3 Favored 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 122.538 2.159 . . . . 73.1 111.671 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -82.65 88.26 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.503 -0.925 . . . . 75.12 108.503 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 13.6 t70 -159.09 -179.25 7.85 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.294 -1.743 . . . . 70.03 106.294 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -91.13 -29.68 17.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.172 -0.677 . . . . 75.43 109.172 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.525 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 39.5 ptt180 -75.8 149.12 37.99 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.311 0.577 . . . . 75.03 111.534 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 164' ' ' CYS . 34.8 m -129.84 151.23 50.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.725 0.774 . . . . 64.14 112.949 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.23 139.23 51.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.439 -1.689 . . . . 53.22 106.439 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.0 p -75.35 133.35 41.25 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.045 0.45 . . . . 70.5 110.263 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.06 132.37 54.87 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.769 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.44 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 65.43 112.177 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.54 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.1 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.41 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.21 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.04 110.928 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.43 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.43 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.548 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.3 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.8 m170 -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.1 109.165 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.458 ' HD2' HD13 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.31 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.51 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 74.11 106.685 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.11 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 74.21 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 39.4 t -116.14 133.68 55.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 65.34 106.766 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.556 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 2.5 ttmp? -136.01 125.79 25.62 Favored 'General case' 0 N--CA 1.418 -2.04 0 C-N-CA 120.754 -0.378 . . . . 74.52 111.412 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -134.66 99.15 4.25 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.317 -0.402 . . . . 75.22 110.626 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.26 -52.96 4.73 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.912 -0.586 . . . . 52.13 114.167 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.3 t -86.31 103.86 15.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.117 0.484 . . . . 74.42 111.386 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.75 85.68 3.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.086 0.946 . . . . 73.22 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -103.08 160.17 27.02 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 114.647 -1.161 . . . . 74.54 109.465 174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.45 156.49 13.96 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 123.556 2.838 . . . . 74.42 113.115 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.42 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.21 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.34 112.118 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.14 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.53 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.43 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.03 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 61.41 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 62.13 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t -118.92 151.22 38.54 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 52.1 107.839 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.7 136.82 33.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.463 0.649 . . . . 73.21 111.354 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 190' ' ' GLU . 26.3 mmt180 -115.39 139.46 49.99 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 124.785 1.234 . . . . 75.12 112.425 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.67 118.64 43.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.152 -1.055 . . . . 63.32 108.152 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 60.9 p -133.71 -174.94 3.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.963 -0.384 . . . . 73.03 109.963 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.74 62.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.927 0.491 . . . . 74.14 110.704 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -89.99 -14.88 33.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.154 0.502 . . . . 74.1 109.786 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.22 -122.12 5.21 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.875 -0.89 . . . . 72.1 110.875 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 79.1 mt -100.13 122.91 43.72 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.909 0.862 . . . . 74.51 112.116 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 183' ' ' ARG . 9.9 mm-40 -107.08 147.24 30.24 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.2 -1.364 . . . . 75.44 110.392 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -109.68 133.47 53.09 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.706 -0.85 . . . . 72.14 108.706 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -130.76 151.64 79.15 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 75.32 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.33 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.41 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.54 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.41 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.04 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 71.12 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.2 111.936 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.44 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.55 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.12 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.21 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.452 ' O ' HG21 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.43 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.32 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 74.43 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 205' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.13 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 53.15 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.458 HD13 ' HD2' ' A' ' 159' ' ' ARG . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 75.14 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.42 110.44 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 72.52 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.35 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.12 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 71.13 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.43 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 74.1 110.769 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.469 ' CD ' ' H1 ' ' A' ' 128' ' ' GLY . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.34 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.35 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.579 ' OD1' HD13 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.32 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.31 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.2 110.256 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.34 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.41 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.21 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 75.33 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.42 110.105 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 64.43 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.51 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.33 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.23 111.721 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.13 110.775 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.12 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.33 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.48 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 71.14 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 72.4 109.141 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.3 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 72.03 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.11 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.42 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.55 109.168 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.44 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.579 HD13 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.1 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.42 107.067 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 72.24 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.23 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 75.4 109.054 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.14 108.39 172.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo -64.87 146.98 89.13 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.21 110.783 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.15 -15.67 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.684 -1.228 . . . . 61.25 107.684 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.1 t30 65.41 97.8 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.792 -1.549 . . . . 72.24 112.169 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -92.11 91.26 7.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.42 -0.955 . . . . 74.51 108.42 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 C--O 1.241 0.616 0 C-N-CA 124.092 0.957 . . . . 73.23 110.99 -179.236 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.531 0 N-CA-C 111.327 -0.709 . . . . 62.25 111.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 m -71.44 105.85 3.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.131 0.491 . . . . 73.33 110.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -69.5 146.88 51.54 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 115.331 -0.849 . . . . 74.14 109.168 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 m -77.6 92.37 4.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.411 0.624 . . . . 65.44 110.191 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -134.88 123.0 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.828 -1.545 . . . . 72.1 106.828 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.4 112.66 57.48 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.396 -0.594 . . . . 62.12 109.396 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.424 ' HG3' ' ND2' ' A' ' 244' ' ' ASN . 71.0 Cg_exo -47.23 130.48 17.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 44.24 111.882 176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.3 m -94.17 24.87 4.08 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.27 0.557 . . . . 73.23 110.733 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.79 -42.8 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.314 -0.857 . . . . 74.43 110.057 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.6 m 58.86 81.57 0.16 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.777 1.028 . . . . 65.41 113.777 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.98 142.95 29.23 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 115.13 -0.941 . . . . 75.12 110.588 175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 -55.8 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.629 1.553 . . . . 74.24 109.596 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -138.99 -58.43 0.6 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.249 -1.389 . . . . 70.24 107.249 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.2 t70 69.8 158.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.435 1.494 . . . . 63.41 112.519 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -142.52 -50.03 0.36 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.945 0.402 . . . . 71.35 110.109 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -83.74 138.83 33.09 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.546 -0.752 . . . . 72.45 110.355 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 66.7 m -108.76 140.68 41.84 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 64.1 112.181 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.37 128.88 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 114.225 -1.352 . . . . 75.45 109.295 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -98.58 132.63 43.84 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.507 -1.294 . . . . 75.32 107.507 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.16 155.48 42.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.808 -0.357 . . . . 72.22 111.569 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.34 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 74.11 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.42 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.3 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.3 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 73.34 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.42 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 75.2 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 73.15 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.24 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.33 110.378 171.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.41 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 75.25 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.22 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.51 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.44 109.404 -174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 41.6 t -116.88 150.2 38.83 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.32 111.139 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -132.45 120.24 21.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.681 -0.488 . . . . 72.14 109.681 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -147.45 114.79 6.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.316 0.646 . . . . 73.13 109.828 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.17 -66.59 2.87 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.798 -0.637 . . . . 64.33 112.224 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.1 m -70.57 102.7 2.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 123.657 0.783 . . . . 62.23 111.104 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -103.28 87.44 2.88 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.439 -0.949 . . . . 63.23 108.439 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 9.6 mmpt? -123.33 169.01 10.89 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 107.699 -1.222 . . . . 73.2 107.699 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 9.6 Cg_endo -55.23 156.06 17.86 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.368 2.045 . . . . 61.32 110.0 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.2 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.22 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.1 109.546 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.45 107.463 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.43 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 70.1 109.347 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.51 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.22 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 63.24 108.755 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -103.39 139.08 39.26 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 70.04 108.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.81 114.82 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.805 -1.183 . . . . 73.33 107.805 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -112.3 138.2 49.35 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.288 -0.869 . . . . 73.21 109.934 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.28 113.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 108.428 -0.952 . . . . 72.12 108.428 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.8 p -110.9 -179.91 3.87 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.784 -0.644 . . . . 63.32 109.404 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.57 64.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 74.32 110.941 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.8 m -80.65 -24.26 39.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.23 -0.441 . . . . 63.44 110.159 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 139.84 -165.31 25.93 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.455 -0.658 . . . . 37.23 111.455 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.3 133.33 35.41 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.231 -0.655 . . . . 73.24 109.231 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.26 146.77 42.92 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 116.392 -0.367 . . . . 73.41 111.837 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -95.33 135.47 36.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.114 -1.069 . . . . 73.35 108.114 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.68 151.58 60.58 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 116.74 -0.209 . . . . 74.22 110.99 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.41 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.22 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.41 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 73.11 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 72.44 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.24 109.808 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.22 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 74.55 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.495 ' CG2' ' HA3' ' A' ' 204' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.03 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.4 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.11 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 60.15 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 74.24 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.44 111.835 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.53 109.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.24 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.22 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.43 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.12 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.424 ' CD2' ' HG2' ' A' ' 159' ' ' ARG . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 71.34 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.43 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 70.54 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.44 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.567 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.33 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.12 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 71.44 110.507 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 72.32 110.849 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 74.53 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 75.32 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.4 110.976 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.31 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.4 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 227' ' ' ALA . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 75.32 112.516 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 74.54 114.438 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.14 108.656 177.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG21 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.05 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 75.34 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.42 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 72.04 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.24 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.01 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.55 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.04 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.511 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 72.04 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.11 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.33 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.941 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.42 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 74.23 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.425 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 64.13 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 75.22 110.897 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.21 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 71.14 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.03 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.13 109.002 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.4 112.629 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -112.9 0.67 15.21 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.532 -1.284 . . . . 71.32 107.532 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t30 51.57 -84.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.562 1.545 . . . . 73.1 113.241 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -148.44 109.31 4.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.584 -0.895 . . . . 70.14 108.584 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.53 ' O ' ' HD2' ' A' ' 255' ' ' ARG 0.299 5.8 ppt_? . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 113.157 0.799 . . . . 62.42 113.157 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.321 -1.112 . . . . 74.22 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.7 p -86.1 100.47 12.21 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.262 0.553 . . . . 74.34 110.889 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 8.3 mmpt? -94.57 81.51 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.42 -0.585 . . . . 65.55 109.42 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -134.05 4.83 3.54 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.652 -0.704 . . . . 74.52 110.953 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 68.43 112.26 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.009 0.924 . . . . 65.2 112.26 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.2 113.61 32.52 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.024 -1.102 . . . . 75.11 108.024 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.48 104.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.198 3.265 . . . . 64.24 113.875 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.3 m -136.61 1.12 2.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.426 -0.806 . . . . 63.42 110.666 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.33 95.65 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 110.03 -0.359 . . . . 72.45 110.03 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.3 p -127.1 140.3 52.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.859 -0.61 . . . . 71.43 109.903 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.2 pt -107.46 140.75 21.82 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.547 -0.538 . . . . 71.13 109.547 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.16 165.84 28.9 Favored 'Trans proline' 0 C--O 1.245 0.827 0 C-N-CA 122.703 2.268 . . . . 72.14 111.941 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -69.94 153.6 43.04 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 108.786 -0.82 . . . . 72.15 108.786 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.18 123.42 24.44 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.072 0.939 . . . . 74.03 112.884 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -179.61 -37.94 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 103.594 -2.743 . . . . 71.12 103.594 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -130.91 148.89 52.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 112.51 -2.132 . . . . 73.13 105.861 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 96.5 m -110.38 150.1 29.29 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.411 -0.959 . . . . 65.04 108.411 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.4 p -99.09 123.59 51.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.367 0.603 . . . . 74.24 110.698 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 p -82.0 120.37 25.16 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.79 -1.189 . . . . 62.22 107.79 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.86 154.22 51.74 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.386 -0.525 . . . . 73.12 110.281 -174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.21 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.41 110.37 -173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.44 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 63.13 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.03 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 74.43 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 44.24 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.45 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.44 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.517 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 72.11 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.21 109.447 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.52 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 75.32 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.4 107.794 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.33 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.35 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t -134.57 133.65 40.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.31 109.545 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -133.84 136.12 44.21 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.878 -0.415 . . . . 75.1 109.878 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -147.39 140.55 25.2 Favored 'General case' 0 C--N 1.275 -2.638 0 O-C-N 124.077 0.86 . . . . 75.2 109.276 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.2 -46.35 3.52 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.137 -0.554 . . . . 71.15 112.323 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -135.46 131.02 35.64 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.864 -0.421 . . . . 62.21 109.864 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 242' ' ' SER . 34.6 t70 -99.58 86.39 3.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.771 0.796 . . . . 70.14 109.671 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -94.07 155.66 39.88 Favored Pre-proline 0 C--N 1.277 -2.559 0 CA-C-N 114.655 -1.157 . . . . 75.15 109.199 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.57 156.26 23.02 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.979 2.453 . . . . 71.54 112.695 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 74.23 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 37.27 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.3 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 65.02 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.42 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.12 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 72.34 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.4 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.1 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.464 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t -102.52 153.26 20.24 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.1 107.297 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.77 123.29 58.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.166 0.508 . . . . 70.22 109.852 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -108.59 129.14 55.32 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.907 -1.146 . . . . 75.3 107.907 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.3 113.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.331 -0.618 . . . . 74.23 109.331 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.4 p -120.07 -179.46 3.93 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.498 -0.556 . . . . 65.23 109.498 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.87 -24.25 60.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.171 -0.677 . . . . 64.41 109.171 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.6 p -82.24 -1.7 50.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.705 -0.68 . . . . 51.23 111.161 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 110.21 -147.0 17.32 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.845 -0.616 . . . . 74.51 111.776 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.411 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -83.83 128.47 34.56 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.05 0.452 . . . . 63.01 110.247 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -113.81 143.18 45.09 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.82 -0.627 . . . . 74.24 111.915 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -96.07 125.89 40.93 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 114.464 -1.244 . . . . 75.24 108.37 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.464 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 -134.17 151.89 77.32 Favored Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.665 -0.865 . . . . 74.54 108.665 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.22 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.04 106.86 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.42 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.51 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 72.3 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 65.4 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.52 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 75.11 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.22 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.24 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.54 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.44 114.08 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 65.11 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.23 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.24 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 74.53 109.916 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.475 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.53 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 70.22 109.257 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.12 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.45 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.24 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.35 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.44 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.433 ' O ' HG21 ' A' ' 226' ' ' VAL . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.41 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.45 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.44 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.476 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.12 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.04 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.31 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.43 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.45 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.35 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.4 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 73.42 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.52 109.55 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.3 109.964 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.51 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.42 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.42 110.952 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.41 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.03 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.33 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 74.5 112.803 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.14 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 73.14 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 70.14 106.746 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.496 ' HB3' ' OD1' ' A' ' 169' ' ' ASP . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 73.21 113.2 -170.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.44 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.03 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.476 HD13 ' OD1' ' A' ' 222' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 73.33 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 72.45 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.44 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 73.34 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 74.15 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.43 108.517 169.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo -62.85 134.01 44.63 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.22 109.428 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -81.42 -9.48 59.72 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.858 -0.423 . . . . 64.11 109.858 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 73.45 -39.56 0.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.233 1.413 . . . . 73.21 110.126 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 252' ' ' ALA . 34.9 tt0 -73.24 94.3 1.97 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.266 -1.383 . . . . 74.13 107.266 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.999 -1.852 . . . . 74.1 105.999 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.282 0 N-CA-C 110.676 -0.97 . . . . 72.22 110.676 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -71.96 118.55 14.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.476 -0.564 . . . . 73.54 109.476 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.478 ' HZ2' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -163.36 179.04 7.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 105.633 -1.988 . . . . 75.24 105.633 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 130' ' ' LYS . 48.8 m -52.77 121.81 7.93 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.148 0.499 . . . . 71.11 110.244 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 112.85 5.22 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.041 -0.981 . . . . 72.11 112.88 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.88 109.6 59.28 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.28 -25.73 76.84 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.892 2.395 . . . . 74.1 111.761 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t 61.59 74.31 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.332 1.053 . . . . 74.41 111.152 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.1 mt -102.96 101.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 115.107 -0.951 . . . . 74.41 108.462 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -108.06 109.63 21.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.223 -0.658 . . . . 75.1 109.223 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.11 143.69 29.27 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 116.121 -0.491 . . . . 73.43 111.437 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.47 119.94 7.52 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.957 1.771 . . . . 73.43 109.992 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -80.85 83.93 6.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.284 0.846 . . . . 74.01 113.284 -176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.9 85.71 3.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.506 -1.294 . . . . 72.42 107.506 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -163.06 149.03 12.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.608 -1.256 . . . . 74.44 107.608 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -82.75 102.58 11.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.407 -0.917 . . . . 75.34 109.119 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.1 t -110.88 129.22 55.93 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.318 -1.364 . . . . 61.1 107.318 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.82 130.73 51.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.418 0.627 . . . . 74.05 111.392 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.1 m -77.33 117.72 19.11 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.963 0.887 . . . . 61.1 109.654 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.1 158.46 30.62 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.017 -1.447 . . . . 74.42 107.199 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.11 108.319 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.53 111.528 -165.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.24 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 75.34 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.14 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.21 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.24 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 75.03 109.179 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.54 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 71.45 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.14 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.31 107.703 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.32 108.295 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.07 135.54 53.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 63.13 109.468 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -86.34 142.76 28.25 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.185 -1.043 . . . . 74.34 108.185 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -129.95 110.04 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.101 0.408 . . . . 74.33 112.101 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.49 -73.99 2.43 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 116.088 -0.505 . . . . 72.42 113.511 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -136.67 176.4 8.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.79 -0.448 . . . . 65.02 109.79 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -77.87 80.34 4.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.636 0.731 . . . . 71.41 111.888 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -98.4 152.73 38.08 Favored Pre-proline 0 C--N 1.291 -1.938 0 CA-C-N 114.838 -1.074 . . . . 75.23 110.333 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.31 156.97 15.41 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.701 2.934 . . . . 73.31 112.412 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.46 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 71.25 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.12 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.4 109.92 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.14 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.02 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.35 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.01 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 74.21 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -109.33 146.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.04 108.124 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.83 129.43 45.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.39 0.614 . . . . 74.11 110.616 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -122.77 124.55 43.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.301 -1.0 . . . . 75.34 108.301 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.66 121.35 49.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.526 -0.47 . . . . 74.13 110.871 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 24.5 p -115.5 -178.98 3.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.652 -0.704 . . . . 72.24 109.884 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.74 65.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 73.45 111.322 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.4 p -81.79 -18.85 42.67 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.984 0.421 . . . . 72.33 110.901 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.36 -166.86 25.68 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.824 -0.91 . . . . 73.34 110.824 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.88 139.98 33.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.927 -0.709 . . . . 71.33 110.596 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.96 146.26 47.32 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -111.83 125.44 54.01 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.126 -1.065 . . . . 65.41 108.126 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -133.44 155.28 80.86 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.741 -0.837 . . . . 74.15 108.741 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.52 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.31 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.43 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 74.24 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.33 108.557 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.44 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.11 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.11 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 62.11 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 72.03 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.42 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.13 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.14 113.29 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 212' ' ' LEU . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 50.02 111.819 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.44 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 72.45 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.13 111.202 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 206' ' ' ALA . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.52 110.977 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.43 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.01 115.413 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.23 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.01 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.42 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.55 110.667 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.32 110.585 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.47 HG13 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.22 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.515 ' OD1' HD13 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.12 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 70.14 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 75.32 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 75.14 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.42 113.783 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.01 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.04 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 74.23 108.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.23 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 73.12 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.01 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.42 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 74.4 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.44 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 71.04 110.472 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.35 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 73.2 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 221' ' ' VAL . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.44 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 73.21 109.687 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.35 110.336 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.51 111.073 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 60.2 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.4 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.04 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.515 HD13 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 64.22 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 75.4 106.882 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.43 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 62.51 107.432 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 75.45 109.822 171.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.8 Cg_endo -59.65 134.46 57.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.4 112.735 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -83.14 -5.28 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.76 -1.109 . . . . 53.25 109.367 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 47.8 t30 76.49 141.39 0.07 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.936 1.294 . . . . 72.51 110.987 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -76.58 93.96 3.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.763 0.792 . . . . 75.14 109.718 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? . . . . . 0 C--N 1.298 -1.639 0 CA-C-N 114.982 -1.008 . . . . 63.35 113.053 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.674 0 N-CA-C 110.892 -0.883 . . . . 44.2 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.3 p -107.54 172.06 7.04 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.783 -0.451 . . . . 71.32 109.783 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -88.21 76.77 8.39 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.336 -0.987 . . . . 73.34 108.336 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.4 m 73.33 -51.67 0.7 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.767 1.227 . . . . 75.33 109.124 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -140.24 161.35 37.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.979 -1.86 . . . . 74.55 105.979 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.9 115.18 63.29 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 108.084 -1.08 . . . . 73.43 108.084 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.57 112.3 1.21 Allowed 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.543 2.162 . . . . 73.54 111.801 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.0 m 66.01 84.82 0.15 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.738 -1.119 . . . . 75.01 111.044 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.26 100.55 5.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.394 0.616 . . . . 74.32 109.453 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 92.4 7.74 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.243 -0.89 . . . . 72.01 110.542 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -114.85 140.61 25.67 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 106.823 -1.547 . . . . 74.3 106.823 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.21 148.52 85.62 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.136 1.891 . . . . 54.51 110.308 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.82 109.61 2.96 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.086 -0.646 . . . . 73.43 109.637 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.89 141.8 53.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.228 -0.896 . . . . 74.22 112.737 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -137.02 -35.82 0.69 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.253 -1.017 . . . . 65.45 108.253 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 5.7 mpt_? -103.0 146.94 27.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.972 -1.862 . . . . 75.43 105.972 172.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 166' ' ' HIS . 89.5 m -112.58 151.15 30.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 113.937 1.088 . . . . 64.42 113.937 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.58 134.55 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.721 -1.127 . . . . 63.14 109.288 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 p -85.77 127.25 34.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.41 -0.959 . . . . 64.0 108.41 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.68 154.33 43.4 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.92 -0.712 . . . . 74.21 111.414 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 75.54 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.12 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.52 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 64.43 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.45 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.31 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.33 111.582 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.34 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.31 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.43 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.41 108.999 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 73.22 109.332 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HD3' ' O ' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 70.24 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.24 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.42 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 71.44 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 35.0 t -129.55 139.16 51.59 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 61.53 105.371 171.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.429 ' CE ' ' HB2' ' A' ' 242' ' ' SER . 24.3 ttmm -130.27 120.71 24.85 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 114.131 1.159 . . . . 74.04 114.131 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.634 ' HD2' ' SG ' ' A' ' 144' ' ' CYS . 78.6 m-70 -145.73 130.99 18.5 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.848 -1.069 . . . . 61.23 108.58 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.41 -57.67 4.92 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 116.299 -0.409 . . . . 74.33 112.775 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.5 m -89.33 94.37 9.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.148 0.499 . . . . 53.12 111.673 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 9.3 p-10 -83.86 19.25 1.76 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.963 0.905 . . . . 54.44 111.535 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -86.22 161.94 47.64 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.708 -0.678 . . . . 70.24 112.316 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -49.92 159.58 1.62 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 125.083 3.855 . . . . 73.12 112.515 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.31 109.926 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.11 114.528 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 74.22 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.32 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 73.1 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.25 108.605 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.51 110.075 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.23 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.44 108.174 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -103.9 148.77 25.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.34 107.9 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.8 p -101.22 125.89 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-O 121.545 0.688 . . . . 54.45 109.361 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -107.71 115.16 29.64 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.799 -0.815 . . . . 74.13 108.799 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.5 t -88.89 113.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.115 -0.698 . . . . 71.14 109.115 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.4 p -125.59 -174.42 3.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.898 -0.592 . . . . 71.31 110.629 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -18.34 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.126 0.488 . . . . 73.51 110.394 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 m -80.63 -23.5 39.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.388 -0.597 . . . . 64.12 109.388 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.81 -124.49 4.85 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.655 -1.378 . . . . 71.25 109.655 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.32 136.13 40.69 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.372 -0.531 . . . . 71.31 110.193 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.73 133.24 49.53 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.5 -0.926 . . . . 75.01 108.5 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.69 137.17 37.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.04 -0.726 . . . . 74.31 109.04 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.1 148.38 51.47 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.421 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.54 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 70.02 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.54 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.44 109.202 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 65.31 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.23 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.04 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.3 109.915 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.52 106.895 173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.41 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.23 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.01 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.33 111.647 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.02 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.11 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 74.44 110.456 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.01 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 65.31 111.99 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.23 109.787 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 64.44 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.32 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.34 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 73.31 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.13 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.22 110.316 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.21 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.32 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.13 107.278 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.1 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.12 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.32 107.761 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.35 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.34 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.21 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.54 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.55 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.31 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.33 110.6 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 73.3 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.45 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.03 111.201 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.42 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.43 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.33 112.903 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.24 109.321 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 60.13 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.04 110.371 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.429 ' HB2' ' CE ' ' A' ' 165' ' ' LYS . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.52 114.733 -174.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.04 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.32 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 162' ' ' ARG . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.14 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.24 107.305 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 73.2 110.751 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 74.14 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 75.14 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.542 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo -73.28 134.5 21.06 Favored 'Trans proline' 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.23 111.653 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.38 -9.67 32.17 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.286 -1.746 . . . . 54.21 106.286 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.1 t30 67.99 -107.07 0.09 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.594 -2.094 . . . . 74.54 111.996 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.64 1.18 0.39 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.183 0.992 . . . . 73.54 111.541 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 . . . . . 0 N--CA 1.423 -1.79 0 C-N-CA 123.853 0.861 . . . . 74.24 110.046 -171.799 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 111.575 -0.61 . . . . 61.42 111.575 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.4 m -101.85 -11.14 19.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.181 0.515 . . . . 73.43 111.153 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -93.41 -13.4 28.04 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.315 0.578 . . . . 73.41 109.94 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.6 p -79.02 132.49 36.66 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.539 -0.755 . . . . 62.13 110.709 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 136.06 37.17 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.771 -1.196 . . . . 72.05 107.771 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.11 109.34 63.1 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 112.183 0.438 . . . . 71.54 112.183 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.99 -0.08 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.162 1.908 . . . . 75.12 109.796 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m 70.2 -76.95 0.06 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.382 1.473 . . . . 75.33 112.696 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.8 mt 53.77 71.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.332 1.063 . . . . 71.55 108.723 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 m -144.77 177.37 8.76 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.813 -1.085 . . . . 65.13 108.82 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.95 116.81 65.64 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.55 -1.648 . . . . 74.33 106.55 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.45 19.01 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.596 0 C-N-CA 123.094 2.529 . . . . 73.12 114.06 -173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 72.43 127.9 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.314 1.046 . . . . 75.4 112.368 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -170.1 153.36 4.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.418 -2.067 . . . . 74.32 105.418 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.4 -25.77 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.336 -0.616 . . . . 70.31 109.336 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -131.95 111.49 11.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.932 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.0 t -111.65 162.26 15.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.214 -1.032 . . . . 61.12 108.214 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -99.2 125.77 52.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.836 0.827 . . . . 62.4 111.677 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 7.7 p -102.16 117.97 35.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.681 -1.145 . . . . 62.54 109.263 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.07 161.5 42.42 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.635 -0.876 . . . . 75.55 108.635 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.42 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 75.5 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.31 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.23 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 75.11 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 158' ' ' HIS . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.52 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.14 109.178 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.21 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.565 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 71.12 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.434 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 31.9 m170 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.34 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 72.44 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 71.12 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.31 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 64.31 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 71.31 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t -135.95 167.47 21.15 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 52.1 107.61 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.735 ' HE2' ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -78.08 142.28 38.24 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.542 1.163 . . . . 72.41 114.135 -169.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.26 97.76 3.8 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.299 -1.773 . . . . 73.42 106.253 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.0 -66.58 3.84 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.462 -1.055 . . . . 74.15 110.462 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.4 m -139.55 -178.01 5.2 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.79 -1.189 . . . . 63.45 107.79 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.7 -53.41 22.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.361 -0.607 . . . . 74.2 109.361 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 65.56 160.08 0.13 Allowed Pre-proline 0 N--CA 1.478 0.946 0 O-C-N 124.508 1.13 . . . . 73.45 111.525 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.54 152.02 81.66 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 121.338 1.359 . . . . 73.23 108.697 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.02 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.23 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.13 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.24 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 74.23 111.864 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.12 109.558 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.31 111.027 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 52.41 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.42 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t -103.2 143.2 32.94 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.44 108.581 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.33 114.72 33.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.676 -1.231 . . . . 75.31 107.676 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -108.25 119.27 38.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.966 0.412 . . . . 74.52 110.025 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 p -93.68 126.41 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.623 -0.717 . . . . 73.35 110.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 56.1 p -131.51 -179.09 5.16 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.5 -0.773 . . . . 74.41 109.628 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.71 -16.12 60.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.402 0.62 . . . . 72.44 109.777 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.1 m -90.73 -4.59 56.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.388 -0.824 . . . . 65.13 110.17 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.59 -156.9 15.47 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.738 -0.945 . . . . 75.4 110.738 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.78 136.88 39.94 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 117.712 0.756 . . . . 64.43 111.586 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.3 146.39 50.04 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.46 -0.57 . . . . 75.31 109.46 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -92.07 134.19 35.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.19 162.76 55.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.887 -1.153 . . . . 74.33 107.887 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 73.34 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.54 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.44 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.53 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 75.12 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.2 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.13 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 72.45 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.34 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.2 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.54 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 62.14 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.01 113.471 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 61.23 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.23 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 60.31 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.422 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 72.21 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.51 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.24 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.51 108.99 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 72.11 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.11 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.34 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.528 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.13 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.24 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.12 110.334 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.53 110.01 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.44 111.687 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.403 HG13 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.13 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.467 ' OD1' HD13 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.55 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 53.45 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.41 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 74.5 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.31 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.463 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' HG3' ' A' ' 233' ' ' GLN . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 74.21 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.24 110.478 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.45 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.463 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.33 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 238' ' ' MET . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 63.11 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.22 110.955 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.55 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.43 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.49 ' HE2' HG13 ' A' ' 234' ' ' VAL . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 74.31 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.471 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.22 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 64.4 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.01 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.34 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.465 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.31 110.956 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.4 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 74.43 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.53 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.4 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.35 108.72 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 75.33 109.197 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo -59.69 134.57 58.42 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.11 112.795 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -116.94 12.8 14.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.959 -1.018 . . . . 62.15 109.034 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 59.1 t30 72.46 138.98 0.05 Allowed 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.817 1.323 . . . . 73.04 110.672 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -82.11 74.48 9.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.545 0.688 . . . . 75.42 111.268 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.306 1.443 . . . . 63.22 108.241 178.582 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 110.375 -1.09 . . . . 53.4 110.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.9 m -81.64 98.01 8.16 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 117.298 0.549 . . . . 74.52 111.073 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.48 97.26 6.06 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.885 -0.598 . . . . 72.32 110.853 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -148.4 88.04 1.62 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.45 0.643 . . . . 65.12 111.651 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.67 68.81 0.75 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.013 -1.106 . . . . 64.23 108.013 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 113.36 56.47 Favored Pre-proline 0 N--CA 1.417 -2.104 0 CA-C-N 113.942 -1.481 . . . . 74.42 109.811 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.39 112.09 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 63.21 110.585 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.4 p -123.83 34.11 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.22 1.01 . . . . 75.34 108.629 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.4 mt -77.61 -25.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.106 -1.406 . . . . 74.35 108.725 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.7 t 70.41 -164.28 0.16 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.571 -1.27 . . . . 72.31 107.571 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -79.15 115.88 56.03 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.731 -0.84 . . . . 75.45 108.731 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.32 80.31 3.12 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.691 2.26 . . . . 63.3 114.017 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -154.82 136.66 14.5 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 105.67 -1.974 . . . . 72.22 105.67 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.66 86.47 7.12 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.145 -1.022 . . . . 63.34 112.017 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -143.87 -51.92 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.053 -1.43 . . . . 74.42 108.262 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -142.78 142.25 31.86 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.017 -0.992 . . . . 73.23 109.838 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.2 t -145.68 137.67 25.38 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.588 -0.893 . . . . 73.24 108.588 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.86 139.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 113.072 0.767 . . . . 75.14 113.072 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 p -92.75 127.91 38.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.219 -1.03 . . . . 61.42 108.219 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.32 155.99 48.78 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.71 -0.223 . . . . 74.55 111.319 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.43 107.354 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 53.14 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.42 112.435 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.32 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.42 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 74.24 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.21 112.032 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 64.35 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.52 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.501 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 73.1 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 75.02 111.546 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 73.22 106.741 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 74.51 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 74.01 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.469 ' NH1' ' HB3' ' A' ' 164' ' ' CYS . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.55 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 73.34 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.469 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p -128.36 166.22 19.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.42 112.086 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.5 tpmt? -79.86 142.22 35.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.341 -0.845 . . . . 70.51 110.007 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -131.31 160.59 34.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.56 -1.274 . . . . 74.13 107.56 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.67 62.09 0.47 Allowed Glycine 0 CA--C 1.522 0.479 0 O-C-N 123.934 0.771 . . . . 37.25 113.126 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 t 179.85 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.405 -1.702 . . . . 72.3 106.405 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.2 85.65 7.17 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.852 0.834 . . . . 72.33 111.192 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.88 163.13 17.99 Favored Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 114.245 -1.343 . . . . 70.35 109.823 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -65.37 157.78 56.14 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.02 2.48 . . . . 70.31 109.317 170.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 245' ' ' LEU . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 62.23 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.425 ' CA ' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 55.32 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 73.42 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.34 107.207 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 74.1 112.424 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.43 108.683 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 45.12 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 72.32 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t -103.39 138.78 39.67 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.41 108.058 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.35 114.84 35.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.709 -0.848 . . . . 75.34 108.709 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -108.34 133.38 52.63 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.941 -0.572 . . . . 74.11 110.038 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.57 119.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 108.833 -0.803 . . . . 74.32 108.833 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.1 p -118.63 -178.86 3.64 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.992 -0.744 . . . . 74.12 108.992 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.35 60.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.326 0.584 . . . . 71.15 110.196 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.9 m -85.79 -23.1 27.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.489 -0.778 . . . . 62.31 110.214 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.85 -137.21 9.08 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 110.93 -0.868 . . . . 74.15 110.93 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 61.8 mt -101.45 143.21 31.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 113.123 0.786 . . . . 74.51 113.123 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -137.41 140.15 41.15 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 114.794 -1.094 . . . . 72.11 108.795 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -113.64 125.78 54.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 119.923 -0.711 . . . . 74.44 110.219 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.07 141.0 37.26 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.292 -0.867 . . . . 60.33 109.882 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.55 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.32 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 75.14 107.218 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.14 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.24 111.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.44 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.14 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.414 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 72.25 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.42 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 73.13 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 73.23 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.32 113.623 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 74.24 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.04 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.14 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.492 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.2 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 72.31 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.12 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 72.24 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 65.22 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.53 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.1 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.43 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 74.2 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 73.25 109.432 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 73.21 110.544 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 74.02 111.246 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.23 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.582 ' OD1' HD13 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.21 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.25 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.35 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.3 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.43 111.0 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.4 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.02 109.206 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 75.44 110.802 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.14 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 72.23 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.43 111.252 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 73.45 109.061 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.424 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.05 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.31 109.643 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 74.1 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.11 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.54 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.13 110.178 177.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.582 HD13 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.11 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 70.01 107.944 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 74.14 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 73.32 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.45 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.24 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo -66.95 133.07 29.99 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.11 110.427 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.99 -2.76 52.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.212 -1.033 . . . . 73.0 108.212 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -87.71 80.1 8.02 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.519 -1.218 . . . . 71.43 108.37 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -119.63 89.53 3.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.316 -1.311 . . . . 75.45 108.564 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 104.877 -2.268 . . . . 74.51 104.877 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.755 -0.938 . . . . 61.43 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 m -87.55 -35.29 18.23 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.903 0.352 . . . . 75.51 110.23 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 58.72 82.42 0.14 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.979 -1.009 . . . . 74.41 108.871 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 t -73.25 103.41 3.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.97 0.891 . . . . 72.31 111.873 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 134' ' ' PRO . 5.9 mmpt? -102.31 -19.71 14.9 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.371 -0.831 . . . . 73.02 109.976 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.94 109.29 14.41 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 109.163 -0.68 . . . . 72.12 109.163 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 55.5 Cg_endo -75.71 139.73 22.81 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.45 2.1 . . . . 64.42 111.729 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 p -78.75 -19.95 51.08 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.501 0.667 . . . . 50.12 109.981 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.66 100.21 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.268 -0.878 . . . . 75.25 110.427 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.3 t -153.04 122.53 6.75 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.412 -1.699 . . . . 73.21 106.412 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.84 143.57 58.31 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 112.776 0.658 . . . . 71.33 112.776 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.65 110.25 0.7 Allowed 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.844 2.363 . . . . 74.22 111.504 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -134.24 19.81 3.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.826 -0.624 . . . . 63.32 110.862 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.17 71.8 4.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.959 0.885 . . . . 72.52 111.062 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.74 -24.97 14.83 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.732 -1.951 . . . . 75.11 105.732 171.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -116.88 148.59 41.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.36 -1.746 . . . . 74.31 106.468 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 4.0 t -109.35 128.43 55.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 104.189 -2.523 . . . . 71.4 104.189 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.96 127.76 67.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 114.527 1.306 . . . . 44.1 114.527 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.9 p -98.97 122.09 41.78 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.463 -1.244 . . . . 74.4 107.95 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.52 156.57 42.62 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.84 0.087 . . . . 54.12 110.873 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 74.01 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.445 ' H ' ' CD1' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.32 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.23 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.4 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.34 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.35 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 72.14 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 54.45 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.2 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.532 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.21 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.31 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 75.3 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.02 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.45 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 164' ' ' CYS . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.44 107.966 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p -129.9 162.61 28.2 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.42 110.994 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 242' ' ' SER . 33.7 mmtp -118.15 138.72 52.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 121.505 0.669 . . . . 74.43 111.56 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -146.46 96.84 2.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.692 -1.596 . . . . 73.44 106.692 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.29 -31.69 7.44 Favored Glycine 0 C--N 1.295 -1.71 0 N-CA-C 107.677 -2.169 . . . . 44.14 107.677 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.3 m 62.37 175.55 0.14 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 115.092 1.515 . . . . 71.02 115.092 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.274 3.4 m-20 64.53 -0.21 0.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.784 1.772 . . . . 63.51 115.784 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.67 128.57 76.78 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.727 -0.842 . . . . 75.35 108.727 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.27 155.46 29.64 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.131 2.554 . . . . 64.43 111.601 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 71.11 109.908 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.22 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.46 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.43 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 71.41 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.43 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.571 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.1 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 73.25 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 71.32 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.405 ' HG ' ' CD ' ' A' ' 217' ' ' GLU . 33.6 t -103.43 146.17 28.9 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 61.33 107.497 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.5 123.82 61.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.06 0.457 . . . . 71.33 110.143 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.512 ' HB2' ' OE1' ' A' ' 192' ' ' GLN . 30.4 tpt180 -112.51 128.84 56.46 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.498 -0.556 . . . . 73.25 109.498 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.62 113.39 29.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.068 -0.716 . . . . 75.33 109.068 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 47.6 p -119.86 -177.34 3.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.03 -0.73 . . . . 75.21 109.03 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.28 -15.33 61.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.331 0.586 . . . . 73.42 109.871 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -82.23 -14.6 55.28 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.597 -0.728 . . . . 71.34 109.465 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.59 -147.95 17.69 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 109.975 -1.25 . . . . 52.14 109.975 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.58 124.24 41.76 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.794 0.797 . . . . 74.12 110.191 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.5 146.62 47.94 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.821 -0.627 . . . . 75.53 110.888 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.37 137.2 37.42 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.974 -0.557 . . . . 72.12 110.978 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 46.5 mt-30 -121.6 153.58 59.54 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 107.599 -1.26 . . . . 74.34 107.599 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.11 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.32 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.42 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 71.22 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.54 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 71.21 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.31 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.33 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.33 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.33 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 63.21 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 43.3 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 65.23 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 62.21 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.53 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.22 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.13 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 62.24 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 74.52 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.498 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.33 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 74.03 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.42 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 0.8 OUTLIER -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.41 113.476 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.02 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.43 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.31 109.438 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.51 110.623 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.35 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.14 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.21 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.1 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 74.1 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.22 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.51 110.827 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 45.05 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.55 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.14 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 74.23 110.256 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 74.11 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.41 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.54 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.32 109.759 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 71.2 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 74.45 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 75.13 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 75.11 112.918 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 63.24 109.77 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.51 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 72.54 109.69 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.51 115.345 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.33 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.24 111.342 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.24 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 74.32 108.657 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.22 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo -59.67 134.68 59.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 64.14 111.556 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.07 -11.47 43.98 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.383 -0.826 . . . . 71.11 110.569 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 53.25 45.3 28.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.835 -0.802 . . . . 75.42 108.835 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 215' ' ' ASN . 14.3 pt20 -44.43 101.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.524 2.416 . . . . 71.1 117.524 -171.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 254' ' ' GLN . 15.8 ttm180 . . . . . 0 CA--C 1.511 -0.546 0 C-N-CA 125.485 1.514 . . . . 75.12 108.655 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 111.486 -0.646 . . . . 54.31 111.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -77.47 138.74 39.41 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.136 0.493 . . . . 74.21 111.766 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -105.23 -37.88 6.73 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.742 -0.663 . . . . 73.42 109.304 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.8 m 71.9 -33.5 0.27 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.617 1.167 . . . . 71.31 112.363 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.591 ' HE3' ' N ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -64.05 145.17 56.37 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 110.137 -0.32 . . . . 73.23 110.137 176.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.49 109.32 56.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 103.38 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.46 2.774 . . . . 61.25 113.935 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 m -152.67 93.08 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.564 -1.272 . . . . 74.15 107.564 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.9 mt -119.2 117.0 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.869 -0.605 . . . . 65.21 110.39 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.0 m -74.78 106.11 6.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.661 -0.866 . . . . 60.54 108.661 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.3 143.87 27.49 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 113.62 0.97 . . . . 70.35 113.62 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.4 138.34 38.62 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.573 2.182 . . . . 73.45 109.854 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . 0.268 16.3 p-80 -81.48 61.62 5.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 115.466 1.654 . . . . 63.41 115.466 -173.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -179.01 89.78 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.834 0.854 . . . . 73.01 111.928 171.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -131.15 102.9 6.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.209 -0.905 . . . . 75.21 109.789 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -88.2 102.91 15.27 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.051 -1.833 . . . . 74.52 106.051 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 3.3 p -113.6 162.11 16.61 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 114.375 1.25 . . . . 63.51 114.375 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.57 142.16 16.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.263 -1.335 . . . . 51.23 108.432 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.0 m -70.88 139.64 50.84 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.236 0.541 . . . . 74.34 109.842 -177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.58 153.53 20.0 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.731 -0.84 . . . . 75.21 108.731 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.1 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.515 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 63.31 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.51 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.53 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.33 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.33 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.11 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.41 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.41 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.516 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 63.15 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 25.6 m170 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 71.22 110.644 176.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.44 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.32 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.34 109.33 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.33 109.196 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 205' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 74.33 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.14 152.48 33.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 74.22 110.042 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.2 tpmt? -86.31 121.27 28.64 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.664 0.616 . . . . 73.51 112.664 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.407 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 29.7 t-80 -110.64 146.72 35.68 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.822 -2.288 . . . . 74.43 104.822 168.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.12 64.49 2.38 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.783 -0.723 . . . . 71.03 112.519 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 26.4 m -148.79 112.15 4.98 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.517 -0.92 . . . . 65.11 108.517 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.71 81.62 8.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.182 0.991 . . . . 70.42 109.564 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 171' ' ' PRO . 67.9 mttm -135.58 167.3 22.95 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 113.87 -1.514 . . . . 75.41 107.117 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 8.0 Cg_endo -52.28 154.79 10.43 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.556 2.171 . . . . 65.21 111.636 175.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 71.12 111.904 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 72.52 114.312 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.2 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.44 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 72.31 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.24 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 75.13 108.774 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 37.72 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.44 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t -103.73 145.37 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.3 107.883 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.19 129.33 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 121.558 0.694 . . . . 72.33 110.205 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 185' ' ' THR . 30.5 tpt180 -117.65 131.62 56.62 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.441 -0.8 . . . . 72.01 109.909 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.91 113.81 30.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.312 -0.996 . . . . 72.21 108.312 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.481 HG21 ' HG3' ' A' ' 183' ' ' ARG . 24.4 p -118.79 -175.31 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.539 -0.3 . . . . 61.11 111.406 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.96 -20.02 61.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.979 0.419 . . . . 74.32 110.638 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -89.64 -9.15 50.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.062 -0.517 . . . . 61.42 111.128 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.53 -135.05 9.65 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.58 -0.608 . . . . 53.23 111.58 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 60.7 mt -100.51 134.26 43.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 121.448 0.642 . . . . 73.23 112.139 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -129.41 138.52 51.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.771 -1.104 . . . . 74.44 109.587 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -113.21 134.62 54.49 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.617 -0.512 . . . . 65.24 109.617 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.31 163.71 49.15 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.534 -0.757 . . . . 61.31 109.286 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 74.35 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.21 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.04 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.52 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.43 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.33 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 74.23 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.45 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.41 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 65.32 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.34 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.21 111.679 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.43 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.34 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 73.14 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.44 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.405 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.24 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 72.13 107.524 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.51 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.2 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 74.3 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.557 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 71.34 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.45 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 71.22 111.038 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 250' ' ' LYS . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 74.31 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.1 111.231 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 73.44 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.34 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 63.31 107.89 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 73.52 107.072 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.55 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.32 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.44 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 71.51 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 73.23 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 73.34 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.13 110.617 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.33 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 72.41 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 71.2 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.45 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.54 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.407 ' HE2' HG13 ' A' ' 234' ' ' VAL . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.23 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.33 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.04 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.14 111.055 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 65.44 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.11 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.14 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.43 110.504 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.21 106.881 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.32 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.42 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.11 107.894 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.34 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.557 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo -55.93 134.52 64.58 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 72.14 111.32 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -91.34 0.37 57.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.36 -0.837 . . . . 73.44 110.404 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t30 66.06 16.16 10.35 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.265 1.031 . . . . 75.02 109.326 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 59.54 88.47 0.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.272 -1.331 . . . . 72.42 111.612 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.674 -0.862 . . . . 74.41 108.674 -179.24 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.23 -1.148 . . . . 75.1 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.1 m -95.23 157.04 16.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.735 -0.468 . . . . 71.31 109.735 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -86.35 82.62 7.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.449 0.642 . . . . 70.33 110.29 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.3 p -137.04 171.33 14.66 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.982 -1.008 . . . . 65.05 108.799 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -134.06 128.35 34.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.988 0.423 . . . . 74.15 110.387 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.09 108.77 59.02 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.149 -1.056 . . . . 71.35 108.149 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.49 -25.06 48.45 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.87 2.38 . . . . 73.32 113.058 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 t 63.45 25.51 14.54 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.697 0.76 . . . . 71.54 110.319 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.6 pt -82.09 24.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 113.71 1.004 . . . . 74.11 113.71 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 t -130.92 113.83 14.51 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.234 -1.395 . . . . 72.3 107.234 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.425 HD11 ' O ' ' A' ' 138' ' ' ILE . 2.5 pp -114.46 142.37 28.04 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.025 0.75 . . . . 75.03 113.025 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.0 112.99 1.68 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.486 2.124 . . . . 62.12 111.037 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -130.22 -21.98 2.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.291 -0.413 . . . . 71.42 111.776 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 142' ' ' PHE . 16.3 t70 59.59 -159.78 0.29 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.724 0.81 . . . . 72.13 109.56 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 64.9 m-85 -98.48 -45.28 6.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.725 -0.842 . . . . 73.22 108.725 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -94.53 142.16 27.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.334 -0.848 . . . . 75.3 110.725 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 14.0 p -146.78 163.21 36.72 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.973 -0.558 . . . . 70.52 111.021 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.45 139.63 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.38 -0.6 . . . . 73.21 109.38 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.9 p -77.11 136.25 38.62 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.033 -0.728 . . . . 75.2 109.033 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.29 156.61 43.48 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 121.087 -0.245 . . . . 73.43 111.641 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 74.53 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.31 111.026 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.15 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.12 112.785 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.33 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.13 110.133 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.12 110.661 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.41 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.41 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 73.04 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 75.31 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 73.2 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 74.24 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 74.25 111.874 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 71.22 108.231 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p -127.97 143.45 51.09 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.41 106.976 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -79.6 121.18 24.95 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.257 0.551 . . . . 75.14 110.896 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.4 110.04 21.87 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 70.21 111.199 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.49 -85.01 0.85 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 116.263 -0.426 . . . . 62.03 112.959 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -116.28 164.77 14.02 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.648 -0.871 . . . . 62.21 108.648 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.1 77.43 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.824 1.297 . . . . 71.31 111.063 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -86.95 154.91 55.57 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 113.69 -1.595 . . . . 75.05 110.061 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.3 149.89 89.07 Favored 'Trans proline' 0 C--O 1.258 1.478 0 C-N-CA 122.532 2.155 . . . . 64.23 112.052 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.46 ' H ' HD13 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 71.3 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.23 116.175 -174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.02 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 75.21 107.155 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.4 111.877 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.44 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 74.42 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -103.51 136.75 42.65 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.01 108.237 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.95 117.47 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.442 0.639 . . . . 74.3 110.059 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -114.09 132.1 56.16 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.702 -0.851 . . . . 71.01 108.702 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.23 113.17 32.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.483 -0.932 . . . . 73.31 108.483 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.0 p -115.75 -174.68 2.57 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.687 -0.486 . . . . 72.31 109.687 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.53 64.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.374 0.607 . . . . 73.2 109.495 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.3 m -80.68 -12.25 59.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.436 -0.802 . . . . 73.34 109.649 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.29 -164.76 12.1 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.139 -0.553 . . . . 63.43 111.857 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.12 126.83 30.93 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.937 -0.764 . . . . 74.33 108.937 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -129.26 124.54 34.73 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.635 0.731 . . . . 74.14 110.282 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -104.4 126.71 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.087 -0.961 . . . . 74.32 108.498 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -147.5 159.69 40.88 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.21 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.41 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.43 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.21 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 61.51 108.856 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 54.22 110.92 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.34 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.11 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.04 108.358 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.23 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 72.01 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 64.25 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 75.22 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.21 111.491 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.31 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.439 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.24 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.11 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.23 110.337 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.31 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.44 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.526 ' HB2' ' HG2' ' A' ' 254' ' ' GLN . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.21 113.016 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.23 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.5 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.54 109.454 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.35 110.78 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.33 111.493 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.21 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.515 ' OD1' HD13 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.34 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.23 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.44 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.23 108.895 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.34 112.234 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.11 110.247 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 52.11 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.02 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 65.51 108.892 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.13 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.52 111.676 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.34 111.077 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.31 110.683 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.12 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.53 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.666 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 72.44 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.34 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.53 112.685 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.666 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.1 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.35 110.24 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.44 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.515 HD13 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.21 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.41 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 75.04 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.44 108.42 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.13 107.636 170.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo -60.63 134.38 54.0 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 71.25 108.517 174.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.15 0.1 57.34 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.469 -0.493 . . . . 64.21 110.589 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 60.45 78.13 0.29 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.16 -1.422 . . . . 72.13 107.16 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.526 ' HG2' ' HB2' ' A' ' 215' ' ' ASN . 45.2 mt-30 -52.34 114.87 1.49 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.167 -1.378 . . . . 74.23 112.601 -171.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 114.376 -1.283 . . . . 73.2 110.968 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 109.96 -0.385 . . . . 44.11 109.96 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.13 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 62.21 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 154' ' ' VAL . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.54 111.087 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.21 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.15 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 62.42 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.42 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.23 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.24 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 74.52 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 64.24 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.51 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 71.24 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.14 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 74.24 109.71 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.24 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.34 108.652 -177.687 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo . . . . . 0 C--O 1.239 0.553 0 CA-C-O 121.155 0.398 . . . . 71.12 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.4 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.416 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.54 114.853 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.45 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.34 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.41 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.22 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.549 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.02 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.42 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 73.33 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 64.02 109.088 -178.573 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.42 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 70.02 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.11 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 72.33 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.41 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 72.02 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.21 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 173' ' ' GLY . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.31 108.878 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.24 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.04 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 201' ' ' VAL . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.33 111.997 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.01 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 63.43 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 71.55 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.3 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.31 112.323 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.44 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 54.2 109.709 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.01 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.2 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.32 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 61.45 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.13 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.22 110.199 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.492 HG22 ' HG3' ' A' ' 220' ' ' GLU . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.3 110.032 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 74.04 110.751 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.4 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.13 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 35.34 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.401 HG13 ' SD ' ' A' ' 237' ' ' MET . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.11 106.61 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 65.43 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.51 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 63.43 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.13 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 51.31 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 234' ' ' VAL . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 63.32 109.024 172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 71.53 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.1 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.32 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 62.11 111.187 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.11 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.4 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.34 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.55 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.3 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 63.3 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.53 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 61.04 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.23 110.545 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.41 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.24 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 61.21 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 70.45 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.2 109.207 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 218' ' ' VAL . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.21 107.361 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 64.44 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.648 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo . . . . . 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 61.52 111.073 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.418 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 211' ' ' LEU . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.51 111.087 -172.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.14 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.32 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.41 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.23 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 70.22 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG12 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.45 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.32 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.53 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.14 111.244 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.41 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.545 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 65.52 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.14 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.545 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.23 111.249 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-O 120.995 0.331 . . . . 75.1 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 55.24 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.32 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.44 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' HG22 ' A' ' 201' ' ' VAL . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 65.02 107.018 175.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.41 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.23 109.753 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 22.12 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.1 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.1 107.359 178.552 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.202 -0.666 . . . . 75.34 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.32 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.22 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 231' ' ' LEU . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.51 106.596 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.23 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.34 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.22 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 53.45 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 70.52 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 175' ' ' TYR . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.21 108.601 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.41 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 35.42 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.33 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 209' ' ' THR . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.23 112.576 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.23 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.01 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.42 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 205' ' ' LEU . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 74.15 110.49 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.41 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 212' ' ' LEU . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.12 112.449 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 249' ' ' VAL . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.21 109.994 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.44 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.32 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 61.02 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.35 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.43 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.41 109.495 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 52.51 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' HG22 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.53 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.13 108.604 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.43 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.33 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.4 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.1 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.22 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.4 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.21 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.2 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 55.22 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 195' ' ' ILE . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.13 110.369 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.21 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.497 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.24 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 230' ' ' THR . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.43 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.2 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.15 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.34 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.567 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.15 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 54.44 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.22 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.21 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 72.42 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.43 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.435 ' HA ' HH11 ' A' ' 162' ' ' ARG . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.41 108.858 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 72.41 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.22 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.33 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.02 108.864 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 218' ' ' VAL . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.1 108.651 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.41 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 71.31 108.833 173.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo . . . . . 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 44.33 111.777 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.878 -0.786 . . . . 61.33 108.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.12 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 246' ' ' ILE . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 53.33 111.514 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.43 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.45 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.54 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.583 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 62.12 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.44 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.45 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.562 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 71.34 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.23 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.23 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 65.55 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.53 108.779 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 64.22 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.04 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 54.02 108.691 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--O 1.243 0.774 0 N-CA-C 109.129 -1.143 . . . . 74.13 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 72.0 111.491 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.53 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.432 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 70.14 110.079 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.32 106.208 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 63.42 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 53.34 109.574 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.464 ' HB3' HD11 ' A' ' 231' ' ' LEU . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.45 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 63.31 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.13 107.415 178.504 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.072 -1.084 . . . . 74.12 108.072 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.4 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.3 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.02 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 61.34 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.44 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.34 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 70.31 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 64.24 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.486 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 70.22 107.605 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.23 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.42 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.04 113.659 -174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 52.43 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.02 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.31 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 205' ' ' LEU . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 64.52 110.347 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.3 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 209' ' ' THR . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.11 113.499 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 249' ' ' VAL . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 64.34 111.078 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.33 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 63.34 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.599 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.33 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 45.22 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.3 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.33 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.11 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.01 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.11 109.818 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.43 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.32 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.31 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 64.21 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 64.05 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.43 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 178' ' ' ASP . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.21 111.744 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.42 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' MET . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 64.32 112.393 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.21 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 41.51 110.266 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.13 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 72.12 108.794 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 64.45 112.39 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.41 109.3 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 43.24 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.11 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 33.25 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.05 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.3 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 149' ' ' ILE . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.14 107.373 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.15 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 212' ' ' LEU . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.44 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.599 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo . . . . . 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 55.24 109.629 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 109.84 -0.43 . . . . 54.34 109.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 63.05 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 60.52 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.15 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.14 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 158' ' ' HIS . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.8 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.31 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.14 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.534 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.32 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.416 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 62.35 108.554 170.044 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG22 ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 61.23 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 212' ' ' LEU . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.42 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.536 HH11 ' HA ' ' A' ' 244' ' ' ASN . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 63.34 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.21 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.42 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 61.04 112.285 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.251 1.148 0 CA-C-O 121.09 0.371 . . . . 73.44 112.56 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.1 107.947 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.52 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.45 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 71.11 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.05 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 63.14 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 64.53 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.3 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.04 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 61.1 106.373 176.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 108.528 -0.916 . . . . 71.1 108.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.54 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.45 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 62.14 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.2 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.21 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 72.21 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.4 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.05 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.33 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.13 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.42 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 63.31 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 60.12 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 73.42 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.21 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 211' ' ' LEU . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.45 111.105 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.43 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 209' ' ' THR . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 71.32 111.653 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 249' ' ' VAL . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.04 107.901 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 63.24 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 53.3 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.41 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.35 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 72.24 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 249' ' ' VAL . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 64.3 109.467 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 220' ' ' GLU . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 52.03 110.446 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.43 110.865 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 64.33 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 44.51 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 73.22 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.52 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.11 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 64.11 111.301 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.54 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.42 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 54.4 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.33 109.541 176.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.05 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.44 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.23 112.078 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 230' ' ' THR . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.42 111.337 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 53.54 110.879 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.11 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.04 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.441 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.33 112.666 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 235' ' ' THR . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 72.33 109.267 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.12 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.44 111.004 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.3 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 63.21 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.536 ' HA ' HH11 ' A' ' 162' ' ' ARG . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 52.02 108.411 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 241' ' ' ASN . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.11 110.416 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 71.11 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.11 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.41 108.004 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 218' ' ' VAL . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.05 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.429 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 71.24 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 64.44 110.48 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 109.583 -0.525 . . . . 72.33 109.583 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.42 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 70.14 110.522 -175.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.43 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 71.35 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.1 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.42 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 45.35 111.399 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.42 110.528 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 54.32 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.1 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.12 108.824 171.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 52.24 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 62.42 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 212' ' ' LEU . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 61.31 108.735 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.434 HH11 HG12 ' A' ' 246' ' ' ILE . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 71.41 108.939 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.52 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.12 107.346 175.908 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--O 1.247 0.969 0 CA-C-O 121.045 0.352 . . . . 74.12 112.758 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.664 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.02 110.975 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 24.21 114.924 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.41 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.41 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.33 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 72.54 107.937 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.615 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.15 109.975 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 34.24 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 72.14 111.964 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.443 ' HB2' ' HA3' ' A' ' 194' ' ' GLY . 42.2 t . . . . . 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.35 109.046 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.42 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 181' ' ' SER . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.15 111.967 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.51 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 64.53 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.54 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 51.45 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 72.13 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.33 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.444 HG22 ' CA ' ' A' ' 173' ' ' GLY . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.22 108.811 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.04 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.13 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 32.21 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 50.54 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.45 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.1 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.11 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 44.55 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 63.24 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 71.11 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.43 HD21 HG11 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 62.13 109.62 -176.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.41 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.23 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.4 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.14 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.31 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 65.21 110.366 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 250' ' ' LYS . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.05 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 31.41 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 43.11 110.812 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 42.3 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 53.5 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.33 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 224' ' ' ILE 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.33 114.275 -177.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.3 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.4 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 62.43 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 55.22 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.45 111.517 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 51.11 111.073 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.03 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.13 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.12 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.14 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.21 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.42 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 53.12 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.05 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.542 ' HB2' HD13 ' A' ' 245' ' ' LEU . 3.2 m-20 -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 63.11 107.325 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.1 113.778 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.54 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.23 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 241' ' ' ASN . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 54.53 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG12 HH11 ' A' ' 162' ' ' ARG . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 60.43 108.104 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.21 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.24 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 218' ' ' VAL . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.45 108.704 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.44 106.624 171.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo . . . . . 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.31 111.574 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 120.759 0.314 . . . . 73.24 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.22 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.1 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.02 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.1 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.03 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.24 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 158' ' ' HIS . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.35 112.185 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.15 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 64.42 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.13 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.428 ' HB2' HG13 ' A' ' 154' ' ' VAL . 2.1 m-70 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.41 110.265 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.24 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 73.44 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 65.54 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.14 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 64.51 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--O 1.254 1.325 0 CA-C-O 120.839 0.266 . . . . 74.04 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 64.45 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.4 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 201' ' ' VAL . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.14 107.914 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 63.42 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.13 110.51 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 62.02 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.3 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.42 108.917 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 119.464 -0.303 . . . . 73.13 110.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.22 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.24 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.4 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.33 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 61.14 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.23 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 175' ' ' TYR . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.45 107.776 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.24 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 71.53 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 65.43 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 209' ' ' THR . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.15 113.758 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 40.12 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 62.44 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.12 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 205' ' ' LEU . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.11 112.129 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 63.02 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.05 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 65.34 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.24 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.41 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.42 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.33 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 249' ' ' VAL . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 71.35 110.93 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.443 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 55.01 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.32 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.533 HG11 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 64.44 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 62.32 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.52 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 65.24 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 52.35 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 224' ' ' ILE 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.44 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.54 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.44 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 233' ' ' GLN . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.04 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 71.22 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.12 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.14 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.33 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.3 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.21 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.21 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 71.45 109.176 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.55 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 61.42 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 70.11 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 50.54 110.049 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.23 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 43.53 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.41 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.24 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.22 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.23 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 61.41 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 218' ' ' VAL . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 41.22 108.562 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.443 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.13 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 53.22 111.964 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 110.208 -0.293 . . . . 73.43 110.208 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.32 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 74.43 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 70.35 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 52.23 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.25 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.24 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 53.34 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.23 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.23 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 44.43 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.53 110.017 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 60.35 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.24 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.2 110.514 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.609 ' HG2' HD12 ' A' ' 149' ' ' ILE . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.22 108.987 174.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 64.45 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.469 ' N ' HD23 ' A' ' 163' ' ' LEU . 5.6 p . . . . . 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 N-CA-C 108.372 -1.434 . . . . 75.31 108.372 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.45 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.453 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.21 115.206 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.13 108.955 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 63.33 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 235' ' ' THR . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.3 111.23 175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.54 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.518 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.42 107.953 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.53 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.12 111.164 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 55.13 106.984 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 CA--C 1.506 -0.727 0 CA-C-O 119.815 -0.136 . . . . 73.12 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.43 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 63.14 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 74.4 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.11 109.501 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 53.31 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.3 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 60.01 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 63.51 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 173' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.41 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 62.52 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 33.34 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.31 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.21 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.32 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.44 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.42 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.24 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 52.45 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 72.42 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 249' ' ' VAL . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 60.42 108.443 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 55.05 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 50.44 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.32 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.131 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.43 110.673 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.24 109.979 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.34 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.22 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 42.55 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.12 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 54.51 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.43 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.44 114.375 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 52.23 109.186 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.13 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 62.15 107.638 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 234' ' ' VAL . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.12 109.585 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 63.45 110.326 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.33 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 51.44 111.864 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 230' ' ' THR . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.24 111.656 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.41 110.519 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.02 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.11 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.12 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 235' ' ' THR . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.24 109.09 176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.14 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.529 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.41 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.2 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.04 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 53.41 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 241' ' ' ASN . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.13 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 149' ' ' ILE . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 65.01 107.529 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 71.1 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.45 109.386 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 53.42 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo . . . . . 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 108.423 -0.954 . . . . 52.11 108.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.505 HD11 ' HG ' ' A' ' 211' ' ' LEU . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.13 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.04 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 35.5 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.13 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.32 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.21 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 158' ' ' HIS . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.31 112.347 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.14 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 44.12 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.34 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.414 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 70.44 108.139 170.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.14 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.43 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.51 108.446 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 70.24 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.51 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.33 111.921 175.866 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo . . . . . 0 C--O 1.247 0.96 0 CA-C-O 121.79 0.662 . . . . 73.34 112.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.52 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.43 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.443 ' HB3' HD13 ' A' ' 200' ' ' LEU . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.52 110.787 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.22 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.33 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 63.53 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.01 109.303 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.22 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.12 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 50.45 108.17 -176.68 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.556 -0.905 . . . . 73.34 108.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.3 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.2 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 61.42 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 62.31 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 54.42 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 214' ' ' VAL . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 63.43 107.776 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 73.22 108.853 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.15 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.54 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.21 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.44 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.1 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 62.03 110.686 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.43 108.648 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.24 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.521 ' HB ' ' CD2' ' A' ' 211' ' ' LEU . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.02 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.31 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 44.12 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.471 HD22 ' CG2' ' A' ' 249' ' ' VAL . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 64.35 106.943 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.2 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.51 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 61.12 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.15 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 249' ' ' VAL . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.24 108.877 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 63.21 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.31 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.508 HG11 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.43 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.441 ' OD1' HD22 ' A' ' 245' ' ' LEU . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.1 112.172 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.24 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.11 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.33 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.43 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.32 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.21 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 45.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 73.31 110.095 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 178' ' ' ASP . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 61.3 109.559 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.44 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.02 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 230' ' ' THR . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.14 111.541 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.42 109.708 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.34 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.13 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 72.33 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.32 109.159 176.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 22.44 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 64.23 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.55 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 238' ' ' MET . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.12 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 53.12 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.22 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 218' ' ' VAL . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.33 108.523 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 54.42 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo . . . . . 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.41 111.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.45 0.167 . . . . 51.4 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.32 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 246' ' ' ILE . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.41 109.798 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 64.42 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.2 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 60.42 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 55.3 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.41 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.24 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 50.3 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.23 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 70.45 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.53 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 63.13 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 72.23 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 72.44 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.474 ' N ' HD23 ' A' ' 163' ' ' LEU . 36.6 t . . . . . 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.4 107.564 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.246 0.894 0 N-CA-C 110.506 -0.613 . . . . 72.24 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.12 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.3 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.54 109.332 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.609 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.55 106.666 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.14 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.14 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.35 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 63.04 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 110.28 -0.267 . . . . 71.32 110.28 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.24 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.01 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 63.43 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.4 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.34 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 65.41 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.11 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 206' ' ' ALA . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.52 109.71 175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.43 107.753 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.23 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.33 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.03 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.521 HD23 ' HG ' ' A' ' 163' ' ' LEU . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.24 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.11 110.426 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 52.35 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 44.14 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.477 ' HB ' HD13 ' A' ' 211' ' ' LEU . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 70.43 111.393 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.11 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 209' ' ' THR . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.21 107.321 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.21 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.03 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.11 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.466 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.23 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 249' ' ' VAL . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 51.35 110.94 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.02 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 248' ' ' THR . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.13 111.39 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 63.01 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 63.31 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 71.41 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.24 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.3 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.32 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 63.13 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.34 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 32.31 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.43 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.21 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.02 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 52.42 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 239' ' ' VAL . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 72.31 110.404 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 62.0 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.12 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.497 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.22 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 235' ' ' THR . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.32 109.683 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.2 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.402 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.13 111.767 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.04 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.14 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.43 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 241' ' ' ASN . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.42 110.885 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 149' ' ' ILE . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.14 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 73.24 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 218' ' ' VAL . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 60.05 107.688 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.51 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo . . . . . 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.33 111.427 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.018 -1.105 . . . . 25.45 108.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.33 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 63.11 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.12 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.11 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.32 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.4 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.43 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.05 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 64.45 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.682 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 64.05 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.14 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 73.42 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.55 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.45 108.01 -176.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.34 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.52 108.936 172.407 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 N--CA 1.482 0.808 0 N-CA-C 110.391 -0.657 . . . . 74.3 110.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 71.02 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.24 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 60.03 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.43 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 235' ' ' THR . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.34 111.752 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 74.31 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.33 108.779 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.33 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 52.01 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.41 109.123 -178.129 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.537 -0.171 . . . . 63.22 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.23 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.03 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 64.43 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 43.5 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 214' ' ' VAL . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.54 108.285 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.05 109.728 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 50.54 108.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 70.35 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.23 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.13 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.45 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.52 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.41 107.6 176.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.1 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.496 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 62.15 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 33.15 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 71.14 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.12 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.41 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 199' ' ' ARG . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.13 114.368 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.55 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.22 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.22 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 249' ' ' VAL . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.2 110.149 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 250' ' ' LYS . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 71.11 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.04 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.34 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 34.44 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.43 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.51 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.427 HG21 HG23 ' A' ' 218' ' ' VAL . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.45 112.493 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.487 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 40.33 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 54.2 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.12 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 234' ' ' VAL . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.22 109.72 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 33.2 110.164 175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.32 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.1 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 230' ' ' THR . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 72.4 111.195 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 239' ' ' VAL . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.22 110.843 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.14 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.24 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.3 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 235' ' ' THR . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.01 109.642 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 64.32 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.588 ' HB2' HD23 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.05 110.8 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 65.11 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.4 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 65.24 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 241' ' ' ASN . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.23 109.3 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.33 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 50.43 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.44 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HD22 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 64.04 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.54 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 74.23 110.855 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 120.537 0.208 . . . . 52.42 110.769 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.44 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 246' ' ' ILE . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 54.13 112.177 -170.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.54 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.1 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.41 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.21 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 158' ' ' HIS . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.04 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.43 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.43 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.563 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.3 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.516 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.1 109.165 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HD2' HD12 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.31 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.51 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 211' ' ' LEU . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 61.42 106.685 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.11 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 72.05 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 63.12 106.766 174.27 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--O 1.249 1.029 0 CA-C-O 121.174 0.406 . . . . 74.42 113.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.42 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.21 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.422 ' HB3' ' HG ' ' A' ' 200' ' ' LEU . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.34 112.118 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.14 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.53 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.22 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.03 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 43.02 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 55.35 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 42.44 107.839 177.274 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 70.44 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.33 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.41 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.54 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.41 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.04 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 65.11 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 174' ' ' PHE . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.2 111.936 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.44 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.55 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.12 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.21 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.43 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.32 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 61.31 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 211' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.13 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 42.14 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.693 HD11 HG22 ' A' ' 161' ' ' VAL . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 55.14 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 249' ' ' VAL . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.42 110.44 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 70.45 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.35 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.12 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 45.15 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.43 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 249' ' ' VAL . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 71.11 110.769 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.535 HG22 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.34 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.35 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.588 ' OD1' HD12 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.32 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.31 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.2 110.256 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.34 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.41 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.21 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 74.44 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 234' ' ' VAL . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.42 110.105 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 61.21 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.51 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.33 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 230' ' ' THR . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.23 111.721 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.13 110.775 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.12 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.33 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.587 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 54.13 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 235' ' ' THR . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 71.22 109.141 176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.3 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 62.34 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.11 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.55 109.168 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.44 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.588 HD12 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.1 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 149' ' ' ILE . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.42 107.067 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 43.41 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.23 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 218' ' ' VAL . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 54.01 109.054 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.14 108.39 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo . . . . . 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.21 110.783 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 120.818 0.342 . . . . 72.22 111.569 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.34 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 62.11 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.42 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.3 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.3 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 71.23 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.42 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 62.21 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 44.43 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.24 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.404 ' CE1' HG13 ' A' ' 219' ' ' ILE . 2.2 m-70 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.33 110.378 171.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.546 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.41 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 74.32 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.22 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.51 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.44 109.404 -174.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.412 ' N ' HD23 ' A' ' 163' ' ' LEU . 41.6 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.32 111.139 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.252 1.209 0 N-CA-C 110.0 -0.808 . . . . 61.32 110.0 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.2 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.633 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.22 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.1 109.546 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 201' ' ' VAL . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.45 107.463 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.43 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 65.42 109.347 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.51 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.22 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 54.23 108.755 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 65.11 108.301 -179.126 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.168 0.032 . . . . 74.22 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.31 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.22 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.41 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 71.02 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 71.15 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.24 109.808 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.22 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 70.41 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.633 ' CG2' ' HA2' ' A' ' 173' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.03 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.4 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.11 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 44.41 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 72.14 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.44 111.835 -174.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.53 109.591 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.11 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.22 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.43 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.12 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 249' ' ' VAL . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 64.55 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.43 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 60.14 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.24 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.33 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.12 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 249' ' ' VAL . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 70.01 110.507 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 158' ' ' HIS . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 70.1 110.849 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 72.14 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 41.23 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.449 ' HB2' HD12 ' A' ' 245' ' ' LEU . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.4 110.976 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.31 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.4 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 73.13 112.516 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.491 ' H ' HG22 ' A' ' 224' ' ' ILE 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 72.05 114.438 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.14 108.656 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 54.05 108.329 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.05 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 74.43 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.42 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 62.41 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.24 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.01 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.55 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.457 ' HG3' HG13 ' A' ' 224' ' ' ILE . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.04 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.534 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 71.13 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.11 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.22 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.941 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.42 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 72.12 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 63.12 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 241' ' ' ASN . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 64.23 110.897 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.14 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 64.33 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.03 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.542 HG21 HD22 ' A' ' 212' ' ' LEU . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.13 109.002 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 64.45 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo . . . . . 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.4 112.629 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.704 0 N-CA-C 110.281 -0.266 . . . . 73.12 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.21 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 160' ' ' ARG . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.41 110.37 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.44 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 44.52 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.03 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 51.11 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 33.31 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.45 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.44 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 70.32 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.21 109.447 171.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.21 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 64.43 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 148' ' ' ILE . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.4 107.794 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.33 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.35 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.31 109.545 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo . . . . . 0 C--O 1.246 0.906 0 CA-C-O 120.899 0.291 . . . . 63.11 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 62.43 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 34.53 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.3 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 63.24 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.42 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.12 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 71.41 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.4 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.1 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.1 107.297 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 . . . . . 0 N--CA 1.436 -1.158 0 N-CA-C 108.665 -0.865 . . . . 74.54 108.665 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.22 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 231' ' ' LEU . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.04 106.86 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.42 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.51 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 61.03 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 64.41 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.52 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 61.54 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.22 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.24 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.54 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 163' ' ' LEU . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.44 114.08 -171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 40.13 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.23 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.24 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 55.53 109.916 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.53 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 249' ' ' VAL . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 64.4 109.257 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.12 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.45 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.24 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.533 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.35 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.44 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.41 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.482 ' HG3' HG22 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.45 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.44 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.526 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.12 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.04 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.31 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.43 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.45 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.35 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.4 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 64.3 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.52 109.55 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 195' ' ' ILE . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.15 109.964 174.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.4 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.42 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.42 110.952 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.13 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.03 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.33 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 73.12 112.803 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.14 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 41.31 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.56 ' HB2' HD13 ' A' ' 245' ' ' LEU . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 65.13 106.746 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 72.34 113.2 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.44 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.03 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 71.44 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 70.34 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.44 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 71.15 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 54.33 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.43 108.517 169.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo . . . . . 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.22 109.428 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.199 -1.408 . . . . 72.24 107.199 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 159' ' ' ARG . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.11 108.319 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.623 HD13 ' HG2' ' A' ' 162' ' ' ARG . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.53 111.528 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.24 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 72.33 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.14 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.21 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.24 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 154' ' ' VAL . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 64.32 109.179 172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.35 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.542 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.577 ' HD2' HG21 ' A' ' 148' ' ' ILE . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 70.4 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.14 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.623 ' HG2' HD13 ' A' ' 149' ' ' ILE . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.1 107.703 175.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.32 108.295 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 163' ' ' LEU . 75.1 m . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 61.31 109.468 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.241 0.656 0 CA-C-O 120.912 0.297 . . . . 73.31 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 60.43 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.12 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.21 109.92 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.14 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.02 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.35 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.01 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 73.43 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.04 108.124 -179.248 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.51 -0.588 0 N-CA-C 108.741 -0.837 . . . . 73.41 108.741 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.52 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.31 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.22 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 72.11 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.22 108.557 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.44 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.11 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.11 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 55.24 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 64.23 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.42 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.13 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 163' ' ' LEU . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.14 113.29 -174.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 41.41 111.819 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.44 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 71.55 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 148' ' ' ILE . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.13 111.202 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.52 110.977 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.43 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.01 115.413 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.23 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.01 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.3 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.55 110.667 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.32 110.585 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.22 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.536 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.12 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 61.04 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 226' ' ' VAL . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 73.51 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 62.23 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 224' ' ' ILE . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.42 113.783 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.01 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.04 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 70.32 108.354 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.23 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 64.51 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.01 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 62.33 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.44 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 70.21 110.472 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.35 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 71.4 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.509 ' HB3' HD21 ' A' ' 172' ' ' LEU . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.44 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 235' ' ' THR . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 72.32 109.687 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.35 110.336 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.44 ' HB2' HD13 ' A' ' 245' ' ' LEU . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.51 111.073 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 54.13 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.4 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.04 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 63.15 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 149' ' ' ILE . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 74.52 106.882 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.43 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 71.33 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 218' ' ' VAL . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 53.33 107.432 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' THR 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 74.31 109.822 171.23 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.8 Cg_endo . . . . . 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.4 112.735 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 120.729 0.3 . . . . 32.42 111.414 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 73.34 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.596 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.12 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.52 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 62.11 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.45 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.31 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 158' ' ' HIS . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.33 111.582 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.04 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.31 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.43 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.447 ' HB2' HG13 ' A' ' 154' ' ' VAL . 3.5 m-70 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.41 108.999 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 211' ' ' LEU . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 65.43 109.332 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.622 ' H ' ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 65.43 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.24 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.42 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 62.41 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 54.03 105.371 171.229 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 112.515 0.159 . . . . 73.12 112.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.611 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.31 109.926 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.473 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.11 114.528 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 72.13 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.14 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 70.02 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.2 108.605 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.643 ' HB3' HD11 ' A' ' 231' ' ' LEU . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.51 110.075 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.23 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.44 108.174 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.34 107.9 179.002 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 110.421 -0.214 . . . . 74.44 110.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.54 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 43.41 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.54 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.44 109.202 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 62.12 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.23 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.04 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.3 109.915 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.473 HG22 ' CA ' ' A' ' 173' ' ' GLY . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.52 106.895 173.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.41 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.23 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.01 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 209' ' ' THR . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.33 111.647 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.02 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.11 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 205' ' ' LEU . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 63.14 110.456 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.01 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.482 ' HB3' HH11 ' A' ' 159' ' ' ARG . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 64.33 111.99 -176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' HB1' ' A' ' 206' ' ' ALA . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.23 109.787 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 63.32 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.32 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.34 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 63.04 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.13 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 249' ' ' VAL . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.22 110.316 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.21 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.32 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.427 HG23 ' HB ' ' A' ' 224' ' ' ILE . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.13 107.278 173.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.1 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.12 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 221' ' ' VAL . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.32 107.761 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.35 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.34 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.21 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.54 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.55 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.31 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.33 110.6 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 63.4 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.45 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.03 111.201 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.42 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.43 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.605 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.33 112.903 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.24 109.321 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 11.11 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.04 110.371 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.52 114.733 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.04 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.32 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.14 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 149' ' ' ILE . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.24 107.305 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.439 HD12 ' SD ' ' A' ' 238' ' ' MET . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 71.41 110.751 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 62.21 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 218' ' ' VAL . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 62.43 108.633 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 64.35 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo . . . . . 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.23 111.653 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.635 -0.876 . . . . 75.55 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 211' ' ' LEU . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.42 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 60.31 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.31 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.23 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 41.54 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 155' ' ' PRO . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.52 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 154' ' ' VAL . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.14 109.178 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.21 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.567 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 62.54 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.483 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 1.6 m-70 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.34 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.534 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 64.04 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 65.13 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.31 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 61.21 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 62.22 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 33.54 107.61 -179.018 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.697 -1.309 . . . . 73.23 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.02 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.23 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.13 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.24 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 235' ' ' THR . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 51.31 111.864 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.12 109.558 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 231' ' ' LEU . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.31 111.027 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 40.01 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.42 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.44 108.581 -177.507 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.887 -1.153 . . . . 74.33 107.887 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 72.2 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.54 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.44 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.53 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 73.43 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.2 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.13 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 50.13 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.34 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.2 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.54 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 44.24 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.01 113.471 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 54.43 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.23 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 51.21 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.433 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 63.33 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.51 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 148' ' ' ILE . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.24 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 249' ' ' VAL . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.51 108.99 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 64.31 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.11 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.34 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.13 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.24 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 249' ' ' VAL . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.12 110.334 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.534 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.53 110.01 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' HG22 ' A' ' 219' ' ' ILE . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.44 111.687 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.13 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.483 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.14 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 42.21 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.41 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 72.1 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.31 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 234' ' ' VAL . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 45.11 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.24 110.478 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.45 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.33 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 230' ' ' THR . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 62.54 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 176' ' ' ILE . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.22 110.955 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.55 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.43 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.415 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 70.0 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.22 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 63.35 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.01 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.34 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.31 110.956 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.4 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 61.13 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.53 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.4 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 218' ' ' VAL . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.35 108.72 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.534 ' CD ' HD11 ' A' ' 219' ' ' ILE . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 64.25 109.197 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo . . . . . 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.11 112.795 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 111.319 0.118 . . . . 74.55 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 211' ' ' LEU . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.43 107.354 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 52.3 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 154' ' ' VAL . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.32 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.42 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 61.12 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 150' ' ' ASP . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.21 112.032 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 62.45 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.52 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.523 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 71.41 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 154' ' ' VAL . 2.0 m-70 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 73.54 111.546 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 159' ' ' ARG . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 72.32 106.741 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 64.23 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.554 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.43 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 205' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 72.3 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.42 112.086 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.317 -1.07 . . . . 65.23 109.317 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 61.14 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 53.33 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 72.21 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.34 107.207 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.45 HD11 ' OG1' ' A' ' 235' ' ' THR . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 70.32 112.424 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.43 108.683 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 10.44 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 61.1 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.1 108.058 -179.173 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 109.882 -0.414 . . . . 45.52 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.55 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.32 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 231' ' ' LEU . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 74.14 107.218 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.14 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.24 111.068 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.44 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.14 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 61.32 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.42 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 53.14 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 34.21 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 163' ' ' LEU . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.32 113.623 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 63.13 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.04 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.14 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.528 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.2 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 62.31 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 148' ' ' ILE . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.12 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 52.44 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 24.25 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.53 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.1 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.43 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 249' ' ' VAL . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 64.01 109.432 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.428 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 71.43 110.544 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 71.34 111.246 -176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.23 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.599 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.21 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.23 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.35 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.3 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 219' ' ' ILE . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.01 111.0 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.4 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.02 109.206 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 195' ' ' ILE . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 60.12 110.802 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.14 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 71.34 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 230' ' ' THR . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.43 111.252 -178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.45 ' OG1' HD11 ' A' ' 176' ' ' ILE . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 53.41 109.061 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.529 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.05 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.31 109.643 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 53.43 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.11 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.54 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.13 110.178 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.11 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 149' ' ' ILE . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 63.42 107.944 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 70.03 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 71.14 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.595 HG21 HD22 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.31 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.24 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo . . . . . 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.11 110.427 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.262 0.077 . . . . 44.01 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 211' ' ' LEU . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 53.34 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.32 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.23 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.4 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.34 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.21 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 63.3 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 42.22 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.2 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.543 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.21 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.31 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 73.32 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.02 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.45 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 172' ' ' LEU . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.44 107.966 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.42 110.994 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.242 0.699 0 N-CA-C 111.601 -0.192 . . . . 64.43 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 62.42 109.908 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.22 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.43 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 63.44 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.43 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.571 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.1 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 43.23 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 61.31 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 40.05 107.497 -178.755 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.599 -1.26 . . . . 73.22 107.599 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.11 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.32 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.4 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 52.01 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.54 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 62.54 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.31 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.33 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.33 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.33 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 53.1 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 21.44 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 61.31 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 54.05 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.53 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.22 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.13 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 42.22 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 62.21 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.33 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 71.13 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.42 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.41 113.476 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.02 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.43 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 249' ' ' VAL . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.24 109.438 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 226' ' ' VAL . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.51 110.623 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.35 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.14 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.21 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.1 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 73.24 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.22 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 218' ' ' VAL . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.51 110.827 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 34.13 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.55 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.14 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 73.35 110.256 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 65.45 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.41 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.54 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.32 109.759 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 44.2 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 61.02 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 74.2 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.456 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 72.41 112.918 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.407 ' HA ' ' HB3' ' A' ' 242' ' ' SER . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 44.22 109.77 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.51 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.491 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.5 m-20 -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.69 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 239' ' ' VAL . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.51 115.345 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.33 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 241' ' ' ASN . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.24 111.342 -175.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 149' ' ' ILE . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.24 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 218' ' ' VAL . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 55.01 108.657 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.22 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 53.41 111.556 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 108.731 -0.84 . . . . 72.24 108.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.1 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 61.45 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.51 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.53 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.33 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.33 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.11 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.41 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.41 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 55.42 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 62.15 110.644 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.44 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.32 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 212' ' ' LEU . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.34 109.33 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.33 109.196 -176.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.578 HD22 HD23 ' A' ' 172' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 53.15 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 60.15 110.042 -179.204 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 120.77 0.237 . . . . 65.21 111.636 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 163' ' ' LEU . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 42.24 111.904 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 204' ' ' GLY . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 60.34 114.312 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.2 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.44 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 60.3 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.24 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 64.43 108.774 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 34.24 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.44 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.3 107.883 179.656 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.286 -0.635 . . . . 52.13 109.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 62.33 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.21 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.04 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.4 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.43 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.33 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 71.21 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.45 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.487 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.41 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 60.45 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.34 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 173' ' ' GLY . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.21 111.679 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.43 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.34 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 61.13 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.44 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.24 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 161' ' ' VAL . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 64.24 107.524 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.41 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.2 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 71.24 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 62.33 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.45 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 249' ' ' VAL . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 64.53 111.038 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 73.42 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.1 111.231 -178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 63.45 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.408 ' HB2' HD12 ' A' ' 245' ' ' LEU . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.34 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 62.44 107.89 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.446 ' H ' ' H ' ' A' ' 223' ' ' GLY . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 71.12 107.072 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.55 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.32 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.44 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 43.34 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 60.23 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 55.31 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.13 110.617 176.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.33 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 71.3 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 64.43 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.42 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.54 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG2' HD21 ' A' ' 245' ' ' LEU . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.23 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.33 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.04 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 245' ' ' LEU . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.14 111.055 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 63.24 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.11 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.14 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 238' ' ' MET . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.43 110.504 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.21 106.881 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.32 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.42 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 218' ' ' VAL . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.11 107.894 175.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.34 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 60.44 111.32 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 111.641 0.237 . . . . 73.11 111.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 73.02 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.75 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.31 111.026 -176.202 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.15 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.12 112.785 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.33 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.13 110.133 -175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.12 110.661 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.41 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.41 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 64.3 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 74.21 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 72.42 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.558 ' HB2' HD12 ' A' ' 149' ' ' ILE . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 73.24 111.874 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 64.43 108.231 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.41 106.976 174.388 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo . . . . . 0 C--O 1.258 1.478 0 CA-C-O 121.019 0.341 . . . . 64.23 112.052 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 61.4 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.575 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.23 116.175 -174.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.02 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 72.04 107.155 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.444 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.4 111.877 177.26 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.44 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 71.13 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.01 108.237 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 119.405 -0.331 . . . . 75.13 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.41 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.43 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.21 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.496 ' CD1' HD23 ' A' ' 212' ' ' LEU . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 53.41 108.856 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 44.15 110.92 -177.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.34 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.11 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.575 HG22 ' CA ' ' A' ' 173' ' ' GLY . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.04 108.358 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.23 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 53.51 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 63.04 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 71.51 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 212' ' ' LEU . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.21 111.491 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.31 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.24 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.11 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 148' ' ' ILE . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.496 HD23 ' CD1' ' A' ' 197' ' ' ILE . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.23 110.337 177.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.31 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.44 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.21 113.016 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.23 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.14 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 249' ' ' VAL . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.54 109.454 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.486 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.35 110.78 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.486 ' HG3' HG22 ' A' ' 219' ' ' ILE . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.33 111.493 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.21 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.537 ' OD1' HD12 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.34 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.23 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.44 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.23 108.895 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 218' ' ' VAL . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.34 112.234 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.11 110.247 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 40.51 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.02 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 64.22 108.892 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.13 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.52 111.676 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 230' ' ' THR . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.34 111.077 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.407 HG23 HD11 ' A' ' 176' ' ' ILE . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.31 110.683 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.12 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.53 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.67 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 70.3 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.24 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 245' ' ' LEU . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.53 112.685 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.1 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.35 110.24 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.44 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.537 HD12 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.21 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 149' ' ' ILE . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.41 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 72.45 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 218' ' ' VAL . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.44 108.42 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.402 ' CD ' HD11 ' A' ' 219' ' ' ILE . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.13 107.636 170.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 63.42 108.517 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.896 0 N-CA-C 110.183 -1.167 . . . . 45.03 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -97.63 105.9 18.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.393 0.596 . . . . 75.53 110.98 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 130' ' ' LYS . 71.8 mmtt -118.37 84.16 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 122.089 0.947 . . . . 74.25 111.473 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -96.86 146.67 24.72 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.91 -1.496 . . . . 61.13 108.819 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 10.0 mptt -101.3 84.83 2.69 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.323 -1.362 . . . . 74.1 107.323 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.43 114.85 54.84 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.624 -0.716 . . . . 73.04 110.935 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.81 135.05 31.68 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.027 1.818 . . . . 73.22 110.773 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.9 p -77.67 87.16 3.95 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.596 0.713 . . . . 74.23 110.719 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.46 HD13 HH11 ' A' ' 162' ' ' ARG . 71.9 mt -84.03 112.57 21.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 114.996 -1.002 . . . . 75.34 111.365 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.1 t -93.01 118.18 30.89 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.314 -1.735 . . . . 55.13 106.314 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -95.34 130.73 31.45 Favored Pre-proline 0 N--CA 1.434 -1.271 0 C-N-CA 119.52 -0.872 . . . . 71.22 110.677 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.93 175.39 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.899 2.399 . . . . 52.25 109.976 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -83.85 86.79 7.11 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.788 0.804 . . . . 52.43 109.541 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -114.31 139.6 49.31 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.308 -1.315 . . . . 54.53 107.576 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.52 17.6 21.85 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.53 0.937 . . . . 73.14 113.53 -173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -126.33 125.52 42.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.935 -0.765 . . . . 51.5 108.935 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 164' ' ' CYS . 70.3 m -127.78 144.05 51.1 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.689 -0.804 . . . . 74.15 111.79 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.58 135.09 26.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.685 -1.228 . . . . 62.43 107.685 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.3 p -80.77 116.33 20.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.163 -1.051 . . . . 65.45 108.163 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.07 157.84 26.1 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.452 -1.249 . . . . 44.11 109.96 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.13 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 62.21 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 154' ' ' VAL . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.54 111.087 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.21 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.15 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 62.42 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.42 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.23 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.24 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 74.52 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 64.24 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.51 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 71.24 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.14 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.46 HH11 HD13 ' A' ' 136' ' ' ILE . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 74.24 109.71 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.24 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 36.5 t -124.61 149.15 47.39 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.34 108.652 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 9.3 mmpt? -79.83 143.68 34.17 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.837 0.827 . . . . 74.14 112.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -123.1 104.03 8.94 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.357 -1.292 . . . . 73.01 108.006 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -92.37 0.39 Allowed Glycine 0 C--N 1.312 -0.774 0 O-C-N 123.722 0.639 . . . . 60.32 112.274 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.5 t -111.92 168.56 9.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.357 -0.609 . . . . 54.43 109.357 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.18 85.87 6.73 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.023 0.916 . . . . 70.33 112.744 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.34 149.26 72.09 Favored Pre-proline 0 C--N 1.29 -1.982 0 CA-C-N 114.443 -1.253 . . . . 64.14 109.14 170.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -53.94 155.4 14.83 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.157 2.572 . . . . 71.12 112.452 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.4 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.416 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.54 114.853 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.45 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.34 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.41 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.22 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.549 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.02 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.42 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 73.33 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t -104.76 153.18 21.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 64.02 109.088 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.47 120.89 44.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.418 ' NH1' HG22 ' A' ' 185' ' ' THR . 1.4 tmt_? -108.03 124.51 50.29 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.8 -1.926 . . . . 71.05 105.8 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -95.44 129.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.785 -0.45 . . . . 64.23 109.785 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.418 HG22 ' NH1' ' A' ' 183' ' ' ARG . 44.3 p -130.3 -179.66 5.38 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.013 -0.736 . . . . 63.02 109.013 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.77 -16.12 61.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.266 0.555 . . . . 72.13 109.71 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.9 m -80.78 -24.68 38.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.478 -0.783 . . . . 71.45 109.349 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.19 -143.5 14.97 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.976 -0.63 . . . . 62.43 112.249 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.25 117.11 33.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 121.129 0.49 . . . . 74.14 110.448 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.49 146.48 48.03 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 115.668 -0.696 . . . . 74.3 110.364 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.76 143.92 30.35 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.913 -0.585 . . . . 74.03 110.22 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -136.0 151.65 74.16 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.42 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 70.02 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.11 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 72.33 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.41 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 72.02 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.21 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 173' ' ' GLY . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.31 108.878 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.24 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.04 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 201' ' ' VAL . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.33 111.997 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.01 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 63.43 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 71.55 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.3 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.31 112.323 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.44 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 54.2 109.709 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.01 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.2 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.32 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 61.45 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.13 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.22 110.199 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.492 HG22 ' HG3' ' A' ' 220' ' ' GLU . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.3 110.032 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 74.04 110.751 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.4 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.13 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 35.34 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.401 HG13 ' SD ' ' A' ' 237' ' ' MET . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.11 106.61 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 65.43 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.51 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 63.43 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.13 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 51.31 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 234' ' ' VAL . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 63.32 109.024 172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 71.53 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.1 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.32 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 62.11 111.187 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.11 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.4 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.34 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.55 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.3 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 63.3 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.53 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 61.04 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.456 ' HA ' ' HG2' ' A' ' 165' ' ' LYS . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.23 110.545 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.41 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.24 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 61.21 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 70.45 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.2 109.207 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 218' ' ' VAL . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.21 107.361 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 64.44 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.648 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo -62.26 132.79 40.33 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 61.52 111.073 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -92.83 -8.42 43.6 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.239 -0.892 . . . . 71.01 109.789 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 56.75 37.95 29.16 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.824 0.821 . . . . 63.21 109.756 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 66.88 67.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.88 -1.509 . . . . 75.33 110.485 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.153 1.381 . . . . 74.11 108.965 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.784 -0.927 . . . . 70.02 110.784 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.4 m -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.969 0.385 . . . . 54.45 110.121 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.61 152.39 27.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.076 0.465 . . . . 63.14 110.624 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.7 m -156.51 145.96 20.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.481 -2.044 . . . . 70.43 105.481 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -67.77 141.44 56.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.538 0.608 . . . . 62.03 110.658 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -97.74 114.08 64.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 115.977 -0.556 . . . . 73.54 110.626 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.62 38.69 0.58 Allowed 'Trans proline' 0 C--O 1.208 -0.988 0 C-N-CA 123.144 2.563 . . . . 50.33 112.024 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.0 m -76.27 -5.54 47.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.895 0.379 . . . . 55.31 111.089 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.7 pt -129.36 154.76 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 116.111 -0.495 . . . . 74.11 110.512 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 m 72.51 15.14 5.13 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.159 0.983 . . . . 64.14 113.09 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.7 pt -111.97 139.23 22.11 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 110.256 -0.276 . . . . 72.51 110.256 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.91 -159.93 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.747 2.298 . . . . 70.14 110.19 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -74.03 87.05 1.84 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.032 -1.099 . . . . 74.24 108.032 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -93.09 145.33 24.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.042 -0.981 . . . . 61.23 111.151 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.27 4.84 27.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.282 -0.417 . . . . 74.31 111.622 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -88.58 148.05 24.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.353 -0.61 . . . . 75.12 109.353 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.52 129.33 55.57 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.526 -0.916 . . . . 75.15 108.526 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.3 122.14 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.325 0 CA-C-N 115.556 -0.747 . . . . 74.3 109.893 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.3 p -80.14 119.74 23.33 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.356 -1.35 . . . . 45.33 107.356 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.55 154.64 42.4 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 211' ' ' LEU . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.51 111.087 -172.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.14 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.32 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.41 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.23 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 70.22 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG12 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.45 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.32 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.53 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.14 111.244 176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.52 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.41 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.545 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 65.52 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.14 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.545 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p -143.4 142.28 31.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.23 111.249 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 143.81 46.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.185 -0.672 . . . . 44.43 109.185 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -94.82 137.73 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.985 0.421 . . . . 73.44 110.532 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.21 -28.85 12.16 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.381 -0.827 . . . . 52.44 111.359 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.2 m 66.28 160.89 0.14 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.773 0.829 . . . . 60.23 112.474 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 74.76 8.99 4.2 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.612 0.968 . . . . 73.33 113.612 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.0 148.1 37.28 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 107.565 -1.272 . . . . 72.33 107.565 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.69 157.83 30.92 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.391 2.727 . . . . 75.1 111.824 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 55.24 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.32 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.44 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' HG22 ' A' ' 201' ' ' VAL . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 65.02 107.018 175.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.41 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.23 109.753 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 22.12 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.1 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t -102.33 143.31 32.24 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.1 107.359 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.49 123.58 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 121.58 0.705 . . . . 64.04 111.119 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -109.61 114.25 27.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.468 -0.938 . . . . 73.34 108.468 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -91.09 121.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.857 -0.424 . . . . 73.0 109.857 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 44.4 p -126.46 176.45 7.15 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.986 -0.552 . . . . 75.13 109.636 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.3 -15.74 63.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.22 0.533 . . . . 64.14 110.591 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 m -89.41 -12.48 40.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.04 -0.527 . . . . 75.4 110.301 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.62 -158.13 21.17 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.644 -0.982 . . . . 72.22 110.644 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.2 pp -100.13 143.68 30.05 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.297 0.549 . . . . 74.4 112.02 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -115.19 132.82 56.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.738 -0.665 . . . . 61.11 109.384 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.51 125.69 50.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.962 -1.125 . . . . 75.31 107.962 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -131.11 154.02 81.89 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 109.202 -0.666 . . . . 75.34 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.32 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.22 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 231' ' ' LEU . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.51 106.596 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.23 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.34 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.22 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 53.45 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 70.52 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 175' ' ' TYR . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.21 108.601 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.41 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 35.42 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.33 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 209' ' ' THR . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.23 112.576 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.23 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.01 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.42 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 205' ' ' LEU . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 74.15 110.49 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.41 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 212' ' ' LEU . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.12 112.449 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 249' ' ' VAL . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.21 109.994 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.44 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.32 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 61.02 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.35 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.43 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.41 109.495 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 52.51 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' HG22 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.53 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.13 108.604 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.43 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.33 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.4 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.1 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.22 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.4 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.21 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.2 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 55.22 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 195' ' ' ILE . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.13 110.369 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.21 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.497 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.24 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 230' ' ' THR . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.43 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.2 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.15 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.34 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.567 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.15 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 54.44 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.22 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.21 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 72.42 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.43 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.435 ' HA ' HH11 ' A' ' 162' ' ' ARG . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.41 108.858 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 72.41 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.22 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.33 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.02 108.864 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 218' ' ' VAL . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.1 108.651 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.41 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 71.31 108.833 173.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo -59.62 134.31 57.05 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 44.33 111.777 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.72 47.5 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.502 -0.772 . . . . 65.53 109.345 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.93 88.56 0.07 Allowed 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.213 0.945 . . . . 71.04 112.019 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.0 93.32 4.44 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.496 -0.927 . . . . 73.45 108.496 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 . . . . . 0 C--N 1.287 -2.138 0 CA-C-N 114.759 -1.11 . . . . 74.4 110.98 -175.251 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 111.196 -0.762 . . . . 74.4 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t 71.09 8.47 6.48 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.308 1.043 . . . . 62.31 112.655 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.02 -60.21 1.99 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.096 0.474 . . . . 62.44 110.714 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.4 m -81.39 93.92 6.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.844 -0.616 . . . . 70.35 110.179 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.81 153.84 43.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.386 -0.825 . . . . 73.04 108.792 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.39 112.29 65.39 Favored Pre-proline 0 C--N 1.29 -1.986 0 N-CA-C 107.514 -1.291 . . . . 50.35 107.514 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 108.98 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.315 2.677 . . . . 75.21 112.3 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -151.07 -45.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.224 -0.898 . . . . 74.1 110.867 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt 67.06 98.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.808 -1.087 . . . . 71.44 109.684 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.7 m -77.42 80.32 3.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.603 -0.726 . . . . 74.52 112.563 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.7 pt -114.91 132.09 23.15 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.161 -0.927 . . . . 75.3 109.773 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -92.12 -167.48 0.2 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 122.559 2.173 . . . . 73.14 110.682 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -84.91 77.28 10.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.991 -1.485 . . . . 72.02 106.991 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -144.0 82.66 1.72 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.416 -0.811 . . . . 75.34 109.405 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 63.4 m-85 -135.57 -24.92 1.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.914 0.709 . . . . 64.32 112.914 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -86.55 112.99 22.09 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.341 -1.726 . . . . 65.14 106.341 170.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 205' ' ' LEU . 66.2 m -110.59 135.63 50.94 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 115.026 1.491 . . . . 71.31 115.026 -167.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.44 139.74 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 73.52 104.833 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 17.6 m -83.84 119.13 24.48 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 117.694 -1.603 . . . . 71.32 109.893 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.34 143.67 26.2 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.31 -1.314 . . . . 61.33 108.878 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.12 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 246' ' ' ILE . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 53.33 111.514 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.43 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.45 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.54 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.583 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 62.12 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.44 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.45 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.562 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 71.34 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.23 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.23 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 65.55 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 146' ' ' SER . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.53 108.779 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 64.22 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.04 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t -122.25 166.55 14.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 54.02 108.691 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 243' ' ' SER . 7.4 ptpp? -127.19 143.22 51.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.086 0.469 . . . . 53.1 112.12 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -108.12 101.23 10.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.296 -0.411 . . . . 73.14 110.964 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.88 -55.32 3.04 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-O 121.613 0.563 . . . . 60.43 112.372 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.7 m -135.69 -178.4 5.11 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.058 -1.46 . . . . 65.41 107.058 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.3 -60.56 2.17 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.516 -0.474 . . . . 53.14 110.918 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 59.92 167.52 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 123.902 0.751 . . . . 74.33 112.339 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.81 155.19 61.25 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.657 1.571 . . . . 74.13 109.129 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 72.0 111.491 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.53 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.432 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 70.14 110.079 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.32 106.208 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 63.42 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 53.34 109.574 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.464 ' HB3' HD11 ' A' ' 231' ' ' LEU . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.45 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 63.31 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t -103.69 144.18 31.79 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.13 107.415 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 191' ' ' LYS . 63.2 t -93.37 115.36 32.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 106.513 -1.662 . . . . 70.41 106.513 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -106.84 131.8 53.53 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 108.092 -1.077 . . . . 71.14 108.092 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.3 113.8 31.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.65 -0.87 . . . . 73.44 108.65 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.8 p -120.84 -178.22 3.68 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.239 -0.652 . . . . 74.15 109.239 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.66 -15.46 60.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.06 -0.719 . . . . 61.45 109.06 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -84.99 -8.59 58.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.335 -0.848 . . . . 62.51 109.365 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.55 -140.89 16.64 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.069 -0.514 . . . . 31.54 112.831 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.17 124.55 45.72 Favored 'General case' 0 CA--C 1.476 -1.884 0 CA-C-O 120.882 0.372 . . . . 72.4 110.583 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.65 136.32 37.35 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.408 -0.815 . . . . 61.23 110.297 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 182' ' ' VAL . 48.4 mtpt -104.19 127.11 51.77 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.367 -0.533 . . . . 73.12 110.831 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -132.91 156.67 79.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.072 -1.084 . . . . 74.12 108.072 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.4 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.3 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.02 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 61.34 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.44 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.34 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 70.31 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 64.24 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.486 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 70.22 107.605 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.23 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.42 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 144' ' ' CYS . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.04 113.659 -174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 52.43 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.02 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.31 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.494 HG21 ' CB ' ' A' ' 146' ' ' SER . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 64.52 110.347 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.3 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 209' ' ' THR . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.11 113.499 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 249' ' ' VAL . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 64.34 111.078 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.33 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 63.34 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.599 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.33 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 45.22 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.3 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.33 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.11 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.01 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.11 109.818 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.43 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.32 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.31 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 64.21 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 64.05 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.43 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 178' ' ' ASP . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.21 111.744 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.42 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' MET . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 64.32 112.393 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.21 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 41.51 110.266 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.13 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 72.12 108.794 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 64.45 112.39 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.41 109.3 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 43.24 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.11 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 33.25 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.585 ' HA ' ' HE2' ' A' ' 165' ' ' LYS . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.253 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.05 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.3 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 149' ' ' ILE . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.14 107.373 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.15 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 212' ' ' LEU . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.44 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.599 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo -61.95 135.69 56.94 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 55.24 109.629 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -34.59 71.36 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.707 -0.679 . . . . 65.3 110.929 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 65.6 11.26 7.35 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.871 0.844 . . . . 70.51 110.308 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -134.06 86.38 2.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.085 -1.82 . . . . 75.55 106.085 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 107.388 -1.338 . . . . 63.11 107.388 -176.197 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.153 0 N-CA-C 110.619 -0.992 . . . . 42.15 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.5 m -79.63 94.83 5.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.196 0.498 . . . . 75.22 110.667 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -120.68 -60.21 1.68 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.738 -0.665 . . . . 72.33 109.378 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.2 m 51.45 72.21 0.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.192 0.933 . . . . 55.33 110.775 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -103.02 137.39 41.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.279 -0.873 . . . . 72.42 111.019 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -101.13 108.29 54.02 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.67 -1.233 . . . . 42.1 107.67 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 133' ' ' ALA . 3.2 Cg_exo -81.28 170.36 14.89 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.499 2.133 . . . . 70.41 111.455 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.9 m -77.13 -22.46 52.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.231 -1.026 . . . . 73.11 108.231 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.7 mt 72.6 114.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 114.372 -1.285 . . . . 42.04 111.757 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 t -80.98 97.16 7.35 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.861 -0.792 . . . . 64.22 108.861 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -77.58 143.32 67.71 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.452 -0.794 . . . . 72.41 110.155 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.92 113.77 0.65 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.81 3.007 . . . . 74.1 113.53 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -146.07 23.1 1.37 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.907 -0.775 . . . . 73.34 108.907 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.711 ' HB3' ' O ' ' A' ' 143' ' ' ARG . 18.8 m-20 -83.82 133.38 34.75 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.796 -1.093 . . . . 64.3 111.802 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -92.16 -20.04 21.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.593 -1.262 . . . . 64.14 107.593 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.711 ' O ' ' HB3' ' A' ' 141' ' ' ASP . 40.5 ttm180 -120.31 142.57 48.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.251 -2.129 . . . . 70.3 105.251 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.0 t -106.74 128.91 54.61 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.962 -0.755 . . . . 72.23 108.962 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.0 139.11 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 115.052 -0.976 . . . . 71.52 110.758 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -81.45 139.64 35.1 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.815 -1.084 . . . . 72.32 109.594 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.54 153.69 46.25 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 116.242 -0.435 . . . . 54.34 109.84 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 63.05 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 60.52 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.15 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.14 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 158' ' ' HIS . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.8 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.31 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.14 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.534 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.32 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.416 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 62.35 108.554 170.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG22 ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 61.23 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 212' ' ' LEU . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.42 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.536 HH11 ' HA ' ' A' ' 244' ' ' ASN . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 63.34 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.21 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.42 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p -116.71 161.03 19.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 61.04 112.285 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.557 ' NZ ' ' HA ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -104.76 144.68 31.41 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 123.411 0.685 . . . . 61.42 109.839 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -118.26 101.88 8.54 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.832 -0.622 . . . . 63.1 110.163 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -43.52 0.53 Allowed Glycine 0 N--CA 1.467 0.762 0 O-C-N 124.32 1.012 . . . . 62.5 114.398 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.2 p -142.91 160.5 40.22 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.251 -1.018 . . . . 63.24 108.251 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 1.5 p30 -53.49 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.327 1.017 . . . . 72.04 112.355 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 59.95 161.46 0.1 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 123.318 0.647 . . . . 73.54 111.875 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.85 155.97 64.67 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 122.397 2.065 . . . . 73.44 112.56 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.1 107.947 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.52 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.45 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 71.11 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.05 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 63.14 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 64.53 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.3 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.04 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t -107.51 149.3 28.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 61.1 106.373 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.36 127.32 49.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 119.666 -0.814 . . . . 75.22 111.7 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -110.82 136.0 50.53 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.877 -1.157 . . . . 72.23 107.877 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.6 t -106.68 113.94 44.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.162 -0.615 . . . . 74.12 109.9 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.5 p -110.52 -174.7 2.54 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.076 -0.511 . . . . 74.44 110.497 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.31 71.5 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.899 0.381 . . . . 55.15 111.848 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 p -80.26 -23.52 40.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.038 -0.528 . . . . 73.24 110.517 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.21 -153.65 22.47 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.436 -0.888 . . . . 61.11 111.826 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.406 ' H ' ' CD2' ' A' ' 189' ' ' LEU . 1.5 pt? -83.47 135.54 34.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.878 -0.415 . . . . 64.33 109.878 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -137.34 146.1 44.17 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.635 -0.876 . . . . 72.53 108.635 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -101.19 125.78 47.84 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.275 -0.57 . . . . 75.41 111.179 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.01 166.05 11.5 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.184 -0.917 . . . . 71.1 108.528 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.54 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.45 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 62.14 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.2 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.21 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 72.21 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.4 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.05 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.33 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.13 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.42 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 63.31 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 60.12 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 73.42 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.21 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 211' ' ' LEU . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.45 111.105 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.43 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 209' ' ' THR . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 71.32 111.653 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 249' ' ' VAL . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.04 107.901 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 63.24 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 53.3 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.41 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.35 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 72.24 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 249' ' ' VAL . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 64.3 109.467 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 220' ' ' GLU . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 52.03 110.446 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.43 110.865 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 64.33 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 44.51 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 73.22 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.52 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.11 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 64.11 111.301 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.54 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.42 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 54.4 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.33 109.541 176.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.05 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.44 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.23 112.078 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 230' ' ' THR . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.42 111.337 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 53.54 110.879 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.11 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.04 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.441 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.33 112.666 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 235' ' ' THR . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 72.33 109.267 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.12 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.44 111.004 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.3 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 63.21 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.536 ' HA ' HH11 ' A' ' 162' ' ' ARG . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 52.02 108.411 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 241' ' ' ASN . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.11 110.416 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 71.11 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.11 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.41 108.004 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 218' ' ' VAL . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.05 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 71.24 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo -59.81 134.6 58.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 64.44 110.48 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.75 -0.25 57.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.624 0.726 . . . . 52.32 109.585 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.51 66.72 0.76 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.468 -1.242 . . . . 73.32 108.3 -176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 69.38 -37.83 0.38 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.002 1.321 . . . . 72.32 114.48 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.304 -1.38 0 C-N-CA 122.85 0.46 . . . . 73.24 111.21 -178.176 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.935 -0.866 . . . . 61.13 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.9 m -109.97 -25.3 10.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.484 -0.486 . . . . 72.42 110.525 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 44.48 82.02 0.03 OUTLIER 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.27 1.028 . . . . 75.42 112.33 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -147.15 119.17 8.19 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.308 0.575 . . . . 65.0 112.118 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 127.4 18.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.532 -1.655 . . . . 74.13 106.532 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 109.03 58.68 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 120.123 -0.631 . . . . 73.3 111.335 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.46 -27.66 9.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.779 1.653 . . . . 65.53 109.404 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 m -86.71 84.74 7.32 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.855 -1.066 . . . . 60.44 110.232 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.59 -15.94 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.853 -1.166 . . . . 72.34 107.853 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -45.14 111.09 0.29 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.949 1.7 . . . . 42.32 111.943 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.7 pt -92.66 144.23 28.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.766 -0.652 . . . . 61.14 110.633 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.77 179.01 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.679 1.586 . . . . 74.23 109.351 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -74.94 -22.75 58.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.518 -0.873 . . . . 70.11 109.045 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.0 98.75 8.08 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.744 -1.206 . . . . 73.42 107.744 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -97.83 98.22 9.64 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.141 -0.689 . . . . 72.55 109.141 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -126.77 108.1 10.74 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.923 -1.14 . . . . 62.11 107.923 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.6 p -110.52 143.93 40.13 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.634 -0.506 . . . . 62.22 109.634 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.43 141.2 41.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.351 -0.386 . . . . 51.31 111.689 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 p -71.43 138.19 48.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.141 0.496 . . . . 71.51 110.532 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.6 158.25 43.8 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.522 -0.763 . . . . 72.33 109.583 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.42 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 70.14 110.522 -175.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.43 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 71.35 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.1 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.42 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 45.35 111.399 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.42 110.528 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 54.32 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.1 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.12 108.824 171.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 52.24 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 62.42 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 212' ' ' LEU . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 61.31 108.735 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.434 HH11 HG12 ' A' ' 246' ' ' ILE . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 71.41 108.939 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.52 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p -118.54 167.97 11.12 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.12 107.346 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -77.91 121.83 24.68 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.212 0.53 . . . . 75.14 111.904 -171.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -136.39 149.93 48.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.967 -1.123 . . . . 72.42 107.967 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 66.68 12.49 59.38 Favored Glycine 0 CA--C 1.519 0.295 0 O-C-N 123.661 0.601 . . . . 74.45 113.815 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m 67.17 -68.81 0.14 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 124.319 1.048 . . . . 72.33 112.595 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -133.4 5.8 3.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 121.536 -0.728 . . . . 73.25 111.867 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -62.83 143.27 97.13 Favored Pre-proline 0 C--O 1.245 0.865 0 CA-C-N 116.536 -0.302 . . . . 72.11 111.443 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.89 156.15 16.2 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 123.652 2.901 . . . . 74.12 112.758 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.664 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.02 110.975 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 24.21 114.924 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.41 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.41 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.33 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 72.54 107.937 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.615 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.15 109.975 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 34.24 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.532 ' HB ' ' NZ ' ' A' ' 191' ' ' LYS . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 72.14 111.964 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.443 ' HB2' ' HA3' ' A' ' 194' ' ' GLY . 42.2 t -102.52 154.25 19.29 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.35 109.046 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HE2' ' A' ' 191' ' ' LYS . 91.9 t -110.78 114.5 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.428 -0.952 . . . . 73.14 108.428 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.479 ' HB3' ' HG3' ' A' ' 190' ' ' GLU . 17.0 tpp180 -108.53 125.72 52.13 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.259 -1.015 . . . . 74.34 108.259 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.03 113.82 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.523 -0.547 . . . . 72.4 109.523 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.7 p -115.3 -178.33 3.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.19 -0.459 . . . . 65.55 110.461 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.89 66.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.754 0.312 . . . . 73.04 111.378 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.0 m -83.5 -16.63 44.84 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.883 0.373 . . . . 61.31 110.785 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.02 -154.51 21.93 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.125 -0.79 . . . . 44.2 111.125 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.91 143.58 27.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.584 -0.895 . . . . 63.11 108.584 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 183' ' ' ARG . 10.8 pt-20 -134.14 144.23 48.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.63 -0.508 . . . . 74.35 109.63 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.532 ' NZ ' ' HB ' ' A' ' 180' ' ' THR . 2.0 mmmp? -105.51 126.88 52.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.573 -0.529 . . . . 64.52 109.573 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -134.48 162.44 57.67 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.42 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 181' ' ' SER . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.15 111.967 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.51 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 64.53 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.54 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 51.45 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 72.13 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.33 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.444 HG22 ' CA ' ' A' ' 173' ' ' GLY . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.22 108.811 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.04 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.13 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 32.21 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 50.54 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.45 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.1 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.11 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 44.55 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 63.24 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 71.11 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.43 HD21 HG11 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 62.13 109.62 -176.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.41 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.23 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.4 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.14 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.31 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 65.21 110.366 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 250' ' ' LYS . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.05 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 31.41 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 43.11 110.812 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 42.3 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 53.5 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.33 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 224' ' ' ILE 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.33 114.275 -177.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.3 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.4 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 62.43 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 55.22 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.45 111.517 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 51.11 111.073 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.03 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.13 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.12 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.14 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.21 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.42 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 53.12 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.05 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.542 ' HB2' HD13 ' A' ' 245' ' ' LEU . 3.2 m-20 -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 63.11 107.325 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.1 113.778 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.54 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.23 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 241' ' ' ASN . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 54.53 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG12 HH11 ' A' ' 162' ' ' ARG . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 60.43 108.104 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.21 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.24 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 218' ' ' VAL . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.45 108.704 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.44 106.624 171.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo -61.78 134.71 51.85 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.31 111.574 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.77 -9.79 58.9 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.652 -0.87 . . . . 74.02 108.652 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 50.1 t30 70.29 75.8 0.21 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.837 -1.529 . . . . 74.53 111.77 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -89.79 107.69 19.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.024 -1.102 . . . . 74.42 108.024 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 107.738 -1.208 . . . . 65.13 107.738 -177.352 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 112.328 -0.309 . . . . 74.41 112.328 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -74.3 121.03 20.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.927 -0.768 . . . . 74.41 108.927 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.78 95.95 0.06 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.793 0.806 . . . . 74.41 111.601 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -129.65 157.58 41.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.992 -1.004 . . . . 74.12 108.34 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.62 128.92 33.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.748 -0.381 . . . . 71.43 110.149 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 134' ' ' PRO . . . -105.34 110.47 64.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.785 -0.821 . . . . 44.02 108.785 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 133' ' ' ALA . 10.6 Cg_endo -56.52 -47.22 24.98 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.722 2.282 . . . . 70.4 112.083 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.4 m 55.98 86.38 0.06 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.297 1.039 . . . . 72.03 112.688 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.86 94.27 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.328 -0.99 . . . . 43.02 108.328 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.9 p -151.64 157.14 41.73 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.211 -0.904 . . . . 73.22 110.242 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -95.12 142.74 25.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 109.867 -0.42 . . . . 62.11 109.867 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.15 102.39 0.92 Allowed 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.091 1.86 . . . . 74.4 111.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -85.38 149.26 25.56 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.277 -0.874 . . . . 65.24 109.831 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -136.94 93.84 2.89 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.601 0.715 . . . . 74.32 110.768 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.09 -70.74 0.68 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.423 -1.325 . . . . 72.53 107.423 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -144.75 127.54 16.29 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.523 -0.762 . . . . 72.42 109.907 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 166' ' ' HIS . 27.2 p -115.51 146.45 41.68 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.078 -1.082 . . . . 61.42 108.078 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.71 135.33 35.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.362 0.601 . . . . 74.12 112.027 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 205' ' ' LEU . 12.1 p -87.94 119.87 28.71 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.569 -1.271 . . . . 51.24 107.569 171.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.5 156.64 47.34 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.895 -0.593 . . . . 73.24 111.112 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.22 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.1 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.02 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.1 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.03 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.24 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 158' ' ' HIS . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.35 112.185 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.15 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 64.42 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.13 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.428 ' HB2' HG13 ' A' ' 154' ' ' VAL . 2.1 m-70 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.41 110.265 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.24 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 73.44 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 65.54 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.14 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 64.51 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.69 148.73 40.78 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.8 OUTLIER -89.65 127.94 35.99 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.036 -1.468 . . . . 75.21 107.036 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 19.5 t-80 -141.93 131.65 24.15 Favored 'General case' 0 CA--C 1.484 -1.58 0 O-C-N 123.0 0.187 . . . . 71.33 110.929 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.77 -47.28 3.48 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.018 -0.833 . . . . 61.01 111.018 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.5 t 174.41 -175.28 0.08 Allowed 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.426 -1.324 . . . . 63.11 107.426 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.12 83.75 6.7 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.964 0.888 . . . . 61.24 111.127 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.94 156.52 55.11 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.586 -1.188 . . . . 74.05 109.151 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.13 157.16 55.01 Favored 'Trans proline' 0 C--O 1.254 1.325 0 C-N-CA 123.345 2.697 . . . . 74.04 111.692 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 64.45 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.4 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 201' ' ' VAL . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.14 107.914 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 63.42 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.13 110.51 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 62.02 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.3 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t -109.61 149.24 29.98 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.42 108.917 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.94 113.81 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 106.56 -1.644 . . . . 62.12 106.56 174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -108.23 133.32 52.63 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 116.077 -0.511 . . . . 74.5 110.302 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 119.02 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 115.449 -0.796 . . . . 53.11 109.751 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 64.0 p -119.07 -174.8 2.78 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.969 -0.752 . . . . 72.11 108.969 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.257 0.551 . . . . 63.14 109.596 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.6 m -91.02 -17.84 25.6 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.935 -0.575 . . . . 74.54 111.005 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.68 -153.67 20.57 Favored Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 120.286 -0.959 . . . . 74.1 112.457 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.91 134.1 36.64 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 120.815 0.34 . . . . 35.01 110.601 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.32 146.99 45.27 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.631 -0.713 . . . . 45.15 110.571 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.07 125.78 44.65 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.407 -1.331 . . . . 71.03 107.407 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -143.7 150.52 50.7 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 122.175 -0.328 . . . . 73.13 110.471 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.22 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.24 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.4 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.33 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 61.14 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.23 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 175' ' ' TYR . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.45 107.776 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.24 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 71.53 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 65.43 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 209' ' ' THR . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.15 113.758 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 40.12 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 62.44 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.12 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 205' ' ' LEU . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.11 112.129 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 63.02 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.05 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 65.34 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.24 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.41 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.42 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.33 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 249' ' ' VAL . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 71.35 110.93 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.443 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 55.01 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.32 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.533 HG11 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 64.44 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 62.32 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.52 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 65.24 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 52.35 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 224' ' ' ILE 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.44 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.54 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.44 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 233' ' ' GLN . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.04 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 71.22 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.12 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.14 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.33 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.3 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.21 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.21 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 71.45 109.176 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.55 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 61.42 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 70.11 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 50.54 110.049 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.23 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 43.53 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.41 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.24 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.22 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.23 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 61.41 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 218' ' ' VAL . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 41.22 108.562 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.443 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.13 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo -61.16 133.56 47.56 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 53.22 111.964 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -98.39 8.37 44.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.234 0.54 . . . . 55.44 110.091 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -78.66 86.79 4.61 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.736 -1.209 . . . . 73.14 107.736 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.25 116.67 14.06 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.297 -0.865 . . . . 71.15 112.066 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 . . . . . 0 C--N 1.306 -1.301 0 CA-C-N 115.391 -0.822 . . . . 74.31 110.458 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.885 -0.886 . . . . 54.14 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 t -77.09 105.61 8.27 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.168 0.509 . . . . 73.21 109.697 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.74 44.31 2.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.058 0.932 . . . . 71.1 109.05 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 m -62.65 -23.49 67.12 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.824 -1.535 . . . . 71.45 109.346 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.85 123.43 21.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.236 -0.893 . . . . 71.4 109.201 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.42 108.39 61.67 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 109.967 -0.383 . . . . 74.34 109.967 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.27 -2.75 9.42 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.453 2.102 . . . . 63.01 111.109 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m 67.8 18.81 9.7 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.221 1.008 . . . . 63.31 111.883 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.91 -16.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.467 0.651 . . . . 63.24 110.506 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.2 t -107.02 142.87 35.96 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 107.882 -1.155 . . . . 42.54 107.882 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.0 mm -84.43 133.58 44.36 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.121 -1.066 . . . . 75.21 108.121 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -67.69 76.61 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.511 2.141 . . . . 74.12 111.424 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -162.14 24.23 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.017 -2.216 . . . . 64.34 105.017 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.765 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 10.0 t70 -70.5 142.93 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 113.496 -1.684 . . . . 75.51 109.685 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.97 1.14 52.61 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 114.774 1.398 . . . . 65.21 114.774 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.765 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 19.2 ptt180 -91.92 117.02 29.41 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.337 -1.345 . . . . 61.24 110.55 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 40.5 t -110.32 129.43 55.75 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.751 -1.203 . . . . 71.55 107.751 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.74 135.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.043 0.449 . . . . 52.32 111.081 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.2 p -82.15 137.77 34.88 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.803 -0.814 . . . . 60.34 108.803 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -152.71 154.77 35.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 110.208 -0.293 . . . . 73.43 110.208 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.32 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 74.43 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 70.35 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 52.23 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.25 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.24 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 53.34 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.23 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.23 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 44.43 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.53 110.017 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 60.35 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.24 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.2 110.514 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.609 ' HG2' HD12 ' A' ' 149' ' ' ILE . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.22 108.987 174.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 64.45 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.469 ' N ' HD23 ' A' ' 163' ' ' LEU . 5.6 p -143.24 165.23 28.04 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 168' ' ' SER . 0.1 OUTLIER -108.31 142.36 38.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 120.05 -0.66 . . . . 72.31 110.246 176.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -97.36 98.25 9.81 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.612 -0.722 . . . . 64.11 110.795 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.05 -39.32 2.04 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 121.284 -0.484 . . . . 73.42 113.691 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 165' ' ' LYS . 33.9 m -142.38 151.14 41.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.054 -0.674 . . . . 45.15 111.104 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 165' ' ' LYS . 21.4 t70 -71.99 89.77 1.12 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.864 0.84 . . . . 75.31 112.141 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -80.8 156.63 72.54 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.174 -0.921 . . . . 62.42 109.739 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.51 156.24 61.8 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.635 2.223 . . . . 75.31 108.372 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.45 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.453 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.21 115.206 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.13 108.955 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 63.33 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 235' ' ' THR . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.3 111.23 175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.54 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.518 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.42 107.953 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.53 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 191' ' ' LYS . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.12 111.164 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t -103.52 142.0 35.04 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 55.13 106.984 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 191' ' ' LYS . 39.8 t -93.35 114.58 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.179 -1.415 . . . . 70.22 107.179 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -107.98 118.95 38.09 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.679 -1.146 . . . . 62.44 109.322 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.36 113.42 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 106.763 -1.569 . . . . 54.23 106.763 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -109.42 171.82 7.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 108.941 -0.763 . . . . 71.45 108.941 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.85 63.74 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.106 0.479 . . . . 74.24 109.928 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 m -98.06 -0.69 44.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.689 -0.687 . . . . 64.42 111.143 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.92 -143.97 17.12 Favored Glycine 0 CA--C 1.498 -1.023 0 C-N-CA 120.516 -0.85 . . . . 75.34 112.04 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.66 128.63 39.94 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.567 0.699 . . . . 72.23 112.316 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.75 146.72 49.05 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 114.29 -1.323 . . . . 75.31 108.929 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -114.71 125.31 53.58 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.623 -1.621 . . . . 75.32 106.623 175.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -136.75 149.87 68.26 Favored Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 120.528 -0.469 . . . . 73.12 110.683 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.43 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 63.14 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 74.4 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.11 109.501 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 53.31 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.3 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 60.01 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 63.51 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 173' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.41 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 62.52 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 33.34 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.31 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.21 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.32 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.44 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.42 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.24 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 52.45 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 72.42 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 249' ' ' VAL . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 60.42 108.443 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 55.05 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 50.44 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.32 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.131 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.43 110.673 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.24 109.979 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.34 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.22 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 42.55 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.12 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 54.51 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.43 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.44 114.375 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 52.23 109.186 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.13 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 62.15 107.638 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 234' ' ' VAL . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.12 109.585 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 63.45 110.326 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.33 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 51.44 111.864 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 230' ' ' THR . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.24 111.656 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.41 110.519 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.02 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.11 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.12 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 235' ' ' THR . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.24 109.09 176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.14 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.529 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.41 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.2 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.04 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 53.41 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 241' ' ' ASN . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.13 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 149' ' ' ILE . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 65.01 107.529 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 71.1 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.45 109.386 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 53.42 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo -59.98 134.43 56.52 Favored 'Trans proline' 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.79 -38.04 66.81 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.407 -0.815 . . . . 63.12 112.181 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 t30 49.21 81.35 0.05 Allowed 'General case' 0 C--N 1.347 0.484 0 O-C-N 124.349 1.03 . . . . 72.15 109.328 -171.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.34 -56.79 17.58 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.025 -0.988 . . . . 71.12 111.65 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 123.579 0.751 . . . . 74.22 109.384 176.204 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.411 0 N-CA-C 110.311 -1.115 . . . . 73.2 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 p -93.38 141.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.949 0.404 . . . . 63.34 112.084 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.71 100.46 3.43 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.695 1.198 . . . . 73.25 107.836 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.2 m -81.11 107.12 13.64 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.25 -0.432 . . . . 73.34 111.041 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 128.99 44.48 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.661 -0.496 . . . . 71.05 109.661 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.21 108.78 57.01 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.745 -0.465 . . . . 64.45 109.745 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.37 115.15 2.24 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.83 2.353 . . . . 54.23 110.761 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -83.71 84.91 7.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.312 0.577 . . . . 64.51 109.666 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.8 138.12 44.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.344 -1.354 . . . . 54.15 107.344 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.9 m -74.19 97.39 2.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.417 0.627 . . . . 74.34 110.569 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -77.67 144.01 68.52 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.451 -0.795 . . . . 64.15 110.203 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.85 146.2 93.98 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.461 2.107 . . . . 63.01 111.462 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -95.26 103.24 15.09 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 116.429 -0.351 . . . . 53.43 110.295 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.67 133.2 34.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.705 -0.85 . . . . 73.51 108.705 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -87.22 3.82 45.02 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.192 0.52 . . . . 72.32 110.32 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -75.18 149.0 39.1 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.364 -1.347 . . . . 52.21 107.364 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.5 t -108.43 127.29 53.77 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.819 -1.152 . . . . 75.34 108.662 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.55 141.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.249 -1.389 . . . . 75.45 107.249 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 161' ' ' VAL . 7.7 t -84.92 136.33 33.68 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 107.859 -1.163 . . . . 42.13 107.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.79 147.64 39.52 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.423 -0.954 . . . . 52.11 108.423 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.505 HD11 ' HG ' ' A' ' 211' ' ' LEU . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.13 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.04 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 35.5 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.13 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.32 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.21 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 158' ' ' HIS . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.31 112.347 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.14 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 44.12 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.34 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.414 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 70.44 108.139 170.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.14 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.43 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' ' 146' ' ' SER . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.51 108.446 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 70.24 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.51 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.02 134.81 52.42 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.33 111.921 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 170' ' ' LYS . 68.1 mttm -135.27 143.46 46.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.758 -0.46 . . . . 62.24 109.758 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.48 95.52 5.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.217 0.451 . . . . 75.01 112.217 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.85 -27.94 2.56 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 115.001 0.761 . . . . 71.32 115.001 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.0 t -104.05 133.96 48.13 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.088 0.471 . . . . 73.03 111.488 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.01 80.7 3.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.72 0.771 . . . . 64.3 109.739 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 63.8 mttp -101.23 163.09 18.6 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.286 -0.87 . . . . 71.41 111.144 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.99 156.6 15.26 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 123.058 2.505 . . . . 73.34 112.486 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.52 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.43 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.443 ' HB3' HD13 ' A' ' 200' ' ' LEU . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.52 110.787 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.22 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.33 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 63.53 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.01 109.303 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.22 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.12 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t -100.81 145.94 27.91 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 50.45 108.17 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.0 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.771 -0.65 . . . . 62.21 109.699 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.427 ' HG3' HG23 ' A' ' 185' ' ' THR . 2.9 tpp180 -109.97 112.0 23.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.273 -1.01 . . . . 74.31 108.273 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.33 113.7 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.642 -0.503 . . . . 72.35 109.642 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.427 HG23 ' HG3' ' A' ' 183' ' ' ARG . 26.4 p -124.32 -174.32 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.716 -0.674 . . . . 60.24 111.882 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.29 70.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.595 -0.73 . . . . 63.21 111.81 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.3 p -80.7 -24.13 39.07 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.513 . . . . 52.41 110.272 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.77 -145.1 15.62 Favored Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.313 -1.515 . . . . 22.02 109.313 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -92.48 140.27 29.74 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.139 -1.024 . . . . 61.35 109.42 176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.96 139.2 52.06 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.85 -0.426 . . . . 74.43 109.85 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -99.89 125.38 45.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.054 -1.091 . . . . 73.32 108.054 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 152.25 79.2 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.556 -0.905 . . . . 73.34 108.556 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.3 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.2 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 61.42 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 62.31 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 54.42 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 214' ' ' VAL . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 63.43 107.776 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 73.22 108.853 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.15 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.54 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.21 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.44 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.1 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 62.03 110.686 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.43 108.648 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.24 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 146' ' ' SER . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.02 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.31 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 44.12 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.471 HD22 ' CG2' ' A' ' 249' ' ' VAL . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 64.35 106.943 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.2 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.51 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 61.12 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.15 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 249' ' ' VAL . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.24 108.877 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 63.21 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.31 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.508 HG11 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.43 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.441 ' OD1' HD22 ' A' ' 245' ' ' LEU . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.1 112.172 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.24 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.11 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.33 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.43 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.32 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.21 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 45.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 73.31 110.095 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 178' ' ' ASP . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 61.3 109.559 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.44 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.02 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 230' ' ' THR . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.14 111.541 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.42 109.708 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.34 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.13 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 72.33 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.32 109.159 176.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 22.44 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 64.23 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.55 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 238' ' ' MET . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.12 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 53.12 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.22 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 218' ' ' VAL . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.33 108.523 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 54.42 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo -56.35 135.08 68.21 Favored 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.41 111.829 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.5 -27.42 66.98 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.021 -0.991 . . . . 53.32 109.263 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.9 t30 58.7 96.09 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.497 1.123 . . . . 64.04 110.564 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -76.72 101.07 5.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.316 0.579 . . . . 63.25 110.344 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 106.468 -1.678 . . . . 52.03 106.468 -178.931 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.606 0 N-CA-C 111.162 -0.775 . . . . 74.31 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.6 m -86.32 125.46 33.64 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.2 -0.296 . . . . 72.34 110.2 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -131.4 142.09 49.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.207 -0.664 . . . . 65.54 109.207 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.4 m -91.62 118.69 30.85 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.802 -0.814 . . . . 64.33 108.802 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.19 99.38 7.77 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.519 -0.919 . . . . 74.54 108.519 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 134' ' ' PRO . . . -84.2 112.37 40.73 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 109.049 -0.723 . . . . 41.53 109.049 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 133' ' ' ALA . 9.8 Cg_endo -52.96 113.42 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.767 2.312 . . . . 75.43 111.222 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.5 m -95.54 92.4 6.63 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.302 -0.999 . . . . 71.33 108.302 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -112.73 106.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 115.311 -0.859 . . . . 74.12 110.242 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.2 m -75.82 110.8 10.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.437 -1.32 . . . . 64.14 107.437 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 34.0 pt -80.21 124.68 82.55 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 116.636 -0.256 . . . . 74.41 111.391 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 11.4 Cg_exo -73.54 179.23 5.77 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.715 2.277 . . . . 45.21 112.055 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.56 82.02 7.0 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.77 0.795 . . . . 63.41 111.132 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -167.0 161.43 14.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.395 -2.076 . . . . 71.45 105.395 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.45 87.82 2.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 115.942 1.83 . . . . 73.14 115.942 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 103.01 12.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.203 -2.147 . . . . 65.21 105.203 162.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 58.6 m -113.66 138.15 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.854 -0.739 . . . . 72.12 111.343 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.62 139.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 108.068 -1.086 . . . . 74.41 108.068 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 205' ' ' LEU . 17.4 m -92.51 134.69 34.72 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.001 -1.111 . . . . 60.34 108.001 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.71 156.51 46.76 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.454 -0.339 . . . . 51.4 110.794 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.32 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 246' ' ' ILE . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.41 109.798 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 64.42 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.2 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 60.42 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 55.3 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.41 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.24 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 50.3 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.23 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 70.45 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.53 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 63.13 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 72.23 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 72.44 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.474 ' N ' HD23 ' A' ' 163' ' ' LEU . 36.6 t -132.55 166.72 21.43 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.4 107.564 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.0 OUTLIER -78.0 138.66 38.94 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.638 -1.245 . . . . 74.15 107.638 -176.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -131.75 110.5 10.91 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.114 -0.366 . . . . 74.51 111.976 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.84 -63.89 4.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.39 -0.368 . . . . 64.21 112.985 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.1 t -150.13 -178.79 6.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.614 -1.624 . . . . 75.11 106.614 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.9 82.09 4.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.922 0.868 . . . . 73.5 110.557 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.13 154.35 43.22 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.455 -1.248 . . . . 61.32 110.96 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.99 158.06 56.36 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 123.828 3.019 . . . . 72.24 110.506 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.12 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.3 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.54 109.332 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.609 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.55 106.666 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.14 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.14 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.35 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 63.04 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -103.12 150.08 23.99 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.11 114.71 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.497 -1.297 . . . . 74.1 107.497 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 31.5 tpt180 -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.318 -0.623 . . . . 74.33 109.318 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.12 113.72 30.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.491 -0.559 . . . . 73.52 109.491 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 52.1 p -113.3 -174.15 2.4 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.999 -1.112 . . . . 54.41 107.999 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.02 60.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.187 0.518 . . . . 62.12 109.722 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -84.23 -25.13 29.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.378 0.609 . . . . 64.43 109.712 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.05 -167.96 27.14 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 110.593 -1.003 . . . . 45.44 110.593 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.9 pp -100.54 138.3 37.78 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.442 -0.577 . . . . 74.03 109.442 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.17 146.25 50.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.623 -0.431 . . . . 70.1 110.243 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.75 135.37 38.8 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.319 -1.363 . . . . 53.54 107.319 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.06 155.48 58.62 Favored Pre-proline 0 C--N 1.286 -2.154 0 C-N-CA 120.393 -0.523 . . . . 71.32 110.28 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.24 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.01 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 63.43 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.4 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.34 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 65.41 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.11 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 206' ' ' ALA . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.52 109.71 175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.43 107.753 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.23 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.33 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.03 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD11 ' OG ' ' A' ' 146' ' ' SER . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.24 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.11 110.426 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 52.35 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 44.14 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.477 ' HB ' HD13 ' A' ' 211' ' ' LEU . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 70.43 111.393 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.11 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 209' ' ' THR . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.21 107.321 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.21 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.03 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.11 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.466 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.23 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 249' ' ' VAL . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 51.35 110.94 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.02 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 248' ' ' THR . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.13 111.39 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 63.01 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 63.31 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 71.41 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.24 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.3 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.32 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 63.13 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.34 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 32.31 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.43 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.21 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.02 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 52.42 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 239' ' ' VAL . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 72.31 110.404 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 62.0 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.12 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.497 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.22 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 235' ' ' THR . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.32 109.683 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.2 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.402 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.13 111.767 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.04 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.14 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.43 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 241' ' ' ASN . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.42 110.885 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 149' ' ' ILE . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.14 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 73.24 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 218' ' ' VAL . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 60.05 107.688 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.51 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo -58.28 133.84 57.72 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.33 111.427 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.81 -6.88 57.92 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.214 -0.903 . . . . 72.33 110.352 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 59.91 33.66 21.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.358 1.075 . . . . 70.35 108.637 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.38 89.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.9 -1.5 . . . . 73.23 112.518 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.105 1.762 . . . . 74.21 110.112 176.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 111.208 -0.757 . . . . 75.43 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.1 m -73.43 130.81 40.92 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.751 0.421 . . . . 61.0 109.942 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 11.6 mptt -80.96 78.25 7.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.059 0.933 . . . . 74.05 111.358 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.7 m -162.02 -62.97 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.72 -1.585 . . . . 62.15 106.72 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 56.79 86.33 0.07 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.537 1.135 . . . . 62.52 113.373 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 118.47 60.07 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.462 -0.79 . . . . 71.13 109.726 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.8 -179.27 4.07 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.588 2.192 . . . . 73.25 111.134 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.7 m 68.95 108.77 0.05 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.687 0.795 . . . . 74.44 110.284 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -73.55 94.76 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.542 0.687 . . . . 72.02 110.195 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.6 p -101.35 115.08 29.68 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 115.323 -0.853 . . . . 55.12 110.456 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -109.26 142.75 26.28 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 109.094 -0.706 . . . . 61.42 109.094 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.01 117.22 4.05 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.825 2.35 . . . . 65.21 112.796 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -100.9 73.95 1.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.705 -1.22 . . . . 74.32 107.705 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 28.9 t70 -135.42 -168.4 2.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.501 -1.296 . . . . 63.45 107.501 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.455 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 85.0 t80 -83.16 -34.81 25.93 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 119.092 0.86 . . . . 71.02 109.775 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -121.74 148.98 43.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.984 -0.553 . . . . 64.42 110.904 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 164' ' ' CYS . 32.4 m -125.04 150.44 46.77 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.014 -1.476 . . . . 50.52 107.014 176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.81 140.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.522 -0.548 . . . . 45.34 109.522 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.638 ' HB3' HG21 ' A' ' 209' ' ' THR . 21.6 t -88.45 138.83 31.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.278 0.561 . . . . 72.52 109.613 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.12 44.66 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.018 -1.105 . . . . 25.45 108.018 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.33 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 63.11 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.12 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.11 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.32 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.4 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.43 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.05 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 64.45 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.682 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 64.05 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.14 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 73.42 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.55 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.45 108.01 -176.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.34 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . 16.5 t -143.53 129.4 19.44 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.52 108.936 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' N ' ' HD3' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -138.94 145.14 39.44 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.515 1.126 . . . . 73.44 111.677 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 82.2 m-70 -135.87 160.2 39.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 110.092 -0.336 . . . . 72.54 110.092 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.81 -68.94 2.17 Favored Glycine 0 CA--C 1.509 -0.338 0 O-C-N 123.585 0.553 . . . . 74.14 112.262 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 m -117.74 128.33 54.78 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.198 -1.038 . . . . 75.52 108.198 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -93.97 89.59 6.13 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.557 0.694 . . . . 62.34 111.768 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.26 135.51 94.95 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 75.11 107.696 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.52 156.75 13.5 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.16 2.573 . . . . 74.3 110.391 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 71.02 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.24 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 60.03 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.43 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 235' ' ' THR . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.34 111.752 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 74.31 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.33 108.779 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.33 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 52.01 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -103.2 141.86 35.15 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.41 109.123 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -94.11 114.04 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 107.799 -1.186 . . . . 73.23 107.799 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -108.51 120.08 41.38 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.49 -0.777 . . . . 72.12 110.004 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.91 126.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.168 -0.678 . . . . 45.43 109.168 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.5 p -128.47 179.0 5.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.673 -0.862 . . . . 70.02 108.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.36 61.16 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.317 0.58 . . . . 63.14 110.132 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.9 m -87.57 -9.77 53.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.852 -0.613 . . . . 75.32 110.346 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.79 -152.85 17.65 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 109.776 -1.329 . . . . 51.35 109.776 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -100.35 135.25 42.08 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.174 0.987 . . . . 64.43 111.682 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.99 142.92 49.33 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.915 -1.143 . . . . 73.5 107.915 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -111.86 135.74 52.08 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.5 -0.48 . . . . 73.54 109.707 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -144.65 156.25 56.32 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.853 -0.612 . . . . 63.22 110.537 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.23 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.03 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 64.43 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 43.5 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 214' ' ' VAL . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.54 108.285 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.05 109.728 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 50.54 108.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 70.35 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.23 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.13 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.45 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.52 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.41 107.6 176.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.1 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.638 HG21 ' HB3' ' A' ' 146' ' ' SER . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 62.15 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 33.15 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 71.14 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.12 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.41 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 199' ' ' ARG . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.13 114.368 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.55 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.22 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.22 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 249' ' ' VAL . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.2 110.149 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 250' ' ' LYS . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 71.11 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.04 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.34 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 34.44 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.43 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.51 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.427 HG21 HG23 ' A' ' 218' ' ' VAL . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.45 112.493 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.487 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 40.33 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 54.2 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.12 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 234' ' ' VAL . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.22 109.72 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 33.2 110.164 175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.32 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.1 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 230' ' ' THR . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 72.4 111.195 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 239' ' ' VAL . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.22 110.843 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.14 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.24 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.3 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 235' ' ' THR . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.01 109.642 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 64.32 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.588 ' HB2' HD23 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.05 110.8 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 65.11 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.4 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 65.24 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 241' ' ' ASN . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.23 109.3 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.33 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 50.43 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.44 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HD22 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 64.04 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.54 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo -60.75 134.8 56.03 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 74.23 110.855 176.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.84 59.62 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.979 -0.555 . . . . 64.44 110.233 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 54.5 t30 66.63 -177.06 0.2 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 124.275 0.984 . . . . 62.3 108.73 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 12.7 mm-40 -80.91 88.8 5.86 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.739 -0.837 . . . . 61.31 108.739 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.213 -1.403 . . . . 73.45 107.213 -178.472 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.424 0 N-CA-C 110.097 -1.201 . . . . 73.43 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.7 m -79.22 81.85 5.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 120.536 0.207 . . . . 72.41 111.365 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -175.78 92.97 0.06 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.423 0.689 . . . . 73.32 109.766 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -74.11 107.03 6.06 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.215 -0.448 . . . . 75.3 110.759 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -114.38 145.93 41.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.092 0.472 . . . . 74.44 111.909 -177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.64 108.43 58.11 Favored Pre-proline 0 N--CA 1.422 -1.827 0 N-CA-C 105.538 -2.023 . . . . 54.45 105.538 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.98 -5.96 18.14 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.426 2.084 . . . . 53.12 112.881 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.8 m 57.35 75.35 0.37 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.014 0.912 . . . . 73.52 109.923 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.2 mt -91.49 104.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.82 -1.082 . . . . 73.2 109.554 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 p -70.65 102.04 2.19 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 52.43 110.215 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.5 pt -94.38 137.99 22.55 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.976 -0.556 . . . . 64.04 109.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.65 137.67 65.3 Favored 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 122.538 2.159 . . . . 73.1 111.671 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -82.65 88.26 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.503 -0.925 . . . . 72.12 108.503 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 13.6 t70 -159.09 -179.25 7.85 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.294 -1.743 . . . . 70.03 106.294 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -91.13 -29.68 17.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.172 -0.677 . . . . 75.43 109.172 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 39.5 ptt180 -75.8 149.12 37.99 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.311 0.577 . . . . 75.03 111.534 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 164' ' ' CYS . 34.8 m -129.84 151.23 50.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.725 0.774 . . . . 64.14 112.949 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.23 139.23 51.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.439 -1.689 . . . . 53.22 106.439 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.0 p -75.35 133.35 41.25 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.045 0.45 . . . . 70.5 110.263 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.06 132.37 54.87 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.769 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.44 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 246' ' ' ILE . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 54.13 112.177 -170.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.54 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.1 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.41 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.21 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 158' ' ' HIS . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.04 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.43 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.43 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.563 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.3 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.516 ' HB2' HG13 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.1 109.165 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HD2' HD12 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.31 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.51 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 211' ' ' LEU . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 61.42 106.685 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.11 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 72.05 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 39.4 t -116.14 133.68 55.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 63.12 106.766 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 2.5 ttmp? -136.01 125.79 25.62 Favored 'General case' 0 N--CA 1.418 -2.04 0 C-N-CA 120.754 -0.378 . . . . 64.32 111.412 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -134.66 99.15 4.25 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.317 -0.402 . . . . 75.22 110.626 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.26 -52.96 4.73 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.912 -0.586 . . . . 52.13 114.167 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.3 t -86.31 103.86 15.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.117 0.484 . . . . 72.05 111.386 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.75 85.68 3.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.086 0.946 . . . . 34.5 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -103.08 160.17 27.02 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 114.647 -1.161 . . . . 74.54 109.465 174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.45 156.49 13.96 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 123.556 2.838 . . . . 74.42 113.115 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.42 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.21 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.422 ' HB3' ' HG ' ' A' ' 200' ' ' LEU . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.34 112.118 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.14 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.53 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.22 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.03 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 43.02 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 55.35 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t -118.92 151.22 38.54 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 42.44 107.839 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.7 136.82 33.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.463 0.649 . . . . 73.21 111.354 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 190' ' ' GLU . 26.3 mmt180 -115.39 139.46 49.99 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 124.785 1.234 . . . . 65.02 112.425 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.67 118.64 43.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.152 -1.055 . . . . 61.12 108.152 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 60.9 p -133.71 -174.94 3.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.963 -0.384 . . . . 71.44 109.963 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.74 62.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.927 0.491 . . . . 72.45 110.704 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -89.99 -14.88 33.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.154 0.502 . . . . 74.1 109.786 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.22 -122.12 5.21 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.875 -0.89 . . . . 62.21 110.875 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 79.1 mt -100.13 122.91 43.72 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.909 0.862 . . . . 74.51 112.116 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 183' ' ' ARG . 9.9 mm-40 -107.08 147.24 30.24 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.2 -1.364 . . . . 74.13 110.392 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -109.68 133.47 53.09 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.706 -0.85 . . . . 72.14 108.706 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -130.76 151.64 79.15 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 70.44 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.33 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.41 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.54 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.41 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.04 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 65.11 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 174' ' ' PHE . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.2 111.936 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.44 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.55 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.12 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.21 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.43 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.32 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 61.31 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 211' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.13 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 42.14 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.693 HD11 HG22 ' A' ' 161' ' ' VAL . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 55.14 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 249' ' ' VAL . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.42 110.44 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 70.45 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.35 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.12 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 45.15 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.43 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 249' ' ' VAL . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 71.11 110.769 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.535 HG22 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.34 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.35 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.588 ' OD1' HD12 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.32 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.31 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.2 110.256 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.34 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.41 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.21 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 74.44 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 234' ' ' VAL . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.42 110.105 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 61.21 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.51 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.33 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 230' ' ' THR . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.23 111.721 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.13 110.775 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.12 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.33 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.587 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 54.13 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 235' ' ' THR . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 71.22 109.141 176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.3 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 62.34 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.11 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.55 109.168 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.44 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.588 HD12 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.1 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 149' ' ' ILE . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.42 107.067 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 43.41 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.23 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 218' ' ' VAL . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 54.01 109.054 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.14 108.39 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo -64.87 146.98 89.13 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.21 110.783 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.15 -15.67 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.684 -1.228 . . . . 61.25 107.684 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.1 t30 65.41 97.8 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.792 -1.549 . . . . 72.24 112.169 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 6.4 tp60 -92.11 91.26 7.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.42 -0.955 . . . . 71.31 108.42 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 C--O 1.241 0.616 0 C-N-CA 124.092 0.957 . . . . 73.23 110.99 -179.236 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.531 0 N-CA-C 111.327 -0.709 . . . . 62.25 111.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 m -71.44 105.85 3.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.131 0.491 . . . . 73.33 110.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -69.5 146.88 51.54 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 115.331 -0.849 . . . . 74.14 109.168 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 m -77.6 92.37 4.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.411 0.624 . . . . 65.44 110.191 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -134.88 123.0 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.828 -1.545 . . . . 72.1 106.828 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.4 112.66 57.48 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.396 -0.594 . . . . 62.12 109.396 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.445 ' HG3' ' ND2' ' A' ' 244' ' ' ASN . 71.0 Cg_exo -47.23 130.48 17.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 35.12 111.882 176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.3 m -94.17 24.87 4.08 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.27 0.557 . . . . 73.23 110.733 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.79 -42.8 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.314 -0.857 . . . . 74.43 110.057 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.6 m 58.86 81.57 0.16 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.777 1.028 . . . . 64.14 113.777 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.6 pp -114.98 142.95 29.23 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 115.13 -0.941 . . . . 75.12 110.588 175.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 13.9 Cg_exo -70.2 -55.8 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.629 1.553 . . . . 73.11 109.596 175.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -138.99 -58.43 0.6 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.249 -1.389 . . . . 70.24 107.249 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.2 t70 69.8 158.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.435 1.494 . . . . 63.41 112.519 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -142.52 -50.03 0.36 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.945 0.402 . . . . 62.4 110.109 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -83.74 138.83 33.09 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.546 -0.752 . . . . 62.2 110.355 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 66.7 m -108.76 140.68 41.84 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 64.1 112.181 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.37 128.88 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 114.225 -1.352 . . . . 44.44 109.295 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -98.58 132.63 43.84 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.507 -1.294 . . . . 41.5 107.507 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.16 155.48 42.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.808 -0.357 . . . . 72.22 111.569 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.34 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 62.11 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.42 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.3 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.3 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 71.23 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.42 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 62.21 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 44.43 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.24 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.404 ' CE1' HG13 ' A' ' 219' ' ' ILE . 2.2 m-70 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.33 110.378 171.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.546 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.41 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 74.32 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.22 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.51 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.44 109.404 -174.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.412 ' N ' HD23 ' A' ' 163' ' ' LEU . 41.6 t -116.88 150.2 38.83 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.32 111.139 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -132.45 120.24 21.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.681 -0.488 . . . . 53.34 109.681 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -147.45 114.79 6.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.316 0.646 . . . . 70.4 109.828 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.17 -66.59 2.87 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.798 -0.637 . . . . 64.33 112.224 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.1 m -70.57 102.7 2.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 123.657 0.783 . . . . 62.23 111.104 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -103.28 87.44 2.88 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.439 -0.949 . . . . 63.23 108.439 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 9.6 mmpt? -123.33 169.01 10.89 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 107.699 -1.222 . . . . 62.15 107.699 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 9.6 Cg_endo -55.23 156.06 17.86 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.368 2.045 . . . . 61.32 110.0 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.2 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.633 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.22 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.1 109.546 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 201' ' ' VAL . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.45 107.463 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.43 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 65.42 109.347 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.51 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.22 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.469 HG21 ' HE2' ' A' ' 191' ' ' LYS . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 54.23 108.755 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -103.39 139.08 39.26 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 65.11 108.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.81 114.82 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.805 -1.183 . . . . 73.33 107.805 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -112.3 138.2 49.35 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.288 -0.869 . . . . 53.12 109.934 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.28 113.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 108.428 -0.952 . . . . 72.12 108.428 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.8 p -110.9 -179.91 3.87 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.784 -0.644 . . . . 61.13 109.404 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.57 64.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 74.32 110.941 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.8 m -80.65 -24.26 39.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.23 -0.441 . . . . 63.44 110.159 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 139.84 -165.31 25.93 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.455 -0.658 . . . . 33.1 111.455 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.3 133.33 35.41 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.231 -0.655 . . . . 73.24 109.231 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.26 146.77 42.92 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 116.392 -0.367 . . . . 73.41 111.837 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.469 ' HE2' HG21 ' A' ' 180' ' ' THR . 57.7 mtpt -95.33 135.47 36.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.114 -1.069 . . . . 71.22 108.114 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.68 151.58 60.58 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 116.74 -0.209 . . . . 74.22 110.99 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.31 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.22 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.41 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 71.02 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 71.15 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.24 109.808 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.22 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 70.41 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.633 ' CG2' ' HA2' ' A' ' 173' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.03 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.4 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.11 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 44.41 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 72.14 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.44 111.835 -174.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.53 109.591 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.11 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.22 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.43 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.12 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 249' ' ' VAL . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 64.55 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.43 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 60.14 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.24 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.33 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.12 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 249' ' ' VAL . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 70.01 110.507 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 158' ' ' HIS . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 70.1 110.849 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 72.14 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 41.23 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.449 ' HB2' HD12 ' A' ' 245' ' ' LEU . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.4 110.976 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.31 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.4 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 73.13 112.516 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.491 ' H ' HG22 ' A' ' 224' ' ' ILE 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 72.05 114.438 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.14 108.656 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 54.05 108.329 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.05 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 74.43 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.42 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 62.41 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.24 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.01 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.55 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.457 ' HG3' HG13 ' A' ' 224' ' ' ILE . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.04 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.534 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 71.13 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.11 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.22 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.941 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.42 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 72.12 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 63.12 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 241' ' ' ASN . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 64.23 110.897 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.14 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 64.33 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.03 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.542 HG21 HD22 ' A' ' 212' ' ' LEU . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.13 109.002 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 64.45 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.4 112.629 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -112.9 0.67 15.21 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.532 -1.284 . . . . 71.32 107.532 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t30 51.57 -84.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.562 1.545 . . . . 73.1 113.241 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -148.44 109.31 4.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.584 -0.895 . . . . 70.14 108.584 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.548 ' O ' ' HD2' ' A' ' 255' ' ' ARG 0.299 5.8 ppt_? . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 113.157 0.799 . . . . 62.12 113.157 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.321 -1.112 . . . . 74.22 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.7 p -86.1 100.47 12.21 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.262 0.553 . . . . 74.34 110.889 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 8.3 mmpt? -94.57 81.51 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.42 -0.585 . . . . 65.55 109.42 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -134.05 4.83 3.54 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.652 -0.704 . . . . 74.52 110.953 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 68.43 112.26 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.009 0.924 . . . . 65.2 112.26 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.2 113.61 32.52 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.024 -1.102 . . . . 75.11 108.024 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.48 104.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.198 3.265 . . . . 64.24 113.875 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.3 m -136.61 1.12 2.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.426 -0.806 . . . . 63.42 110.666 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.33 95.65 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 110.03 -0.359 . . . . 51.13 110.03 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.3 p -127.1 140.3 52.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.859 -0.61 . . . . 55.24 109.903 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.2 pt -107.46 140.75 21.82 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.547 -0.538 . . . . 71.13 109.547 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.16 165.84 28.9 Favored 'Trans proline' 0 C--O 1.245 0.827 0 C-N-CA 122.703 2.268 . . . . 72.14 111.941 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -69.94 153.6 43.04 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 108.786 -0.82 . . . . 72.15 108.786 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.18 123.42 24.44 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.072 0.939 . . . . 74.03 112.884 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -179.61 -37.94 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 103.594 -2.743 . . . . 71.12 103.594 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -130.91 148.89 52.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 112.51 -2.132 . . . . 63.2 105.861 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 96.5 m -110.38 150.1 29.29 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.411 -0.959 . . . . 65.04 108.411 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.4 p -99.09 123.59 51.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.367 0.603 . . . . 72.13 110.698 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 p -82.0 120.37 25.16 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.79 -1.189 . . . . 55.24 107.79 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.86 154.22 51.74 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.386 -0.525 . . . . 73.12 110.281 -174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.21 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 160' ' ' ARG . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.41 110.37 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.44 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 44.52 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.03 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 51.11 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 33.31 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.45 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.44 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 70.32 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.21 109.447 171.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.21 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 64.43 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 148' ' ' ILE . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.4 107.794 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.33 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.35 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t -134.57 133.65 40.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.31 109.545 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -133.84 136.12 44.21 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.878 -0.415 . . . . 75.1 109.878 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -147.39 140.55 25.2 Favored 'General case' 0 C--N 1.275 -2.638 0 O-C-N 124.077 0.86 . . . . 75.2 109.276 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.2 -46.35 3.52 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.137 -0.554 . . . . 71.15 112.323 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -135.46 131.02 35.64 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.864 -0.421 . . . . 62.21 109.864 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 242' ' ' SER . 34.6 t70 -99.58 86.39 3.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.771 0.796 . . . . 64.43 109.671 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -94.07 155.66 39.88 Favored Pre-proline 0 C--N 1.277 -2.559 0 CA-C-N 114.655 -1.157 . . . . 74.23 109.199 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.57 156.26 23.02 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.979 2.453 . . . . 63.11 112.695 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 62.43 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 34.53 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.3 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 63.24 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.42 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.12 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 71.41 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.4 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.1 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t -102.52 153.26 20.24 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.1 107.297 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.77 123.29 58.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.166 0.508 . . . . 54.13 109.852 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -108.59 129.14 55.32 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.907 -1.146 . . . . 75.3 107.907 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.3 113.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.331 -0.618 . . . . 74.23 109.331 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.4 p -120.07 -179.46 3.93 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.498 -0.556 . . . . 32.0 109.498 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.87 -24.25 60.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.171 -0.677 . . . . 64.41 109.171 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.6 p -82.24 -1.7 50.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.705 -0.68 . . . . 51.23 111.161 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 110.21 -147.0 17.32 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.845 -0.616 . . . . 74.51 111.776 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -83.83 128.47 34.56 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.05 0.452 . . . . 52.22 110.247 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -113.81 143.18 45.09 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.82 -0.627 . . . . 74.24 111.915 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 191' ' ' LYS . 7.6 mmpt? -96.07 125.89 40.93 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 114.464 -1.244 . . . . 74.2 108.37 177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 -134.17 151.89 77.32 Favored Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.665 -0.865 . . . . 74.54 108.665 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.22 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 231' ' ' LEU . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.04 106.86 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.42 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.51 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 61.03 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 64.41 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.52 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 61.54 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.22 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.24 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.54 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 163' ' ' LEU . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.44 114.08 -171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 40.13 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.23 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.24 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 55.53 109.916 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.53 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 249' ' ' VAL . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 64.4 109.257 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.12 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.45 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.24 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.35 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.44 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.41 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.482 ' HG3' HG22 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.45 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.44 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.526 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.12 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.04 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.31 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.43 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.45 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.35 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.4 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 64.3 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.52 109.55 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 195' ' ' ILE . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.15 109.964 174.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.4 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.42 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.42 110.952 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.13 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.03 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.33 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 73.12 112.803 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.14 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 41.31 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.56 ' HB2' HD13 ' A' ' 245' ' ' LEU . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 65.13 106.746 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 169' ' ' ASP . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 72.34 113.2 -170.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.44 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.03 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 71.44 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 70.34 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.44 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 71.15 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 54.33 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.43 108.517 169.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo -62.85 134.01 44.63 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.22 109.428 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -81.42 -9.48 59.72 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.858 -0.423 . . . . 63.01 109.858 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 73.45 -39.56 0.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.233 1.413 . . . . 73.21 110.126 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 252' ' ' ALA . 34.9 tt0 -73.24 94.3 1.97 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.266 -1.383 . . . . 64.41 107.266 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.999 -1.852 . . . . 74.1 105.999 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.282 0 N-CA-C 110.676 -0.97 . . . . 71.51 110.676 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -71.96 118.55 14.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.476 -0.564 . . . . 73.54 109.476 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -163.36 179.04 7.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 105.633 -1.988 . . . . 73.1 105.633 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.416 ' H ' ' HG3' ' A' ' 130' ' ' LYS . 48.8 m -52.77 121.81 7.93 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.148 0.499 . . . . 71.11 110.244 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 112.85 5.22 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.041 -0.981 . . . . 72.11 112.88 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.88 109.6 59.28 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 107.717 -1.216 . . . . 64.01 107.717 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.28 -25.73 76.84 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.892 2.395 . . . . 74.1 111.761 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t 61.59 74.31 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.332 1.053 . . . . 74.41 111.152 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.1 mt -102.96 101.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 115.107 -0.951 . . . . 74.41 108.462 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -108.06 109.63 21.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.223 -0.658 . . . . 73.12 109.223 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.451 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.5 pp -112.11 143.69 29.27 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 116.121 -0.491 . . . . 73.43 111.437 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.47 119.94 7.52 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.957 1.771 . . . . 73.43 109.992 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -80.85 83.93 6.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.284 0.846 . . . . 74.01 113.284 -176.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.9 85.71 3.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.506 -1.294 . . . . 72.42 107.506 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -163.06 149.03 12.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.608 -1.256 . . . . 72.32 107.608 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -82.75 102.58 11.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.407 -0.917 . . . . 75.34 109.119 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.1 t -110.88 129.22 55.93 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.318 -1.364 . . . . 61.1 107.318 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.82 130.73 51.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.418 0.627 . . . . 74.05 111.392 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 205' ' ' LEU . 72.1 m -77.33 117.72 19.11 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.963 0.887 . . . . 61.1 109.654 174.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.1 158.46 30.62 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.017 -1.447 . . . . 72.24 107.199 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 159' ' ' ARG . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.11 108.319 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.623 HD13 ' HG2' ' A' ' 162' ' ' ARG . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.53 111.528 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.24 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 72.33 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.14 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.21 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.24 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 154' ' ' VAL . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 64.32 109.179 172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.35 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.542 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.577 ' HD2' HG21 ' A' ' 148' ' ' ILE . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 70.4 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.14 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.623 ' HG2' HD13 ' A' ' 149' ' ' ILE . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.1 107.703 175.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.32 108.295 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 163' ' ' LEU . 75.1 m -116.07 135.54 53.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 61.31 109.468 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -86.34 142.76 28.25 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.185 -1.043 . . . . 74.34 108.185 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -129.95 110.04 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.101 0.408 . . . . 74.33 112.101 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.49 -73.99 2.43 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 116.088 -0.505 . . . . 72.42 113.511 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -136.67 176.4 8.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.79 -0.448 . . . . 52.11 109.79 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -77.87 80.34 4.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.636 0.731 . . . . 71.41 111.888 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -98.4 152.73 38.08 Favored Pre-proline 0 C--N 1.291 -1.938 0 CA-C-N 114.838 -1.074 . . . . 75.23 110.333 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.31 156.97 15.41 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.701 2.934 . . . . 73.31 112.412 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 60.43 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.12 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.21 109.92 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.14 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.02 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.35 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.01 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 73.43 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -109.33 146.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.04 108.124 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.83 129.43 45.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.39 0.614 . . . . 73.34 110.616 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -122.77 124.55 43.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.301 -1.0 . . . . 75.34 108.301 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.66 121.35 49.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.526 -0.47 . . . . 74.13 110.871 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 24.5 p -115.5 -178.98 3.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.652 -0.704 . . . . 72.24 109.884 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.74 65.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 71.25 111.322 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.4 p -81.79 -18.85 42.67 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.984 0.421 . . . . 61.1 110.901 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.36 -166.86 25.68 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.824 -0.91 . . . . 73.34 110.824 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.8 pp -82.88 139.98 33.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.927 -0.709 . . . . 71.33 110.596 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.96 146.26 47.32 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -111.83 125.44 54.01 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.126 -1.065 . . . . 65.41 108.126 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -133.44 155.28 80.86 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.741 -0.837 . . . . 73.41 108.741 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.52 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.31 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.22 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 72.11 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.22 108.557 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.44 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.11 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.11 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 55.24 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 64.23 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.42 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.13 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.477 HD11 ' OG ' ' A' ' 146' ' ' SER . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.14 113.29 -174.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 41.41 111.819 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.44 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 71.55 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 148' ' ' ILE . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.13 111.202 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.52 110.977 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.43 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.01 115.413 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.23 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.01 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.3 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.55 110.667 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.32 110.585 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.22 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.536 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.12 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 61.04 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 226' ' ' VAL . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 73.51 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 62.23 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 224' ' ' ILE . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.42 113.783 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.01 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.04 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 70.32 108.354 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.23 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 64.51 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.01 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 62.33 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.44 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 70.21 110.472 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.35 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 71.4 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.509 ' HB3' HD21 ' A' ' 172' ' ' LEU . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.44 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 235' ' ' THR . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 72.32 109.687 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.35 110.336 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.44 ' HB2' HD13 ' A' ' 245' ' ' LEU . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.51 111.073 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 54.13 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.4 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.04 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 63.15 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 149' ' ' ILE . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 74.52 106.882 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.43 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 71.33 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 218' ' ' VAL . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 53.33 107.432 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' THR 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 74.31 109.822 171.23 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.8 Cg_endo -59.65 134.46 57.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.4 112.735 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -83.14 -5.28 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.76 -1.109 . . . . 53.25 109.367 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 47.8 t30 76.49 141.39 0.07 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.936 1.294 . . . . 63.51 110.987 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -76.58 93.96 3.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.763 0.792 . . . . 74.33 109.718 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? . . . . . 0 C--N 1.298 -1.639 0 CA-C-N 114.982 -1.008 . . . . 63.35 113.053 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.674 0 N-CA-C 110.892 -0.883 . . . . 35.15 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.3 p -107.54 172.06 7.04 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.783 -0.451 . . . . 71.32 109.783 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -88.21 76.77 8.39 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.336 -0.987 . . . . 73.34 108.336 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.4 m 73.33 -51.67 0.7 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.767 1.227 . . . . 75.33 109.124 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -140.24 161.35 37.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.979 -1.86 . . . . 62.21 105.979 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 136' ' ' ILE . . . -89.9 115.18 63.29 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 108.084 -1.08 . . . . 73.43 108.084 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.57 112.3 1.21 Allowed 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.543 2.162 . . . . 64.32 111.801 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.0 m 66.01 84.82 0.15 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.738 -1.119 . . . . 75.01 111.044 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 133' ' ' ALA . 61.4 mt -81.26 100.55 5.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.394 0.616 . . . . 61.53 109.453 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 92.4 7.74 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.243 -0.89 . . . . 72.01 110.542 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -114.85 140.61 25.67 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 106.823 -1.547 . . . . 45.33 106.823 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.21 148.52 85.62 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.136 1.891 . . . . 54.51 110.308 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.82 109.61 2.96 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.086 -0.646 . . . . 73.43 109.637 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.89 141.8 53.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.228 -0.896 . . . . 74.22 112.737 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -137.02 -35.82 0.69 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.253 -1.017 . . . . 65.45 108.253 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 143' ' ' ARG . 5.7 mpt_? -103.0 146.94 27.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.972 -1.862 . . . . 75.43 105.972 172.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 166' ' ' HIS . 89.5 m -112.58 151.15 30.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 113.937 1.088 . . . . 64.42 113.937 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.58 134.55 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.721 -1.127 . . . . 63.14 109.288 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 p -85.77 127.25 34.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.41 -0.959 . . . . 64.0 108.41 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.68 154.33 43.4 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.92 -0.712 . . . . 32.42 111.414 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 73.34 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.596 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.12 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.52 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 62.11 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.45 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.31 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 158' ' ' HIS . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.33 111.582 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.04 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.31 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.43 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.447 ' HB2' HG13 ' A' ' 154' ' ' VAL . 3.5 m-70 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.41 108.999 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 211' ' ' LEU . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 65.43 109.332 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.622 ' H ' ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 65.43 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.24 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.42 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 62.41 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 35.0 t -129.55 139.16 51.59 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 54.03 105.371 171.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 169' ' ' ASP . 24.3 ttmm -130.27 120.71 24.85 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 114.131 1.159 . . . . 74.04 114.131 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.632 ' HD2' ' SG ' ' A' ' 144' ' ' CYS . 78.6 m-70 -145.73 130.99 18.5 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.848 -1.069 . . . . 61.23 108.58 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.41 -57.67 4.92 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 116.299 -0.409 . . . . 74.33 112.775 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.5 m -89.33 94.37 9.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.148 0.499 . . . . 51.03 111.673 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 9.3 p-10 -83.86 19.25 1.76 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.963 0.905 . . . . 51.45 111.535 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -86.22 161.94 47.64 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.708 -0.678 . . . . 70.24 112.316 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -49.92 159.58 1.62 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 125.083 3.855 . . . . 73.12 112.515 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.611 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.31 109.926 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.473 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.11 114.528 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 72.13 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.14 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 70.02 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.2 108.605 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.643 ' HB3' HD11 ' A' ' 231' ' ' LEU . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.51 110.075 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.23 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' ' 191' ' ' LYS . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.44 108.174 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -103.9 148.77 25.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.34 107.9 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.8 p -101.22 125.89 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-O 121.545 0.688 . . . . 54.45 109.361 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.531 ' HG3' HG23 ' A' ' 185' ' ' THR . 28.5 tpt180 -107.71 115.16 29.64 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.799 -0.815 . . . . 74.13 108.799 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.5 t -88.89 113.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.115 -0.698 . . . . 71.14 109.115 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 183' ' ' ARG . 45.4 p -125.59 -174.42 3.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.898 -0.592 . . . . 71.31 110.629 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -18.34 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.126 0.488 . . . . 71.44 110.394 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 m -80.63 -23.5 39.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.388 -0.597 . . . . 64.12 109.388 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.81 -124.49 4.85 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.655 -1.378 . . . . 71.25 109.655 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -100.32 136.13 40.69 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.372 -0.531 . . . . 50.12 110.193 176.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.73 133.24 49.53 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.5 -0.926 . . . . 75.01 108.5 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 180' ' ' THR . 52.9 mtpt -97.69 137.17 37.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.04 -0.726 . . . . 74.31 109.04 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.1 148.38 51.47 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.421 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.54 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 43.41 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.54 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.44 109.202 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 62.12 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.23 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.04 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.3 109.915 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.473 HG22 ' CA ' ' A' ' 173' ' ' GLY . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.52 106.895 173.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.41 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.23 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.01 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 209' ' ' THR . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.33 111.647 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.02 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.11 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 205' ' ' LEU . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 63.14 110.456 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.01 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.482 ' HB3' HH11 ' A' ' 159' ' ' ARG . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 64.33 111.99 -176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' HB1' ' A' ' 206' ' ' ALA . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.23 109.787 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 63.32 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.32 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.34 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 63.04 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.13 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 249' ' ' VAL . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.22 110.316 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.21 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.32 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.427 HG23 ' HB ' ' A' ' 224' ' ' ILE . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.13 107.278 173.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.1 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.12 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 221' ' ' VAL . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.32 107.761 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.35 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.34 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.21 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.54 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.55 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.31 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.33 110.6 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 63.4 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.45 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.03 111.201 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.42 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.43 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.605 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.33 112.903 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.24 109.321 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 11.11 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.04 110.371 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.438 ' HB2' ' CE ' ' A' ' 165' ' ' LYS . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.52 114.733 -174.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.04 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.32 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.14 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 149' ' ' ILE . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.24 107.305 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.439 HD12 ' SD ' ' A' ' 238' ' ' MET . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 71.41 110.751 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 62.21 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 218' ' ' VAL . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 62.43 108.633 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 64.35 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo -73.28 134.5 21.06 Favored 'Trans proline' 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.23 111.653 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.38 -9.67 32.17 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.286 -1.746 . . . . 54.21 106.286 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.1 t30 67.99 -107.07 0.09 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.594 -2.094 . . . . 74.54 111.996 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.64 1.18 0.39 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.183 0.992 . . . . 72.4 111.541 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 . . . . . 0 N--CA 1.423 -1.79 0 C-N-CA 123.853 0.861 . . . . 74.24 110.046 -171.799 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 111.575 -0.61 . . . . 42.42 111.575 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.4 m -101.85 -11.14 19.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.181 0.515 . . . . 73.43 111.153 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -93.41 -13.4 28.04 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.315 0.578 . . . . 73.41 109.94 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.6 p -79.02 132.49 36.66 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.539 -0.755 . . . . 62.13 110.709 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 136.06 37.17 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.771 -1.196 . . . . 72.05 107.771 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.11 109.34 63.1 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 112.183 0.438 . . . . 64.12 112.183 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.99 -0.08 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.162 1.908 . . . . 75.12 109.796 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m 70.2 -76.95 0.06 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.382 1.473 . . . . 73.12 112.696 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.8 mt 53.77 71.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.332 1.063 . . . . 71.55 108.723 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 m -144.77 177.37 8.76 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.813 -1.085 . . . . 65.13 108.82 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.95 116.81 65.64 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.55 -1.648 . . . . 74.33 106.55 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.45 19.01 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.596 0 C-N-CA 123.094 2.529 . . . . 73.12 114.06 -173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 72.43 127.9 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.314 1.046 . . . . 73.1 112.368 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -170.1 153.36 4.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.418 -2.067 . . . . 74.32 105.418 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.4 -25.77 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.336 -0.616 . . . . 70.31 109.336 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -131.95 111.49 11.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.081 -0.509 . . . . 65.13 110.932 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.0 t -111.65 162.26 15.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.214 -1.032 . . . . 61.12 108.214 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -99.2 125.77 52.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.836 0.827 . . . . 62.4 111.677 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 205' ' ' LEU . 7.7 p -102.16 117.97 35.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.681 -1.145 . . . . 62.54 109.263 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.07 161.5 42.42 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.635 -0.876 . . . . 75.55 108.635 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 211' ' ' LEU . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.42 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 60.31 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.31 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.23 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 41.54 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 155' ' ' PRO . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.52 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 154' ' ' VAL . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.14 109.178 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.21 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.567 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 62.54 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.483 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 1.6 m-70 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.34 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.534 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 64.04 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 65.13 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.31 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 61.21 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 62.22 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t -135.95 167.47 21.15 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 33.54 107.61 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.735 ' HE2' ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -78.08 142.28 38.24 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.542 1.163 . . . . 72.41 114.135 -169.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.26 97.76 3.8 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.299 -1.773 . . . . 72.13 106.253 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.0 -66.58 3.84 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.462 -1.055 . . . . 74.15 110.462 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.4 m -139.55 -178.01 5.2 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.79 -1.189 . . . . 63.45 107.79 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.7 -53.41 22.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.361 -0.607 . . . . 74.2 109.361 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 65.56 160.08 0.13 Allowed Pre-proline 0 N--CA 1.478 0.946 0 O-C-N 124.508 1.13 . . . . 73.45 111.525 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.54 152.02 81.66 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 121.338 1.359 . . . . 73.23 108.697 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.02 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.23 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.13 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.24 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 235' ' ' THR . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 51.31 111.864 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.12 109.558 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 231' ' ' LEU . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.31 111.027 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 40.01 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.42 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t -103.2 143.2 32.94 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.44 108.581 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.33 114.72 33.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.676 -1.231 . . . . 75.31 107.676 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -108.25 119.27 38.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.966 0.412 . . . . 74.52 110.025 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 p -93.68 126.41 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.623 -0.717 . . . . 73.35 110.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 56.1 p -131.51 -179.09 5.16 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.5 -0.773 . . . . 73.33 109.628 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.71 -16.12 60.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.402 0.62 . . . . 72.44 109.777 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.1 m -90.73 -4.59 56.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.388 -0.824 . . . . 60.33 110.17 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.59 -156.9 15.47 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.738 -0.945 . . . . 75.4 110.738 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.7 pp -100.78 136.88 39.94 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 117.712 0.756 . . . . 62.24 111.586 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.3 146.39 50.04 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.46 -0.57 . . . . 75.31 109.46 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -92.07 134.19 35.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.19 162.76 55.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.887 -1.153 . . . . 74.33 107.887 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 72.2 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.54 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.44 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.53 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 73.43 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.2 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.13 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 50.13 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.34 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.2 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.54 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 44.24 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.523 HD11 ' OG ' ' A' ' 146' ' ' SER . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.01 113.471 -173.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 54.43 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.23 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 51.21 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.433 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 63.33 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.51 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 148' ' ' ILE . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.24 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 249' ' ' VAL . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.51 108.99 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 64.31 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.11 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.34 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.13 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.24 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 249' ' ' VAL . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.12 110.334 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.534 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.53 110.01 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' HG22 ' A' ' 219' ' ' ILE . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.44 111.687 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.13 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.483 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.14 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 42.21 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.41 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 72.1 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.31 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 234' ' ' VAL . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 45.11 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.24 110.478 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.45 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.33 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 230' ' ' THR . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 62.54 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 176' ' ' ILE . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.22 110.955 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.55 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.43 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.415 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 70.0 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.22 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 63.35 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.01 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.34 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.31 110.956 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.4 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 61.13 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.53 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.4 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 218' ' ' VAL . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.35 108.72 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.534 ' CD ' HD11 ' A' ' 219' ' ' ILE . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 64.25 109.197 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo -59.69 134.57 58.42 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.11 112.795 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -116.94 12.8 14.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.959 -1.018 . . . . 52.1 109.034 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 59.1 t30 72.46 138.98 0.05 Allowed 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.817 1.323 . . . . 73.04 110.672 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -82.11 74.48 9.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.545 0.688 . . . . 75.42 111.268 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.306 1.443 . . . . 60.12 108.241 178.582 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 110.375 -1.09 . . . . 53.4 110.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.9 m -81.64 98.01 8.16 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 117.298 0.549 . . . . 74.52 111.073 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.48 97.26 6.06 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.885 -0.598 . . . . 72.12 110.853 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -148.4 88.04 1.62 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.45 0.643 . . . . 65.12 111.651 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.67 68.81 0.75 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.013 -1.106 . . . . 64.23 108.013 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 113.36 56.47 Favored Pre-proline 0 N--CA 1.417 -2.104 0 CA-C-N 113.942 -1.481 . . . . 41.13 109.811 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.39 112.09 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 63.21 110.585 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.4 p -123.83 34.11 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.22 1.01 . . . . 71.13 108.629 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.4 mt -77.61 -25.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.106 -1.406 . . . . 72.32 108.725 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.7 t 70.41 -164.28 0.16 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.571 -1.27 . . . . 43.2 107.571 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -79.15 115.88 56.03 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.731 -0.84 . . . . 75.45 108.731 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.32 80.31 3.12 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.691 2.26 . . . . 55.43 114.017 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -154.82 136.66 14.5 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 105.67 -1.974 . . . . 72.22 105.67 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.66 86.47 7.12 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.145 -1.022 . . . . 63.34 112.017 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -143.87 -51.92 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.053 -1.43 . . . . 74.42 108.262 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -142.78 142.25 31.86 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.017 -0.992 . . . . 64.45 109.838 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.2 t -145.68 137.67 25.38 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.588 -0.893 . . . . 65.33 108.588 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.86 139.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 113.072 0.767 . . . . 75.14 113.072 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 p -92.75 127.91 38.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.219 -1.03 . . . . 61.04 108.219 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.32 155.99 48.78 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.71 -0.223 . . . . 74.55 111.319 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 211' ' ' LEU . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.43 107.354 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 52.3 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 154' ' ' VAL . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.32 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.42 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 61.12 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 150' ' ' ASP . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.21 112.032 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 62.45 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.52 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.523 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 71.41 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 154' ' ' VAL . 2.0 m-70 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 73.54 111.546 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 159' ' ' ARG . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 72.32 106.741 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 64.23 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.554 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.43 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 205' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 72.3 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p -128.36 166.22 19.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.42 112.086 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.5 tpmt? -79.86 142.22 35.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.341 -0.845 . . . . 70.51 110.007 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -131.31 160.59 34.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.56 -1.274 . . . . 74.13 107.56 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.67 62.09 0.47 Allowed Glycine 0 CA--C 1.522 0.479 0 O-C-N 123.934 0.771 . . . . 32.15 113.126 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 t 179.85 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.405 -1.702 . . . . 72.11 106.405 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.2 85.65 7.17 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.852 0.834 . . . . 72.33 111.192 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.88 163.13 17.99 Favored Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 114.245 -1.343 . . . . 70.35 109.823 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -65.37 157.78 56.14 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.02 2.48 . . . . 65.23 109.317 170.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 61.14 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 53.33 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 72.21 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.34 107.207 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.45 HD11 ' OG1' ' A' ' 235' ' ' THR . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 70.32 112.424 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.43 108.683 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 10.44 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 61.1 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t -103.39 138.78 39.67 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.1 108.058 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.35 114.84 35.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.709 -0.848 . . . . 75.34 108.709 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -108.34 133.38 52.63 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.941 -0.572 . . . . 74.11 110.038 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.57 119.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 108.833 -0.803 . . . . 74.32 108.833 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.1 p -118.63 -178.86 3.64 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.992 -0.744 . . . . 71.22 108.992 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.35 60.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.326 0.584 . . . . 55.14 110.196 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.9 m -85.79 -23.1 27.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.489 -0.778 . . . . 31.13 110.214 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.85 -137.21 9.08 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 110.93 -0.868 . . . . 62.11 110.93 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 189' ' ' LEU . 61.8 mt -101.45 143.21 31.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 113.123 0.786 . . . . 72.25 113.123 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -137.41 140.15 41.15 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 114.794 -1.094 . . . . 72.11 108.795 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -113.64 125.78 54.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 119.923 -0.711 . . . . 70.1 110.219 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.07 141.0 37.26 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.292 -0.867 . . . . 45.52 109.882 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.55 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.32 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 231' ' ' LEU . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 74.14 107.218 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.51 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.14 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.24 111.068 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.44 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.14 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 61.32 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.42 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 53.14 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 34.21 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 163' ' ' LEU . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.32 113.623 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 63.13 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.04 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.14 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.528 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.2 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 62.31 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 148' ' ' ILE . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.12 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 52.44 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 24.25 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.53 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.1 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.43 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 72.11 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 249' ' ' VAL . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 64.01 109.432 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.428 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 71.43 110.544 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 71.34 111.246 -176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.23 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.599 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.21 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.23 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.35 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.3 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 219' ' ' ILE . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.01 111.0 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.4 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.02 109.206 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 195' ' ' ILE . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 60.12 110.802 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.14 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 71.34 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 230' ' ' THR . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.43 111.252 -178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.45 ' OG1' HD11 ' A' ' 176' ' ' ILE . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 53.41 109.061 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.529 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.05 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.31 109.643 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 53.43 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.11 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.54 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.13 110.178 177.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.11 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 149' ' ' ILE . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 63.42 107.944 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 70.03 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 71.14 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.595 HG21 HD22 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.31 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.24 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo -66.95 133.07 29.99 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.11 110.427 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.99 -2.76 52.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.212 -1.033 . . . . 71.31 108.212 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -87.71 80.1 8.02 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.519 -1.218 . . . . 62.35 108.37 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -119.63 89.53 3.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.316 -1.311 . . . . 75.45 108.564 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 104.877 -2.268 . . . . 74.24 104.877 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.755 -0.938 . . . . 61.43 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 m -87.55 -35.29 18.23 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.903 0.352 . . . . 75.51 110.23 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 58.72 82.42 0.14 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.979 -1.009 . . . . 74.41 108.871 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 t -73.25 103.41 3.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.97 0.891 . . . . 54.45 111.873 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -102.31 -19.71 14.9 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.371 -0.831 . . . . 55.4 109.976 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.94 109.29 14.41 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 109.163 -0.68 . . . . 72.12 109.163 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 55.5 Cg_endo -75.71 139.73 22.81 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.45 2.1 . . . . 64.42 111.729 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 p -78.75 -19.95 51.08 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.501 0.667 . . . . 50.12 109.981 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.66 100.21 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.268 -0.878 . . . . 61.44 110.427 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.3 t -153.04 122.53 6.75 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.412 -1.699 . . . . 73.21 106.412 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.4 pp -79.84 143.57 58.31 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 112.776 0.658 . . . . 61.01 112.776 -175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.65 110.25 0.7 Allowed 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.844 2.363 . . . . 74.22 111.504 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -134.24 19.81 3.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.826 -0.624 . . . . 63.32 110.862 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.17 71.8 4.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.959 0.885 . . . . 72.52 111.062 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.74 -24.97 14.83 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.732 -1.951 . . . . 75.11 105.732 171.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -116.88 148.59 41.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.36 -1.746 . . . . 71.11 106.468 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 4.0 t -109.35 128.43 55.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 104.189 -2.523 . . . . 64.22 104.189 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.96 127.76 67.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 114.527 1.306 . . . . 34.22 114.527 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.9 p -98.97 122.09 41.78 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.463 -1.244 . . . . 74.4 107.95 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.52 156.57 42.62 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.84 0.087 . . . . 44.01 110.873 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 211' ' ' LEU . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 53.34 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.32 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.23 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.4 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.34 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.21 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 63.3 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 42.22 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.2 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.543 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.21 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.31 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 73.32 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.02 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.45 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 172' ' ' LEU . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.44 107.966 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p -129.9 162.61 28.2 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.42 110.994 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 242' ' ' SER . 33.7 mmtp -118.15 138.72 52.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 121.505 0.669 . . . . 74.43 111.56 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -146.46 96.84 2.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.692 -1.596 . . . . 73.44 106.692 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.29 -31.69 7.44 Favored Glycine 0 C--N 1.295 -1.71 0 N-CA-C 107.677 -2.169 . . . . 44.14 107.677 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.3 m 62.37 175.55 0.14 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 115.092 1.515 . . . . 71.02 115.092 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.274 3.4 m-20 64.53 -0.21 0.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.784 1.772 . . . . 63.51 115.784 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.3 tttt -78.67 128.57 76.78 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.727 -0.842 . . . . 75.35 108.727 175.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 52.8 Cg_exo -57.27 155.46 29.64 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.131 2.554 . . . . 64.43 111.601 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 62.42 109.908 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.22 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.43 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 63.44 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.43 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.571 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.1 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 43.23 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 61.31 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t -103.43 146.17 28.9 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 40.05 107.497 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.5 123.82 61.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.06 0.457 . . . . 71.33 110.143 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.523 ' HB2' ' OE1' ' A' ' 192' ' ' GLN . 30.4 tpt180 -112.51 128.84 56.46 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.498 -0.556 . . . . 73.25 109.498 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.62 113.39 29.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.068 -0.716 . . . . 75.33 109.068 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 47.6 p -119.86 -177.34 3.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.03 -0.73 . . . . 75.21 109.03 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.28 -15.33 61.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.331 0.586 . . . . 71.42 109.871 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -82.23 -14.6 55.28 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.597 -0.728 . . . . 71.34 109.465 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.59 -147.95 17.69 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 109.975 -1.25 . . . . 52.14 109.975 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.7 pp -97.58 124.24 41.76 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.794 0.797 . . . . 74.12 110.191 176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.5 146.62 47.94 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.821 -0.627 . . . . 62.13 110.888 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.37 137.2 37.42 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.974 -0.557 . . . . 71.33 110.978 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.523 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 46.5 mt-30 -121.6 153.58 59.54 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 107.599 -1.26 . . . . 73.22 107.599 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.11 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.32 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.4 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 52.01 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.54 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 62.54 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.31 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.33 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.33 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.33 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 53.1 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 21.44 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 61.31 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 54.05 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.53 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.22 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.13 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 42.22 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 62.21 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.33 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 71.13 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.42 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 3.8 m-20 -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.41 113.476 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.02 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.43 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 249' ' ' VAL . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.24 109.438 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 226' ' ' VAL . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.51 110.623 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.35 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.14 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.21 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.1 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 73.24 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.22 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 218' ' ' VAL . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.51 110.827 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 34.13 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.55 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.14 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 73.35 110.256 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 65.45 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.41 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.54 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.32 109.759 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 44.2 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 61.02 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 74.2 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.456 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 72.41 112.918 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.407 ' HA ' ' HB3' ' A' ' 242' ' ' SER . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 44.22 109.77 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.51 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.491 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.5 m-20 -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.69 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.51 115.345 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.33 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 241' ' ' ASN . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.24 111.342 -175.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 149' ' ' ILE . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.24 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 218' ' ' VAL . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 55.01 108.657 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.22 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo -59.67 134.68 59.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 53.41 111.556 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.07 -11.47 43.98 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.383 -0.826 . . . . 71.11 110.569 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 53.25 45.3 28.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.835 -0.802 . . . . 75.42 108.835 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 215' ' ' ASN . 14.3 pt20 -44.43 101.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.524 2.416 . . . . 71.1 117.524 -171.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 254' ' ' GLN . 15.8 ttm180 . . . . . 0 CA--C 1.511 -0.546 0 C-N-CA 125.485 1.514 . . . . 75.12 108.655 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 111.486 -0.646 . . . . 54.31 111.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -77.47 138.74 39.41 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.136 0.493 . . . . 74.21 111.766 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -105.23 -37.88 6.73 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.742 -0.663 . . . . 73.42 109.304 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.8 m 71.9 -33.5 0.27 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.617 1.167 . . . . 71.31 112.363 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.593 ' HE3' ' N ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -64.05 145.17 56.37 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 110.137 -0.32 . . . . 64.54 110.137 176.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.49 109.32 56.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 103.38 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.46 2.774 . . . . 61.25 113.935 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 m -152.67 93.08 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.564 -1.272 . . . . 74.15 107.564 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.9 mt -119.2 117.0 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.869 -0.605 . . . . 65.21 110.39 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.0 m -74.78 106.11 6.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.661 -0.866 . . . . 60.54 108.661 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.4 pp -103.3 143.87 27.49 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 113.62 0.97 . . . . 70.35 113.62 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.4 138.34 38.62 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.573 2.182 . . . . 73.45 109.854 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . 0.268 16.3 p-80 -81.48 61.62 5.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 115.466 1.654 . . . . 63.31 115.466 -173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -179.01 89.78 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.834 0.854 . . . . 73.01 111.928 171.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -131.15 102.9 6.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.209 -0.905 . . . . 75.21 109.789 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -88.2 102.91 15.27 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.051 -1.833 . . . . 74.52 106.051 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 3.3 p -113.6 162.11 16.61 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 114.375 1.25 . . . . 63.51 114.375 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.57 142.16 16.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.263 -1.335 . . . . 45.25 108.432 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 9.0 m -70.88 139.64 50.84 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.236 0.541 . . . . 74.34 109.842 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.58 153.53 20.0 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.731 -0.84 . . . . 72.24 108.731 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.1 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 61.45 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.51 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.53 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.33 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.33 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.11 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.41 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.41 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 55.42 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 62.15 110.644 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.44 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.32 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 212' ' ' LEU . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.34 109.33 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.33 109.196 -176.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.578 HD22 HD23 ' A' ' 172' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 53.15 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.14 152.48 33.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 60.15 110.042 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 1.2 tpmt? -86.31 121.27 28.64 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.664 0.616 . . . . 73.44 112.664 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.419 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 29.7 t-80 -110.64 146.72 35.68 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.822 -2.288 . . . . 74.43 104.822 168.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.12 64.49 2.38 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.783 -0.723 . . . . 71.03 112.519 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 26.4 m -148.79 112.15 4.98 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.517 -0.92 . . . . 65.11 108.517 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.71 81.62 8.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.182 0.991 . . . . 70.42 109.564 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 171' ' ' PRO . 67.9 mttm -135.58 167.3 22.95 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 113.87 -1.514 . . . . 75.41 107.117 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 8.0 Cg_endo -52.28 154.79 10.43 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.556 2.171 . . . . 65.21 111.636 175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 163' ' ' LEU . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 42.24 111.904 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 204' ' ' GLY . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 60.34 114.312 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.2 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.44 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 60.3 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.24 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 64.43 108.774 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 34.24 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.44 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t -103.73 145.37 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.3 107.883 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.19 129.33 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 121.558 0.694 . . . . 72.33 110.205 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.558 ' HG3' HG23 ' A' ' 185' ' ' THR . 30.5 tpt180 -117.65 131.62 56.62 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.441 -0.8 . . . . 72.01 109.909 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.91 113.81 30.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.312 -0.996 . . . . 71.44 108.312 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 183' ' ' ARG . 24.4 p -118.79 -175.31 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.539 -0.3 . . . . 61.11 111.406 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.96 -20.02 61.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.979 0.419 . . . . 52.15 110.638 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -89.64 -9.15 50.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.062 -0.517 . . . . 54.22 111.128 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.53 -135.05 9.65 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.58 -0.608 . . . . 53.23 111.58 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 189' ' ' LEU . 60.7 mt -100.51 134.26 43.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 121.448 0.642 . . . . 63.31 112.139 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -129.41 138.52 51.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.771 -1.104 . . . . 74.44 109.587 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -113.21 134.62 54.49 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.617 -0.512 . . . . 64.04 109.617 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.31 163.71 49.15 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.534 -0.757 . . . . 52.13 109.286 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 62.33 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.21 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.04 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.4 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.43 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.33 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 71.21 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.45 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.487 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.41 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 60.45 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.34 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 173' ' ' GLY . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.21 111.679 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.43 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.34 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 61.13 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.44 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.24 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 161' ' ' VAL . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 64.24 107.524 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.41 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.2 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 71.24 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 62.33 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.45 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 249' ' ' VAL . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 64.53 111.038 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 73.42 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.1 111.231 -178.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 63.45 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.408 ' HB2' HD12 ' A' ' 245' ' ' LEU . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.34 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 62.44 107.89 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.446 ' H ' ' H ' ' A' ' 223' ' ' GLY . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 71.12 107.072 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.55 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.32 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.44 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 43.34 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 60.23 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 55.31 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.13 110.617 176.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.33 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 71.3 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 64.43 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.42 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.54 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG2' HD21 ' A' ' 245' ' ' LEU . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.23 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.33 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.04 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 245' ' ' LEU . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.14 111.055 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 63.24 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.11 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.14 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 238' ' ' MET . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.43 110.504 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.21 106.881 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.32 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.42 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 218' ' ' VAL . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.11 107.894 175.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.34 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo -55.93 134.52 64.58 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 60.44 111.32 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -91.34 0.37 57.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.36 -0.837 . . . . 73.44 110.404 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t30 66.06 16.16 10.35 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.265 1.031 . . . . 75.02 109.326 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 59.54 88.47 0.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.272 -1.331 . . . . 64.41 111.612 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.674 -0.862 . . . . 74.41 108.674 -179.24 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.23 -1.148 . . . . 75.1 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.1 m -95.23 157.04 16.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.735 -0.468 . . . . 71.31 109.735 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -86.35 82.62 7.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.449 0.642 . . . . 42.14 110.29 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.3 p -137.04 171.33 14.66 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.982 -1.008 . . . . 65.05 108.799 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -134.06 128.35 34.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.988 0.423 . . . . 74.15 110.387 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.09 108.77 59.02 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.149 -1.056 . . . . 71.21 108.149 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.49 -25.06 48.45 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.87 2.38 . . . . 73.32 113.058 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 t 63.45 25.51 14.54 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.697 0.76 . . . . 71.54 110.319 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.6 pt -82.09 24.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 113.71 1.004 . . . . 72.35 113.71 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 t -130.92 113.83 14.51 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.234 -1.395 . . . . 72.3 107.234 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.5 pp -114.46 142.37 28.04 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.025 0.75 . . . . 75.03 113.025 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 39.7 Cg_exo -62.0 112.99 1.68 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.486 2.124 . . . . 62.12 111.037 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -130.22 -21.98 2.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.291 -0.413 . . . . 71.42 111.776 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 142' ' ' PHE . 16.3 t70 59.59 -159.78 0.29 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.724 0.81 . . . . 72.13 109.56 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.454 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 64.9 m-85 -98.48 -45.28 6.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.725 -0.842 . . . . 73.22 108.725 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -94.53 142.16 27.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.334 -0.848 . . . . 72.1 110.725 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 14.0 p -146.78 163.21 36.72 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.973 -0.558 . . . . 70.44 111.021 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.45 139.63 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.38 -0.6 . . . . 73.21 109.38 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.9 p -77.11 136.25 38.62 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.033 -0.728 . . . . 75.2 109.033 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.29 156.61 43.48 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 121.087 -0.245 . . . . 73.11 111.641 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 73.02 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.75 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.31 111.026 -176.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.15 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.12 112.785 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.33 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.13 110.133 -175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.12 110.661 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.41 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.41 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 64.3 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 74.21 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 72.42 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.558 ' HB2' HD12 ' A' ' 149' ' ' ILE . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 73.24 111.874 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 64.43 108.231 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p -127.97 143.45 51.09 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.41 106.976 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 243' ' ' SER . 39.8 ttmt -79.6 121.18 24.95 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.257 0.551 . . . . 75.14 110.896 -174.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.4 110.04 21.87 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 62.22 111.199 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.49 -85.01 0.85 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 116.263 -0.426 . . . . 54.44 112.959 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -116.28 164.77 14.02 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.648 -0.871 . . . . 62.21 108.648 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.1 77.43 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.824 1.297 . . . . 71.31 111.063 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -86.95 154.91 55.57 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 113.69 -1.595 . . . . 64.23 110.061 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.3 149.89 89.07 Favored 'Trans proline' 0 C--O 1.258 1.478 0 C-N-CA 122.532 2.155 . . . . 64.23 112.052 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 61.4 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.575 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.23 116.175 -174.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.02 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 72.04 107.155 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.444 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.4 111.877 177.26 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.44 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 71.13 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -103.51 136.75 42.65 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.01 108.237 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.95 117.47 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.442 0.639 . . . . 74.3 110.059 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -114.09 132.1 56.16 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.702 -0.851 . . . . 71.01 108.702 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.23 113.17 32.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.483 -0.932 . . . . 73.31 108.483 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.0 p -115.75 -174.68 2.57 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.687 -0.486 . . . . 72.31 109.687 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.53 64.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.374 0.607 . . . . 73.2 109.495 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.3 m -80.68 -12.25 59.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.436 -0.802 . . . . 73.34 109.649 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.29 -164.76 12.1 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.139 -0.553 . . . . 63.43 111.857 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.12 126.83 30.93 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.937 -0.764 . . . . 74.33 108.937 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -129.26 124.54 34.73 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.635 0.731 . . . . 74.14 110.282 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -104.4 126.71 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.087 -0.961 . . . . 73.21 108.498 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -147.5 159.69 40.88 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.21 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.41 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.43 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.21 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.496 ' CD1' HD23 ' A' ' 212' ' ' LEU . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 53.41 108.856 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 44.15 110.92 -177.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.34 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.11 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.575 HG22 ' CA ' ' A' ' 173' ' ' GLY . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.04 108.358 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.23 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 53.51 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 63.04 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 71.51 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 212' ' ' LEU . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.21 111.491 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.31 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.24 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.11 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 148' ' ' ILE . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.496 HD23 ' CD1' ' A' ' 197' ' ' ILE . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.23 110.337 177.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.31 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.44 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.613 ' HB2' ' HG2' ' A' ' 254' ' ' GLN . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.21 113.016 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.23 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.14 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 249' ' ' VAL . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.54 109.454 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.486 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.35 110.78 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.486 ' HG3' HG22 ' A' ' 219' ' ' ILE . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.33 111.493 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.21 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.537 ' OD1' HD12 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.34 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.23 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.44 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.23 108.895 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 218' ' ' VAL . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.34 112.234 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.11 110.247 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 40.51 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.02 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 64.22 108.892 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.13 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.52 111.676 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 230' ' ' THR . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.34 111.077 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.407 HG23 HD11 ' A' ' 176' ' ' ILE . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.31 110.683 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.12 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.53 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 70.3 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.24 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 245' ' ' LEU . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.53 112.685 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.1 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.35 110.24 177.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.44 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.537 HD12 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.21 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 149' ' ' ILE . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.41 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 72.45 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 218' ' ' VAL . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.44 108.42 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.402 ' CD ' HD11 ' A' ' 219' ' ' ILE . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.13 107.636 170.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo -60.63 134.38 54.0 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 63.42 108.517 174.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.15 0.1 57.34 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.469 -0.493 . . . . 62.31 110.589 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 60.45 78.13 0.29 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.16 -1.422 . . . . 62.35 107.16 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.613 ' HG2' ' HB2' ' A' ' 215' ' ' ASN . 45.2 mt-30 -52.34 114.87 1.49 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.167 -1.378 . . . . 73.32 112.601 -171.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' H ' ' HD3' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 114.376 -1.283 . . . . 73.2 110.968 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 109.96 -0.385 . . . . 44.109999999999999 109.96 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.129999999999995 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 62.210000000000001 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 154' ' ' VAL . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.540000000000006 111.087 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.209999999999994 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.149999999999999 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 62.420000000000002 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.420000000000002 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.230000000000004 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.239999999999995 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 74.519999999999996 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 64.239999999999995 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.510000000000005 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 71.239999999999995 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.140000000000001 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 74.239999999999995 109.71 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.239999999999995 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 36.5 t . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.340000000000003 108.652 -177.687 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo . . . . . 0 C--O 1.239 0.553 0 CA-C-O 121.155 0.398 . . . . 71.120000000000005 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.400000000000006 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.416 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.540000000000006 114.853 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.450000000000003 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.340000000000003 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.409999999999997 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.219999999999999 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.549 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.019999999999996 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.420000000000002 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 73.329999999999998 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 64.019999999999996 109.088 -178.573 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.717 -0.475 . . . . 72.549999999999997 109.717 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.420000000000002 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 70.019999999999996 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.109999999999999 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 72.329999999999998 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.409999999999997 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 72.019999999999996 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.209999999999994 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 173' ' ' GLY . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.310000000000002 108.878 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.239999999999995 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.040000000000006 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 201' ' ' VAL . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.329999999999998 111.997 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.009999999999998 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 63.43 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 71.549999999999997 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.299999999999997 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.310000000000002 112.323 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.439999999999998 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 54.200000000000003 109.709 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.010000000000005 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.200000000000003 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.319999999999993 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 61.450000000000003 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.129999999999995 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.219999999999999 110.199 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.492 HG22 ' HG3' ' A' ' 220' ' ' GLU . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.299999999999997 110.032 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 74.040000000000006 110.751 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.399999999999999 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.129999999999995 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 35.340000000000003 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.401 HG13 ' SD ' ' A' ' 237' ' ' MET . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.109999999999999 106.61 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 65.430000000000007 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.510000000000005 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 63.43 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.130000000000003 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 51.310000000000002 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 234' ' ' VAL . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 63.32 109.024 172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 71.530000000000001 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.099999999999994 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.319999999999993 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 62.109999999999999 111.187 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.109999999999999 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.400000000000006 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.340000000000003 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.549999999999997 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.299999999999997 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 63.299999999999997 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.530000000000001 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 61.039999999999999 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.230000000000004 110.545 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.409999999999997 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.239999999999995 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 61.210000000000001 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 70.450000000000003 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.200000000000003 109.207 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 218' ' ' VAL . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.209999999999994 107.361 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 64.439999999999998 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.648 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo . . . . . 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 61.520000000000003 111.073 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.418 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 211' ' ' LEU . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.510000000000005 111.087 -172.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.140000000000001 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.319999999999993 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.409999999999997 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.230000000000004 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 70.219999999999999 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG12 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.450000000000003 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.319999999999993 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.530000000000001 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 34.3 m170 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.140000000000001 111.244 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.519999999999996 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.409999999999997 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.545 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 65.519999999999996 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.140000000000001 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.545 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.229999999999997 111.249 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-O 120.995 0.331 . . . . 75.099999999999994 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 55.240000000000002 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.319999999999993 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.439999999999998 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' HG22 ' A' ' 201' ' ' VAL . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 65.019999999999996 107.018 175.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.409999999999997 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.230000000000004 109.753 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 22.120000000000001 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.099999999999994 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.099999999999994 107.359 178.552 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.202 -0.666 . . . . 75.340000000000003 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.32 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.219999999999999 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 231' ' ' LEU . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.510000000000005 106.596 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.230000000000004 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.340000000000003 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.219999999999999 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 53.450000000000003 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 70.519999999999996 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 175' ' ' TYR . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.209999999999994 108.601 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.409999999999997 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 35.420000000000002 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.329999999999998 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 209' ' ' THR . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.229999999999997 112.576 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.230000000000004 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.010000000000005 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.420000000000002 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 205' ' ' LEU . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 74.150000000000006 110.49 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.409999999999997 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 212' ' ' LEU . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.120000000000005 112.449 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 249' ' ' VAL . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.209999999999994 109.994 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.439999999999998 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.319999999999993 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 61.020000000000003 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.350000000000001 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.430000000000007 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.409999999999997 109.495 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 52.509999999999998 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' HG22 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.530000000000001 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.129999999999995 108.604 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.430000000000007 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.329999999999998 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.400000000000006 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.099999999999994 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.219999999999999 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.399999999999999 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.210000000000001 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.200000000000003 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 55.219999999999999 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 195' ' ' ILE . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.130000000000003 110.369 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.209999999999994 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.497 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.239999999999995 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 230' ' ' THR . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.430000000000007 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.200000000000003 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.150000000000006 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.340000000000003 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.567 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.150000000000006 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 54.439999999999998 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.219999999999999 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.209999999999994 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 72.420000000000002 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.430000000000007 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.435 ' HA ' HH11 ' A' ' 162' ' ' ARG . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.409999999999997 108.858 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 72.409999999999997 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.219999999999999 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.329999999999998 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.019999999999996 108.864 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 218' ' ' VAL . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.100000000000001 108.651 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 71.310000000000002 108.833 173.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo . . . . . 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 44.329999999999998 111.777 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.878 -0.786 . . . . 61.329999999999998 108.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.120000000000005 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 246' ' ' ILE . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 53.329999999999998 111.514 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.430000000000007 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.450000000000003 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.540000000000006 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.583 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 62.119999999999997 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.439999999999998 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.450000000000003 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.562 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 71.340000000000003 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.230000000000004 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.230000000000004 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 65.549999999999997 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.530000000000001 108.779 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 64.219999999999999 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.040000000000006 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 54.020000000000003 108.691 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--O 1.243 0.774 0 N-CA-C 109.129 -1.143 . . . . 74.129999999999995 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 72.0 111.491 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.530000000000001 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.432 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 70.140000000000001 110.079 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.319999999999993 106.208 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 63.420000000000002 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 53.340000000000003 109.574 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.464 ' HB3' HD11 ' A' ' 231' ' ' LEU . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.450000000000003 108.615 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.450000000000003 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 63.310000000000002 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.130000000000003 107.415 178.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.072 -1.084 . . . . 74.120000000000005 108.072 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.400000000000006 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.299999999999997 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.019999999999996 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 61.340000000000003 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.439999999999998 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.340000000000003 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 70.310000000000002 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 64.239999999999995 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.486 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 70.219999999999999 107.605 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.230000000000004 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.420000000000002 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 209' ' ' THR . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.040000000000006 113.659 -174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 52.43 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.019999999999996 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.310000000000002 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 205' ' ' LEU . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 64.519999999999996 110.347 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.299999999999997 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 209' ' ' THR . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.109999999999999 113.499 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 249' ' ' VAL . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 64.340000000000003 111.078 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.010000000000005 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.329999999999998 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 63.340000000000003 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.599 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.329999999999998 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 45.219999999999999 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.299999999999997 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.329999999999998 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.109999999999999 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.530000000000001 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.010000000000005 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.109999999999999 109.818 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.430000000000007 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.319999999999993 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.310000000000002 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 64.209999999999994 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 64.049999999999997 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.430000000000007 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 178' ' ' ASP . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.209999999999994 111.744 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.420000000000002 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' MET . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 64.319999999999993 112.393 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.209999999999994 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 41.509999999999998 110.266 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.129999999999995 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 72.120000000000005 108.794 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 112.39 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.409999999999997 109.3 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 43.240000000000002 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.109999999999999 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 33.25 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.253 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.049999999999997 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.299999999999997 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 149' ' ' ILE . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.140000000000001 107.373 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.420000000000002 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.150000000000006 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 212' ' ' LEU . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.439999999999998 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 71.230000000000004 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.599 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo . . . . . 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 55.240000000000002 109.629 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 109.84 -0.43 . . . . 54.340000000000003 109.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 63.049999999999997 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 60.520000000000003 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.150000000000006 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.140000000000001 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.310000000000002 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 158' ' ' HIS . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 50.100000000000001 111.8 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.310000000000002 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.140000000000001 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.534 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.539 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.1 m170 -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 62.350000000000001 108.554 170.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG22 ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.129999999999995 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 61.229999999999997 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 212' ' ' LEU . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.420000000000002 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.536 HH11 ' HA ' ' A' ' 244' ' ' ASN . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 63.340000000000003 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.209999999999994 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.42 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 61.039999999999999 112.285 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.251 1.148 0 CA-C-O 121.09 0.371 . . . . 73.439999999999998 112.56 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.099999999999994 107.947 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.519999999999996 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.450000000000003 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 71.109999999999999 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.049999999999997 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 63.140000000000001 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 64.530000000000001 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.299999999999997 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.039999999999999 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 61.100000000000001 106.373 176.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 108.528 -0.916 . . . . 71.099999999999994 108.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.540000000000006 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.450000000000003 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 62.140000000000001 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.200000000000003 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.209999999999994 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 72.209999999999994 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.400000000000006 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.049999999999997 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.329999999999998 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.129999999999995 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.420000000000002 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 63.310000000000002 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 60.119999999999997 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.209999999999994 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 211' ' ' LEU . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.450000000000003 111.105 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.430000000000007 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 209' ' ' THR . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 71.319999999999993 111.653 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 249' ' ' VAL . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.040000000000006 107.901 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 63.240000000000002 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 53.299999999999997 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.409999999999997 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.349999999999994 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 72.239999999999995 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 249' ' ' VAL . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 64.299999999999997 109.467 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 220' ' ' GLU . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 52.030000000000001 110.446 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.430000000000007 110.865 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 64.329999999999998 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 44.509999999999998 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 73.219999999999999 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.519999999999996 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.109999999999999 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 64.109999999999999 111.301 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.540000000000006 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.420000000000002 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 54.399999999999999 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.329999999999998 109.541 176.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.049999999999997 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.230000000000004 112.078 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 230' ' ' THR . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.420000000000002 111.337 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 53.539999999999999 110.879 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.109999999999999 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.040000000000006 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.441 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.329999999999998 112.666 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 235' ' ' THR . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 72.329999999999998 109.267 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.119999999999997 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.439999999999998 111.004 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.299999999999997 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 63.210000000000001 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.536 ' HA ' HH11 ' A' ' 162' ' ' ARG . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 52.020000000000003 108.411 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 241' ' ' ASN . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.109999999999999 110.416 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 71.109999999999999 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.109999999999999 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.409999999999997 108.004 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 218' ' ' VAL . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.049999999999997 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 71.239999999999995 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo . . . . . 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 64.439999999999998 110.48 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.945 0 N-CA-C 109.583 -0.525 . . . . 72.329999999999998 109.583 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.420000000000002 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 70.140000000000001 110.522 -175.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.430000000000007 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 71.349999999999994 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.099999999999994 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.420000000000002 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 45.350000000000001 111.399 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.420000000000002 110.528 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 54.32 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.099999999999994 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.436 ' CE1' HG21 ' A' ' 219' ' ' ILE . 18.3 m170 -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.120000000000005 108.824 171.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 52.240000000000002 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 62.420000000000002 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 212' ' ' LEU . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 61.310000000000002 108.735 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.434 HH11 HG12 ' A' ' 246' ' ' ILE . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 71.409999999999997 108.939 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.519999999999996 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p . . . . . 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.120000000000005 107.346 175.908 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 C--O 1.247 0.969 0 CA-C-O 121.045 0.352 . . . . 74.120000000000005 112.758 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.664 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.019999999999996 110.975 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 24.210000000000001 114.924 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.409999999999997 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.409999999999997 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.329999999999998 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 72.540000000000006 107.937 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.615 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.150000000000006 109.975 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 34.240000000000002 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 111.964 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.443 ' HB2' ' HA3' ' A' ' 194' ' ' GLY . 42.2 t . . . . . 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.349999999999994 109.046 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 108.671 -0.862 . . . . 73.030000000000001 108.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.420000000000002 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 181' ' ' SER . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.149999999999999 111.967 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.510000000000005 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 64.530000000000001 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.540000000000006 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 51.450000000000003 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 72.129999999999995 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.329999999999998 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.444 HG22 ' CA ' ' A' ' 173' ' ' GLY . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.219999999999999 108.811 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.040000000000006 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.130000000000003 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 32.210000000000001 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 50.539999999999999 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.450000000000003 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.099999999999994 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.109999999999999 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 44.549999999999997 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 63.240000000000002 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 71.109999999999999 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.43 HD21 HG11 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 109.62 -176.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.409999999999997 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.230000000000004 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.399999999999999 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.140000000000001 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.310000000000002 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 65.209999999999994 110.366 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 250' ' ' LYS . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.049999999999997 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 31.41 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 43.109999999999999 110.812 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 42.299999999999997 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 53.5 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.329999999999998 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 224' ' ' ILE 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.329999999999998 114.275 -177.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.299999999999997 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.400000000000006 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 62.43 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 55.219999999999999 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.450000000000003 111.517 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 51.109999999999999 111.073 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.030000000000001 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.129999999999995 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.120000000000005 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.140000000000001 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.209999999999994 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.420000000000002 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 53.119999999999997 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.049999999999997 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.542 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 63.109999999999999 107.325 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.099999999999994 113.778 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.539999999999999 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.230000000000004 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 241' ' ' ASN . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 54.530000000000001 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG12 HH11 ' A' ' 162' ' ' ARG . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 60.43 108.104 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.209999999999994 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.239999999999995 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 218' ' ' VAL . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.450000000000003 108.704 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.439999999999998 106.624 171.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo . . . . . 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.310000000000002 111.574 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.219999999999999 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.020000000000003 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.099999999999994 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.030000000000001 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.239999999999995 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 158' ' ' HIS . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.350000000000001 112.185 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.150000000000006 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 64.420000000000002 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.129999999999995 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.428 ' HB2' HG13 ' A' ' 154' ' ' VAL . 41.0 m170 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.409999999999997 110.265 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.239999999999995 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 73.439999999999998 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 65.540000000000006 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.140000000000001 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 64.510000000000005 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--O 1.254 1.325 0 CA-C-O 120.839 0.266 . . . . 74.040000000000006 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 64.450000000000003 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.400000000000006 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 201' ' ' VAL . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.140000000000001 107.914 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 63.420000000000002 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.129999999999995 110.51 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 62.020000000000003 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.299999999999997 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.420000000000002 108.917 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 119.464 -0.303 . . . . 73.129999999999995 110.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.219999999999999 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.240000000000002 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.400000000000006 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.310000000000002 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.329999999999998 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 61.140000000000001 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.230000000000004 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 175' ' ' TYR . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.450000000000003 107.776 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.239999999999995 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 71.530000000000001 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 65.430000000000007 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 209' ' ' THR . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.149999999999999 113.758 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 40.119999999999997 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 62.439999999999998 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.120000000000005 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 205' ' ' LEU . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.109999999999999 112.129 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 63.020000000000003 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.049999999999997 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.239999999999995 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.409999999999997 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.420000000000002 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.329999999999998 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 249' ' ' VAL . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 71.349999999999994 110.93 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.443 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 55.009999999999998 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.319999999999993 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.533 HG11 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 64.439999999999998 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 62.32 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.519999999999996 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 65.239999999999995 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 52.350000000000001 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 224' ' ' ILE 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.439999999999998 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.540000000000006 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.439999999999998 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 233' ' ' GLN . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.040000000000006 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 71.219999999999999 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.120000000000005 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.140000000000001 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.329999999999998 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.299999999999997 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.209999999999994 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.209999999999994 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 71.450000000000003 109.176 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.55 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 61.420000000000002 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 70.109999999999999 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 50.539999999999999 110.049 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.230000000000004 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 43.530000000000001 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.409999999999997 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.140000000000001 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.239999999999995 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.219999999999999 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.229999999999997 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 61.409999999999997 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 218' ' ' VAL . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 41.219999999999999 108.562 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.443 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.129999999999995 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 53.219999999999999 111.964 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 110.208 -0.293 . . . . 73.430000000000007 110.208 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.319999999999993 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 74.430000000000007 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 70.349999999999994 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 52.229999999999997 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.25 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.239999999999995 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 53.340000000000003 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.229999999999997 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.230000000000004 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 44.43 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.444 ' CE1' HG21 ' A' ' 219' ' ' ILE . 33.3 m170 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.530000000000001 110.017 172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 60.350000000000001 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.200000000000003 110.514 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.609 ' HG2' HD12 ' A' ' 149' ' ' ILE . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.219999999999999 108.987 174.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 64.450000000000003 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.469 ' N ' HD23 ' A' ' 163' ' ' LEU . 5.6 p . . . . . 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 N-CA-C 108.372 -1.434 . . . . 75.310000000000002 108.372 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.450000000000003 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.453 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.209999999999994 115.206 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.129999999999995 108.955 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 63.329999999999998 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 235' ' ' THR . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.299999999999997 111.23 175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.540000000000006 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.518 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.420000000000002 107.953 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.530000000000001 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.120000000000005 111.164 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 55.130000000000003 106.984 179.072 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 CA--C 1.506 -0.727 0 CA-C-O 119.815 -0.136 . . . . 73.120000000000005 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.430000000000007 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 63.140000000000001 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 74.400000000000006 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.109999999999999 109.501 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 53.310000000000002 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.299999999999997 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 60.009999999999998 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 63.509999999999998 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 173' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.409999999999997 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 62.520000000000003 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 33.340000000000003 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.310000000000002 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.209999999999994 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.319999999999993 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.439999999999998 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.420000000000002 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.240000000000002 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 52.450000000000003 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 72.420000000000002 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 249' ' ' VAL . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 60.420000000000002 108.443 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 55.049999999999997 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 50.439999999999998 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.319999999999993 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.131 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.430000000000007 110.673 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.444 HG21 ' CE1' ' A' ' 158' ' ' HIS . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.239999999999995 109.979 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.340000000000003 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.219999999999999 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 42.549999999999997 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.120000000000005 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 54.509999999999998 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.430000000000007 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.439999999999998 114.375 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 52.229999999999997 109.186 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.130000000000003 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 62.149999999999999 107.638 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 234' ' ' VAL . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.120000000000005 109.585 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 63.450000000000003 110.326 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.329999999999998 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 51.439999999999998 111.864 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 230' ' ' THR . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.240000000000002 111.656 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.409999999999997 110.519 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.019999999999996 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.109999999999999 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.120000000000005 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 235' ' ' THR . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.239999999999995 109.09 176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.140000000000001 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.529 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.409999999999997 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.200000000000003 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.040000000000006 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 53.409999999999997 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 241' ' ' ASN . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.130000000000003 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 149' ' ' ILE . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 65.010000000000005 107.529 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 71.099999999999994 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.450000000000003 109.386 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 53.420000000000002 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo . . . . . 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.832 0 N-CA-C 108.423 -0.954 . . . . 52.109999999999999 108.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.505 HD11 ' HG ' ' A' ' 211' ' ' LEU . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.129999999999995 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.040000000000006 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 35.5 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.129999999999995 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.319999999999993 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.209999999999994 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 158' ' ' HIS . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.310000000000002 112.347 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.140000000000001 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 44.119999999999997 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.340000000000003 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.414 ' HB2' HG13 ' A' ' 154' ' ' VAL . 15.9 m170 -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 70.439999999999998 108.139 170.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.140000000000001 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.430000000000007 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.510000000000005 108.446 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 70.239999999999995 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.510000000000005 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.329999999999998 111.921 175.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo . . . . . 0 C--O 1.247 0.96 0 CA-C-O 121.79 0.662 . . . . 73.340000000000003 112.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.519999999999996 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.430000000000007 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.443 ' HB3' HD13 ' A' ' 200' ' ' LEU . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.520000000000003 110.787 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.219999999999999 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.329999999999998 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 63.530000000000001 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.009999999999998 109.303 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.219999999999999 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.120000000000005 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 50.450000000000003 108.17 -176.68 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.556 -0.905 . . . . 73.340000000000003 108.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.299999999999997 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.200000000000003 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 61.420000000000002 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 62.310000000000002 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 54.420000000000002 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 214' ' ' VAL . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 63.43 107.776 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 73.219999999999999 108.853 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.149999999999999 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.540000000000006 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.209999999999994 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.439999999999998 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.099999999999994 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 62.030000000000001 110.686 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.430000000000007 108.648 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.240000000000002 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.521 ' HB ' ' CD2' ' A' ' 211' ' ' LEU . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.019999999999996 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.310000000000002 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 44.119999999999997 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.471 HD22 ' CG2' ' A' ' 249' ' ' VAL . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 64.349999999999994 106.943 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.200000000000003 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.510000000000005 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 61.119999999999997 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.150000000000006 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 249' ' ' VAL . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.239999999999995 108.877 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 63.210000000000001 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.310000000000002 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.508 HG11 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.430000000000007 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.441 ' OD1' HD22 ' A' ' 245' ' ' LEU . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.099999999999994 112.172 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.239999999999995 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.109999999999999 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.329999999999998 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.430000000000007 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.210000000000001 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 45.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 73.310000000000002 110.095 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 178' ' ' ASP . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 61.299999999999997 109.559 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.439999999999998 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.019999999999996 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 230' ' ' THR . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.140000000000001 111.541 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.420000000000002 109.708 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.340000000000003 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.129999999999995 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 72.329999999999998 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.319999999999993 109.159 176.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 22.440000000000001 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 64.230000000000004 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.549999999999997 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.109999999999999 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 238' ' ' MET . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.119999999999997 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 53.119999999999997 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.219999999999999 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 218' ' ' VAL . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.329999999999998 108.523 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 54.420000000000002 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo . . . . . 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.409999999999997 111.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.45 0.167 . . . . 51.399999999999999 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.319999999999993 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 246' ' ' ILE . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.409999999999997 109.798 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 64.420000000000002 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.200000000000003 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 60.420000000000002 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 55.299999999999997 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.409999999999997 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.239999999999995 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 50.299999999999997 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.230000000000004 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 70.450000000000003 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.530000000000001 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 63.130000000000003 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 72.230000000000004 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 72.439999999999998 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.474 ' N ' HD23 ' A' ' 163' ' ' LEU . 36.6 t . . . . . 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.400000000000006 107.564 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 C--O 1.246 0.894 0 N-CA-C 110.506 -0.613 . . . . 72.239999999999995 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.120000000000005 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.299999999999997 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.540000000000006 109.332 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.609 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.549999999999997 106.666 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.140000000000001 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.140000000000001 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.349999999999994 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 63.039999999999999 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 110.28 -0.267 . . . . 71.319999999999993 110.28 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.239999999999995 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.010000000000005 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 63.43 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.400000000000006 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.340000000000003 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 65.409999999999997 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.109999999999999 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 206' ' ' ALA . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.519999999999996 109.71 175.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.430000000000007 107.753 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.230000000000004 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.329999999999998 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.030000000000001 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.521 HD23 ' HG ' ' A' ' 163' ' ' LEU . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.239999999999995 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.109999999999999 110.426 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 52.350000000000001 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 44.140000000000001 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.477 ' HB ' HD13 ' A' ' 211' ' ' LEU . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 70.430000000000007 111.393 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.109999999999999 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 209' ' ' THR . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.209999999999994 107.321 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.209999999999994 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.030000000000001 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.109999999999999 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.466 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.230000000000004 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 249' ' ' VAL . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 51.350000000000001 110.94 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.019999999999996 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 248' ' ' THR . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 111.39 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 63.009999999999998 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 63.310000000000002 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 71.409999999999997 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.239999999999995 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.299999999999997 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.319999999999993 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 63.130000000000003 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.340000000000003 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 32.310000000000002 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.430000000000007 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.210000000000001 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.020000000000003 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 52.420000000000002 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 239' ' ' VAL . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 72.310000000000002 110.404 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 62.0 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.120000000000005 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.497 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.219999999999999 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 235' ' ' THR . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.319999999999993 109.683 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.200000000000003 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.402 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.130000000000003 111.767 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.040000000000006 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.140000000000001 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.430000000000007 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 241' ' ' ASN . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 110.885 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 149' ' ' ILE . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.140000000000001 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 73.239999999999995 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.150000000000006 108.036 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 218' ' ' VAL . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 60.049999999999997 107.688 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.510000000000005 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo . . . . . 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.329999999999998 111.427 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.018 -1.105 . . . . 25.449999999999999 108.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.329999999999998 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 63.109999999999999 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.119999999999997 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.109999999999999 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.319999999999993 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.400000000000006 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.430000000000007 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.049999999999997 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 64.450000000000003 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.682 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 64.049999999999997 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.140000000000001 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 73.420000000000002 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.450000000000003 108.01 -176.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.340000000000003 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.519999999999996 108.936 172.407 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 N--CA 1.482 0.808 0 N-CA-C 110.391 -0.657 . . . . 74.299999999999997 110.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 71.019999999999996 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.239999999999995 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 60.030000000000001 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.430000000000007 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 235' ' ' THR . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.340000000000003 111.752 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 74.310000000000002 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.329999999999998 108.779 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.329999999999998 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 52.009999999999998 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.409999999999997 109.123 -178.129 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.537 -0.171 . . . . 63.219999999999999 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.229999999999997 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.030000000000001 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 64.430000000000007 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 43.5 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 214' ' ' VAL . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.540000000000006 108.285 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.049999999999997 109.728 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 50.539999999999999 108.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 70.349999999999994 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.229999999999997 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.130000000000003 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.450000000000003 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.519999999999996 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.409999999999997 107.6 176.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.099999999999994 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.496 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 62.149999999999999 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 33.149999999999999 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 71.140000000000001 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.120000000000005 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.409999999999997 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 199' ' ' ARG . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.129999999999995 114.368 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.549999999999997 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.219999999999999 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.219999999999999 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 249' ' ' VAL . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.200000000000003 110.149 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 250' ' ' LYS . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 71.109999999999999 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.040000000000006 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.129999999999995 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.340000000000003 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 34.439999999999998 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.430000000000007 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.509999999999998 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.427 HG21 HG23 ' A' ' 218' ' ' VAL . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.450000000000003 112.493 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.487 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 40.329999999999998 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 54.200000000000003 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.120000000000005 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 234' ' ' VAL . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.219999999999999 109.72 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 33.200000000000003 110.164 175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.319999999999993 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.099999999999994 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 230' ' ' THR . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 72.400000000000006 111.195 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 239' ' ' VAL . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.219999999999999 110.843 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.140000000000001 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.239999999999995 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.299999999999997 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 235' ' ' THR . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.010000000000005 109.642 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 64.319999999999993 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.588 ' HB2' HD23 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.049999999999997 110.8 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 65.109999999999999 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.400000000000006 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 65.239999999999995 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 241' ' ' ASN . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.230000000000004 109.3 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.329999999999998 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 50.43 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.439999999999998 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HD22 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 64.040000000000006 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.540000000000006 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 74.230000000000004 110.855 176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 120.537 0.208 . . . . 52.420000000000002 110.769 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.439999999999998 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 246' ' ' ILE . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 54.130000000000003 112.177 -170.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.540000000000006 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.099999999999994 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.409999999999997 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.209999999999994 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 158' ' ' HIS . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.040000000000006 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.430000000000007 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.430000000000007 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.563 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.299999999999997 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.516 ' HB2' HG13 ' A' ' 154' ' ' VAL . 17.8 m170 -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.099999999999994 109.165 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HD2' HD12 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.310000000000002 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.510000000000005 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 211' ' ' LEU . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 61.420000000000002 106.685 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.109999999999999 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 72.049999999999997 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 63.119999999999997 106.766 174.27 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--O 1.249 1.029 0 CA-C-O 121.174 0.406 . . . . 74.420000000000002 113.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.420000000000002 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.210000000000001 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.422 ' HB3' ' HG ' ' A' ' 200' ' ' LEU . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.340000000000003 112.118 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.140000000000001 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.530000000000001 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.030000000000001 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 43.020000000000003 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 55.350000000000001 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 42.439999999999998 107.839 177.274 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 109.741 -0.466 . . . . 72.239999999999995 109.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 70.439999999999998 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.329999999999998 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.409999999999997 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.540000000000006 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.409999999999997 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.040000000000006 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 65.109999999999999 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 174' ' ' PHE . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.200000000000003 111.936 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.439999999999998 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.549999999999997 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.119999999999997 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.209999999999994 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.430000000000007 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.319999999999993 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 61.310000000000002 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 211' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.129999999999995 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 42.140000000000001 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.693 HD11 HG22 ' A' ' 161' ' ' VAL . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 55.140000000000001 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 249' ' ' VAL . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.420000000000002 110.44 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 70.450000000000003 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.349999999999994 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.120000000000005 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 45.149999999999999 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.430000000000007 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 249' ' ' VAL . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 71.109999999999999 110.769 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.535 HG22 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.340000000000003 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.349999999999994 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.588 ' OD1' HD12 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.319999999999993 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.310000000000002 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.200000000000003 110.256 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.340000000000003 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.409999999999997 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.209999999999994 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 74.439999999999998 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 234' ' ' VAL . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.420000000000002 110.105 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 61.210000000000001 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.510000000000005 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.329999999999998 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 230' ' ' THR . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.230000000000004 111.721 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.129999999999995 110.775 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.120000000000005 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.329999999999998 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.587 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 54.130000000000003 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 235' ' ' THR . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 71.219999999999999 109.141 176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.299999999999997 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 62.340000000000003 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.109999999999999 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.549999999999997 109.168 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.439999999999998 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.588 HD12 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.100000000000001 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 149' ' ' ILE . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.420000000000002 107.067 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 43.409999999999997 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.230000000000004 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 218' ' ' VAL . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 54.009999999999998 109.054 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.140000000000001 108.39 172.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo . . . . . 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.209999999999994 110.783 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 120.818 0.342 . . . . 72.219999999999999 111.569 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.340000000000003 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 62.109999999999999 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.420000000000002 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.299999999999997 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.299999999999997 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 71.230000000000004 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.420000000000002 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 62.210000000000001 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 44.43 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.239999999999995 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.329999999999998 110.378 171.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.546 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.409999999999997 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 74.319999999999993 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.219999999999999 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.510000000000005 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.439999999999998 109.404 -174.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.412 ' N ' HD23 ' A' ' 163' ' ' LEU . 41.6 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.319999999999993 111.139 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.252 1.209 0 N-CA-C 110.0 -0.808 . . . . 61.32 110.0 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.200000000000003 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.633 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.219999999999999 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.099999999999994 109.546 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 201' ' ' VAL . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.450000000000003 107.463 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.430000000000007 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 65.420000000000002 109.347 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.510000000000005 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.219999999999999 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 54.229999999999997 108.755 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 65.109999999999999 108.301 -179.126 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.168 0.032 . . . . 74.219999999999999 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.310000000000002 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.219999999999999 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.409999999999997 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 71.019999999999996 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 71.150000000000006 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.240000000000002 109.808 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.219999999999999 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 70.409999999999997 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.633 ' CG2' ' HA2' ' A' ' 173' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.030000000000001 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.400000000000006 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.109999999999999 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 44.409999999999997 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 72.140000000000001 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.439999999999998 111.835 -174.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.530000000000001 109.591 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.109999999999999 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.219999999999999 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.430000000000007 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.120000000000005 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 249' ' ' VAL . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 64.549999999999997 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.430000000000007 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 60.140000000000001 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.239999999999995 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.329999999999998 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.120000000000005 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 249' ' ' VAL . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 70.010000000000005 110.507 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 70.099999999999994 110.849 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 41.229999999999997 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.449 ' HB2' HD12 ' A' ' 245' ' ' LEU . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.400000000000006 110.976 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.310000000000002 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.400000000000006 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 73.129999999999995 112.516 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.491 ' H ' HG22 ' A' ' 224' ' ' ILE 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 72.049999999999997 114.438 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.140000000000001 108.656 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 54.049999999999997 108.329 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.049999999999997 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 74.430000000000007 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.420000000000002 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 62.409999999999997 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.239999999999995 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.010000000000005 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.549999999999997 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.457 ' HG3' HG13 ' A' ' 224' ' ' ILE . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.040000000000006 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.534 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 71.129999999999995 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.109999999999999 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.219999999999999 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 109.941 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.420000000000002 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 72.120000000000005 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 63.119999999999997 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 241' ' ' ASN . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 64.230000000000004 110.897 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.140000000000001 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 64.329999999999998 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.030000000000001 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.542 HG21 HD22 ' A' ' 212' ' ' LEU . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.129999999999995 109.002 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 64.450000000000003 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo . . . . . 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.400000000000006 112.629 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.704 0 N-CA-C 110.281 -0.266 . . . . 73.120000000000005 110.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.209999999999994 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 160' ' ' ARG . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.409999999999997 110.37 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.439999999999998 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 44.520000000000003 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.030000000000001 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 51.109999999999999 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 33.310000000000002 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.450000000000003 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.439999999999998 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 70.319999999999993 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.209999999999994 109.447 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.209999999999994 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 64.430000000000007 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 148' ' ' ILE . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.400000000000006 107.794 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.329999999999998 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.349999999999994 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.310000000000002 109.545 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo . . . . . 0 C--O 1.246 0.906 0 CA-C-O 120.899 0.291 . . . . 63.109999999999999 112.695 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 62.43 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 34.530000000000001 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.299999999999997 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 63.240000000000002 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.420000000000002 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.120000000000005 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 71.409999999999997 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.400000000000006 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.100000000000001 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.099999999999994 107.297 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 . . . . . 0 N--CA 1.436 -1.158 0 N-CA-C 108.665 -0.865 . . . . 74.540000000000006 108.665 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.219999999999999 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 231' ' ' LEU . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.040000000000006 106.86 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.420000000000002 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.510000000000005 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 61.030000000000001 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 64.409999999999997 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.519999999999996 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 61.539999999999999 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.219999999999999 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.240000000000002 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.539999999999999 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 163' ' ' LEU . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.439999999999998 114.08 -171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 40.130000000000003 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.230000000000004 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.239999999999995 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 55.530000000000001 109.916 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.530000000000001 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 249' ' ' VAL . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 64.400000000000006 109.257 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.120000000000005 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.450000000000003 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.239999999999995 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.533 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.349999999999994 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.439999999999998 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.409999999999997 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.482 ' HG3' HG22 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.450000000000003 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.439999999999998 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.526 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.120000000000005 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.040000000000006 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.310000000000002 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.430000000000007 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.450000000000003 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.350000000000001 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.400000000000006 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 64.299999999999997 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.520000000000003 109.55 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 195' ' ' ILE . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.150000000000006 109.964 174.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.400000000000006 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.420000000000002 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.420000000000002 110.952 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.129999999999995 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.030000000000001 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.329999999999998 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 73.120000000000005 112.803 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.140000000000001 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 41.310000000000002 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.56 ' HB2' HD13 ' A' ' 245' ' ' LEU . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 65.129999999999995 106.746 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 72.340000000000003 113.2 -170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.439999999999998 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.030000000000001 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 71.439999999999998 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 70.340000000000003 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.439999999999998 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 71.150000000000006 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 54.329999999999998 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.487 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.430000000000007 108.517 169.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo . . . . . 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.219999999999999 109.428 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.199 -1.408 . . . . 72.239999999999995 107.199 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 159' ' ' ARG . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.109999999999999 108.319 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.623 HD13 ' HG2' ' A' ' 162' ' ' ARG . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.530000000000001 111.528 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.239999999999995 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 72.329999999999998 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.140000000000001 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.209999999999994 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.239999999999995 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 154' ' ' VAL . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 64.319999999999993 109.179 172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.349999999999994 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.542 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.219999999999999 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.439999999999998 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.577 ' HD2' HG21 ' A' ' 148' ' ' ILE . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 70.400000000000006 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.140000000000001 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.623 ' HG2' HD13 ' A' ' 149' ' ' ILE . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.099999999999994 107.703 175.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.319999999999993 108.295 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 163' ' ' LEU . 75.1 m . . . . . 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 61.310000000000002 109.468 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.241 0.656 0 CA-C-O 120.912 0.297 . . . . 73.310000000000002 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 60.43 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.120000000000005 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.209999999999994 109.92 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.140000000000001 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.019999999999996 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.350000000000001 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.009999999999998 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 73.430000000000007 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.039999999999999 108.124 -179.248 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.51 -0.588 0 N-CA-C 108.741 -0.837 . . . . 73.409999999999997 108.741 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.519999999999996 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.310000000000002 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.219999999999999 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 72.109999999999999 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.219999999999999 108.557 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.439999999999998 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.109999999999999 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.109999999999999 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 55.240000000000002 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 64.230000000000004 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.420000000000002 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.129999999999995 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 163' ' ' LEU . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.140000000000001 113.29 -174.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 41.409999999999997 111.819 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.439999999999998 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 71.549999999999997 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 148' ' ' ILE . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.129999999999995 111.202 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.519999999999996 110.977 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.430000000000007 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.009999999999998 115.413 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.230000000000004 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.009999999999998 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.299999999999997 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.667 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.319999999999993 110.585 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.219999999999999 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.536 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.119999999999997 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 61.039999999999999 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 226' ' ' VAL . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 73.510000000000005 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 62.229999999999997 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 224' ' ' ILE . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.420000000000002 113.783 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.010000000000005 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.039999999999999 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 70.319999999999993 108.354 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.230000000000004 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 64.510000000000005 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.010000000000005 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 62.329999999999998 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.439999999999998 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 70.209999999999994 110.472 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.349999999999994 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 71.400000000000006 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.509 ' HB3' HD21 ' A' ' 172' ' ' LEU . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.439999999999998 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 235' ' ' THR . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 72.319999999999993 109.687 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.349999999999994 110.336 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.44 ' HB2' HD13 ' A' ' 245' ' ' LEU . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.510000000000005 111.073 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 54.130000000000003 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.400000000000006 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.040000000000006 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 63.149999999999999 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 149' ' ' ILE . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 74.519999999999996 106.882 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.430000000000007 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 71.329999999999998 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 218' ' ' VAL . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 53.329999999999998 107.432 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' THR 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 74.310000000000002 109.822 171.23 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.8 Cg_endo . . . . . 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.400000000000006 112.735 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 120.729 0.3 . . . . 32.420000000000002 111.414 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 73.340000000000003 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.596 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.120000000000005 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.520000000000003 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 62.109999999999999 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.450000000000003 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.310000000000002 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 158' ' ' HIS . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.329999999999998 111.582 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.039999999999999 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.310000000000002 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.430000000000007 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.447 ' HB2' HG13 ' A' ' 154' ' ' VAL . 58.0 m170 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.409999999999997 108.999 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 211' ' ' LEU . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 65.430000000000007 109.332 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.622 ' HD2' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 65.430000000000007 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.240000000000002 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.420000000000002 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 62.409999999999997 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 54.030000000000001 105.371 171.229 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 112.515 0.159 . . . . 73.120000000000005 112.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.611 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.310000000000002 109.926 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.473 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.109999999999999 114.528 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 72.129999999999995 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.140000000000001 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 70.019999999999996 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.200000000000003 108.605 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.643 ' HB3' HD11 ' A' ' 231' ' ' LEU . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.510000000000005 110.075 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.230000000000004 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.439999999999998 108.174 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.340000000000003 107.9 179.002 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 110.421 -0.214 . . . . 74.439999999999998 110.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.540000000000006 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 43.409999999999997 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.540000000000006 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.439999999999998 109.202 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 62.119999999999997 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.229999999999997 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.040000000000006 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.299999999999997 109.915 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.473 HG22 ' CA ' ' A' ' 173' ' ' GLY . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.520000000000003 106.895 173.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.409999999999997 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.229999999999997 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.010000000000005 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 209' ' ' THR . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.329999999999998 111.647 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.019999999999996 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.109999999999999 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 205' ' ' LEU . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 63.140000000000001 110.456 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.010000000000005 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.482 ' HB3' HH11 ' A' ' 159' ' ' ARG . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 64.329999999999998 111.99 -176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' HB1' ' A' ' 206' ' ' ALA . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.230000000000004 109.787 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 63.32 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.319999999999993 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.340000000000003 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 63.039999999999999 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.129999999999995 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 249' ' ' VAL . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.219999999999999 110.316 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.209999999999994 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.319999999999993 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.427 HG23 ' HB ' ' A' ' 224' ' ' ILE . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.129999999999995 107.278 173.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.099999999999994 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.120000000000005 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 221' ' ' VAL . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.319999999999993 107.761 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.350000000000001 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.340000000000003 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.210000000000001 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.540000000000006 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.549999999999997 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.310000000000002 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.329999999999998 110.6 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 63.399999999999999 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.349999999999994 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.450000000000003 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.030000000000001 111.201 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.430000000000007 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.605 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.329999999999998 112.903 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.239999999999995 109.321 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 11.109999999999999 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.039999999999999 110.371 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.519999999999996 114.733 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.040000000000006 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.319999999999993 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.140000000000001 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 149' ' ' ILE . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.239999999999995 107.305 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.439 HD12 ' SD ' ' A' ' 238' ' ' MET . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 71.409999999999997 110.751 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 62.210000000000001 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 218' ' ' VAL . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 62.43 108.633 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 64.349999999999994 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo . . . . . 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.230000000000004 111.653 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.635 -0.876 . . . . 75.549999999999997 108.635 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 211' ' ' LEU . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.420000000000002 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 60.310000000000002 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.310000000000002 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.230000000000004 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 41.539999999999999 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 155' ' ' PRO . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.519999999999996 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 154' ' ' VAL . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.140000000000001 109.178 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.209999999999994 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.567 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 62.539999999999999 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.483 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 31.9 m170 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.340000000000003 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.534 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 64.040000000000006 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 65.129999999999995 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.310000000000002 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 61.210000000000001 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 62.219999999999999 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 33.539999999999999 107.61 -179.018 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.697 -1.309 . . . . 73.230000000000004 108.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.019999999999996 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.230000000000004 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.129999999999995 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.239999999999995 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 235' ' ' THR . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 51.310000000000002 111.864 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.120000000000005 109.558 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 231' ' ' LEU . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.310000000000002 111.027 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 40.009999999999998 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.420000000000002 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.439999999999998 108.581 -177.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.887 -1.153 . . . . 74.329999999999998 107.887 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 72.200000000000003 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.540000000000006 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.439999999999998 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.530000000000001 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.200000000000003 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.129999999999995 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 50.130000000000003 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.340000000000003 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.200000000000003 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.539999999999999 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 44.240000000000002 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.010000000000005 113.471 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 54.43 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.230000000000004 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 51.210000000000001 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.433 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 63.329999999999998 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.509999999999998 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 148' ' ' ILE . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.239999999999995 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 249' ' ' VAL . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.510000000000005 108.99 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 64.310000000000002 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.109999999999999 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.340000000000003 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.129999999999995 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.239999999999995 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 249' ' ' VAL . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.119999999999997 110.334 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.534 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.530000000000001 110.01 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' HG22 ' A' ' 219' ' ' ILE . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.439999999999998 111.687 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.129999999999995 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.483 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.140000000000001 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 42.210000000000001 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.409999999999997 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 72.099999999999994 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.310000000000002 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.450000000000003 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 234' ' ' VAL . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 45.109999999999999 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.239999999999995 110.478 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.450000000000003 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.329999999999998 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 230' ' ' THR . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 62.539999999999999 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 176' ' ' ILE . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.219999999999999 110.955 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.549999999999997 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.430000000000007 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.415 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 70.0 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.219999999999999 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 63.350000000000001 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.010000000000005 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.340000000000003 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.310000000000002 110.956 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.400000000000006 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 61.130000000000003 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.530000000000001 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.400000000000006 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 218' ' ' VAL . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.349999999999994 108.72 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.534 ' CD ' HD11 ' A' ' 219' ' ' ILE . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 64.25 109.197 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo . . . . . 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.109999999999999 112.795 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 111.319 0.118 . . . . 74.549999999999997 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 211' ' ' LEU . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.430000000000007 107.354 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 52.299999999999997 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 154' ' ' VAL . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.420000000000002 112.435 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.319999999999993 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.420000000000002 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 61.119999999999997 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 150' ' ' ASP . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.209999999999994 112.032 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 62.450000000000003 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.519999999999996 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.523 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 71.409999999999997 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 154' ' ' VAL . 40.3 m170 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 73.540000000000006 111.546 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 159' ' ' ARG . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 72.319999999999993 106.741 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 73.120000000000005 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 64.230000000000004 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.554 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.430000000000007 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 205' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 72.299999999999997 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.086 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.317 -1.07 . . . . 65.230000000000004 109.317 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 61.140000000000001 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 53.329999999999998 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 72.209999999999994 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.340000000000003 107.207 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.45 HD11 ' OG1' ' A' ' 235' ' ' THR . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 70.319999999999993 112.424 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.430000000000007 108.683 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 10.44 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 61.100000000000001 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.099999999999994 108.058 -179.173 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 109.882 -0.414 . . . . 45.520000000000003 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.549999999999997 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.319999999999993 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 231' ' ' LEU . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 74.140000000000001 107.218 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.510000000000005 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.140000000000001 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.240000000000002 111.068 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.439999999999998 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.140000000000001 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 61.32 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.420000000000002 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 53.140000000000001 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 34.210000000000001 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 163' ' ' LEU . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.319999999999993 113.623 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 63.130000000000003 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.040000000000006 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.140000000000001 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.528 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.200000000000003 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 62.310000000000002 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 148' ' ' ILE . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.120000000000005 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 52.439999999999998 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 24.25 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.530000000000001 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.099999999999994 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.430000000000007 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 249' ' ' VAL . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 64.010000000000005 109.432 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.428 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 71.430000000000007 110.544 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 71.340000000000003 111.246 -176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.229999999999997 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.599 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.209999999999994 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.230000000000004 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.349999999999994 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.299999999999997 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 219' ' ' ILE . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.010000000000005 111.0 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.400000000000006 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.019999999999996 109.206 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 195' ' ' ILE . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 60.119999999999997 110.802 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.140000000000001 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 71.340000000000003 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 230' ' ' THR . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.430000000000007 111.252 -178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.45 ' OG1' HD11 ' A' ' 176' ' ' ILE . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 53.409999999999997 109.061 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.529 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.049999999999997 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.310000000000002 109.643 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 53.43 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.109999999999999 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.540000000000006 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 110.178 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.109999999999999 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 149' ' ' ILE . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 63.420000000000002 107.944 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 70.030000000000001 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 71.140000000000001 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.595 HG21 HD22 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.310000000000002 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.239999999999995 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo . . . . . 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.109999999999999 110.427 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.262 0.077 . . . . 44.009999999999998 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 211' ' ' LEU . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 53.340000000000003 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.319999999999993 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.230000000000004 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.400000000000006 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.340000000000003 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.209999999999994 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 63.299999999999997 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 42.219999999999999 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.200000000000003 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.543 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.209999999999994 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.310000000000002 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 73.319999999999993 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.019999999999996 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.450000000000003 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.219999999999999 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 172' ' ' LEU . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.439999999999998 107.966 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.420000000000002 110.994 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.242 0.699 0 N-CA-C 111.601 -0.192 . . . . 64.430000000000007 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 62.420000000000002 109.908 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.219999999999999 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.430000000000007 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 63.439999999999998 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.430000000000007 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.571 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.099999999999994 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 43.229999999999997 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 61.310000000000002 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 40.049999999999997 107.497 -178.755 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.599 -1.26 . . . . 73.219999999999999 107.599 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.109999999999999 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.319999999999993 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.400000000000006 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 52.009999999999998 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.540000000000006 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 62.539999999999999 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.310000000000002 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.329999999999998 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.329999999999998 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.329999999999998 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 53.100000000000001 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 21.440000000000001 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 61.310000000000002 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 54.049999999999997 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.530000000000001 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.219999999999999 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.129999999999995 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 42.219999999999999 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 62.210000000000001 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.329999999999998 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 71.129999999999995 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.420000000000002 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.445 HD22 ' N ' ' A' ' 215' ' ' ASN . 0.8 OUTLIER -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.409999999999997 113.476 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.019999999999996 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.430000000000007 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 249' ' ' VAL . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.239999999999995 109.438 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 226' ' ' VAL . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.510000000000005 110.623 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.350000000000001 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.140000000000001 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.209999999999994 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.100000000000001 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 73.239999999999995 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.219999999999999 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 218' ' ' VAL . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.510000000000005 110.827 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 34.130000000000003 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.549999999999997 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.140000000000001 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 73.349999999999994 110.256 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 65.450000000000003 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.409999999999997 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.540000000000006 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.319999999999993 109.759 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 44.200000000000003 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 61.020000000000003 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 74.200000000000003 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.456 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 72.409999999999997 112.918 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.407 ' HA ' ' HB3' ' A' ' 242' ' ' SER . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 44.219999999999999 109.77 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.510000000000005 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 71.420000000000002 109.69 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 239' ' ' VAL . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.510000000000005 115.345 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.329999999999998 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.140000000000001 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 241' ' ' ASN . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.239999999999995 111.342 -175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 149' ' ' ILE . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.239999999999995 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 218' ' ' VAL . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 55.009999999999998 108.657 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.219999999999999 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 53.409999999999997 111.556 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 108.731 -0.84 . . . . 72.239999999999995 108.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.099999999999994 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 61.450000000000003 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.510000000000005 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.530000000000001 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.329999999999998 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.329999999999998 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.109999999999999 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.409999999999997 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.409999999999997 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 55.420000000000002 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 25.6 m170 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 62.149999999999999 110.644 176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.439999999999998 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.319999999999993 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 212' ' ' LEU . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.340000000000003 109.33 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.329999999999998 109.196 -176.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.578 HD22 HD23 ' A' ' 172' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 53.149999999999999 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 60.149999999999999 110.042 -179.204 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 120.77 0.237 . . . . 65.209999999999994 111.636 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 163' ' ' LEU . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 42.240000000000002 111.904 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 204' ' ' GLY . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 60.340000000000003 114.312 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.200000000000003 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.439999999999998 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 60.299999999999997 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.239999999999995 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 64.430000000000007 108.774 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 34.240000000000002 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.439999999999998 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.299999999999997 107.883 179.656 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.286 -0.635 . . . . 52.130000000000003 109.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 62.329999999999998 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.209999999999994 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.040000000000006 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.400000000000006 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.430000000000007 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.329999999999998 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 71.209999999999994 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.450000000000003 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.487 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.409999999999997 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 60.450000000000003 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.340000000000003 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 173' ' ' GLY . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.209999999999994 111.679 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.430000000000007 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.340000000000003 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 61.130000000000003 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.439999999999998 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.239999999999995 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 161' ' ' VAL . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 64.239999999999995 107.524 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.409999999999997 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.200000000000003 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 71.239999999999995 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 62.329999999999998 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.450000000000003 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 249' ' ' VAL . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 64.530000000000001 111.038 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 73.420000000000002 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.099999999999994 111.231 -178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 63.450000000000003 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.408 ' HB2' HD12 ' A' ' 245' ' ' LEU . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.340000000000003 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 62.439999999999998 107.89 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.446 ' H ' ' H ' ' A' ' 223' ' ' GLY . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 71.120000000000005 107.072 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.549999999999997 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.319999999999993 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.439999999999998 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 43.340000000000003 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 60.229999999999997 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 55.310000000000002 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.129999999999995 110.617 176.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.329999999999998 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 71.299999999999997 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 64.430000000000007 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.420000000000002 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.540000000000006 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG2' HD21 ' A' ' 245' ' ' LEU . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.230000000000004 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.329999999999998 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.039999999999999 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 245' ' ' LEU . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.140000000000001 111.055 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 63.240000000000002 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.109999999999999 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.140000000000001 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 238' ' ' MET . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.430000000000007 110.504 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.209999999999994 106.881 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.319999999999993 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.420000000000002 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 218' ' ' VAL . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.109999999999999 107.894 175.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.340000000000003 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 60.439999999999998 111.32 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 111.641 0.237 . . . . 73.109999999999999 111.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 73.019999999999996 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.75 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.310000000000002 111.026 -176.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.150000000000006 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.119999999999997 112.785 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.329999999999998 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.130000000000003 110.133 -175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.119999999999997 110.661 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.409999999999997 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.409999999999997 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 64.299999999999997 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 74.209999999999994 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 72.409999999999997 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.558 ' HB2' HD12 ' A' ' 149' ' ' ILE . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 73.239999999999995 111.874 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 64.430000000000007 108.231 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.409999999999997 106.976 174.388 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo . . . . . 0 C--O 1.258 1.478 0 CA-C-O 121.019 0.341 . . . . 64.230000000000004 112.052 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 61.399999999999999 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.575 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.230000000000004 116.175 -174.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.019999999999996 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 72.040000000000006 107.155 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.444 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.400000000000006 111.877 177.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.439999999999998 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 71.129999999999995 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.009999999999998 108.237 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 119.405 -0.331 . . . . 75.129999999999995 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.409999999999997 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.430000000000007 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.209999999999994 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.496 ' CD1' HD23 ' A' ' 212' ' ' LEU . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 53.409999999999997 108.856 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 44.149999999999999 110.92 -177.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.340000000000003 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.109999999999999 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.575 HG22 ' CA ' ' A' ' 173' ' ' GLY . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.039999999999999 108.358 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.229999999999997 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 53.509999999999998 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 63.039999999999999 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 71.510000000000005 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 212' ' ' LEU . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.209999999999994 111.491 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.310000000000002 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.239999999999995 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.109999999999999 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 148' ' ' ILE . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.496 HD23 ' CD1' ' A' ' 197' ' ' ILE . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.230000000000004 110.337 177.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.310000000000002 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.439999999999998 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.209999999999994 113.016 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.230000000000004 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.140000000000001 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 249' ' ' VAL . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.539999999999999 109.454 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.486 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.349999999999994 110.78 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.486 ' HG3' HG22 ' A' ' 219' ' ' ILE . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.329999999999998 111.493 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.209999999999994 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.537 ' OD1' HD12 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.340000000000003 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.229999999999997 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.439999999999998 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.230000000000004 108.895 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 218' ' ' VAL . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.340000000000003 112.234 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.109999999999999 110.247 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 40.509999999999998 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.019999999999996 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 64.219999999999999 108.892 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.130000000000003 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.519999999999996 111.676 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 230' ' ' THR . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.340000000000003 111.077 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.407 HG23 HD11 ' A' ' 176' ' ' ILE . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.310000000000002 110.683 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.340000000000003 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.120000000000005 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.530000000000001 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.67 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 70.299999999999997 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.239999999999995 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 245' ' ' LEU . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.530000000000001 112.685 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.099999999999994 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.349999999999994 110.24 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.439999999999998 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.537 HD12 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.209999999999994 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 149' ' ' ILE . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.420000000000002 109.119 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.409999999999997 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 72.450000000000003 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 218' ' ' VAL . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.439999999999998 108.42 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.402 ' CD ' HD11 ' A' ' 219' ' ' ILE . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.129999999999995 107.636 170.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 63.420000000000002 108.517 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.896 0 N-CA-C 110.183 -1.167 . . . . 45.030000000000001 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -97.63 105.9 18.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.393 0.596 . . . . 75.530000000000001 110.98 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 130' ' ' LYS . 71.8 mmtt -118.37 84.16 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 122.089 0.947 . . . . 74.25 111.473 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.5 t -96.86 146.67 24.72 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.91 -1.496 . . . . 61.130000000000003 108.819 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 132' ' ' LYS . 10.0 mptt -101.3 84.83 2.69 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.323 -1.362 . . . . 74.099999999999994 107.323 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.43 114.85 54.84 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.624 -0.716 . . . . 73.040000000000006 110.935 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.81 135.05 31.68 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.027 1.818 . . . . 73.219999999999999 110.773 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.9 p -77.67 87.16 3.95 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.596 0.713 . . . . 74.230000000000004 110.719 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.46 HD13 HH11 ' A' ' 162' ' ' ARG . 71.9 mt -84.03 112.57 21.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 114.996 -1.002 . . . . 75.340000000000003 111.365 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.1 t -93.01 118.18 30.89 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.314 -1.735 . . . . 55.130000000000003 106.314 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -95.34 130.73 31.45 Favored Pre-proline 0 N--CA 1.434 -1.271 0 C-N-CA 119.52 -0.872 . . . . 71.219999999999999 110.677 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.93 175.39 2.1 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.899 2.399 . . . . 52.25 109.976 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -83.85 86.79 7.11 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.788 0.804 . . . . 52.43 109.541 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -114.31 139.6 49.31 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.308 -1.315 . . . . 54.530000000000001 107.576 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.52 17.6 21.85 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 113.53 0.937 . . . . 73.140000000000001 113.53 -173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -126.33 125.52 42.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.935 -0.765 . . . . 51.5 108.935 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 164' ' ' CYS . 70.3 m -127.78 144.05 51.1 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.689 -0.804 . . . . 74.150000000000006 111.79 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.58 135.09 26.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.685 -1.228 . . . . 62.43 107.685 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.3 p -80.77 116.33 20.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.163 -1.051 . . . . 65.450000000000003 108.163 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.07 157.84 26.1 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.452 -1.249 . . . . 44.109999999999999 109.96 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 42.4 mm -92.86 106.81 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.641 -1.614 . . . . 74.129999999999995 106.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 32.0 pt -98.89 155.69 3.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.016 -0.993 . . . . 62.210000000000001 110.333 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 154' ' ' VAL . 23.7 m-20 69.09 8.98 7.16 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 124.478 1.111 . . . . 73.540000000000006 111.087 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.48 -29.2 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.167 0.987 . . . . 71.209999999999994 112.302 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.15 -15.11 58.58 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.209 0.528 . . . . 61.149999999999999 110.876 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 mm -110.79 -56.01 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.181 -0.463 . . . . 62.420000000000002 111.006 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 9.3 p -66.4 142.21 97.6 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 123.177 0.591 . . . . 65.420000000000002 110.508 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 12.0 Cg_exo -71.37 156.61 58.38 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.872 2.381 . . . . 64.230000000000004 111.414 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.66 -11.77 1.51 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.158 1.383 . . . . 71.239999999999995 112.527 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.513 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 33.9 p -72.32 -18.57 61.76 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.731 0.812 . . . . 74.519999999999996 110.922 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -124.12 147.29 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 64.239999999999995 110.602 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.49 131.4 51.64 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.195 -1.039 . . . . 74.510000000000005 108.195 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.1 mtt180 -122.4 123.78 42.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.376 0.51 . . . . 71.239999999999995 112.376 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.82 136.43 55.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.428 -0.952 . . . . 75.140000000000001 108.428 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.46 HH11 HD13 ' A' ' 136' ' ' ILE . 55.4 ttp180 -99.83 125.19 45.73 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.877 -0.729 . . . . 74.239999999999995 109.71 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.2 tt -92.72 135.45 34.09 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.516 -1.29 . . . . 75.239999999999995 107.516 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 36.5 t -124.61 149.15 47.39 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.652 -0.87 . . . . 65.340000000000003 108.652 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 9.3 mmpt? -79.83 143.68 34.17 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.837 0.827 . . . . 74.140000000000001 112.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -123.1 104.03 8.94 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.357 -1.292 . . . . 73.010000000000005 108.006 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -92.37 0.39 Allowed Glycine 0 C--N 1.312 -0.774 0 O-C-N 123.722 0.639 . . . . 60.32 112.274 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.5 t -111.92 168.56 9.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.357 -0.609 . . . . 54.43 109.357 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.18 85.87 6.73 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.023 0.916 . . . . 70.329999999999998 112.744 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.34 149.26 72.09 Favored Pre-proline 0 C--N 1.29 -1.982 0 CA-C-N 114.443 -1.253 . . . . 64.140000000000001 109.14 170.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -53.94 155.4 14.83 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.157 2.572 . . . . 71.120000000000005 112.452 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.3 mp -68.7 148.03 50.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.456 -0.942 . . . . 74.400000000000006 108.456 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.416 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -84.09 29.37 3.87 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 119.807 -1.187 . . . . 71.540000000000006 114.853 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 17.3 p90 -142.74 147.55 35.79 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.404 -0.591 . . . . 75.450000000000003 109.404 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -113.54 155.13 25.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.340000000000003 107.723 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.6 pt -125.85 153.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.48 0.657 . . . . 75.409999999999997 112.676 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.65 178.63 6.7 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.737 -1.209 . . . . 75.219999999999999 107.737 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.549 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.3 p-10 -119.07 162.13 19.1 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.072 -0.714 . . . . 72.019999999999996 109.072 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.8 -155.43 20.83 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.043 -1.223 . . . . 51.420000000000002 110.043 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 m -126.79 125.45 41.73 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.435 -0.95 . . . . 73.329999999999998 108.435 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 30.9 t -104.76 153.18 21.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.088 -0.708 . . . . 64.019999999999996 109.088 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.47 120.89 44.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.047 -0.723 . . . . 73.209999999999994 109.047 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.418 ' NH1' HG22 ' A' ' 185' ' ' THR . 1.4 tmt_? -108.03 124.51 50.29 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.8 -1.926 . . . . 71.049999999999997 105.8 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.7 t -95.44 129.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.785 -0.45 . . . . 64.230000000000004 109.785 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.418 HG22 ' NH1' ' A' ' 183' ' ' ARG . 44.3 p -130.3 -179.66 5.38 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.013 -0.736 . . . . 63.020000000000003 109.013 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.77 -16.12 61.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.266 0.555 . . . . 72.129999999999995 109.71 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.9 m -80.78 -24.68 38.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.478 -0.783 . . . . 71.450000000000003 109.349 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.19 -143.5 14.97 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.976 -0.63 . . . . 62.43 112.249 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.25 117.11 33.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 121.129 0.49 . . . . 74.140000000000001 110.448 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.49 146.48 48.03 Favored 'General case' 0 N--CA 1.404 -2.725 0 CA-C-N 115.668 -0.696 . . . . 74.299999999999997 110.364 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.76 143.92 30.35 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.913 -0.585 . . . . 74.030000000000001 110.22 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -136.0 151.65 74.16 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.717 -0.475 . . . . 72.549999999999997 109.717 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.76 113.68 2.85 Favored 'Trans proline' 0 C--O 1.245 0.858 0 N-CA-C 107.723 -1.683 . . . . 62.32 107.723 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.0 149.72 18.39 Favored Glycine 0 N--CA 1.422 -2.293 0 C-N-CA 119.862 -1.161 . . . . 73.420000000000002 112.909 -172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 38.9 mm -109.05 117.86 55.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.423 -1.695 . . . . 70.019999999999996 106.423 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 42.7 m-85 -109.88 154.52 22.94 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.955 -0.758 . . . . 71.109999999999999 108.955 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.8 mt -74.45 132.54 33.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.806 -1.183 . . . . 72.329999999999998 107.806 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 25.7 t -85.51 -50.05 7.57 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.985 -0.447 . . . . 72.409999999999997 109.809 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.69 154.22 13.43 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.087 -0.708 . . . . 72.019999999999996 109.087 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 174' ' ' PHE . 67.6 mt -104.84 145.45 30.37 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.479 -0.564 . . . . 74.209999999999994 109.479 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 173' ' ' GLY . 21.8 m -72.63 130.65 85.32 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.878 -0.786 . . . . 64.310000000000002 108.878 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.78 125.56 18.08 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.177 1.918 . . . . 71.239999999999995 110.111 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.06 13.87 78.31 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.47 -0.872 . . . . 64.040000000000006 110.962 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 201' ' ' VAL . . . -88.83 159.6 29.28 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.997 -0.441 . . . . 65.329999999999998 111.997 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 31.4 tp -48.85 -46.59 42.49 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.948 1.299 . . . . 62.009999999999998 112.957 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.414 0.626 . . . . 63.43 111.253 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -75.15 -40.8 59.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.365 -0.834 . . . . 71.549999999999997 109.333 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.5 m -67.81 -41.8 82.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.904 -0.589 . . . . 51.299999999999997 112.152 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 7.8 p -68.61 -33.68 74.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.323 0.49 . . . . 73.310000000000002 112.323 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.78 23.93 75.61 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.253 -1.139 . . . . 72.439999999999998 110.253 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 97.2 mt -102.51 -2.05 29.35 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.115 0.566 . . . . 54.200000000000003 109.709 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.66 144.05 31.05 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.043 -1.466 . . . . 70.010000000000005 107.043 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -123.32 164.54 18.6 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.881 0.372 . . . . 72.200000000000003 110.484 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.41 -31.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.598 0 N-CA-C 113.26 0.837 . . . . 71.319999999999993 113.26 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.53 -23.49 56.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 113.417 0.895 . . . . 61.450000000000003 113.417 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 64.6 m-20 -62.53 134.91 57.07 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 123.579 0.55 . . . . 72.129999999999995 111.629 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 1.1 pm0 -94.88 139.22 31.62 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 115.907 -0.588 . . . . 61.43 111.264 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -76.15 135.99 25.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.316 -0.857 . . . . 71.219999999999999 110.199 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.492 HG22 ' HG3' ' A' ' 220' ' ' GLU . 50.1 mm -103.48 -46.8 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.17 0.509 . . . . 73.299999999999997 110.032 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.7 mt-10 -140.0 149.03 42.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.829 -0.623 . . . . 74.040000000000006 110.751 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 223' ' ' GLY . 30.3 m -131.67 106.74 12.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.047 -0.979 . . . . 62.399999999999999 109.271 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.0 t30 73.18 -28.71 0.19 Allowed 'General case' 0 N--CA 1.513 2.709 0 C-N-CA 125.839 1.656 . . . . 65.129999999999995 111.7 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.97 -9.4 0.98 Allowed Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.646 -1.782 . . . . 35.340000000000003 108.646 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.401 HG13 ' SD ' ' A' ' 237' ' ' MET . 30.1 mm -81.45 123.73 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.61 -1.626 . . . . 74.109999999999999 106.61 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.38 140.25 36.14 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.314 -0.995 . . . . 65.430000000000007 108.314 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.69 3.83 2.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 116.622 -0.263 . . . . 73.510000000000005 111.284 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.08 121.4 22.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.449 -0.945 . . . . 63.43 108.449 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.39 -6.05 83.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.821 -0.704 . . . . 54.130000000000003 113.018 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -93.47 149.7 21.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.841 -0.8 . . . . 51.310000000000002 108.841 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 234' ' ' VAL . 25.6 p -90.61 169.55 10.91 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.024 -0.732 . . . . 63.32 109.024 172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 178' ' ' ASP . 7.7 mp -64.95 -33.55 76.3 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 120.796 0.331 . . . . 71.530000000000001 110.225 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.17 -51.17 71.13 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.207 -0.906 . . . . 71.099999999999994 108.924 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 237' ' ' MET . 84.1 mm-40 -66.15 -44.12 85.06 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.587 -0.733 . . . . 64.319999999999993 112.574 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -66.83 -48.92 78.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 120.531 -0.467 . . . . 62.109999999999999 111.187 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.8 p -57.61 -49.58 75.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.362 -0.535 . . . . 63.109999999999999 110.597 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.87 -39.43 71.49 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.623 -0.717 . . . . 71.400000000000006 111.245 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -69.44 -44.48 71.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.856 -0.794 . . . . 70.340000000000003 108.856 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -65.95 -41.73 90.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.778 -0.646 . . . . 72.549999999999997 112.718 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -68.63 -25.6 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.403 0 CA-C-O 121.447 0.642 . . . . 75.299999999999997 109.573 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.0 -42.76 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.735 -0.666 . . . . 63.299999999999997 110.847 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 41.3 m-80 -100.03 30.86 3.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.651 -0.704 . . . . 71.530000000000001 110.669 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.0 p -56.21 -27.54 55.14 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.776 1.028 . . . . 61.039999999999999 113.776 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.456 ' HA ' ' HG2' ' A' ' 165' ' ' LYS . 30.0 t -70.24 -42.69 71.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.688 0.28 . . . . 74.230000000000004 110.545 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.47 96.96 2.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.929 0.871 . . . . 64.409999999999997 108.998 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 57.5 tp -124.99 128.78 49.11 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.312 -0.858 . . . . 75.239999999999995 110.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.62 118.87 43.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.978 -1.119 . . . . 61.210000000000001 107.978 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.2 mp -105.78 118.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.006 -1.109 . . . . 70.450000000000003 108.006 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 41.3 m -111.5 117.45 33.05 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.587 -0.733 . . . . 60.200000000000003 109.207 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.583 HG12 HG12 ' A' ' 218' ' ' VAL . 27.2 m -122.09 168.72 14.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 107.361 -1.348 . . . . 74.209999999999994 107.361 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -116.63 128.3 26.11 Favored Pre-proline 0 C--N 1.269 -2.899 0 N-CA-C 106.527 -1.657 . . . . 64.439999999999998 106.527 170.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.648 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 23.3 Cg_endo -62.26 132.79 40.33 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 120.693 0.929 . . . . 61.520000000000003 111.073 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -92.83 -8.42 43.6 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.239 -0.892 . . . . 71.010000000000005 109.789 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 56.75 37.95 29.16 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.824 0.821 . . . . 63.210000000000001 109.756 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 66.88 67.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.88 -1.509 . . . . 75.329999999999998 110.485 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.153 1.381 . . . . 74.109999999999999 108.965 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.784 -0.927 . . . . 70.019999999999996 110.784 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.4 m -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.969 0.385 . . . . 54.450000000000003 110.121 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.61 152.39 27.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.076 0.465 . . . . 63.140000000000001 110.624 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.7 m -156.51 145.96 20.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.481 -2.044 . . . . 70.430000000000007 105.481 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -67.77 141.44 56.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.538 0.608 . . . . 62.030000000000001 110.658 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -97.74 114.08 64.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 115.977 -0.556 . . . . 73.540000000000006 110.626 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.62 38.69 0.58 Allowed 'Trans proline' 0 C--O 1.208 -0.988 0 C-N-CA 123.144 2.563 . . . . 50.329999999999998 112.024 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.0 m -76.27 -5.54 47.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.895 0.379 . . . . 55.310000000000002 111.089 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.7 pt -129.36 154.76 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 116.111 -0.495 . . . . 74.109999999999999 110.512 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 m 72.51 15.14 5.13 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.159 0.983 . . . . 64.140000000000001 113.09 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.7 pt -111.97 139.23 22.11 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 110.256 -0.276 . . . . 72.510000000000005 110.256 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.91 -159.93 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.747 2.298 . . . . 70.140000000000001 110.19 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -74.03 87.05 1.84 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.032 -1.099 . . . . 74.239999999999995 108.032 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -93.09 145.33 24.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.042 -0.981 . . . . 61.229999999999997 111.151 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.27 4.84 27.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.282 -0.417 . . . . 74.310000000000002 111.622 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -88.58 148.05 24.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.353 -0.61 . . . . 75.120000000000005 109.353 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.52 129.33 55.57 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.526 -0.916 . . . . 75.150000000000006 108.526 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.3 122.14 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.325 0 CA-C-N 115.556 -0.747 . . . . 74.299999999999997 109.893 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.3 p -80.14 119.74 23.33 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.356 -1.35 . . . . 45.329999999999998 107.356 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.55 154.64 42.4 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.675 -0.861 . . . . 55.43 108.675 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 211' ' ' LEU . 33.6 pt -95.59 155.14 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 108.688 -0.856 . . . . 61.43 108.688 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -136.47 150.63 27.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 120.798 -0.361 . . . . 75.510000000000005 111.087 -172.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.69 17.93 1.37 Allowed 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 124.656 1.183 . . . . 53.140000000000001 112.721 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.77 -29.6 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 113.546 0.943 . . . . 64.319999999999993 113.546 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.16 -36.04 58.92 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.562 -0.455 . . . . 75.409999999999997 111.23 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.08 -33.97 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.446 0.641 . . . . 75.230000000000004 109.312 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 155' ' ' PRO . 61.4 t -71.7 134.76 83.78 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.538 -0.756 . . . . 70.219999999999999 110.771 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' HG12 ' A' ' 154' ' ' VAL . 34.6 Cg_endo -67.12 155.99 68.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.206 1.938 . . . . 75.450000000000003 109.541 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.71 -10.87 21.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.192 0.52 . . . . 75.319999999999993 112.301 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.598 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 34.6 p -72.42 -20.39 61.43 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.799 -0.637 . . . . 74.530000000000001 111.363 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 34.3 m170 -117.32 149.57 40.26 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.825 -0.547 . . . . 70.140000000000001 111.244 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -131.84 127.82 37.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.329 -0.989 . . . . 73.519999999999996 108.329 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 97.0 mtt180 -117.41 129.1 55.63 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 121.005 -0.278 . . . . 71.25 110.277 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.61 144.43 26.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.726 -0.472 . . . . 72.409999999999997 109.726 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.545 HH12 ' HB3' ' A' ' 164' ' ' CYS . 1.1 tmm_? -103.53 119.53 39.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.584 -1.635 . . . . 65.519999999999996 106.584 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 69.0 tp -100.39 139.75 35.62 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-N 115.922 -0.581 . . . . 72.140000000000001 112.355 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.545 ' HB3' HH12 ' A' ' 162' ' ' ARG . 6.2 p -143.4 142.28 31.18 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.231 1.012 . . . . 52.229999999999997 111.249 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 143.81 46.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.185 -0.672 . . . . 44.43 109.185 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -94.82 137.73 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.985 0.421 . . . . 73.439999999999998 110.532 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.21 -28.85 12.16 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.381 -0.827 . . . . 52.439999999999998 111.359 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 60.2 m 66.28 160.89 0.14 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.773 0.829 . . . . 60.229999999999997 112.474 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 74.76 8.99 4.2 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.612 0.968 . . . . 73.329999999999998 113.612 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.0 148.1 37.28 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 107.565 -1.272 . . . . 72.329999999999998 107.565 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.69 157.83 30.92 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.391 2.727 . . . . 75.099999999999994 111.824 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -71.3 172.4 9.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.565 -0.902 . . . . 55.240000000000002 108.565 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.92 20.85 13.28 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.378 -1.392 . . . . 65.319999999999993 113.363 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' HB3' HD13 ' A' ' 200' ' ' LEU . 42.0 p90 -161.28 160.76 30.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.933 0.493 . . . . 72.439999999999998 109.871 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' HG22 ' A' ' 201' ' ' VAL . 75.5 m-85 -116.34 153.63 31.65 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.018 -1.475 . . . . 65.019999999999996 107.018 175.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.5 pt -119.56 149.31 22.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.211 0.529 . . . . 75.25 112.303 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -132.02 -178.91 5.11 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.695 -1.224 . . . . 74.409999999999997 107.695 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.8 p-10 -124.8 159.62 30.58 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.943 -0.703 . . . . 65.230000000000004 109.753 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.47 -163.24 30.5 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.643 -1.383 . . . . 22.120000000000001 109.643 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.9 p -108.17 134.32 51.19 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.406 0.622 . . . . 71.099999999999994 111.483 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.8 t -102.33 143.31 32.24 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.359 -1.349 . . . . 72.099999999999994 107.359 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.49 123.58 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 121.58 0.705 . . . . 64.040000000000006 111.119 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -109.61 114.25 27.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.468 -0.938 . . . . 73.340000000000003 108.468 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -91.09 121.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.857 -0.424 . . . . 73.0 109.857 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 44.4 p -126.46 176.45 7.15 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.986 -0.552 . . . . 75.129999999999995 109.636 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.3 -15.74 63.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.22 0.533 . . . . 64.140000000000001 110.591 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 m -89.41 -12.48 40.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.04 -0.527 . . . . 75.400000000000006 110.301 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.62 -158.13 21.17 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.644 -0.982 . . . . 72.219999999999999 110.644 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.2 pp -100.13 143.68 30.05 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.297 0.549 . . . . 74.400000000000006 112.02 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -115.19 132.82 56.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.738 -0.665 . . . . 61.109999999999999 109.384 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.51 125.69 50.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.962 -1.125 . . . . 75.310000000000002 107.962 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -131.11 154.02 81.89 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 109.202 -0.666 . . . . 75.340000000000003 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.04 110.78 1.58 Allowed 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 121.943 1.762 . . . . 61.32 109.747 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -112.43 143.5 17.61 Favored Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.619 -0.801 . . . . 73.219999999999999 111.835 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 231' ' ' LEU . 27.0 mm -100.11 117.6 45.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.596 -1.631 . . . . 72.510000000000005 106.596 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 95.7 m-85 -113.63 156.51 23.57 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.479 0.181 . . . . 74.230000000000004 110.681 -174.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 214' ' ' VAL . 69.3 mt -72.77 132.38 33.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.547 -1.279 . . . . 73.340000000000003 107.547 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.8 t -87.01 -47.77 8.66 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.904 -0.498 . . . . 73.219999999999999 109.898 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -165.42 155.41 13.05 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.809 -1.182 . . . . 53.450000000000003 107.809 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.5 mm? -90.4 141.59 28.58 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.931 -1.137 . . . . 70.519999999999996 107.931 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 175' ' ' TYR . 97.7 t -77.29 120.07 80.05 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 108.601 -0.888 . . . . 71.209999999999994 108.601 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.26 124.44 16.18 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.03 1.82 . . . . 75.409999999999997 110.05 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.52 86.15 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.048 -1.072 . . . . 35.420000000000002 111.665 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.37 154.79 44.7 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.938 -1.265 . . . . 75.329999999999998 109.938 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 209' ' ' THR . 30.2 tp -53.09 -50.12 65.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.576 0.584 . . . . 62.229999999999997 112.576 -174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.06 -31.86 70.92 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 121.011 0.434 . . . . 72.230000000000004 111.627 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.82 -51.95 16.83 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.32 -0.993 . . . . 73.010000000000005 108.32 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.9 t -66.28 -30.37 70.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.24 -0.891 . . . . 74.420000000000002 111.653 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 205' ' ' LEU . 12.3 t -86.38 -26.83 24.59 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.398 -0.521 . . . . 74.150000000000006 110.49 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.18 45.76 84.53 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.31 -0.471 . . . . 63.409999999999997 112.665 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 212' ' ' LEU . 90.4 mt -101.03 -6.6 24.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.449 0.537 . . . . 75.120000000000005 112.449 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 249' ' ' VAL . 79.1 mt -140.31 161.44 37.68 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.366 0.416 . . . . 74.209999999999994 109.994 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.96 160.2 16.2 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.665 -0.494 . . . . 72.439999999999998 109.665 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 197' ' ' ILE . 91.1 t -64.18 -37.94 81.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-O 121.367 0.603 . . . . 71.319999999999993 111.646 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -73.35 -21.86 60.43 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 114.951 1.463 . . . . 61.020000000000003 114.951 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.5 m-20 -61.56 144.39 54.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.724 0.774 . . . . 53.350000000000001 112.139 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 11.5 pt-20 -101.97 145.23 29.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.091 -0.959 . . . . 75.430000000000007 110.081 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -85.91 137.82 20.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.867 -0.606 . . . . 72.409999999999997 109.495 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.3 mm -105.33 -52.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.309 0.576 . . . . 52.509999999999998 110.671 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' HG22 ' A' ' 219' ' ' ILE . 42.5 mt-10 -139.31 147.34 41.47 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 121.496 0.665 . . . . 73.530000000000001 111.602 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.48 105.76 14.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 114.723 -1.126 . . . . 72.129999999999995 108.604 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.6 m-20 59.74 28.6 18.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.686 0.624 . . . . 64.430000000000007 112.686 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.35 -7.72 66.49 Favored Glycine 0 C--N 1.318 -0.44 0 C-N-CA 120.542 -0.837 . . . . 51.329999999999998 112.23 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.57 108.66 19.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.185 -1.043 . . . . 74.400000000000006 108.185 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.7 136.0 53.61 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.411 -0.959 . . . . 64.099999999999994 108.411 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 219' ' ' ILE . 34.6 m -77.17 1.46 2.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 123.467 0.48 . . . . 64.219999999999999 111.456 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.21 122.42 23.62 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.637 -0.875 . . . . 63.399999999999999 108.637 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.78 -2.93 84.79 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.81 -0.632 . . . . 62.210000000000001 111.731 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -100.32 147.07 26.19 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 73.200000000000003 107.818 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.1 p -93.61 166.37 12.27 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.046 -0.724 . . . . 55.219999999999999 109.046 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 195' ' ' ILE . 9.5 mp -58.16 -36.45 73.03 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.123 0.264 . . . . 55.130000000000003 110.369 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.17 -45.84 89.98 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.745 0.653 . . . . 74.209999999999994 109.89 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.497 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 78.5 mm-40 -75.16 -40.15 59.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.7 -0.682 . . . . 74.239999999999995 112.244 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 230' ' ' THR . 24.1 t -69.64 -44.23 79.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.318 -0.553 . . . . 64.430000000000007 110.805 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.4 p -59.71 -46.84 87.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.159 -0.617 . . . . 64.200000000000003 110.313 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.81 -45.25 78.31 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.883 -0.599 . . . . 72.150000000000006 110.627 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -64.63 -45.91 84.82 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 109.265 -0.643 . . . . 74.340000000000003 109.265 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.567 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.5 mtm -65.92 -41.62 91.19 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.904 0.705 . . . . 73.150000000000006 112.904 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.06 -31.51 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.085 0.469 . . . . 54.439999999999998 109.825 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.59 93.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.095 0.558 . . . . 73.219999999999999 111.209 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -105.28 21.29 17.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.476 -0.783 . . . . 72.209999999999994 111.258 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.1 p -55.87 -26.7 48.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.184 1.55 . . . . 72.420000000000002 115.184 -172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 p -63.96 -42.64 97.22 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.23 0.538 . . . . 72.430000000000007 111.161 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.435 ' HA ' HH11 ' A' ' 162' ' ' ARG . 4.5 p-10 -145.19 95.94 2.76 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.365 1.079 . . . . 74.409999999999997 108.858 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 222' ' ' ASN . 43.1 tp -115.37 134.99 54.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.274 -1.33 . . . . 72.409999999999997 109.832 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 52.8 mt -104.21 114.38 43.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.437 -1.32 . . . . 72.219999999999999 107.437 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 53.2 mt -111.4 119.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 116.276 -0.42 . . . . 75.329999999999998 109.949 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 91.5 m -107.37 117.24 33.57 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.864 -0.791 . . . . 74.019999999999996 108.864 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 218' ' ' VAL . 15.1 m -126.52 171.65 14.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.651 -0.87 . . . . 61.100000000000001 108.651 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -130.94 137.77 31.5 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 108.833 -0.802 . . . . 71.310000000000002 108.833 173.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 157' ' ' THR . 20.1 Cg_endo -59.62 134.31 57.05 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.894 1.73 . . . . 44.329999999999998 111.777 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -84.72 -14.72 47.5 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.502 -0.772 . . . . 65.530000000000001 109.345 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.93 88.56 0.07 Allowed 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.213 0.945 . . . . 71.040000000000006 112.019 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.0 93.32 4.44 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.496 -0.927 . . . . 73.450000000000003 108.496 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 . . . . . 0 C--N 1.287 -2.138 0 CA-C-N 114.759 -1.11 . . . . 74.400000000000006 110.98 -175.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 111.196 -0.762 . . . . 74.400000000000006 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t 71.09 8.47 6.48 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.308 1.043 . . . . 62.310000000000002 112.655 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.02 -60.21 1.99 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.096 0.474 . . . . 62.439999999999998 110.714 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.4 m -81.39 93.92 6.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.844 -0.616 . . . . 70.349999999999994 110.179 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -142.81 153.84 43.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.386 -0.825 . . . . 73.040000000000006 108.792 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.39 112.29 65.39 Favored Pre-proline 0 C--N 1.29 -1.986 0 N-CA-C 107.514 -1.291 . . . . 50.350000000000001 107.514 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 108.98 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.315 2.677 . . . . 75.209999999999994 112.3 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -151.07 -45.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.224 -0.898 . . . . 74.099999999999994 110.867 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt 67.06 98.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.808 -1.087 . . . . 71.439999999999998 109.684 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.7 m -77.42 80.32 3.91 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.603 -0.726 . . . . 74.519999999999996 112.563 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.7 pt -114.91 132.09 23.15 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 115.161 -0.927 . . . . 75.299999999999997 109.773 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -92.12 -167.48 0.2 Allowed 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 122.559 2.173 . . . . 73.140000000000001 110.682 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -84.91 77.28 10.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.991 -1.485 . . . . 72.019999999999996 106.991 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -144.0 82.66 1.72 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.416 -0.811 . . . . 75.340000000000003 109.405 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 63.4 m-85 -135.57 -24.92 1.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.914 0.709 . . . . 64.319999999999993 112.914 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -86.55 112.99 22.09 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.341 -1.726 . . . . 65.140000000000001 106.341 170.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 205' ' ' LEU . 66.2 m -110.59 135.63 50.94 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 115.026 1.491 . . . . 71.310000000000002 115.026 -167.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.44 139.74 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 73.519999999999996 104.833 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 17.6 m -83.84 119.13 24.48 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 117.694 -1.603 . . . . 71.319999999999993 109.893 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.34 143.67 26.2 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.31 -1.314 . . . . 61.329999999999998 108.878 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 28.0 mm -96.37 107.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.738 -1.578 . . . . 73.120000000000005 106.738 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 246' ' ' ILE . 27.0 pt -100.85 154.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 115.684 -0.689 . . . . 53.329999999999998 111.514 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 67.07 29.19 8.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.617 1.167 . . . . 73.430000000000007 110.644 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.1 m -54.06 -30.06 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 113.839 1.052 . . . . 55.450000000000003 113.839 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.02 -36.29 79.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.06 0.457 . . . . 74.540000000000006 110.759 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.42 -29.3 5.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.443 0.639 . . . . 53.43 109.666 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.583 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 90.9 t -77.51 122.44 85.91 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 115.191 -0.913 . . . . 62.119999999999997 113.269 -177.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.56 155.87 18.65 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.894 2.396 . . . . 74.439999999999998 108.374 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.65 -11.53 7.59 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.783 0.66 . . . . 71.450000000000003 112.783 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.562 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.3 p -78.69 -11.19 59.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 111.857 0.317 . . . . 71.340000000000003 111.857 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -123.38 161.14 25.33 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 110.018 -0.364 . . . . 75.230000000000004 110.018 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -139.71 123.33 17.34 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.217 -1.031 . . . . 75.230000000000004 108.217 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HD3' ' CG2' ' A' ' 154' ' ' VAL . 46.2 mtp85 -113.28 119.57 38.17 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.435 -0.348 . . . . 65.549999999999997 110.581 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 146' ' ' SER . 35.6 m -116.97 141.48 35.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.779 -0.823 . . . . 72.530000000000001 108.779 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -100.35 133.88 44.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.278 -1.749 . . . . 64.219999999999999 106.278 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.4 tp -91.01 139.32 30.88 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.084 0.468 . . . . 71.040000000000006 111.401 -172.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 33.3 t -122.25 166.55 14.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.555 1.142 . . . . 54.020000000000003 108.691 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 243' ' ' SER . 7.4 ptpp? -127.19 143.22 51.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.086 0.469 . . . . 53.100000000000001 112.12 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -108.12 101.23 10.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.296 -0.411 . . . . 73.140000000000001 110.964 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.88 -55.32 3.04 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-O 121.613 0.563 . . . . 60.43 112.372 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.7 m -135.69 -178.4 5.11 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.058 -1.46 . . . . 65.409999999999997 107.058 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.3 -60.56 2.17 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.516 -0.474 . . . . 53.140000000000001 110.918 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 59.92 167.52 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 123.902 0.751 . . . . 74.329999999999998 112.339 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.81 155.19 61.25 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.657 1.571 . . . . 74.129999999999995 109.129 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.3 mp -66.6 162.24 21.4 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.022 0.439 . . . . 72.0 111.491 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.9 27.3 1.66 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.895 0.718 . . . . 40.530000000000001 114.895 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.432 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.0 p90 -159.17 150.22 19.98 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 122.701 0.4 . . . . 70.140000000000001 110.079 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 54.4 m-85 -105.0 154.1 20.57 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.208 -1.775 . . . . 74.319999999999993 106.208 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.75 157.42 17.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 118.515 0.598 . . . . 63.420000000000002 111.558 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 14.8 ptt180 -132.35 167.46 19.84 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.444 -0.798 . . . . 53.340000000000003 109.574 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.464 ' HB3' HD11 ' A' ' 231' ' ' LEU . 5.6 p-10 -118.38 162.74 17.81 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.615 -0.883 . . . . 73.450000000000003 108.615 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . 165.94 -169.4 40.2 Favored Glycine 0 N--CA 1.411 -3.02 0 N-CA-C 108.763 -1.735 . . . . 74.450000000000003 108.763 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.6 p -107.63 129.03 55.04 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 117.574 0.687 . . . . 63.310000000000002 110.75 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.4 t -103.69 144.18 31.79 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.415 -1.328 . . . . 52.130000000000003 107.415 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 191' ' ' LYS . 63.2 t -93.37 115.36 32.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 106.513 -1.662 . . . . 70.409999999999997 106.513 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -106.84 131.8 53.53 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 108.092 -1.077 . . . . 71.140000000000001 108.092 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.3 113.8 31.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.65 -0.87 . . . . 73.439999999999998 108.65 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.8 p -120.84 -178.22 3.68 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 109.239 -0.652 . . . . 74.150000000000006 109.239 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.66 -15.46 60.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.06 -0.719 . . . . 61.450000000000003 109.06 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -84.99 -8.59 58.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.335 -0.848 . . . . 62.509999999999998 109.365 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 113.55 -140.89 16.64 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.069 -0.514 . . . . 31.539999999999999 112.831 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.17 124.55 45.72 Favored 'General case' 0 CA--C 1.476 -1.884 0 CA-C-O 120.882 0.372 . . . . 72.400000000000006 110.583 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.65 136.32 37.35 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.408 -0.815 . . . . 61.229999999999997 110.297 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 182' ' ' VAL . 48.4 mtpt -104.19 127.11 51.77 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.367 -0.533 . . . . 73.120000000000005 110.831 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -132.91 156.67 79.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.072 -1.084 . . . . 74.120000000000005 108.072 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 39.9 Cg_exo -59.87 113.75 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.187 1.924 . . . . 73.400000000000006 110.447 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.13 136.22 13.43 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 109.911 -1.276 . . . . 73.299999999999997 109.911 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.7 mm -95.8 116.43 37.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.789 -1.56 . . . . 74.019999999999996 106.789 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 68.1 m-85 -110.8 163.22 14.0 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.914 -0.773 . . . . 61.340000000000003 108.914 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.1 mt -72.94 131.33 35.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.349 -1.723 . . . . 75.439999999999998 106.349 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.9 t -88.02 -47.86 8.2 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 119.667 -0.813 . . . . 63.340000000000003 109.822 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -164.12 150.26 11.09 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.947 -1.131 . . . . 70.310000000000002 107.947 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -92.12 143.66 26.22 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.514 -0.55 . . . . 64.239999999999995 109.514 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.486 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 62.1 t -88.26 121.14 70.57 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.605 -1.258 . . . . 70.219999999999999 107.605 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 125.19 18.19 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 121.873 1.715 . . . . 64.5 109.861 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.17 83.76 Favored Glycine 0 C--N 1.305 -1.142 0 C-N-CA 120.237 -0.982 . . . . 74.230000000000004 110.947 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.72 156.45 31.57 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 108.794 -1.722 . . . . 60.420000000000002 108.794 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 144' ' ' CYS . 55.3 tp -59.32 -50.91 72.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.659 0.985 . . . . 72.040000000000006 113.659 -174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.32 69.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.095 0.474 . . . . 52.43 111.35 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.84 -52.82 10.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.056 -0.974 . . . . 74.019999999999996 108.554 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -68.69 -30.23 68.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.304 -0.862 . . . . 73.310000000000002 111.967 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.494 HG21 ' CB ' ' A' ' 146' ' ' SER . 7.8 t -86.82 -22.45 25.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.037 -0.665 . . . . 64.519999999999996 110.347 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.6 85.93 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 114.421 0.529 . . . . 71.299999999999997 114.421 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 209' ' ' THR . 4.4 mm? -97.22 -32.93 11.67 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.499 0.925 . . . . 74.109999999999999 113.499 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 249' ' ' VAL . 45.0 mt -124.32 151.09 44.7 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.875 -0.73 . . . . 64.340000000000003 111.078 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.07 161.99 18.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.211 -0.45 . . . . 75.010000000000005 110.357 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.44 -29.64 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.659 0.783 . . . . 61.329999999999998 113.09 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -74.45 -24.02 58.99 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.911 -0.493 . . . . 63.340000000000003 111.916 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.599 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.0 m-20 -71.3 144.24 50.04 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 109.73 -0.47 . . . . 63.329999999999998 109.73 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.2 pt-20 -112.68 152.92 28.45 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.108 -0.637 . . . . 45.219999999999999 110.781 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 249' ' ' VAL . 33.4 m -83.61 125.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 115.824 -0.625 . . . . 50.299999999999997 109.721 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.5 -49.49 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.568 -0.742 . . . . 73.329999999999998 109.82 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 41.1 mt-10 -142.48 144.28 32.94 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.109999999999999 111.394 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.33 111.26 28.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.55 -0.907 . . . . 75.530000000000001 108.55 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.69 -54.28 0.68 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.99 1.316 . . . . 73.010000000000005 110.505 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 179.61 12.85 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.818 -1.313 . . . . 62.109999999999999 109.818 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 27.0 mm -94.77 133.07 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.861 -1.163 . . . . 74.430000000000007 107.861 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.6 mt-10 -72.98 -8.39 55.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.932 0.715 . . . . 75.319999999999993 112.932 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 225' ' ' GLU 0.271 17.2 m 61.89 -20.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 126.669 1.988 . . . . 62.310000000000002 114.026 -176.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -77.29 123.05 25.94 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.833 -1.173 . . . . 64.209999999999994 107.833 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.05 -13.51 57.39 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.42 -1.072 . . . . 54.32 110.42 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -99.73 142.55 31.07 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.127 -1.434 . . . . 64.049999999999997 107.127 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 234' ' ' VAL . 7.3 p -84.63 164.56 18.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.561 -0.533 . . . . 71.430000000000007 109.561 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 178' ' ' ASP . 11.0 mp -57.8 -40.09 79.1 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 111.744 0.276 . . . . 73.209999999999994 111.744 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.37 -40.98 88.25 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.821 0.7 . . . . 61.420000000000002 110.627 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' MET . 15.8 mm100 -71.76 -41.54 68.3 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.393 0.516 . . . . 64.319999999999993 112.393 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 230' ' ' THR . 39.2 t -68.21 -44.6 84.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.961 -0.296 . . . . 74.209999999999994 110.763 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 p -61.65 -47.29 86.03 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.539 -0.464 . . . . 41.509999999999998 110.266 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.61 -40.92 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.553 0.533 . . . . 71.129999999999995 110.938 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -66.8 -42.92 85.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.794 -0.817 . . . . 72.120000000000005 108.794 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 75.7 mtm -67.73 -43.67 79.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 112.39 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -66.36 -30.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.3 -0.63 . . . . 74.409999999999997 109.3 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.16 87.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.331 0.586 . . . . 43.240000000000002 110.467 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 40.0 m-80 -103.47 34.07 3.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.44 -0.8 . . . . 72.109999999999999 111.227 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 64.8 p -60.21 -24.01 64.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.386 -0.37 . . . . 33.25 111.882 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.585 ' HA ' ' HE2' ' A' ' 165' ' ' LYS . 24.8 m -67.14 -56.35 10.35 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.253 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -137.81 97.43 3.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.179 0.99 . . . . 74.049999999999997 109.352 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 60.1 tp -112.42 135.1 53.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.285 -0.87 . . . . 62.299999999999997 110.745 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 149' ' ' ILE . 74.1 mt -112.4 114.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.373 -1.343 . . . . 62.140000000000001 107.373 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 56.2 mt -108.86 119.34 58.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.453 -0.573 . . . . 75.420000000000002 109.453 -175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.5 m -109.63 117.34 33.69 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.886 -0.783 . . . . 74.150000000000006 108.886 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 212' ' ' LEU . 18.4 m -124.34 172.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.558 -0.905 . . . . 73.439999999999998 108.558 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HE3' ' OE2' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 135.21 26.72 Favored Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 108.535 -0.913 . . . . 71.230000000000004 108.535 171.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.599 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 25.5 Cg_endo -61.95 135.69 56.94 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.522 1.482 . . . . 55.240000000000002 109.629 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -34.59 71.36 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.707 -0.679 . . . . 65.299999999999997 110.929 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 65.6 11.26 7.35 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.871 0.844 . . . . 70.510000000000005 110.308 -175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -134.06 86.38 2.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.085 -1.82 . . . . 75.549999999999997 106.085 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 107.388 -1.338 . . . . 63.109999999999999 107.388 -176.197 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.153 0 N-CA-C 110.619 -0.992 . . . . 42.149999999999999 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.5 m -79.63 94.83 5.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.196 0.498 . . . . 75.219999999999999 110.667 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -120.68 -60.21 1.68 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.738 -0.665 . . . . 72.329999999999998 109.378 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.2 m 51.45 72.21 0.39 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.192 0.933 . . . . 55.329999999999998 110.775 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -103.02 137.39 41.27 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.279 -0.873 . . . . 72.420000000000002 111.019 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -101.13 108.29 54.02 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.67 -1.233 . . . . 42.100000000000001 107.67 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 133' ' ' ALA . 3.2 Cg_exo -81.28 170.36 14.89 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.499 2.133 . . . . 70.409999999999997 111.455 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.9 m -77.13 -22.46 52.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.231 -1.026 . . . . 73.109999999999999 108.231 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.7 mt 72.6 114.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 114.372 -1.285 . . . . 42.039999999999999 111.757 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 t -80.98 97.16 7.35 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.861 -0.792 . . . . 64.219999999999999 108.861 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -77.58 143.32 67.71 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.452 -0.794 . . . . 72.409999999999997 110.155 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.92 113.77 0.65 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.81 3.007 . . . . 74.099999999999994 113.53 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -146.07 23.1 1.37 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.907 -0.775 . . . . 73.340000000000003 108.907 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.711 ' HB3' ' O ' ' A' ' 143' ' ' ARG . 18.8 m-20 -83.82 133.38 34.75 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.796 -1.093 . . . . 64.299999999999997 111.802 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -92.16 -20.04 21.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.593 -1.262 . . . . 64.140000000000001 107.593 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.711 ' O ' ' HB3' ' A' ' 141' ' ' ASP . 40.5 ttm180 -120.31 142.57 48.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.251 -2.129 . . . . 70.299999999999997 105.251 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.0 t -106.74 128.91 54.61 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.962 -0.755 . . . . 72.230000000000004 108.962 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.0 139.11 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 115.052 -0.976 . . . . 71.519999999999996 110.758 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.3 p -81.45 139.64 35.1 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.815 -1.084 . . . . 72.319999999999993 109.594 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.54 153.69 46.25 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 116.242 -0.435 . . . . 54.340000000000003 109.84 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 36.8 mm -95.78 109.25 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 108.12 -1.067 . . . . 63.049999999999997 108.12 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.24 154.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.836 -0.802 . . . . 60.520000000000003 108.836 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 65.1 16.76 10.74 Favored 'General case' 0 C--O 1.206 -1.222 0 O-C-N 123.774 0.671 . . . . 72.5 110.663 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.32 -30.71 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.855 0.862 . . . . 75.150000000000006 112.881 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.25 -24.79 46.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.606 0.717 . . . . 74.140000000000001 110.528 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -92.85 -50.16 12.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.479 -0.782 . . . . 73.310000000000002 109.535 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 158' ' ' HIS . 71.1 t -71.53 125.28 91.78 Favored Pre-proline 0 C--N 1.308 -1.211 0 CA-C-N 114.985 -1.007 . . . . 50.100000000000001 111.8 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 156.51 65.53 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.013 2.475 . . . . 63.310000000000002 109.785 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.62 -21.38 26.7 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.21 0.604 . . . . 74.140000000000001 111.894 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.534 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 22.3 p -70.34 -11.11 60.69 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 112.613 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.539 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 17.1 m170 -125.92 155.19 41.7 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.554 -0.906 . . . . 62.350000000000001 108.554 170.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG22 ' A' ' 249' ' ' VAL . 18.6 tpp180 -132.04 124.07 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.424 -0.954 . . . . 75.129999999999995 108.424 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 87.2 mtt180 -112.99 122.35 47.35 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.802 -0.359 . . . . 61.229999999999997 111.647 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 212' ' ' LEU . 27.3 m -117.52 137.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.24 -0.652 . . . . 50.420000000000002 109.24 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.536 HH11 ' HA ' ' A' ' 244' ' ' ASN . 1.7 tmm_? -100.32 120.34 39.79 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.137 -1.801 . . . . 63.340000000000003 106.137 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.05 133.04 43.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.919 -0.771 . . . . 73.209999999999994 108.919 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.42 ' HB3' ' NH2' ' A' ' 162' ' ' ARG . 5.1 p -116.71 161.03 19.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.225 0.536 . . . . 61.039999999999999 112.285 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.557 ' HA ' ' NZ ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -104.76 144.68 31.41 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 123.411 0.685 . . . . 61.420000000000002 109.839 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -118.26 101.88 8.54 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.832 -0.622 . . . . 63.100000000000001 110.163 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 70.11 -43.52 0.53 Allowed Glycine 0 N--CA 1.467 0.762 0 O-C-N 124.32 1.012 . . . . 62.5 114.398 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.2 p -142.91 160.5 40.22 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.251 -1.018 . . . . 63.240000000000002 108.251 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 1.5 p30 -53.49 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.327 1.017 . . . . 72.040000000000006 112.355 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 59.95 161.46 0.1 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 123.318 0.647 . . . . 73.540000000000006 111.875 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.85 155.97 64.67 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 122.397 2.065 . . . . 73.439999999999998 112.56 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.4 mp -73.47 154.28 40.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.947 -1.131 . . . . 71.099999999999994 107.947 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.95 29.83 1.83 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 115.559 0.983 . . . . 75.519999999999996 115.559 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -162.55 168.89 21.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.549 0.675 . . . . 75.450000000000003 110.811 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -124.41 155.38 38.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.308 -1.367 . . . . 71.109999999999999 107.308 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 23.6 pt -122.08 158.7 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 120.822 0.344 . . . . 72.049999999999997 110.739 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -134.37 172.89 12.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.369 -0.604 . . . . 63.140000000000001 109.369 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.38 154.12 20.74 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.579 -1.267 . . . . 64.530000000000001 107.579 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -174.28 -163.21 27.26 Favored Glycine 0 C--N 1.284 -2.311 0 N-CA-C 109.233 -1.547 . . . . 60.299999999999997 109.233 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.8 p -117.87 125.06 49.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.571 0.7 . . . . 62.039999999999999 112.487 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.3 t -107.51 149.3 28.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.373 -1.714 . . . . 61.100000000000001 106.373 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.36 127.32 49.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 119.666 -0.814 . . . . 75.219999999999999 111.7 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -110.82 136.0 50.53 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.877 -1.157 . . . . 72.230000000000004 107.877 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.6 t -106.68 113.94 44.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.162 -0.615 . . . . 74.120000000000005 109.9 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.5 p -110.52 -174.7 2.54 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.076 -0.511 . . . . 74.439999999999998 110.497 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.31 71.5 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.899 0.381 . . . . 55.149999999999999 111.848 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 p -80.26 -23.52 40.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.038 -0.528 . . . . 73.239999999999995 110.517 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.21 -153.65 22.47 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.436 -0.888 . . . . 61.109999999999999 111.826 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.406 ' H ' ' CD2' ' A' ' 189' ' ' LEU . 1.5 pt? -83.47 135.54 34.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.878 -0.415 . . . . 64.329999999999998 109.878 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -137.34 146.1 44.17 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.635 -0.876 . . . . 72.530000000000001 108.635 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -101.19 125.78 47.84 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.275 -0.57 . . . . 75.409999999999997 111.179 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.01 166.05 11.5 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.184 -0.917 . . . . 71.099999999999994 108.528 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.3 109.99 2.55 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.527 1.485 . . . . 71.540000000000006 108.428 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -101.9 137.7 13.47 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 110.185 -1.166 . . . . 75.450000000000003 110.185 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.84 117.17 44.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.233 -1.395 . . . . 62.140000000000001 107.233 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.2 160.34 20.54 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.035 -0.728 . . . . 74.200000000000003 109.035 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 131.84 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 107.533 -1.284 . . . . 74.209999999999994 107.533 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.1 t -90.72 -47.91 7.36 Favored 'General case' 0 C--N 1.286 -2.177 0 O-C-N 121.834 -0.542 . . . . 72.209999999999994 110.753 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -164.16 154.08 14.49 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.08 -1.082 . . . . 73.400000000000006 108.08 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.1 mm? -93.58 145.18 24.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 110.193 -0.299 . . . . 62.049999999999997 110.193 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.2 t -82.28 126.17 74.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 107.024 -1.472 . . . . 64.329999999999998 107.024 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.82 124.75 16.01 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.054 1.836 . . . . 52.43 111.137 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.67 6.42 89.03 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.653 -0.703 . . . . 64.129999999999995 111.473 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.77 159.43 45.95 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 111.415 -0.674 . . . . 71.420000000000002 111.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.0 -48.5 64.41 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.598 0.759 . . . . 63.310000000000002 112.571 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.36 76.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 111.574 0.213 . . . . 60.119999999999997 111.574 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 38.1 tt0 -70.54 -48.22 56.53 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 109.805 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 40.2 t -58.06 -36.3 72.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.066 -0.97 . . . . 73.209999999999994 111.298 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 211' ' ' LEU . 7.4 t -89.58 -32.42 17.13 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 119.573 -0.851 . . . . 55.450000000000003 111.105 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.31 22.22 73.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.155 -0.545 . . . . 72.430000000000007 112.978 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 209' ' ' THR . 5.8 mp -88.2 -8.04 55.93 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.488 . . . . 71.319999999999993 111.653 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 249' ' ' VAL . 73.1 mt -137.76 144.04 41.44 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.901 -1.148 . . . . 74.040000000000006 107.901 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -127.36 164.42 21.85 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.777 -0.453 . . . . 63.240000000000002 109.777 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.0 m -59.69 -31.15 46.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.807 0 N-CA-C 113.422 0.897 . . . . 53.299999999999997 113.422 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . 0.302 20.2 m120 -78.22 -21.95 49.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.02 1.118 . . . . 71.409999999999997 114.02 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.48 137.74 58.32 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.555 0.693 . . . . 71.349999999999994 109.986 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -98.54 139.92 33.55 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.66 -1.237 . . . . 72.239999999999995 107.66 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 249' ' ' VAL . 32.8 m -83.22 140.69 15.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.571 -0.852 . . . . 64.299999999999997 109.467 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 220' ' ' GLU . 42.7 mm -111.59 -48.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.265 0.555 . . . . 52.030000000000001 110.446 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 219' ' ' ILE . 47.8 mt-10 -136.14 146.38 46.85 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.294 0.568 . . . . 73.430000000000007 110.865 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 223' ' ' GLY . 31.0 m -126.6 105.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.448 -1.251 . . . . 64.329999999999998 108.707 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 t30 76.37 -27.18 0.18 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.212 1.805 . . . . 44.509999999999998 111.244 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 148.58 -9.54 1.05 Allowed Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.011 -1.635 . . . . 73.219999999999999 109.011 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.1 mm -83.01 123.63 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 107.602 -1.259 . . . . 75.519999999999996 107.602 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -70.16 136.4 50.06 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 108.713 -0.847 . . . . 71.109999999999999 108.713 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.9 m -79.88 -3.85 6.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 O-C-N 123.318 0.387 . . . . 64.109999999999999 111.301 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.34 121.83 19.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.825 -0.75 . . . . 75.540000000000006 108.99 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.49 -2.92 85.18 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.896 -0.669 . . . . 70.420000000000002 112.653 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -95.13 145.57 24.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.591 -1.263 . . . . 54.399999999999999 107.591 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 234' ' ' VAL . 28.4 p -89.47 166.3 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.301 -0.559 . . . . 72.329999999999998 109.541 176.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.93 -34.94 75.47 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.374 -0.232 . . . . 74.049999999999997 110.374 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.93 -51.18 70.16 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 109.307 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 81.9 mm-40 -68.67 -46.66 68.52 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.301 -0.863 . . . . 72.230000000000004 112.078 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 230' ' ' THR . 42.7 t -63.64 -45.9 96.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 121.02 -0.272 . . . . 73.420000000000002 111.337 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.8 p -59.87 -47.57 85.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.277 -0.569 . . . . 53.539999999999999 110.879 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.65 -45.4 92.14 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.02 -0.536 . . . . 73.109999999999999 110.81 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -60.55 -42.91 97.53 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.297 0.57 . . . . 74.040000000000006 110.269 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.441 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.4 mtm -67.69 -44.2 78.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.823 -0.626 . . . . 62.329999999999998 112.666 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 235' ' ' THR . 67.6 t -66.76 -32.9 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.267 -0.642 . . . . 72.329999999999998 109.267 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.08 92.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.831 -0.622 . . . . 63.119999999999997 111.179 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.0 m-80 -104.59 25.26 10.5 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.868 -0.606 . . . . 74.439999999999998 111.004 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 40.9 p -54.9 -29.9 56.96 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.903 1.075 . . . . 75.299999999999997 113.903 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.2 p -64.49 -40.89 96.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.43 0.633 . . . . 63.210000000000001 111.516 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.536 ' HA ' HH11 ' A' ' 162' ' ' ARG . 5.0 p-10 -149.71 95.74 2.37 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 122.365 1.079 . . . . 52.020000000000003 108.411 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 241' ' ' ASN . 56.9 tp -118.04 135.0 54.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.262 -1.335 . . . . 72.109999999999999 110.416 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 56.8 mt -108.06 115.09 48.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.316 -1.364 . . . . 71.109999999999999 107.316 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 68.7 mt -112.96 119.72 61.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 120.291 -0.563 . . . . 64.109999999999999 110.65 -175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -104.91 119.06 38.11 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.004 -1.11 . . . . 74.409999999999997 108.004 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 218' ' ' VAL . 18.7 m -123.3 170.27 13.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.583 -0.895 . . . . 75.049999999999997 108.583 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -139.19 137.48 19.3 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 120.92 -0.312 . . . . 71.239999999999995 111.392 173.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 157' ' ' THR . 15.2 Cg_endo -59.81 134.6 58.15 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.156 1.904 . . . . 64.439999999999998 110.48 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.75 -0.25 57.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.624 0.726 . . . . 52.32 109.585 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 62.51 66.72 0.76 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.468 -1.242 . . . . 73.319999999999993 108.3 -176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 69.38 -37.83 0.38 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.002 1.321 . . . . 72.319999999999993 114.48 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--N 1.304 -1.38 0 C-N-CA 122.85 0.46 . . . . 73.239999999999995 111.21 -178.176 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.935 -0.866 . . . . 61.130000000000003 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.9 m -109.97 -25.3 10.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.484 -0.486 . . . . 72.420000000000002 110.525 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 44.48 82.02 0.03 OUTLIER 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.27 1.028 . . . . 75.420000000000002 112.33 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.8 m -147.15 119.17 8.19 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.308 0.575 . . . . 65.0 112.118 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 127.4 18.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.532 -1.655 . . . . 74.129999999999995 106.532 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 109.03 58.68 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 120.123 -0.631 . . . . 73.299999999999997 111.335 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.46 -27.66 9.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.779 1.653 . . . . 65.530000000000001 109.404 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 m -86.71 84.74 7.32 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.855 -1.066 . . . . 60.439999999999998 110.232 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.59 -15.94 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.853 -1.166 . . . . 72.340000000000003 107.853 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -45.14 111.09 0.29 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.949 1.7 . . . . 42.32 111.943 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.7 pt -92.66 144.23 28.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.766 -0.652 . . . . 61.140000000000001 110.633 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.77 179.01 5.12 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.679 1.586 . . . . 74.230000000000004 109.351 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -74.94 -22.75 58.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.518 -0.873 . . . . 70.109999999999999 109.045 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.0 98.75 8.08 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.744 -1.206 . . . . 73.420000000000002 107.744 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -97.83 98.22 9.64 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.141 -0.689 . . . . 72.549999999999997 109.141 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -126.77 108.1 10.74 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.923 -1.14 . . . . 62.109999999999999 107.923 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.6 p -110.52 143.93 40.13 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.634 -0.506 . . . . 62.219999999999999 109.634 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.43 141.2 41.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.351 -0.386 . . . . 51.310000000000002 111.689 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 p -71.43 138.19 48.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.141 0.496 . . . . 71.510000000000005 110.532 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.6 158.25 43.8 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.522 -0.763 . . . . 72.329999999999998 109.583 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 38.6 mm -92.26 107.66 19.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 106.418 -1.697 . . . . 63.420000000000002 106.418 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.44 153.55 4.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.542 -0.753 . . . . 70.140000000000001 110.522 -175.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.81 22.98 13.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.095 0.872 . . . . 71.430000000000007 109.992 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.05 -29.38 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.128 0.971 . . . . 71.349999999999994 112.132 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.8 -19.04 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.268 -0.424 . . . . 73.099999999999994 111.192 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.8 mt -98.63 -56.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.244 -0.434 . . . . 74.420000000000002 110.279 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.9 p -68.91 142.42 93.43 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.559 -0.746 . . . . 45.350000000000001 111.399 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 13.3 Cg_exo -71.69 155.39 58.8 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.042 2.495 . . . . 72.420000000000002 110.528 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.57 -11.34 57.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.181 0.515 . . . . 54.32 112.068 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.1 p -78.91 -1.07 33.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.402 0.62 . . . . 75.099999999999994 111.0 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' CE1' HG21 ' A' ' 219' ' ' ILE . 18.3 m170 -127.51 150.08 49.84 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 124.498 1.119 . . . . 73.120000000000005 108.824 171.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -132.92 117.65 17.94 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.122 -0.49 . . . . 52.240000000000002 110.091 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 96.8 mtt180 -108.14 123.66 49.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.659 -0.7 . . . . 62.420000000000002 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 212' ' ' LEU . 21.7 m -117.89 145.85 23.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.735 -0.839 . . . . 61.310000000000002 108.735 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.434 HH11 HG12 ' A' ' 246' ' ' ILE . 23.3 tpt180 -99.53 126.82 45.56 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.939 -0.763 . . . . 71.409999999999997 108.939 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 36.0 tp -92.46 135.56 33.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.842 -1.17 . . . . 75.519999999999996 107.842 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 27.7 p -118.54 167.97 11.12 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.346 -1.353 . . . . 74.120000000000005 107.346 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -77.91 121.83 24.68 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.212 0.53 . . . . 75.140000000000001 111.904 -171.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -136.39 149.93 48.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.967 -1.123 . . . . 72.420000000000002 107.967 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 66.68 12.49 59.38 Favored Glycine 0 CA--C 1.519 0.295 0 O-C-N 123.661 0.601 . . . . 74.450000000000003 113.815 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 43.7 m 67.17 -68.81 0.14 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 124.319 1.048 . . . . 72.329999999999998 112.595 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -133.4 5.8 3.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 121.536 -0.728 . . . . 73.25 111.867 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -62.83 143.27 97.13 Favored Pre-proline 0 C--O 1.245 0.865 0 CA-C-N 116.536 -0.302 . . . . 72.109999999999999 111.443 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.89 156.15 16.2 Favored 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 123.652 2.901 . . . . 74.120000000000005 112.758 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.664 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.2 mp -60.9 166.12 3.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.252 -0.885 . . . . 74.019999999999996 110.975 -176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -89.7 25.21 11.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.805 -1.188 . . . . 24.210000000000001 114.924 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -140.53 146.77 38.55 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.725 -0.472 . . . . 75.409999999999997 109.725 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -106.69 158.84 16.66 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.647 -1.242 . . . . 72.409999999999997 107.647 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 pt -121.46 155.38 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.298 0.571 . . . . 73.329999999999998 112.179 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 21.8 ptt180 -134.32 171.28 14.49 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 124.885 1.274 . . . . 72.540000000000006 107.937 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.615 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.3 p-10 -125.33 141.79 51.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.28 -0.568 . . . . 75.150000000000006 109.975 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.69 -156.19 9.14 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.865 -1.294 . . . . 34.240000000000002 109.865 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.532 ' HB ' ' NZ ' ' A' ' 191' ' ' LYS . 17.6 p -103.54 136.51 43.13 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.587 0.708 . . . . 72.140000000000001 111.964 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.443 ' HB2' ' HA3' ' A' ' 194' ' ' GLY . 42.2 t -102.52 154.25 19.29 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.764 -1.107 . . . . 65.349999999999994 109.046 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.48 HG22 ' HE2' ' A' ' 191' ' ' LYS . 91.9 t -110.78 114.5 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.428 -0.952 . . . . 73.140000000000001 108.428 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.479 ' HB3' ' HG3' ' A' ' 190' ' ' GLU . 17.0 tpp180 -108.53 125.72 52.13 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.259 -1.015 . . . . 74.340000000000003 108.259 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.03 113.82 33.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.523 -0.547 . . . . 72.400000000000006 109.523 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.7 p -115.3 -178.33 3.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.19 -0.459 . . . . 65.549999999999997 110.461 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.89 66.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.754 0.312 . . . . 73.040000000000006 111.378 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.0 m -83.5 -16.63 44.84 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.883 0.373 . . . . 61.310000000000002 110.785 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 136.02 -154.51 21.93 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.125 -0.79 . . . . 44.200000000000003 111.125 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.91 143.58 27.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.584 -0.895 . . . . 63.109999999999999 108.584 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 183' ' ' ARG . 10.8 pt-20 -134.14 144.23 48.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.63 -0.508 . . . . 74.349999999999994 109.63 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.532 ' NZ ' ' HB ' ' A' ' 180' ' ' THR . 2.0 mmmp? -105.51 126.88 52.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.573 -0.529 . . . . 64.519999999999996 109.573 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -134.48 162.44 57.67 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 108.671 -0.862 . . . . 73.030000000000001 108.671 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.95 115.28 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.068 1.845 . . . . 73.420000000000002 110.098 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 181' ' ' SER . . . -117.5 161.11 13.35 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.792 -0.718 . . . . 51.149999999999999 111.967 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.0 mm -108.33 117.92 54.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.093 -1.077 . . . . 74.510000000000005 108.093 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 43.1 m-85 -110.16 160.85 16.13 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.535 -0.172 . . . . 64.530000000000001 110.535 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.9 mt -73.85 132.74 32.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.543 -1.28 . . . . 73.540000000000006 107.543 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 21.3 t -94.61 -46.74 6.82 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.1 -0.64 . . . . 51.450000000000003 110.97 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -163.78 155.0 16.3 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.073 -1.084 . . . . 72.129999999999995 108.073 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.3 mt -106.7 144.87 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.252 -0.647 . . . . 72.329999999999998 109.252 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.444 HG22 ' CA ' ' A' ' 173' ' ' GLY . 18.1 m -75.62 137.18 70.61 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.811 -0.811 . . . . 71.219999999999999 108.811 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.71 125.06 15.24 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 121.978 1.785 . . . . 73.040000000000006 110.524 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.09 89.01 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.869 -0.681 . . . . 42.130000000000003 111.715 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -75.43 160.72 52.37 Favored Glycine 0 CA--C 1.489 -1.572 0 N-CA-C 111.471 -0.652 . . . . 32.210000000000001 111.471 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.25 -49.9 63.13 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.686 0.795 . . . . 50.539999999999999 112.355 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.89 91.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 74.450000000000003 111.509 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.25 -41.54 57.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.94 -0.573 . . . . 75.099999999999994 109.485 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.3 t -61.88 -44.16 97.38 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.401 -0.818 . . . . 61.109999999999999 111.594 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -83.11 -26.71 30.77 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.806 -0.758 . . . . 44.549999999999997 110.524 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.85 62.37 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.39 -0.368 . . . . 63.240000000000002 113.087 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.52 -26.17 18.9 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 114.15 1.167 . . . . 71.109999999999999 114.15 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.43 HD21 HG11 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -118.87 158.27 26.01 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 109.62 -176.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -122.54 155.42 36.27 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.971 -0.752 . . . . 63.409999999999997 108.971 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.82 -29.02 44.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.017 0 N-CA-C 112.527 0.566 . . . . 73.230000000000004 112.527 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.69 -24.54 63.6 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.315 0.487 . . . . 63.399999999999999 112.315 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 48.0 m-20 -69.18 144.54 53.74 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.578 0.549 . . . . 75.140000000000001 109.91 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 10.8 pt-20 -110.31 150.54 28.6 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.292 -0.563 . . . . 74.310000000000002 110.214 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 249' ' ' VAL . 35.7 m -82.36 126.61 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-O 121.445 0.641 . . . . 65.209999999999994 110.366 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 250' ' ' LYS . 47.1 mm -96.9 -44.97 12.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.264 -0.88 . . . . 75.049999999999997 109.775 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 38.0 mt-10 -143.12 144.61 32.29 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 115.676 -0.693 . . . . 73.0 111.273 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.88 104.02 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.851 -1.068 . . . . 31.41 108.285 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 245' ' ' LEU . 4.4 t30 71.18 1.01 3.64 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.463 1.505 . . . . 43.109999999999999 110.812 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.48 -8.61 10.2 Favored Glycine 0 C--N 1.314 -0.692 0 N-CA-C 110.854 -0.899 . . . . 42.299999999999997 110.854 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 42.4 mm -78.1 127.22 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.56 -1.274 . . . . 53.5 107.56 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 227' ' ' ALA . 46.8 mt-10 -72.08 1.83 6.77 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.068 0.766 . . . . 71.329999999999998 113.068 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 224' ' ' ILE 0.294 26.6 m 61.56 -20.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 126.165 1.786 . . . . 62.329999999999998 114.275 -177.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -68.25 127.87 34.51 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 122.907 0.483 . . . . 73.299999999999997 109.738 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.51 30.85 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 110.693 -0.963 . . . . 72.400000000000006 110.693 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.46 152.67 18.21 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.643 0.735 . . . . 62.43 111.384 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.7 p -90.25 171.53 9.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.597 -1.26 . . . . 55.219999999999999 107.597 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.3 mp -60.49 -38.01 82.94 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 120.765 0.317 . . . . 74.450000000000003 111.517 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.11 -42.29 99.08 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.483 -0.781 . . . . 51.109999999999999 111.073 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 9.3 mm-40 -75.46 -37.47 60.26 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.76 0.652 . . . . 74.030000000000001 112.76 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 230' ' ' THR . 57.4 t -64.89 -48.36 84.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 120.523 -0.471 . . . . 71.129999999999995 110.132 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.8 p -58.24 -45.75 87.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.413 -0.515 . . . . 75.120000000000005 110.702 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.49 -41.37 85.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.614 -0.721 . . . . 72.140000000000001 111.687 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -64.94 -43.95 91.07 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.028 -1.101 . . . . 73.209999999999994 108.028 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 74.8 mtm -64.31 -43.12 95.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 73.420000000000002 112.519 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.73 -31.62 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 109.439 -0.578 . . . . 53.119999999999997 109.439 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.25 94.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.826 -0.624 . . . . 70.049999999999997 111.591 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.542 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -91.82 80.75 5.23 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.325 -1.361 . . . . 63.109999999999999 107.325 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 7.3 m -78.22 -30.72 48.97 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.909 -1.496 . . . . 75.099999999999994 113.778 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 t -81.44 -53.56 6.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.808 -0.357 . . . . 53.539999999999999 111.189 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.74 110.72 7.25 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.474 -0.565 . . . . 74.230000000000004 109.474 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 241' ' ' ASN . 25.1 tp -123.44 135.22 53.98 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.132 -0.692 . . . . 54.530000000000001 109.132 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG12 HH11 ' A' ' 162' ' ' ARG . 58.0 mt -96.44 120.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.104 -1.073 . . . . 60.43 108.104 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 2.6 mp -106.16 119.05 54.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 118.41 -1.316 . . . . 73.209999999999994 108.863 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 40.1 m -116.84 117.64 30.29 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.403 -0.591 . . . . 64.239999999999995 109.403 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.463 HG12 HG12 ' A' ' 218' ' ' VAL . 21.1 m -119.02 168.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.704 -0.85 . . . . 64.450000000000003 108.704 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -114.66 121.51 35.63 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 62.439999999999998 106.624 171.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 21.2 Cg_endo -61.78 134.71 51.85 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.562 1.508 . . . . 64.310000000000002 111.574 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.77 -9.79 58.9 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.652 -0.87 . . . . 74.019999999999996 108.652 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 50.1 t30 70.29 75.8 0.21 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.837 -1.529 . . . . 74.530000000000001 111.77 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -89.79 107.69 19.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.024 -1.102 . . . . 74.420000000000002 108.024 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 . . . . . 0 C--N 1.291 -1.95 0 N-CA-C 107.738 -1.208 . . . . 65.129999999999995 107.738 -177.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 112.328 -0.309 . . . . 74.409999999999997 112.328 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -74.3 121.03 20.69 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.927 -0.768 . . . . 74.409999999999997 108.927 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.78 95.95 0.06 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.793 0.806 . . . . 74.409999999999997 111.601 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -129.65 157.58 41.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.992 -1.004 . . . . 74.120000000000005 108.34 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.62 128.92 33.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.748 -0.381 . . . . 71.430000000000007 110.149 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 134' ' ' PRO . . . -105.34 110.47 64.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.785 -0.821 . . . . 44.020000000000003 108.785 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 133' ' ' ALA . 10.6 Cg_endo -56.52 -47.22 24.98 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.722 2.282 . . . . 70.400000000000006 112.083 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.4 m 55.98 86.38 0.06 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.297 1.039 . . . . 72.030000000000001 112.688 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.86 94.27 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.328 -0.99 . . . . 43.020000000000003 108.328 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.9 p -151.64 157.14 41.73 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.211 -0.904 . . . . 73.219999999999999 110.242 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.5 pt -95.12 142.74 25.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 109.867 -0.42 . . . . 62.109999999999999 109.867 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.15 102.39 0.92 Allowed 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.091 1.86 . . . . 74.400000000000006 111.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -85.38 149.26 25.56 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.277 -0.874 . . . . 65.239999999999995 109.831 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -136.94 93.84 2.89 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.601 0.715 . . . . 74.319999999999993 110.768 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.09 -70.74 0.68 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.423 -1.325 . . . . 72.530000000000001 107.423 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -144.75 127.54 16.29 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.523 -0.762 . . . . 72.420000000000002 109.907 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 166' ' ' HIS . 27.2 p -115.51 146.45 41.68 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.078 -1.082 . . . . 61.420000000000002 108.078 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.71 135.33 35.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.362 0.601 . . . . 74.120000000000005 112.027 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 205' ' ' LEU . 12.1 p -87.94 119.87 28.71 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.569 -1.271 . . . . 51.240000000000002 107.569 171.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.5 156.64 47.34 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.895 -0.593 . . . . 73.239999999999995 111.112 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 39.3 mm -94.44 111.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 105.912 -1.885 . . . . 71.219999999999999 105.912 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 44.5 pt -103.9 170.5 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 111.152 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' A' ' 153' ' ' ILE . 39.5 m-20 61.0 40.25 15.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 124.229 0.956 . . . . 55.020000000000003 109.965 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.21 -35.34 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 113.439 0.903 . . . . 64.099999999999994 113.439 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.41 -18.29 45.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.74 0.781 . . . . 74.030000000000001 110.632 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 150' ' ' ASP . 49.8 mm -92.0 -43.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.384 -0.826 . . . . 73.239999999999995 109.316 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 158' ' ' HIS . 79.6 t -75.93 120.84 83.47 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.298 -0.864 . . . . 63.350000000000001 112.185 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 156.68 52.34 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.838 2.359 . . . . 73.150000000000006 109.197 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.55 -15.84 8.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.044 0.45 . . . . 64.420000000000002 111.942 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.556 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 28.5 p -84.55 -5.33 59.29 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 123.448 0.699 . . . . 74.129999999999995 112.541 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.428 ' HB2' HG13 ' A' ' 154' ' ' VAL . 41.0 m170 -123.55 158.03 32.3 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 121.815 -0.553 . . . . 73.409999999999997 110.265 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -126.88 131.92 51.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.773 -1.566 . . . . 64.239999999999995 106.773 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 37.3 ttm180 -126.58 123.67 38.21 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.654 -0.419 . . . . 73.439999999999998 111.356 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.52 142.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.255 0.55 . . . . 65.540000000000006 110.024 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -106.5 127.81 53.6 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 105.507 -2.034 . . . . 73.140000000000001 105.507 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.27 139.21 30.87 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.104 -0.702 . . . . 64.510000000000005 109.104 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.69 148.73 40.78 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.629 -1.249 . . . . 52.32 107.629 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.8 OUTLIER -89.65 127.94 35.99 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.036 -1.468 . . . . 75.209999999999994 107.036 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 19.5 t-80 -141.93 131.65 24.15 Favored 'General case' 0 CA--C 1.484 -1.58 0 O-C-N 123.0 0.187 . . . . 71.329999999999998 110.929 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.77 -47.28 3.48 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.018 -0.833 . . . . 61.009999999999998 111.018 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.5 t 174.41 -175.28 0.08 Allowed 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.426 -1.324 . . . . 63.109999999999999 107.426 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.12 83.75 6.7 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.964 0.888 . . . . 61.240000000000002 111.127 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -86.94 156.52 55.11 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.586 -1.188 . . . . 74.049999999999997 109.151 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.13 157.16 55.01 Favored 'Trans proline' 0 C--O 1.254 1.325 0 C-N-CA 123.345 2.697 . . . . 74.040000000000006 111.692 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.0 mp -62.25 143.65 56.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.753 -0.832 . . . . 64.450000000000003 108.753 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -79.49 30.31 2.22 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 115.834 1.094 . . . . 75.400000000000006 115.834 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.08 165.18 35.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.195 0.998 . . . . 75.0 111.613 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 201' ' ' VAL . 91.6 m-85 -120.05 163.17 18.05 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.914 -1.143 . . . . 73.140000000000001 107.914 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.0 pt -124.26 157.13 31.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.921 0.391 . . . . 63.420000000000002 111.82 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 28.1 ptt180 -137.99 162.18 34.76 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.739 0.816 . . . . 75.129999999999995 110.51 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -102.2 163.25 12.34 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.248 -0.887 . . . . 62.020000000000003 109.752 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.35 30.57 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.768 -1.333 . . . . 61.25 109.768 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -97.5 136.26 38.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.212 -0.995 . . . . 75.299999999999997 108.63 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.6 t -109.61 149.24 29.98 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.917 -0.771 . . . . 73.420000000000002 108.917 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.94 113.81 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 106.56 -1.644 . . . . 62.119999999999997 106.56 174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -108.23 133.32 52.63 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 116.077 -0.511 . . . . 74.5 110.302 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.25 119.02 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 115.449 -0.796 . . . . 53.109999999999999 109.751 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 64.0 p -119.07 -174.8 2.78 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.969 -0.752 . . . . 72.109999999999999 108.969 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.257 0.551 . . . . 63.140000000000001 109.596 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.6 m -91.02 -17.84 25.6 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.935 -0.575 . . . . 74.540000000000006 111.005 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.68 -153.67 20.57 Favored Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 120.286 -0.959 . . . . 74.099999999999994 112.457 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.91 134.1 36.64 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 120.815 0.34 . . . . 35.009999999999998 110.601 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.32 146.99 45.27 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.631 -0.713 . . . . 45.149999999999999 110.571 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.07 125.78 44.65 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.407 -1.331 . . . . 71.030000000000001 107.407 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -143.7 150.52 50.7 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 122.175 -0.328 . . . . 73.129999999999995 110.471 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.53 121.67 10.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.388 2.058 . . . . 64.219999999999999 110.031 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.61 139.24 12.4 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.518 -1.033 . . . . 53.240000000000002 110.518 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.81 117.71 36.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.113 -1.44 . . . . 64.5 107.113 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 96.6 m-85 -109.94 162.04 14.9 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.31 -0.626 . . . . 74.400000000000006 109.31 -176.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.0 mt -72.72 133.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.134 -1.432 . . . . 75.310000000000002 107.134 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -90.96 -45.0 8.99 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.782 -0.574 . . . . 61.329999999999998 110.648 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -165.2 154.42 12.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.505 -0.924 . . . . 61.140000000000001 108.505 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 4.3 mm? -91.84 144.25 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.811 -0.811 . . . . 74.230000000000004 108.811 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 175' ' ' TYR . 68.9 t -84.37 117.81 69.64 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.776 -1.194 . . . . 73.450000000000003 107.776 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.39 124.33 14.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.762 1.641 . . . . 72.239999999999995 110.295 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 88.9 1.9 79.15 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 120.337 -0.935 . . . . 71.530000000000001 111.303 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.75 157.69 25.55 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 110.607 -0.997 . . . . 65.430000000000007 110.607 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 209' ' ' THR . 59.9 tp -56.02 -44.64 78.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.758 1.021 . . . . 63.149999999999999 113.758 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.27 72.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.065 0.46 . . . . 40.119999999999997 110.389 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -74.87 -49.37 20.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.039 -0.982 . . . . 62.439999999999998 108.589 178.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t -57.55 -43.1 84.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.098 -0.955 . . . . 74.120000000000005 111.486 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 205' ' ' LEU . 15.0 t -89.09 -17.53 29.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.375 -0.93 . . . . 73.109999999999999 112.129 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.6 38.94 90.02 Favored Glycine 0 C--N 1.336 0.565 0 O-C-N 123.126 0.266 . . . . 41.5 113.698 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.78 -5.45 38.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.989 0.423 . . . . 63.020000000000003 111.458 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -130.02 142.12 50.66 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.025 -1.102 . . . . 71.049999999999997 108.025 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -99.98 161.45 13.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.16 -31.92 55.37 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 CA-C-O 121.957 0.884 . . . . 64.239999999999995 110.379 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.92 -24.05 52.46 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 113.529 0.937 . . . . 75.409999999999997 113.529 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.676 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.3 m-20 -62.04 145.12 54.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.561 0.538 . . . . 63.420000000000002 112.228 -172.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.1 pt-20 -106.68 143.78 34.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 72.329999999999998 111.169 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 249' ' ' VAL . 28.8 m -83.06 126.67 40.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.44 0.638 . . . . 71.349999999999994 110.93 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.443 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.7 mm -94.69 -49.34 12.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.794 -0.639 . . . . 55.009999999999998 110.987 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 35.0 mt-10 -149.23 144.67 26.69 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.003 -0.544 . . . . 70.319999999999993 111.166 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.533 HG11 ' SD ' ' A' ' 238' ' ' MET . 26.7 m -125.27 99.65 6.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.935 -0.765 . . . . 64.439999999999998 108.935 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 61.99 11.91 4.55 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.789 1.033 . . . . 62.32 113.789 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.69 -5.97 12.66 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.001 -1.095 . . . . 70.519999999999996 112.466 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 40.7 mm -83.85 122.66 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.191 -1.411 . . . . 65.239999999999995 107.191 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 227' ' ' ALA . 41.8 mm-40 -71.19 -10.24 59.42 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.352 0.407 . . . . 52.350000000000001 111.647 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 224' ' ' ILE 0.29 22.3 m 64.02 -14.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 127.471 2.308 . . . . 74.439999999999998 114.394 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -71.34 126.47 29.72 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.902 -0.777 . . . . 72.540000000000006 108.902 175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.18 68.89 Favored Glycine 0 C--N 1.304 -1.217 0 N-CA-C 111.75 -0.54 . . . . 70.439999999999998 111.75 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 233' ' ' GLN . 0.1 OUTLIER -104.15 143.8 32.43 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.897 -1.89 . . . . 73.040000000000006 105.897 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 31.8 p -81.46 166.79 20.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.708 -0.797 . . . . 71.219999999999999 109.098 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.4 -36.14 75.27 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 120.545 0.212 . . . . 73.120000000000005 110.85 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.29 -44.14 92.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 115.645 -0.707 . . . . 74.140000000000001 110.36 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 14.1 mm100 -73.78 -43.33 59.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.61 -0.723 . . . . 71.329999999999998 111.809 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 40.7 t -63.83 -45.71 96.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 120.698 -0.401 . . . . 74.299999999999997 111.045 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 239' ' ' VAL . 19.2 p -59.93 -44.95 94.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.004 -0.678 . . . . 71.209999999999994 110.226 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.87 -48.73 75.02 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.725 -0.67 . . . . 74.209999999999994 110.946 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.2 tmm? -61.43 -44.52 96.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.542 0.687 . . . . 71.450000000000003 109.176 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.55 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.5 mtm -67.26 -38.49 85.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.227 0.825 . . . . 61.420000000000002 113.227 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 235' ' ' THR . 96.9 t -69.87 -30.03 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.745 0.783 . . . . 70.109999999999999 109.106 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.62 -39.05 92.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.712 0.768 . . . . 50.539999999999999 110.049 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 0.8 OUTLIER -100.32 26.02 7.01 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.129 -0.941 . . . . 72.230000000000004 110.743 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.3 t -65.57 -16.93 64.18 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 113.012 0.745 . . . . 43.530000000000001 113.012 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.9 t -87.2 -36.51 17.95 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.68 -0.637 . . . . 73.409999999999997 109.635 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -137.03 95.85 3.19 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.619 -0.882 . . . . 72.140000000000001 108.619 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 48.6 tp -130.21 134.04 46.99 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.42 0.629 . . . . 73.239999999999995 111.125 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.24 115.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 106.421 -1.696 . . . . 75.219999999999999 106.421 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 55.0 mt -112.8 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.117 -0.492 . . . . 53.229999999999997 110.336 -170.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 89.9 m -109.62 117.36 33.74 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 109.353 -0.61 . . . . 61.409999999999997 109.353 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG12 HG12 ' A' ' 218' ' ' VAL . 17.2 m -121.8 172.31 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.562 -0.903 . . . . 41.219999999999999 108.562 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.443 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -128.93 138.61 33.55 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 108.309 -0.997 . . . . 64.129999999999995 108.309 172.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 24.5 Cg_endo -61.16 133.56 47.56 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.857 1.705 . . . . 53.219999999999999 111.964 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -98.39 8.37 44.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.234 0.54 . . . . 55.439999999999998 110.091 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -78.66 86.79 4.61 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.736 -1.209 . . . . 73.140000000000001 107.736 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.25 116.67 14.06 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.297 -0.865 . . . . 71.150000000000006 112.066 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 . . . . . 0 C--N 1.306 -1.301 0 CA-C-N 115.391 -0.822 . . . . 74.310000000000002 110.458 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.885 -0.886 . . . . 54.140000000000001 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 t -77.09 105.61 8.27 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.168 0.509 . . . . 73.209999999999994 109.697 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -128.74 44.31 2.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.058 0.932 . . . . 71.099999999999994 109.05 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.9 m -62.65 -23.49 67.12 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.824 -1.535 . . . . 71.450000000000003 109.346 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.85 123.43 21.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.236 -0.893 . . . . 71.400000000000006 109.201 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.42 108.39 61.67 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 109.967 -0.383 . . . . 74.340000000000003 109.967 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.27 -2.75 9.42 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.453 2.102 . . . . 63.009999999999998 111.109 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.3 m 67.8 18.81 9.7 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.221 1.008 . . . . 63.310000000000002 111.883 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 pt -76.91 -16.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.467 0.651 . . . . 63.240000000000002 110.506 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.2 t -107.02 142.87 35.96 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 107.882 -1.155 . . . . 42.539999999999999 107.882 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.0 mm -84.43 133.58 44.36 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.121 -1.066 . . . . 75.209999999999994 108.121 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -67.69 76.61 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.511 2.141 . . . . 74.120000000000005 111.424 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -162.14 24.23 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.017 -2.216 . . . . 64.340000000000003 105.017 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.765 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 10.0 t70 -70.5 142.93 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 113.496 -1.684 . . . . 75.510000000000005 109.685 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.97 1.14 52.61 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 114.774 1.398 . . . . 65.209999999999994 114.774 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.765 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 19.2 ptt180 -91.92 117.02 29.41 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 118.337 -1.345 . . . . 61.240000000000002 110.55 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 40.5 t -110.32 129.43 55.75 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.751 -1.203 . . . . 71.549999999999997 107.751 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.74 135.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.043 0.449 . . . . 52.32 111.081 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.2 p -82.15 137.77 34.88 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.803 -0.814 . . . . 60.340000000000003 108.803 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -152.71 154.77 35.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 110.208 -0.293 . . . . 73.430000000000007 110.208 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.4 mm -95.51 111.9 26.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.898 -1.519 . . . . 75.319999999999993 106.898 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.681 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -103.04 162.97 3.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 120.646 -0.422 . . . . 74.430000000000007 111.708 -176.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 63.06 16.55 9.41 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.538 1.135 . . . . 70.349999999999994 110.597 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.3 p -55.4 -30.12 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.13 0.972 . . . . 52.229999999999997 113.061 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -68.43 -41.07 80.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.126 0.489 . . . . 74.25 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.41 -39.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.736 -0.665 . . . . 71.239999999999995 110.602 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.67 123.14 87.94 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.1 0.778 . . . . 53.340000000000003 113.1 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.28 156.91 46.17 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.478 2.785 . . . . 62.229999999999997 110.014 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.66 -16.04 9.49 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.577 0.751 . . . . 74.230000000000004 112.205 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.4 p -69.59 -16.73 63.46 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 116.234 -0.439 . . . . 44.43 112.044 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.444 ' CE1' HG21 ' A' ' 219' ' ' ILE . 33.3 m170 -126.68 157.37 39.21 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.017 -0.364 . . . . 74.530000000000001 110.017 172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -142.24 121.54 13.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.786 0.327 . . . . 60.350000000000001 110.857 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 98.1 mtt180 -111.2 129.28 56.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.74 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.76 151.48 20.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.222 -0.445 . . . . 71.200000000000003 110.514 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.609 ' HG2' HD12 ' A' ' 149' ' ' ILE . 15.5 mmt180 -98.66 129.46 45.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.987 -0.745 . . . . 73.219999999999999 108.987 174.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -117.47 135.91 53.58 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.268 -0.642 . . . . 64.450000000000003 109.268 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.469 ' N ' HD23 ' A' ' 163' ' ' LEU . 5.6 p -143.24 165.23 28.04 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.176 0.99 . . . . 72.25 109.486 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 168' ' ' SER . 0.1 OUTLIER -108.31 142.36 38.72 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 120.05 -0.66 . . . . 72.310000000000002 110.246 176.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -97.36 98.25 9.81 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.612 -0.722 . . . . 64.109999999999999 110.795 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.05 -39.32 2.04 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 121.284 -0.484 . . . . 73.420000000000002 113.691 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 165' ' ' LYS . 33.9 m -142.38 151.14 41.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.054 -0.674 . . . . 45.149999999999999 111.104 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 165' ' ' LYS . 21.4 t70 -71.99 89.77 1.12 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.864 0.84 . . . . 75.310000000000002 112.141 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -80.8 156.63 72.54 Favored Pre-proline 0 C--N 1.292 -1.925 0 CA-C-N 115.174 -0.921 . . . . 62.420000000000002 109.739 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.51 156.24 61.8 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.635 2.223 . . . . 75.310000000000002 108.372 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.2 mp -62.6 135.38 57.36 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.169 -0.678 . . . . 73.450000000000003 109.169 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.453 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -80.28 40.31 2.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.948 -1.12 . . . . 73.209999999999994 115.206 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 21.1 p90 -158.77 147.52 18.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.955 -0.757 . . . . 75.129999999999995 108.955 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -105.61 156.46 18.23 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.724 -1.213 . . . . 63.329999999999998 107.724 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 235' ' ' THR . 23.0 pt -120.37 153.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.021 0.439 . . . . 73.299999999999997 111.23 175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -133.08 167.34 20.5 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.261 -0.882 . . . . 72.540000000000006 110.124 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.518 ' HB3' HD11 ' A' ' 231' ' ' LEU . 2.9 p-10 -114.66 162.38 16.87 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.953 -1.129 . . . . 73.420000000000002 107.953 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.0 -174.97 42.31 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.336 -1.105 . . . . 65.530000000000001 110.336 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 191' ' ' LYS . 3.0 p -92.54 124.24 36.43 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.768 0.795 . . . . 71.120000000000005 111.164 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.1 t -103.52 142.0 35.04 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.984 -1.487 . . . . 55.130000000000003 106.984 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 191' ' ' LYS . 39.8 t -93.35 114.58 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.179 -1.415 . . . . 70.219999999999999 107.179 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -107.98 118.95 38.09 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.679 -1.146 . . . . 62.439999999999998 109.322 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.36 113.42 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 106.763 -1.569 . . . . 54.229999999999997 106.763 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -109.42 171.82 7.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 108.941 -0.763 . . . . 71.450000000000003 108.941 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.85 63.74 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.106 0.479 . . . . 74.239999999999995 109.928 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.5 m -98.06 -0.69 44.07 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.689 -0.687 . . . . 64.420000000000002 111.143 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.92 -143.97 17.12 Favored Glycine 0 CA--C 1.498 -1.023 0 C-N-CA 120.516 -0.85 . . . . 75.340000000000003 112.04 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.66 128.63 39.94 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.567 0.699 . . . . 72.230000000000004 112.316 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.75 146.72 49.05 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 114.29 -1.323 . . . . 75.310000000000002 108.929 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -114.71 125.31 53.58 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.623 -1.621 . . . . 75.319999999999993 106.623 175.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -136.75 149.87 68.26 Favored Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 120.528 -0.469 . . . . 73.120000000000005 110.683 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.5 111.49 0.96 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 122.387 2.058 . . . . 73.430000000000007 110.202 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -113.61 150.4 18.54 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 110.259 -1.137 . . . . 63.140000000000001 110.259 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.69 117.14 46.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.675 -1.232 . . . . 74.400000000000006 107.675 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 72.2 m-85 -110.79 160.47 16.71 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.501 -0.555 . . . . 64.109999999999999 109.501 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.62 132.19 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.188 -1.412 . . . . 53.310000000000002 107.188 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -90.91 -49.16 6.58 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 122.094 -0.379 . . . . 72.299999999999997 111.181 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -165.22 149.54 8.77 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.628 -0.508 . . . . 60.009999999999998 109.628 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.9 mm? -94.41 144.41 25.58 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.571 0.544 . . . . 63.509999999999998 109.69 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 173' ' ' GLY . 15.3 m -85.96 140.56 35.1 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.087 -1.079 . . . . 72.409999999999997 108.087 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.29 124.2 14.31 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.629 1.553 . . . . 62.520000000000003 110.881 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.72 85.19 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.858 -0.686 . . . . 33.340000000000003 111.84 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -80.9 156.3 37.99 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 111.425 -0.67 . . . . 55.310000000000002 111.425 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.3 tt -50.51 -50.94 51.57 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.042 0.756 . . . . 74.209999999999994 113.042 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.93 -28.6 62.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.157 0.504 . . . . 71.319999999999993 111.238 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.9 OUTLIER -73.87 -54.41 8.03 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.169 -1.048 . . . . 64.439999999999998 108.169 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 29.4 t -63.94 -33.03 74.8 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.473 -1.24 . . . . 54.420000000000002 111.829 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.1 t -81.15 -30.84 34.37 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 119.138 -1.025 . . . . 63.240000000000002 110.865 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.73 32.95 70.73 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.146 -0.55 . . . . 52.450000000000003 113.378 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.37 -29.59 17.01 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.163 0.801 . . . . 72.420000000000002 113.163 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 249' ' ' VAL . 23.3 mt -126.48 157.38 38.81 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.443 -0.947 . . . . 60.420000000000002 108.443 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.35 17.11 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.702 0.287 . . . . 55.049999999999997 111.249 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.3 t -58.99 -31.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 72.25 111.986 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -77.33 -23.49 50.95 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.148 -0.478 . . . . 50.439999999999998 111.912 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.8 m-20 -66.61 145.21 55.84 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.836 -0.62 . . . . 74.319999999999993 110.324 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.8 pt-20 -116.04 146.04 42.5 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.131 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 30.1 m -78.27 123.01 34.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.361 0.601 . . . . 74.430000000000007 110.673 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.444 HG21 ' CE1' ' A' ' 158' ' ' HIS . 48.2 mm -92.84 -40.56 12.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.662 -0.699 . . . . 73.239999999999995 109.979 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.6 mt-10 -148.39 144.54 27.56 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 115.821 -0.627 . . . . 73.340000000000003 111.355 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.32 112.23 34.62 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.204 -1.406 . . . . 60.219999999999999 107.204 171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 71.19 -71.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.778 1.231 . . . . 42.549999999999997 108.737 -170.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -164.35 16.02 0.1 Allowed Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.316 -1.514 . . . . 71.120000000000005 109.316 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 36.7 mm -94.56 119.07 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.933 -1.506 . . . . 54.509999999999998 106.933 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.4 mt-10 -73.97 4.66 5.09 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.305 1.224 . . . . 71.430000000000007 114.305 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 18.2 m 55.46 0.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 125.698 1.599 . . . . 73.439999999999998 114.375 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.88 23.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.186 -0.672 . . . . 52.229999999999997 109.186 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.51 53.42 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 121.005 -0.617 . . . . 53.130000000000003 111.924 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 30.1 mmmt -82.69 140.66 32.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.638 -1.245 . . . . 62.149999999999999 107.638 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 234' ' ' VAL . 33.2 p -87.44 168.86 12.74 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.585 -0.524 . . . . 71.120000000000005 109.585 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.2 mp -62.61 -32.06 73.01 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 120.753 0.311 . . . . 63.450000000000003 110.326 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -48.68 80.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 54.329999999999998 108.908 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 30.2 mm-40 -69.84 -45.67 67.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.202 -0.908 . . . . 51.439999999999998 111.864 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 230' ' ' THR . 40.2 t -65.2 -46.36 91.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 120.637 -0.425 . . . . 54.240000000000002 111.656 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 239' ' ' VAL . 34.2 p -59.03 -49.56 77.41 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.204 -0.598 . . . . 54.409999999999997 110.519 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.08 -38.34 79.25 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.996 -0.547 . . . . 74.019999999999996 111.908 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -65.6 -42.36 91.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.244 -1.021 . . . . 73.109999999999999 108.244 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.6 mtm -68.7 -38.28 80.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.578 -0.737 . . . . 75.120000000000005 112.467 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 235' ' ' THR . 61.4 t -68.63 -32.01 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.09 -0.708 . . . . 72.239999999999995 109.09 176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.52 83.84 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.386 0.675 . . . . 71.140000000000001 111.203 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.529 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.7 OUTLIER -94.35 82.92 4.11 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.835 -1.172 . . . . 71.409999999999997 107.835 177.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.3 m -79.24 -52.74 7.74 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.899 1.074 . . . . 74.200000000000003 113.899 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 24.0 t -79.26 -23.53 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.708 -0.397 . . . . 64.040000000000006 111.844 -170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.91 101.62 3.19 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.656 0.741 . . . . 53.409999999999997 110.246 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.529 HD13 ' HB2' ' A' ' 241' ' ' ASN . 57.7 tp -115.7 134.22 55.25 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 63.130000000000003 109.029 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 149' ' ' ILE . 56.0 mt -106.5 115.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.529 -1.286 . . . . 65.010000000000005 107.529 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 69.3 mt -110.12 122.3 64.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 120.866 -0.334 . . . . 71.099999999999994 110.641 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 29.9 m -110.17 117.85 34.81 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.386 -0.598 . . . . 70.450000000000003 109.386 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 24.8 m -122.96 171.98 11.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.615 -1.254 . . . . 74.25 107.615 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.78 36.73 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 107.549 -1.278 . . . . 53.420000000000002 107.549 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 26.6 Cg_endo -59.98 134.43 56.52 Favored 'Trans proline' 0 CA--C 1.498 -1.316 0 C-N-CA 121.621 1.547 . . . . 63.43 109.893 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.79 -38.04 66.81 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.407 -0.815 . . . . 63.119999999999997 112.181 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.1 t30 49.21 81.35 0.05 Allowed 'General case' 0 C--N 1.347 0.484 0 O-C-N 124.349 1.03 . . . . 72.150000000000006 109.328 -171.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.34 -56.79 17.58 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.025 -0.988 . . . . 71.120000000000005 111.65 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 123.579 0.751 . . . . 74.219999999999999 109.384 176.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.411 0 N-CA-C 110.311 -1.115 . . . . 73.200000000000003 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 p -93.38 141.59 28.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.949 0.404 . . . . 63.340000000000003 112.084 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.71 100.46 3.43 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.695 1.198 . . . . 73.25 107.836 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.2 m -81.11 107.12 13.64 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.25 -0.432 . . . . 73.340000000000003 111.041 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 128.99 44.48 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.661 -0.496 . . . . 71.049999999999997 109.661 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.21 108.78 57.01 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.745 -0.465 . . . . 64.450000000000003 109.745 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.37 115.15 2.24 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.83 2.353 . . . . 54.229999999999997 110.761 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -83.71 84.91 7.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.312 0.577 . . . . 64.510000000000005 109.666 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.8 138.12 44.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.344 -1.354 . . . . 54.149999999999999 107.344 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.9 m -74.19 97.39 2.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.417 0.627 . . . . 74.340000000000003 110.569 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -77.67 144.01 68.52 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.451 -0.795 . . . . 64.150000000000006 110.203 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.85 146.2 93.98 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.461 2.107 . . . . 63.009999999999998 111.462 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -95.26 103.24 15.09 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 116.429 -0.351 . . . . 53.43 110.295 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -84.67 133.2 34.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.705 -0.85 . . . . 73.510000000000005 108.705 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -87.22 3.82 45.02 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.192 0.52 . . . . 72.319999999999993 110.32 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -75.18 149.0 39.1 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.364 -1.347 . . . . 52.210000000000001 107.364 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.5 t -108.43 127.29 53.77 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.819 -1.152 . . . . 75.340000000000003 108.662 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.55 141.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.249 -1.389 . . . . 75.450000000000003 107.249 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 161' ' ' VAL . 7.7 t -84.92 136.33 33.68 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 107.859 -1.163 . . . . 42.130000000000003 107.859 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.79 147.64 39.52 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.423 -0.954 . . . . 52.109999999999999 108.423 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.505 HD11 ' HG ' ' A' ' 211' ' ' LEU . 24.7 mm -96.12 106.49 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.174 -1.787 . . . . 72.129999999999995 106.174 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.2 pt -99.75 160.27 3.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 115.763 -0.653 . . . . 75.040000000000006 110.397 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 66.16 24.15 10.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 35.5 111.627 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.87 -29.35 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 114.723 1.379 . . . . 74.129999999999995 114.723 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.81 -35.09 44.74 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.428 0.632 . . . . 74.319999999999993 110.804 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.38 -45.28 18.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.051 -0.977 . . . . 74.209999999999994 109.662 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 158' ' ' HIS . 55.9 t -70.76 128.33 90.97 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 114.819 -1.082 . . . . 73.310000000000002 112.347 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.83 156.22 30.98 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.7 2.266 . . . . 71.140000000000001 109.667 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.81 -19.54 11.84 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.577 0.703 . . . . 44.119999999999997 111.531 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 17.3 p -79.36 -2.31 41.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.843 -0.617 . . . . 72.340000000000003 112.585 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.414 ' HB2' HG13 ' A' ' 154' ' ' VAL . 15.9 m170 -127.55 153.61 46.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.139 -1.06 . . . . 70.439999999999998 108.139 170.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.9 tpp180 -139.92 127.51 21.65 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.69 -0.485 . . . . 65.140000000000001 109.69 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 94.2 mtt180 -115.38 123.77 49.52 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.397 0.435 . . . . 74.430000000000007 111.476 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' ' 146' ' ' SER . 29.2 m -117.61 145.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.446 -0.946 . . . . 73.510000000000005 108.446 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -111.09 123.86 51.03 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.283 -1.006 . . . . 70.239999999999995 108.283 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 205' ' ' LEU . 72.4 mt -92.0 139.61 30.48 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.17 0.588 . . . . 74.510000000000005 111.937 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.02 134.81 52.42 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.461 -0.79 . . . . 63.329999999999998 111.921 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 170' ' ' LYS . 68.1 mttm -135.27 143.46 46.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.758 -0.46 . . . . 62.240000000000002 109.758 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -106.48 95.52 5.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.217 0.451 . . . . 75.010000000000005 112.217 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.85 -27.94 2.56 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 115.001 0.761 . . . . 71.319999999999993 115.001 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.0 t -104.05 133.96 48.13 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.088 0.471 . . . . 73.030000000000001 111.488 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.01 80.7 3.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.72 0.771 . . . . 64.299999999999997 109.739 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 63.8 mttp -101.23 163.09 18.6 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.286 -0.87 . . . . 71.409999999999997 111.144 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.99 156.6 15.26 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 123.058 2.505 . . . . 73.340000000000003 112.486 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.3 mp -75.53 164.83 25.94 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.182 -0.917 . . . . 74.519999999999996 108.624 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -77.37 30.98 1.64 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.599 0.6 . . . . 72.430000000000007 114.599 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.443 ' HB3' HD13 ' A' ' 200' ' ' LEU . 44.3 p90 -160.31 156.23 25.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.147 0.473 . . . . 53.520000000000003 110.787 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -110.19 149.8 29.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.642 -1.614 . . . . 73.219999999999999 106.642 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 pt -118.07 155.44 19.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.291 0.567 . . . . 73.329999999999998 111.891 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -128.8 175.83 8.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.303 -0.862 . . . . 63.530000000000001 108.675 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.6 p-10 -107.56 162.3 14.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.303 -0.628 . . . . 55.009999999999998 109.303 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.23 35.05 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 109.81 -1.316 . . . . 51.219999999999999 109.81 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 32.3 p -127.79 139.02 52.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.003 0.43 . . . . 72.120000000000005 110.232 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.9 t -100.81 145.94 27.91 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.17 -1.048 . . . . 50.450000000000003 108.17 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.0 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.771 -0.65 . . . . 62.210000000000001 109.699 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.427 ' HG3' HG23 ' A' ' 185' ' ' THR . 2.9 tpp180 -109.97 112.0 23.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.273 -1.01 . . . . 74.310000000000002 108.273 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.33 113.7 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.642 -0.503 . . . . 72.349999999999994 109.642 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.427 HG23 ' HG3' ' A' ' 183' ' ' ARG . 26.4 p -124.32 -174.32 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.716 -0.674 . . . . 60.240000000000002 111.882 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.56 -29.29 70.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.595 -0.73 . . . . 63.210000000000001 111.81 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 55.3 p -80.7 -24.13 39.07 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.513 . . . . 52.409999999999997 110.272 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.77 -145.1 15.62 Favored Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.313 -1.515 . . . . 22.02 109.313 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -92.48 140.27 29.74 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.139 -1.024 . . . . 61.350000000000001 109.42 176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.96 139.2 52.06 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.85 -0.426 . . . . 74.430000000000007 109.85 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -99.89 125.38 45.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.054 -1.091 . . . . 73.319999999999993 108.054 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 152.25 79.2 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.556 -0.905 . . . . 73.340000000000003 108.556 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.62 117.26 3.65 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.392 2.061 . . . . 70.299999999999997 110.775 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.31 136.17 10.32 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 110.562 -1.015 . . . . 63.200000000000003 110.562 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.3 mm -105.49 117.77 51.78 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.243 -1.391 . . . . 74.0 107.243 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 64.2 m-85 -110.2 158.61 18.17 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.185 -0.672 . . . . 61.420000000000002 109.185 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.86 132.13 33.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.719 -1.215 . . . . 62.310000000000002 107.719 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.2 t -82.97 -52.05 7.03 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 121.364 -0.835 . . . . 54.420000000000002 108.801 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 214' ' ' VAL . 40.2 ttm180 -164.99 155.18 13.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.776 -1.194 . . . . 63.43 107.776 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.5 mm? -91.83 144.46 25.46 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.853 -0.795 . . . . 73.219999999999999 108.853 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.2 128.02 83.7 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 61.149999999999999 108.832 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.54 124.54 14.85 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.6 1.533 . . . . 74.540000000000006 109.223 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.87 0.12 83.88 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 111.002 -0.839 . . . . 64.209999999999994 111.002 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.71 148.25 25.91 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 111.476 -0.65 . . . . 63.439999999999998 111.476 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.493 HD23 HD23 ' A' ' 163' ' ' LEU . 45.5 tp -60.5 -33.57 72.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.372 0.669 . . . . 75.099999999999994 112.463 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -75.27 -27.69 59.51 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.048 -0.407 . . . . 62.030000000000001 110.686 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 7.0 tp10 -74.51 -45.04 48.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.648 -0.871 . . . . 73.430000000000007 108.648 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -66.49 -29.35 69.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.277 -0.874 . . . . 54.240000000000002 112.653 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 146' ' ' SER . 21.6 p -85.35 -35.22 21.54 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.962 -0.695 . . . . 74.019999999999996 111.981 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.16 15.39 72.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.759 -0.734 . . . . 73.310000000000002 114.044 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 209' ' ' THR . 3.1 mm? -84.58 -11.67 55.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 117.909 0.854 . . . . 44.119999999999997 111.367 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.471 HD22 ' CG2' ' A' ' 249' ' ' VAL . 17.9 mt -127.3 131.57 50.46 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.943 -1.503 . . . . 64.349999999999994 106.943 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.09 163.02 14.0 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.027 -0.36 . . . . 73.200000000000003 110.027 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 215' ' ' ASN . 26.9 m -59.3 -31.37 46.11 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.558 0 N-CA-C 113.466 0.913 . . . . 73.510000000000005 113.466 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 214' ' ' VAL . 3.0 m-20 -78.9 -23.52 44.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.513 -0.742 . . . . 71.0 112.184 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.0 m-20 -64.63 144.75 57.0 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.772 0.67 . . . . 61.119999999999997 110.625 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.8 pt-20 -107.31 147.57 30.1 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.683 -0.407 . . . . 75.150000000000006 109.984 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 249' ' ' VAL . 27.5 m -82.15 134.64 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 108.877 -0.786 . . . . 73.239999999999995 108.877 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.526 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.7 mm -98.36 -53.58 7.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.327 0.584 . . . . 63.210000000000001 110.046 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.0 mt-10 -141.01 144.72 35.19 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.407 -0.815 . . . . 74.310000000000002 111.146 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.508 HG11 ' SD ' ' A' ' 238' ' ' MET . 27.6 m -123.63 106.52 17.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.598 -0.89 . . . . 75.430000000000007 108.598 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.441 ' OD1' HD22 ' A' ' 245' ' ' LEU . 3.9 m-20 66.44 11.45 8.04 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.863 0.865 . . . . 74.099999999999994 112.172 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.1 -8.13 33.19 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.931 -0.868 . . . . 71.239999999999995 110.931 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.5 mm -84.0 111.63 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.598 -0.89 . . . . 73.109999999999999 108.598 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.45 134.48 52.56 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 108.952 -0.759 . . . . 65.329999999999998 108.952 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.6 m -82.17 -4.46 7.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 115.623 -0.717 . . . . 74.430000000000007 110.899 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.9 122.89 19.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 110.252 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.13 -10.65 74.41 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.586 -0.734 . . . . 62.210000000000001 112.905 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -94.7 161.38 14.21 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.648 -0.325 . . . . 45.32 111.035 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 234' ' ' VAL . 38.6 p -96.48 168.16 10.72 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.188 -0.605 . . . . 73.310000000000002 110.095 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 178' ' ' ASP . 8.3 mp -64.55 -33.54 76.15 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 109.559 -0.534 . . . . 61.299999999999997 109.559 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -57.1 -51.07 70.77 Favored 'General case' 0 CA--C 1.49 -1.327 0 O-C-N 123.984 0.802 . . . . 72.439999999999998 109.698 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -71.17 -41.76 69.95 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 113.374 0.879 . . . . 74.019999999999996 113.374 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 230' ' ' THR . 45.4 t -69.4 -42.82 81.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 72.140000000000001 111.541 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 38.6 p -61.49 -47.99 83.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.301 -0.56 . . . . 63.420000000000002 109.708 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -55.5 -44.18 76.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.503 -0.771 . . . . 71.340000000000003 110.658 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.7 tmm? -63.46 -46.43 86.24 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.584 -0.895 . . . . 74.129999999999995 108.584 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.2 mtm -68.43 -35.88 78.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.556 0.947 . . . . 72.329999999999998 113.556 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -74.34 -30.33 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.159 -0.682 . . . . 74.319999999999993 109.159 176.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -60.09 -44.54 94.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.832 0.825 . . . . 22.440000000000001 110.507 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.87 25.18 11.2 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.966 -1.016 . . . . 71.25 111.478 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 56.5 p -55.15 -28.51 53.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.985 1.105 . . . . 64.230000000000004 113.985 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 p -65.87 -27.84 68.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.073 0.463 . . . . 71.549999999999997 112.034 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -152.05 96.34 2.19 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.869 -1.16 . . . . 75.109999999999999 107.869 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 238' ' ' MET . 1.3 tm? -127.25 133.92 50.14 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.006 -1.109 . . . . 63.119999999999997 108.006 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 68.7 mt -109.77 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.051 -1.092 . . . . 73.0 108.051 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.2 mp -106.55 119.92 56.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.05 -0.722 . . . . 53.119999999999997 109.05 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 40.0 m -108.12 116.6 32.27 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.418 -0.956 . . . . 75.219999999999999 108.418 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 218' ' ' VAL . 22.0 m -118.12 169.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.523 -0.917 . . . . 75.329999999999998 108.523 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -125.85 127.52 24.76 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 107.644 -1.243 . . . . 54.420000000000002 107.644 169.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 157' ' ' THR . 13.1 Cg_endo -56.35 135.08 68.21 Favored 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.143 1.895 . . . . 73.409999999999997 111.829 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -67.5 -27.42 66.98 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.021 -0.991 . . . . 53.32 109.263 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.9 t30 58.7 96.09 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.497 1.123 . . . . 64.040000000000006 110.564 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -76.72 101.07 5.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.316 0.579 . . . . 63.25 110.344 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 106.468 -1.678 . . . . 52.030000000000001 106.468 -178.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.606 0 N-CA-C 111.162 -0.775 . . . . 74.310000000000002 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.6 m -86.32 125.46 33.64 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.2 -0.296 . . . . 72.340000000000003 110.2 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.547 ' HD3' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -131.4 142.09 49.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.207 -0.664 . . . . 65.540000000000006 109.207 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.4 m -91.62 118.69 30.85 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.802 -0.814 . . . . 64.329999999999998 108.802 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.19 99.38 7.77 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.519 -0.919 . . . . 74.540000000000006 108.519 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 134' ' ' PRO . . . -84.2 112.37 40.73 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 109.049 -0.723 . . . . 41.530000000000001 109.049 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 133' ' ' ALA . 9.8 Cg_endo -52.96 113.42 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.767 2.312 . . . . 75.430000000000007 111.222 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.5 m -95.54 92.4 6.63 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.302 -0.999 . . . . 71.329999999999998 108.302 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -112.73 106.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 115.311 -0.859 . . . . 74.120000000000005 110.242 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.2 m -75.82 110.8 10.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.437 -1.32 . . . . 64.140000000000001 107.437 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 34.0 pt -80.21 124.68 82.55 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 116.636 -0.256 . . . . 74.409999999999997 111.391 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 11.4 Cg_exo -73.54 179.23 5.77 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.715 2.277 . . . . 45.210000000000001 112.055 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.56 82.02 7.0 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.77 0.795 . . . . 63.409999999999997 111.132 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -167.0 161.43 14.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.395 -2.076 . . . . 71.450000000000003 105.395 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.45 87.82 2.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 115.942 1.83 . . . . 73.140000000000001 115.942 -172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 103.01 12.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.203 -2.147 . . . . 65.209999999999994 105.203 162.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 58.6 m -113.66 138.15 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.854 -0.739 . . . . 72.120000000000005 111.343 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.62 139.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 108.068 -1.086 . . . . 74.409999999999997 108.068 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 205' ' ' LEU . 17.4 m -92.51 134.69 34.72 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.001 -1.111 . . . . 60.340000000000003 108.001 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.71 156.51 46.76 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.454 -0.339 . . . . 51.399999999999999 110.794 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 43.5 mm -93.35 109.45 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.113 -2.18 . . . . 65.319999999999993 105.113 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 246' ' ' ILE . 37.2 pt -98.47 154.67 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 120.12 -0.632 . . . . 64.409999999999997 109.798 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 67.58 12.16 8.74 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.3 1.0 . . . . 64.420000000000002 109.644 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.51 -29.63 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.425 1.09 . . . . 61.43 112.78 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.8 -19.24 60.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.236 0.541 . . . . 75.200000000000003 110.765 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.44 -44.98 7.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.909 -0.587 . . . . 60.420000000000002 109.653 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.93 129.34 90.18 Favored Pre-proline 0 C--N 1.319 -0.754 0 C-N-CA 123.858 0.863 . . . . 55.299999999999997 112.433 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.79 155.6 43.96 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.546 2.164 . . . . 53.409999999999997 109.87 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -60.17 -11.37 6.03 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.858 0.463 . . . . 74.239999999999995 112.035 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 43.9 p -75.53 -17.79 59.98 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 123.008 0.523 . . . . 50.299999999999997 111.007 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -118.84 155.67 30.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.573 -0.529 . . . . 75.230000000000004 109.573 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -133.27 118.9 19.11 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.179 -1.045 . . . . 70.450000000000003 108.179 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 76.6 mtt180 -109.27 123.03 48.6 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 120.661 -0.415 . . . . 72.530000000000001 111.499 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.88 137.06 51.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.857 -1.164 . . . . 63.130000000000003 107.857 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -100.35 118.25 36.21 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.269 -2.123 . . . . 72.230000000000004 105.269 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 5.0 tt -93.25 138.96 31.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.682 -1.229 . . . . 72.439999999999998 107.682 -174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.474 ' N ' HD23 ' A' ' 163' ' ' LEU . 36.6 t -132.55 166.72 21.43 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 72.400000000000006 107.564 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 1.0 OUTLIER -78.0 138.66 38.94 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.638 -1.245 . . . . 74.150000000000006 107.638 -176.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -131.75 110.5 10.91 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.114 -0.366 . . . . 74.510000000000005 111.976 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.84 -63.89 4.31 Favored Glycine 0 CA--C 1.508 -0.402 0 CA-C-N 116.39 -0.368 . . . . 64.209999999999994 112.985 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.1 t -150.13 -178.79 6.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.614 -1.624 . . . . 75.109999999999999 106.614 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.9 82.09 4.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.922 0.868 . . . . 73.5 110.557 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.13 154.35 43.22 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.455 -1.248 . . . . 61.32 110.96 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.99 158.06 56.36 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 123.828 3.019 . . . . 72.239999999999995 110.506 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -63.22 140.08 58.84 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.614 -0.513 . . . . 65.120000000000005 109.614 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.76 40.23 1.37 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 115.918 1.127 . . . . 74.299999999999997 115.918 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 39.6 p90 -162.19 148.13 13.14 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 123.438 0.695 . . . . 74.540000000000006 109.332 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.609 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 64.6 m-85 -111.05 156.57 21.1 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.666 -1.605 . . . . 72.549999999999997 106.666 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -131.08 160.22 42.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 118.203 0.456 . . . . 63.25 111.478 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' HD21 ' A' ' 231' ' ' LEU . 14.2 ptm180 -138.74 178.3 7.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.16 -0.927 . . . . 74.140000000000001 109.731 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -104.33 141.5 36.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.589 -1.264 . . . . 74.140000000000001 107.589 173.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.12 -178.1 29.05 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 107.945 -2.062 . . . . 74.349999999999994 107.945 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 m -113.76 123.46 49.91 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 118.381 1.09 . . . . 63.039999999999999 108.156 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -103.12 150.08 23.99 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 109.342 -0.614 . . . . 55.0 109.342 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.4 t -104.11 114.71 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.497 -1.297 . . . . 74.099999999999994 107.497 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 31.5 tpt180 -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.318 -0.623 . . . . 74.329999999999998 109.318 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.12 113.72 30.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.491 -0.559 . . . . 73.519999999999996 109.491 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 52.1 p -113.3 -174.15 2.4 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.999 -1.112 . . . . 54.409999999999997 107.999 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.02 60.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.187 0.518 . . . . 62.119999999999997 109.722 174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -84.23 -25.13 29.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.378 0.609 . . . . 64.430000000000007 109.712 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 145.05 -167.96 27.14 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 110.593 -1.003 . . . . 45.439999999999998 110.593 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.9 pp -100.54 138.3 37.78 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.442 -0.577 . . . . 74.030000000000001 109.442 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.17 146.25 50.04 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.623 -0.431 . . . . 70.099999999999994 110.243 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.75 135.37 38.8 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.319 -1.363 . . . . 53.539999999999999 107.319 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.06 155.48 58.62 Favored Pre-proline 0 C--N 1.286 -2.154 0 C-N-CA 120.393 -0.523 . . . . 71.319999999999993 110.28 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.73 125.61 15.8 Favored 'Trans proline' 0 N--CA 1.441 -1.616 0 N-CA-C 107.256 -1.863 . . . . 73.239999999999995 107.256 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.92 147.41 17.63 Favored Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 109.871 -1.292 . . . . 70.010000000000005 109.871 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.9 mm -99.82 115.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 N-CA-C 106.54 -1.652 . . . . 63.43 106.54 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 29.3 m-85 -110.87 155.3 22.81 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 108.985 -0.746 . . . . 71.400000000000006 108.985 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.53 131.95 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.651 -1.611 . . . . 72.340000000000003 106.651 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 45.9 p -94.24 -40.49 9.97 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.258 -0.577 . . . . 65.409999999999997 111.267 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -162.71 154.44 18.13 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.102 -1.444 . . . . 63.109999999999999 107.102 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 206' ' ' ALA . 59.1 mt -99.09 144.98 27.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.326 -0.55 . . . . 74.519999999999996 109.71 175.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 46.8 t -75.81 121.81 85.8 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.753 -1.203 . . . . 71.430000000000007 107.753 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.05 125.16 16.88 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.805 1.67 . . . . 74.230000000000004 109.326 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.72 9.23 85.84 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.396 -0.907 . . . . 73.329999999999998 111.066 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.42 160.83 27.09 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.3 -1.12 . . . . 75.030000000000001 110.3 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.547 HD11 ' OG ' ' A' ' 146' ' ' SER . 33.2 tp -58.38 -40.83 83.4 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.236 1.198 . . . . 74.239999999999995 114.236 -173.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 200' ' ' LEU . . . -73.09 -31.45 64.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 121.802 -0.561 . . . . 72.109999999999999 110.426 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.82 -49.09 32.54 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.969 -1.123 . . . . 52.350000000000001 107.969 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 t -56.71 -45.38 81.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.262 1.025 . . . . 44.140000000000001 111.53 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.477 ' HB ' HD13 ' A' ' 211' ' ' LEU . 36.3 p -76.49 -36.03 58.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.327 -0.549 . . . . 70.430000000000007 111.393 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 72.98 13.69 79.06 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.693 -0.963 . . . . 61.109999999999999 110.693 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 209' ' ' THR . 5.6 mp -84.49 -19.26 33.58 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.506 0.722 . . . . 70.25 112.764 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.576 HD22 ' CG2' ' A' ' 249' ' ' VAL . 49.4 mt -124.1 138.97 54.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.321 -1.363 . . . . 64.209999999999994 107.321 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.29 160.97 15.21 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.014 0.435 . . . . 73.209999999999994 111.023 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.5 m -60.4 -30.36 46.23 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.506 0 N-CA-C 113.802 1.038 . . . . 65.030000000000001 113.802 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -77.8 -25.03 48.65 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.718 -0.393 . . . . 63.43 110.958 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 41.8 m-20 -63.8 145.21 56.2 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.084 -0.962 . . . . 55.109999999999999 111.882 -171.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.466 ' CD ' ' HE3' ' A' ' 250' ' ' LYS . 12.8 pt-20 -113.23 148.91 34.57 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.233 -0.44 . . . . 74.230000000000004 110.405 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 249' ' ' VAL . 23.1 m -81.72 130.04 36.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.461 0.648 . . . . 51.350000000000001 110.94 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.44 -41.47 10.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.415 -0.811 . . . . 73.019999999999996 109.463 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 248' ' ' THR . 46.2 mt-10 -142.98 150.0 39.09 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 111.39 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.45 103.44 8.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.85 -1.068 . . . . 63.009999999999998 108.954 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 47.6 t30 72.23 11.41 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.891 2.076 . . . . 63.310000000000002 110.141 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 106.02 -7.47 41.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.481 -1.047 . . . . 71.409999999999997 110.481 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mm -75.64 129.43 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.444 -1.317 . . . . 73.239999999999995 107.444 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 227' ' ' ALA . 43.9 mt-10 -71.82 2.49 5.37 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.936 1.087 . . . . 75.299999999999997 113.936 -172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . 0.296 32.6 m 59.13 -11.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 125.896 1.678 . . . . 74.319999999999993 114.996 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 225' ' ' GLU . . . -66.76 123.91 21.45 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.932 0.396 . . . . 63.130000000000003 110.433 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.97 -16.07 50.89 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.852 -0.613 . . . . 63.340000000000003 111.673 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.37 154.98 17.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.617 0.722 . . . . 32.310000000000002 112.0 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.2 p -101.13 175.74 5.49 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.17 -1.419 . . . . 74.430000000000007 107.17 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 177' ' ' ARG . 9.7 mp -59.98 -36.49 77.27 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.89 -0.724 . . . . 53.210000000000001 109.998 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -56.53 -49.72 73.94 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 123.616 0.573 . . . . 71.25 110.551 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -72.59 -38.11 67.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.818 -0.628 . . . . 61.020000000000003 112.268 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 230' ' ' THR . 34.1 t -69.78 -45.87 76.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 119.914 -0.715 . . . . 52.420000000000002 110.431 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 239' ' ' VAL . 30.1 p -56.61 -47.03 80.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.781 -0.367 . . . . 72.310000000000002 110.404 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.41 -48.91 75.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 62.0 111.28 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -61.65 -41.46 97.56 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.739 0.781 . . . . 72.120000000000005 109.235 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.497 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.8 mtm -68.96 -44.64 72.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.464 -0.789 . . . . 72.219999999999999 113.013 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 235' ' ' THR . 88.2 t -66.24 -32.4 57.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.683 -0.488 . . . . 75.319999999999993 109.683 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.37 -41.51 80.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.839 0.828 . . . . 73.200000000000003 109.746 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.402 ' HB2' HD13 ' A' ' 245' ' ' LEU . 41.6 m-80 -104.72 26.57 8.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.97 -1.014 . . . . 54.130000000000003 111.767 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 85.4 p -65.85 -15.91 63.34 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 70.040000000000006 112.583 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 24.6 t -81.06 -28.39 35.33 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.792 -0.447 . . . . 74.140000000000001 109.792 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -159.2 97.94 1.4 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.815 0.817 . . . . 73.430000000000007 111.609 178.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 241' ' ' ASN . 63.6 tp -128.29 134.34 48.91 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 110.885 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 149' ' ' ILE . 73.8 mt -97.04 114.5 34.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.178 -1.415 . . . . 73.140000000000001 107.178 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 67.2 mt -112.66 119.79 61.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.188 -0.605 . . . . 73.239999999999995 110.695 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.5 m -106.2 116.97 32.85 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.036 -1.098 . . . . 74.150000000000006 108.036 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 218' ' ' VAL . 23.7 m -118.99 165.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.688 -1.227 . . . . 60.049999999999997 107.688 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HE3' ' CD ' ' A' ' 217' ' ' GLU . 0.0 OUTLIER -121.9 121.79 27.96 Favored Pre-proline 0 C--N 1.284 -2.262 0 C-N-CA 119.084 -1.046 . . . . 74.510000000000005 109.363 171.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 14.6 Cg_endo -58.28 133.84 57.72 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 122.044 1.829 . . . . 73.329999999999998 111.427 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.81 -6.88 57.92 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.214 -0.903 . . . . 72.329999999999998 110.352 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 59.91 33.66 21.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.358 1.075 . . . . 70.349999999999994 108.637 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.38 89.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.9 -1.5 . . . . 73.230000000000004 112.518 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.105 1.762 . . . . 74.209999999999994 110.112 176.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 111.208 -0.757 . . . . 75.430000000000007 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.1 m -73.43 130.81 40.92 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.751 0.421 . . . . 61.0 109.942 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 11.6 mptt -80.96 78.25 7.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.059 0.933 . . . . 74.049999999999997 111.358 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.7 m -162.02 -62.97 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.72 -1.585 . . . . 62.149999999999999 106.72 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 56.79 86.33 0.07 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.537 1.135 . . . . 62.520000000000003 113.373 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 118.47 60.07 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 115.462 -0.79 . . . . 71.129999999999995 109.726 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.8 -179.27 4.07 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.588 2.192 . . . . 73.25 111.134 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.7 m 68.95 108.77 0.05 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.687 0.795 . . . . 74.439999999999998 110.284 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.6 mt -73.55 94.76 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.542 0.687 . . . . 72.019999999999996 110.195 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.6 p -101.35 115.08 29.68 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 115.323 -0.853 . . . . 55.119999999999997 110.456 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -109.26 142.75 26.28 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 109.094 -0.706 . . . . 61.420000000000002 109.094 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.01 117.22 4.05 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.825 2.35 . . . . 65.209999999999994 112.796 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -100.9 73.95 1.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.705 -1.22 . . . . 74.319999999999993 107.705 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 28.9 t70 -135.42 -168.4 2.19 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.501 -1.296 . . . . 63.450000000000003 107.501 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.455 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 85.0 t80 -83.16 -34.81 25.93 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 119.092 0.86 . . . . 71.019999999999996 109.775 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -121.74 148.98 43.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.984 -0.553 . . . . 64.420000000000002 110.904 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 164' ' ' CYS . 32.4 m -125.04 150.44 46.77 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.014 -1.476 . . . . 50.520000000000003 107.014 176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.81 140.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.522 -0.548 . . . . 45.340000000000003 109.522 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.638 ' HB3' HG21 ' A' ' 209' ' ' THR . 21.6 t -88.45 138.83 31.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.278 0.561 . . . . 72.519999999999996 109.613 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.12 44.66 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.018 -1.105 . . . . 25.449999999999999 108.018 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 35.0 mm -92.63 107.45 19.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.489 -1.671 . . . . 72.329999999999998 106.489 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.64 167.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.139 -0.937 . . . . 63.109999999999999 111.153 -174.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.67 29.29 12.97 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.91 0.756 . . . . 60.119999999999997 111.687 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.35 -28.88 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 113.96 1.096 . . . . 73.109999999999999 113.96 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.198 0.523 . . . . 64.319999999999993 110.526 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.57 -34.46 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.531 -0.759 . . . . 72.400000000000006 109.964 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 160' ' ' ARG . 86.2 t -65.09 123.52 84.22 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 113.005 0.742 . . . . 72.430000000000007 113.005 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.37 156.68 29.12 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.201 2.601 . . . . 72.049999999999997 109.057 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.36 -14.45 18.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.261 0.553 . . . . 64.450000000000003 111.9 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.682 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 23.4 p -91.98 4.36 53.2 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 112.763 0.653 . . . . 64.049999999999997 112.763 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -127.56 157.7 39.47 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.844 -0.535 . . . . 72.140000000000001 110.541 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -140.63 132.01 26.78 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.397 -0.594 . . . . 73.420000000000002 109.397 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 38.0 mtp85 -123.74 123.59 40.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 111.464 -176.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.9 133.31 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.62 120.47 40.1 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.01 -1.108 . . . . 65.450000000000003 108.01 -176.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.61 133.3 36.11 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 110.096 -0.335 . . . . 74.340000000000003 110.096 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . 16.5 t -143.53 129.4 19.44 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.936 -0.764 . . . . 75.519999999999996 108.936 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -138.94 145.14 39.44 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.515 1.126 . . . . 73.439999999999998 111.677 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 141' ' ' ASP . 82.2 m-70 -135.87 160.2 39.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 110.092 -0.336 . . . . 72.540000000000006 110.092 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.81 -68.94 2.17 Favored Glycine 0 CA--C 1.509 -0.338 0 O-C-N 123.585 0.553 . . . . 74.140000000000001 112.262 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 m -117.74 128.33 54.78 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.198 -1.038 . . . . 75.519999999999996 108.198 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -93.97 89.59 6.13 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.557 0.694 . . . . 62.340000000000003 111.768 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.26 135.51 94.95 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 75.109999999999999 107.696 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.52 156.75 13.5 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.16 2.573 . . . . 74.299999999999997 110.391 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.1 mp -59.82 132.66 54.64 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.517 -0.92 . . . . 71.019999999999996 108.517 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -72.84 37.88 0.75 Allowed Glycine 0 N--CA 1.466 0.683 0 N-CA-C 116.36 1.304 . . . . 75.239999999999995 116.36 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.22 152.29 16.63 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.229 0.515 . . . . 60.030000000000001 109.859 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 49.6 m-85 -109.52 155.46 21.34 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.206 -1.776 . . . . 74.430000000000007 106.206 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 235' ' ' THR . 22.3 pt -116.89 158.84 17.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 118.668 0.667 . . . . 70.340000000000003 111.752 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -137.81 169.27 18.07 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.598 -0.728 . . . . 74.310000000000002 109.827 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.4 p-10 -116.74 147.56 41.91 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.779 -0.823 . . . . 74.329999999999998 108.779 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -168.4 -177.17 39.29 Favored Glycine 0 C--N 1.289 -2.031 0 N-CA-C 110.011 -1.236 . . . . 74.329999999999998 110.011 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.1 m -104.28 126.05 51.06 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.136 -1.061 . . . . 52.009999999999998 108.136 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 t -103.2 141.86 35.15 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 109.123 -0.695 . . . . 64.409999999999997 109.123 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 77.5 t -94.11 114.04 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 107.799 -1.186 . . . . 73.230000000000004 107.799 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -108.51 120.08 41.38 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.49 -0.777 . . . . 72.120000000000005 110.004 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.91 126.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.168 -0.678 . . . . 45.43 109.168 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.5 p -128.47 179.0 5.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.673 -0.862 . . . . 70.019999999999996 108.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.65 -17.36 61.16 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.317 0.58 . . . . 63.140000000000001 110.132 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.9 m -87.57 -9.77 53.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.852 -0.613 . . . . 75.319999999999993 110.346 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.79 -152.85 17.65 Favored Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 109.776 -1.329 . . . . 51.350000000000001 109.776 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -100.35 135.25 42.08 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.174 0.987 . . . . 64.430000000000007 111.682 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.99 142.92 49.33 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.915 -1.143 . . . . 73.5 107.915 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -111.86 135.74 52.08 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.5 -0.48 . . . . 73.540000000000006 109.707 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.65 156.25 56.32 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.853 -0.612 . . . . 63.219999999999999 110.537 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.92 106.73 1.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.182 1.921 . . . . 63.229999999999997 110.079 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -105.85 153.61 17.09 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.666 -0.974 . . . . 44.32 110.666 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.6 mm -104.42 117.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.168 -1.419 . . . . 75.030000000000001 107.168 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 88.0 m-85 -113.01 162.03 16.35 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 51.6 mt -75.37 131.67 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.342 -1.355 . . . . 64.430000000000007 107.342 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 37.5 t -81.83 -55.23 4.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.216 -0.594 . . . . 43.5 109.985 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 214' ' ' VAL . 71.5 ttt180 -164.24 154.85 15.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.285 -1.005 . . . . 72.540000000000006 108.285 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -91.99 136.66 32.99 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.728 -0.471 . . . . 71.049999999999997 109.728 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 60.1 t -76.62 125.68 87.0 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.707 -0.849 . . . . 50.539999999999999 108.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.93 123.68 13.41 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.913 1.742 . . . . 70.349999999999994 110.018 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 1.75 89.49 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.307 -0.949 . . . . 52.229999999999997 111.736 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.42 147.91 21.74 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.798 -1.321 . . . . 54.130000000000003 109.798 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 50.1 tp -54.06 -35.65 62.25 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.333 1.235 . . . . 75.450000000000003 114.333 -173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.41 -27.78 59.17 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.259 -0.9 . . . . 70.519999999999996 110.469 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -76.01 -52.15 10.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.6 -1.259 . . . . 73.409999999999997 107.6 176.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.0 m -55.48 -31.87 62.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.287 1.035 . . . . 72.099999999999994 112.694 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.638 HG21 ' HB3' ' A' ' 146' ' ' SER . 20.1 p -77.6 -33.5 53.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.551 0.575 . . . . 62.149999999999999 112.551 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.28 24.56 76.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.297 -1.121 . . . . 33.149999999999999 110.297 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 91.2 mt -92.61 -46.33 7.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.539 0.94 . . . . 71.140000000000001 113.539 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 249' ' ' VAL . 31.8 mt -108.75 152.68 24.51 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.959 -1.096 . . . . 71.120000000000005 110.093 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -126.01 165.3 19.05 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.956 0.502 . . . . 71.409999999999997 110.382 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 199' ' ' ARG . 20.8 m -61.9 -30.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.368 1.247 . . . . 74.129999999999995 114.368 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.57 -24.3 53.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 74.549999999999997 113.191 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 60.9 m-20 -63.87 128.16 34.6 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.357 -0.608 . . . . 62.219999999999999 109.357 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 11.7 pt-20 -97.89 145.38 26.5 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.967 -0.693 . . . . 75.219999999999999 109.439 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 249' ' ' VAL . 26.9 m -77.81 138.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 115.913 -0.585 . . . . 71.200000000000003 110.149 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 250' ' ' LYS . 36.1 mm -101.78 -58.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.527 -0.76 . . . . 71.109999999999999 109.362 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 219' ' ' ILE . 38.3 mt-10 -139.87 144.1 37.05 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 115.234 -0.894 . . . . 65.040000000000006 111.443 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.75 112.84 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 107.861 -1.163 . . . . 74.129999999999995 107.861 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 71.35 -71.47 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.313 1.445 . . . . 74.340000000000003 108.324 -170.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.63 21.62 0.12 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.628 -1.789 . . . . 34.439999999999998 108.628 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.21 110.53 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.467 -1.308 . . . . 73.430000000000007 107.467 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 41.6 tt0 -68.9 131.85 45.78 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.603 -0.517 . . . . 62.509999999999998 109.603 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.427 HG21 HG23 ' A' ' 218' ' ' VAL . 31.1 m -76.29 -11.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.52 -0.764 . . . . 71.450000000000003 112.493 -175.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.487 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -64.99 122.45 17.03 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 116.246 -0.434 . . . . 40.329999999999998 110.024 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.28 -2.88 75.37 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.691 -0.686 . . . . 54.200000000000003 112.819 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -104.93 161.2 14.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 117.061 0.431 . . . . 72.120000000000005 110.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 234' ' ' VAL . 39.1 p -95.69 167.26 11.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.72 -0.474 . . . . 72.219999999999999 109.72 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.9 mp -63.01 -35.03 78.87 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 110.164 -0.31 . . . . 33.200000000000003 110.164 175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.4 -47.06 86.9 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.44 -0.8 . . . . 70.319999999999993 109.891 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 14.7 mm-40 -72.24 -41.89 66.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.566 0.58 . . . . 72.099999999999994 112.566 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 230' ' ' THR . 49.1 t -65.88 -47.05 86.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.963 -0.695 . . . . 72.400000000000006 111.195 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 239' ' ' VAL . 33.1 p -59.33 -48.8 80.25 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.245 -0.582 . . . . 73.219999999999999 110.843 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.94 -36.02 78.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.775 -0.648 . . . . 73.140000000000001 111.733 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -66.13 -47.81 72.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.299 -1.0 . . . . 75.239999999999995 108.299 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 172' ' ' LEU . 75.2 mtm -63.25 -43.81 96.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.616 -0.72 . . . . 63.299999999999997 112.23 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 235' ' ' THR . 55.4 t -68.77 -25.57 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 121.418 0.628 . . . . 75.010000000000005 109.642 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -61.04 -42.32 98.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.497 0.665 . . . . 64.319999999999993 110.21 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.588 ' HB2' HD23 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -103.87 33.55 3.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.193 -0.912 . . . . 72.049999999999997 110.8 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.6 m -47.46 -49.63 25.04 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.587 1.699 . . . . 65.109999999999999 115.587 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -64.3 -20.46 66.1 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 112.951 0.723 . . . . 72.400000000000006 112.951 -172.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -154.72 94.42 1.67 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.822 0.82 . . . . 65.239999999999995 109.326 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 241' ' ' ASN . 3.4 tm? -130.63 134.65 47.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.265 -0.88 . . . . 70.230000000000004 109.3 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.87 126.07 64.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.415 -0.587 . . . . 72.329999999999998 109.415 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 mp -107.19 119.64 57.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.886 -0.783 . . . . 50.43 108.886 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 58.4 m -106.66 117.14 33.27 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.332 -0.988 . . . . 74.439999999999998 108.332 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HD22 ' A' ' 212' ' ' LEU . 31.7 m -120.65 168.44 13.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.979 -0.378 . . . . 64.040000000000006 109.979 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -129.02 136.54 29.35 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.325 -0.62 . . . . 74.540000000000006 109.325 172.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.1 Cg_endo -60.75 134.8 56.03 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.231 1.954 . . . . 74.230000000000004 110.855 176.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.84 59.62 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.979 -0.555 . . . . 64.439999999999998 110.233 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 54.5 t30 66.63 -177.06 0.2 Allowed 'General case' 0 C--O 1.246 0.905 0 O-C-N 124.275 0.984 . . . . 62.299999999999997 108.73 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 254' ' ' GLN . 12.7 mm-40 -80.91 88.8 5.86 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.739 -0.837 . . . . 61.310000000000002 108.739 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.213 -1.403 . . . . 73.450000000000003 107.213 -178.472 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.424 0 N-CA-C 110.097 -1.201 . . . . 73.430000000000007 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.7 m -79.22 81.85 5.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 120.536 0.207 . . . . 72.409999999999997 111.365 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -175.78 92.97 0.06 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 123.423 0.689 . . . . 73.319999999999993 109.766 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -74.11 107.03 6.06 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.215 -0.448 . . . . 75.299999999999997 110.759 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -114.38 145.93 41.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.092 0.472 . . . . 74.439999999999998 111.909 -177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.64 108.43 58.11 Favored Pre-proline 0 N--CA 1.422 -1.827 0 N-CA-C 105.538 -2.023 . . . . 54.450000000000003 105.538 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.98 -5.96 18.14 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.426 2.084 . . . . 53.119999999999997 112.881 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.8 m 57.35 75.35 0.37 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.014 0.912 . . . . 73.519999999999996 109.923 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.2 mt -91.49 104.34 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.82 -1.082 . . . . 73.200000000000003 109.554 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 p -70.65 102.04 2.19 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 52.43 110.215 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.5 pt -94.38 137.99 22.55 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 115.976 -0.556 . . . . 64.040000000000006 109.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.65 137.67 65.3 Favored 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 122.538 2.159 . . . . 73.099999999999994 111.671 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -82.65 88.26 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.503 -0.925 . . . . 72.120000000000005 108.503 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 143' ' ' ARG . 13.6 t70 -159.09 -179.25 7.85 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.294 -1.743 . . . . 70.030000000000001 106.294 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -91.13 -29.68 17.15 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.172 -0.677 . . . . 75.430000000000007 109.172 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 141' ' ' ASP . 39.5 ptt180 -75.8 149.12 37.99 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.311 0.577 . . . . 75.030000000000001 111.534 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 164' ' ' CYS . 34.8 m -129.84 151.23 50.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.725 0.774 . . . . 64.140000000000001 112.949 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.23 139.23 51.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.439 -1.689 . . . . 53.219999999999999 106.439 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.0 p -75.35 133.35 41.25 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.045 0.45 . . . . 70.5 110.263 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.06 132.37 54.87 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.149 -0.478 . . . . 52.420000000000002 110.769 -174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.74 101.46 12.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.748 -1.575 . . . . 74.439999999999998 106.748 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 246' ' ' ILE . 29.7 pt -99.46 165.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.024 -0.989 . . . . 54.130000000000003 112.177 -170.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.45 ' HB2' ' HD2' ' A' ' 160' ' ' ARG . 24.9 m-20 57.92 23.43 9.8 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 124.554 1.159 . . . . 70.540000000000006 111.177 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.24 -36.26 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.343 0.497 . . . . 71.099999999999994 112.343 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.2 -36.32 30.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.239 0.542 . . . . 50.409999999999997 112.093 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.03 -42.97 32.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.639 0.733 . . . . 65.209999999999994 110.332 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 158' ' ' HIS . 38.4 t -81.85 130.52 60.47 Favored Pre-proline 0 C--N 1.294 -1.807 0 CA-C-N 114.596 -1.184 . . . . 64.040000000000006 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 155.16 64.66 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.995 1.796 . . . . 75.430000000000007 110.296 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -53.76 -19.47 4.29 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.128 0.971 . . . . 73.430000000000007 113.26 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.563 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 7.9 p -76.07 -12.85 60.19 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.946 0.721 . . . . 61.299999999999997 112.946 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.516 ' HB2' HG13 ' A' ' 154' ' ' VAL . 17.8 m170 -117.64 155.16 30.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.165 -0.68 . . . . 73.099999999999994 109.165 171.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HD2' HD12 ' A' ' 211' ' ' LEU . 6.2 tpp180 -135.08 129.72 34.42 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.6 -0.889 . . . . 74.310000000000002 108.6 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 95.6 mtt180 -113.79 121.11 43.05 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.764 0.316 . . . . 73.510000000000005 110.647 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 211' ' ' LEU . 1.9 t -117.77 128.23 74.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 106.685 -1.598 . . . . 61.420000000000002 106.685 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -100.49 135.75 41.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.097 -0.334 . . . . 73.109999999999999 110.097 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.9 140.06 30.17 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.976 -1.12 . . . . 72.049999999999997 107.976 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 39.4 t -116.14 133.68 55.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.766 -1.568 . . . . 63.119999999999997 106.766 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 165' ' ' LYS . 2.5 ttmp? -136.01 125.79 25.62 Favored 'General case' 0 N--CA 1.418 -2.04 0 C-N-CA 120.754 -0.378 . . . . 64.319999999999993 111.412 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -134.66 99.15 4.25 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.317 -0.402 . . . . 75.219999999999999 110.626 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.26 -52.96 4.73 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.912 -0.586 . . . . 52.130000000000003 114.167 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.3 t -86.31 103.86 15.29 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.117 0.484 . . . . 72.049999999999997 111.386 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.75 85.68 3.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 122.086 0.946 . . . . 34.5 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -103.08 160.17 27.02 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 114.647 -1.161 . . . . 74.540000000000006 109.465 174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.45 156.49 13.96 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 123.556 2.838 . . . . 74.420000000000002 113.115 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 238' ' ' MET . 3.8 mp -63.91 161.59 15.35 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.334 -0.617 . . . . 71.420000000000002 109.334 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.66 20.93 12.26 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.721 -1.228 . . . . 44.210000000000001 115.262 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.422 ' HB3' ' HG ' ' A' ' 200' ' ' LEU . 5.4 p90 -160.84 164.53 31.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.975 0.887 . . . . 72.340000000000003 112.118 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -119.41 163.52 17.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.681 -1.229 . . . . 74.140000000000001 107.681 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.2 pt -119.76 158.4 21.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.193 0.52 . . . . 74.530000000000001 111.885 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.77 169.15 18.22 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 108.983 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -108.69 154.83 21.46 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.28 -0.637 . . . . 74.030000000000001 109.28 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.3 19.91 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 111.056 -0.817 . . . . 43.020000000000003 111.056 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.1 p -120.17 135.2 55.05 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 55.350000000000001 112.095 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.8 t -118.92 151.22 38.54 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.839 -1.171 . . . . 42.439999999999998 107.839 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.7 136.82 33.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.463 0.649 . . . . 73.209999999999994 111.354 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 190' ' ' GLU . 26.3 mmt180 -115.39 139.46 49.99 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 124.785 1.234 . . . . 65.019999999999996 112.425 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 63.8 t -96.67 118.64 43.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.152 -1.055 . . . . 61.119999999999997 108.152 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 60.9 p -133.71 -174.94 3.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.963 -0.384 . . . . 71.439999999999998 109.963 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.74 62.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.927 0.491 . . . . 72.450000000000003 110.704 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -89.99 -14.88 33.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.154 0.502 . . . . 74.099999999999994 109.786 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.22 -122.12 5.21 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.875 -0.89 . . . . 62.210000000000001 110.875 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 79.1 mt -100.13 122.91 43.72 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.909 0.862 . . . . 74.510000000000005 112.116 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 183' ' ' ARG . 9.9 mm-40 -107.08 147.24 30.24 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.2 -1.364 . . . . 74.129999999999995 110.392 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -109.68 133.47 53.09 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.706 -0.85 . . . . 72.140000000000001 108.706 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -130.76 151.64 79.15 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.741 -0.466 . . . . 72.239999999999995 109.741 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.58 115.17 3.23 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.873 1.715 . . . . 70.439999999999998 108.449 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -111.32 143.81 17.33 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.137 -1.03 . . . . 73.329999999999998 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.7 mm -102.21 117.52 47.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 106.716 -1.587 . . . . 61.409999999999997 106.716 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 78.5 m-85 -113.5 166.13 11.81 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.588 -0.523 . . . . 74.540000000000006 109.588 -175.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.7 mt -73.83 132.02 34.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.258 -1.015 . . . . 74.409999999999997 108.258 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.4 t -86.21 -53.23 5.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.753 -0.592 . . . . 74.040000000000006 110.505 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -165.22 153.08 11.29 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.235 -1.394 . . . . 65.109999999999999 107.235 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 174' ' ' PHE . 6.5 mp -97.32 145.13 26.41 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.128 -0.629 . . . . 75.200000000000003 111.936 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.12 124.65 87.25 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.696 -1.138 . . . . 70.439999999999998 108.646 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.23 124.42 13.86 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 121.86 1.707 . . . . 73.549999999999997 109.476 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.39 0.23 84.84 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.204 -0.998 . . . . 54.119999999999997 111.078 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.71 153.69 40.76 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.602 -0.999 . . . . 72.209999999999994 110.602 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 209' ' ' THR . 6.9 tt -56.49 -38.98 72.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.872 0.693 . . . . 73.0 112.872 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.63 64.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 O-C-N 121.998 -0.439 . . . . 73.430000000000007 110.077 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.67 -34.54 67.28 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.577 -0.897 . . . . 70.319999999999993 108.577 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.4 m -61.62 -49.0 78.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.952 -0.567 . . . . 61.310000000000002 110.473 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 211' ' ' LEU . 3.4 t -79.4 -23.87 42.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 120.788 -0.365 . . . . 64.129999999999995 111.765 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.01 32.43 66.7 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.849 0.7 . . . . 42.140000000000001 114.849 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.693 HD11 HG22 ' A' ' 161' ' ' VAL . 1.8 pt? -88.96 -18.88 26.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.534 0.568 . . . . 55.140000000000001 112.534 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 249' ' ' VAL . 59.1 mt -118.98 151.56 37.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.595 -0.442 . . . . 52.420000000000002 110.44 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -124.07 165.02 18.22 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.59 -0.522 . . . . 70.450000000000003 109.59 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -30.54 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.902 0.881 . . . . 70.349999999999994 112.228 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -73.42 -24.8 60.31 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.572 0.582 . . . . 74.120000000000005 112.572 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 143.18 58.04 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.203 0.525 . . . . 45.149999999999999 110.835 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 13.4 pt-20 -111.57 141.38 45.22 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.819 -0.628 . . . . 74.430000000000007 109.723 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 249' ' ' VAL . 35.9 m -83.36 136.81 22.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.095 0.474 . . . . 71.109999999999999 110.769 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.535 HG22 ' HG3' ' A' ' 220' ' ' GLU . 34.2 mm -102.9 -57.89 4.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.759 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.0 mt-10 -145.86 147.38 31.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.21 0.529 . . . . 73.340000000000003 111.272 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.1 m -120.35 100.73 9.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.157 -0.929 . . . . 74.349999999999994 108.711 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.588 ' OD1' HD12 ' A' ' 245' ' ' LEU . 16.0 m120 68.15 6.16 5.08 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 124.589 1.156 . . . . 72.25 112.807 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.58 23.13 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.463 -1.055 . . . . 74.319999999999993 110.463 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.43 108.5 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.551 -1.277 . . . . 73.310000000000002 107.551 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 43.5 mt-10 -68.96 138.97 55.01 Favored 'General case' 0 CA--C 1.476 -1.872 0 C-N-CA 120.536 -0.465 . . . . 75.200000000000003 110.256 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.18 -8.06 11.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.281 -0.872 . . . . 71.340000000000003 110.549 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -66.89 123.47 20.28 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.464 -0.789 . . . . 75.409999999999997 110.815 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.33 -7.22 82.27 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.867 -0.606 . . . . 73.209999999999994 112.697 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -97.09 161.14 13.96 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 116.964 0.382 . . . . 74.439999999999998 110.568 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 234' ' ' VAL . 15.2 p -94.84 167.85 11.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 110.105 -0.332 . . . . 74.420000000000002 110.105 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.36 -31.56 72.75 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 110.009 -0.367 . . . . 61.210000000000001 110.009 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.41 -50.99 71.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.329 -0.85 . . . . 75.510000000000005 108.745 176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -65.82 -47.67 74.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.091 -0.958 . . . . 72.329999999999998 112.326 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 230' ' ' THR . 44.6 t -64.45 -45.49 95.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.284 -0.566 . . . . 72.230000000000004 111.721 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.1 p -60.87 -46.36 90.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.047 -0.661 . . . . 64.129999999999995 110.775 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.39 -41.3 84.56 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.07 -0.513 . . . . 73.120000000000005 111.387 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.74 -47.47 80.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.045 -0.724 . . . . 72.329999999999998 109.045 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.587 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.0 mtm -66.13 -36.37 82.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.129 0.788 . . . . 54.130000000000003 113.129 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 235' ' ' THR . 58.7 t -72.32 -33.85 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.141 -0.688 . . . . 71.219999999999999 109.141 176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.88 76.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.627 0.727 . . . . 75.299999999999997 110.265 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 5.5 m-20 -102.99 27.71 6.87 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.593 -1.185 . . . . 62.340000000000003 111.509 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 86.2 p -59.16 -25.31 63.81 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 112.759 0.652 . . . . 74.109999999999999 112.759 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 23.5 t -74.61 -51.75 13.65 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.168 -0.679 . . . . 53.549999999999997 109.168 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.02 97.82 3.72 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.077 0.941 . . . . 75.439999999999998 111.195 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.588 HD12 ' OD1' ' A' ' 222' ' ' ASN . 66.1 tp -124.83 130.77 53.03 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.771 -1.104 . . . . 53.100000000000001 110.138 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 149' ' ' ILE . 71.5 mt -106.38 115.97 49.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.067 -1.457 . . . . 64.420000000000002 107.067 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 61.6 mt -106.16 118.8 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.062 -0.718 . . . . 43.409999999999997 109.062 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.9 m -110.99 117.32 33.01 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.813 -0.81 . . . . 74.230000000000004 108.813 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.559 HG12 HG12 ' A' ' 218' ' ' VAL . 16.8 m -128.62 173.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 109.054 -0.721 . . . . 54.009999999999998 109.054 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 11.5 ptmm? -136.63 134.56 19.61 Favored Pre-proline 0 C--N 1.289 -2.057 0 N-CA-C 108.39 -0.966 . . . . 73.140000000000001 108.39 172.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 157' ' ' THR . 25.4 Cg_endo -64.87 146.98 89.13 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.425 1.416 . . . . 75.209999999999994 110.783 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -94.15 -15.67 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.684 -1.228 . . . . 61.25 107.684 174.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.1 t30 65.41 97.8 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.792 -1.549 . . . . 72.239999999999995 112.169 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 254' ' ' GLN . 6.4 tp60 -92.11 91.26 7.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.42 -0.955 . . . . 71.310000000000002 108.42 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 . . . . . 0 C--O 1.241 0.616 0 C-N-CA 124.092 0.957 . . . . 73.230000000000004 110.99 -179.236 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.531 0 N-CA-C 111.327 -0.709 . . . . 62.25 111.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 m -71.44 105.85 3.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.131 0.491 . . . . 73.329999999999998 110.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -69.5 146.88 51.54 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 115.331 -0.849 . . . . 74.140000000000001 109.168 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 m -77.6 92.37 4.08 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.411 0.624 . . . . 65.439999999999998 110.191 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -134.88 123.0 22.77 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.828 -1.545 . . . . 72.099999999999994 106.828 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.4 112.66 57.48 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.396 -0.594 . . . . 62.119999999999997 109.396 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.445 ' HG3' ' ND2' ' A' ' 244' ' ' ASN . 71.0 Cg_exo -47.23 130.48 17.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 35.119999999999997 111.882 176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.3 m -94.17 24.87 4.08 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.27 0.557 . . . . 73.230000000000004 110.733 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.79 -42.8 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.314 -0.857 . . . . 74.430000000000007 110.057 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.6 m 58.86 81.57 0.16 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.777 1.028 . . . . 64.140000000000001 113.777 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.6 pp -114.98 142.95 29.23 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 115.13 -0.941 . . . . 75.120000000000005 110.588 175.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 13.9 Cg_exo -70.2 -55.8 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.629 1.553 . . . . 73.109999999999999 109.596 175.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -138.99 -58.43 0.6 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.249 -1.389 . . . . 70.239999999999995 107.249 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.2 t70 69.8 158.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.435 1.494 . . . . 63.409999999999997 112.519 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -142.52 -50.03 0.36 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.945 0.402 . . . . 62.399999999999999 110.109 -175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -83.74 138.83 33.09 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.546 -0.752 . . . . 62.200000000000003 110.355 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 66.7 m -108.76 140.68 41.84 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 64.099999999999994 112.181 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.37 128.88 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 114.225 -1.352 . . . . 44.439999999999998 109.295 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -98.58 132.63 43.84 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.507 -1.294 . . . . 41.5 107.507 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.16 155.48 42.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.808 -0.357 . . . . 72.219999999999999 111.569 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 46.2 mm -95.54 111.85 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.986 -1.857 . . . . 73.340000000000003 105.986 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -99.71 158.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 120.87 -0.332 . . . . 62.109999999999999 111.049 -176.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.84 29.29 8.45 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.073 0.858 . . . . 64.420000000000002 110.908 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.92 -29.67 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.2 1.185 . . . . 73.299999999999997 114.2 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.69 -32.3 52.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 73.299999999999997 111.176 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.6 mm -91.19 -43.1 14.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.904 -0.589 . . . . 71.230000000000004 110.789 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.9 t -71.91 121.36 84.36 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 75.420000000000002 112.823 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.95 156.35 47.81 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.896 2.397 . . . . 62.210000000000001 109.311 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.86 -11.7 14.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.011 0.434 . . . . 44.43 111.947 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 19.6 p -72.87 -13.83 61.36 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.916 -0.584 . . . . 73.239999999999995 111.225 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.98 161.14 28.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.267 0.556 . . . . 73.329999999999998 110.378 171.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.546 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 0.5 OUTLIER -135.4 132.01 36.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.459 -1.311 . . . . 70.409999999999997 107.459 177.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.6 mtt180 -120.4 124.28 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 111.785 0.291 . . . . 74.319999999999993 111.785 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.56 137.33 51.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.238 -0.653 . . . . 74.219999999999999 109.238 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 244' ' ' ASN . 1.1 tmm_? -100.84 120.05 39.56 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.631 -1.618 . . . . 73.510000000000005 106.631 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.7 tt -93.43 136.24 33.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.404 -0.591 . . . . 75.439999999999998 109.404 -174.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.412 ' N ' HD23 ' A' ' 163' ' ' LEU . 41.6 t -116.88 150.2 38.83 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.824 -0.626 . . . . 73.319999999999993 111.139 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -132.45 120.24 21.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.681 -0.488 . . . . 53.340000000000003 109.681 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -147.45 114.79 6.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.316 0.646 . . . . 70.400000000000006 109.828 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.17 -66.59 2.87 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 115.798 -0.637 . . . . 64.329999999999998 112.224 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.1 m -70.57 102.7 2.31 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 123.657 0.783 . . . . 62.229999999999997 111.104 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -103.28 87.44 2.88 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.439 -0.949 . . . . 63.229999999999997 108.439 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 9.6 mmpt? -123.33 169.01 10.89 Favored Pre-proline 0 C--N 1.289 -2.045 0 N-CA-C 107.699 -1.222 . . . . 62.149999999999999 107.699 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 9.6 Cg_endo -55.23 156.06 17.86 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.368 2.045 . . . . 61.32 110.0 171.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.0 mp -61.81 146.6 49.08 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.647 -0.872 . . . . 75.200000000000003 108.647 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.633 ' HA2' ' CG2' ' A' ' 201' ' ' VAL . . . -78.5 42.64 2.22 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 116.703 1.441 . . . . 71.219999999999999 116.703 -172.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 38.6 p90 -162.49 147.11 12.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.76 0.824 . . . . 75.099999999999994 109.546 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 201' ' ' VAL . 84.2 m-85 -106.67 150.12 26.56 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.463 -1.31 . . . . 74.450000000000003 107.463 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.57 152.15 18.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.173 0.511 . . . . 64.430000000000007 110.768 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 15.6 ptm180 -130.6 178.09 6.88 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.076 -0.965 . . . . 65.420000000000002 109.347 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.45 162.42 15.1 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.117 -1.438 . . . . 74.510000000000005 107.117 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.29 20.36 Favored Glycine 0 N--CA 1.415 -2.701 0 N-CA-C 109.36 -1.496 . . . . 65.219999999999999 109.36 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.469 HG21 ' HE2' ' A' ' 191' ' ' LYS . 20.4 m -92.85 131.81 37.55 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 108.755 -0.832 . . . . 54.229999999999997 108.755 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.5 t -103.39 139.08 39.26 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.301 -1.0 . . . . 65.109999999999999 108.301 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.81 114.82 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.805 -1.183 . . . . 73.329999999999998 107.805 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -112.3 138.2 49.35 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.288 -0.869 . . . . 53.119999999999997 109.934 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.28 113.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 108.428 -0.952 . . . . 72.120000000000005 108.428 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.8 p -110.9 -179.91 3.87 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.784 -0.644 . . . . 61.130000000000003 109.404 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.57 64.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 74.319999999999993 110.941 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.8 m -80.65 -24.26 39.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.23 -0.441 . . . . 63.439999999999998 110.159 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 139.84 -165.31 25.93 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.455 -0.658 . . . . 33.100000000000001 111.455 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.3 133.33 35.41 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.231 -0.655 . . . . 73.239999999999995 109.231 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.26 146.77 42.92 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 116.392 -0.367 . . . . 73.409999999999997 111.837 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.469 ' HE2' HG21 ' A' ' 180' ' ' THR . 57.7 mtpt -95.33 135.47 36.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.114 -1.069 . . . . 71.219999999999999 108.114 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.68 151.58 60.58 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 116.74 -0.209 . . . . 74.219999999999999 110.99 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -68.06 114.32 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.314 2.009 . . . . 54.310000000000002 110.816 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.45 166.45 12.9 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.15 -1.024 . . . . 71.219999999999999 112.196 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -120.86 118.62 56.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.354 -1.721 . . . . 74.409999999999997 106.354 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -115.84 162.05 17.88 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.839 -0.43 . . . . 71.019999999999996 109.839 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 69.3 mt -73.94 132.9 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.284 -1.376 . . . . 71.150000000000006 107.284 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 19.5 t -97.23 -39.56 9.2 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.071 -0.652 . . . . 62.240000000000002 109.808 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 200' ' ' LEU . 73.0 ttt180 -165.63 155.4 12.6 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.825 -0.806 . . . . 73.219999999999999 108.825 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 199' ' ' ARG . 3.4 mm? -91.87 143.95 25.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.151 -1.426 . . . . 70.409999999999997 107.151 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.633 ' CG2' ' HA2' ' A' ' 173' ' ' GLY . 10.4 m -74.25 140.81 76.67 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 119.164 -1.014 . . . . 65.030000000000001 108.791 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.38 124.18 13.8 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 74.400000000000006 110.638 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.44 19.26 77.55 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.519 -0.764 . . . . 74.109999999999999 112.623 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.511 ' HA3' ' CG2' ' A' ' 201' ' ' VAL . . . -92.14 169.39 32.0 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.708 -0.758 . . . . 44.409999999999997 112.089 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.7 tp -52.9 -50.2 64.39 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.681 0.623 . . . . 72.140000000000001 112.681 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 200' ' ' LEU . . . -70.76 -31.82 68.75 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 111.835 0.309 . . . . 64.439999999999998 111.835 -174.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 40.2 tt0 -74.89 -41.28 60.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.35 0.595 . . . . 75.530000000000001 109.591 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.0 t -67.59 -25.36 65.74 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.171 -0.922 . . . . 62.109999999999999 111.769 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 15.0 t -99.06 -28.57 13.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 119.432 -0.907 . . . . 71.219999999999999 110.847 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.13 36.15 93.06 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.44 -0.41 . . . . 72.430000000000007 112.581 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 90.4 mt -88.96 -18.55 27.2 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.641 -0.329 . . . . 74.120000000000005 111.229 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 249' ' ' VAL . 65.0 mt -129.36 156.89 43.33 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.868 -0.79 . . . . 64.549999999999997 108.868 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.19 164.24 14.78 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.29 0.369 . . . . 71.430000000000007 110.11 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 99.6 t -57.47 -41.46 78.8 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 N-CA-C 112.691 0.626 . . . . 60.140000000000001 112.691 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.27 -21.49 62.96 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 114.565 1.32 . . . . 74.239999999999995 114.565 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 70.0 m-20 -61.7 144.62 54.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.998 0.904 . . . . 75.329999999999998 112.521 -172.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.62 138.24 39.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.674 -1.148 . . . . 73.120000000000005 109.336 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 249' ' ' VAL . 33.3 m -86.73 132.99 30.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 120.578 -0.449 . . . . 70.010000000000005 110.507 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.02 -43.66 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.302 -0.408 . . . . 70.099999999999994 110.849 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 224' ' ' ILE . 49.4 mt-10 -139.66 144.57 37.69 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.228 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 224' ' ' ILE . 29.5 m -123.86 99.88 7.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.592 -1.185 . . . . 41.229999999999997 108.229 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.449 ' HB2' HD12 ' A' ' 245' ' ' LEU . 8.1 t30 74.32 -52.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.724 2.01 . . . . 74.400000000000006 110.976 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -173.34 11.6 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.619 -0.992 . . . . 71.310000000000002 110.619 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 22.8 mm -93.63 132.11 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 106.918 -1.512 . . . . 72.400000000000006 106.918 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.39 -3.31 42.56 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.516 0.561 . . . . 73.129999999999995 112.516 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.491 ' H ' HG22 ' A' ' 224' ' ' ILE 0.25 21.0 m 57.0 -2.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 126.429 1.892 . . . . 72.049999999999997 114.438 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.2 123.27 29.93 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.656 -0.868 . . . . 70.140000000000001 108.656 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.38 74.4 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.047 -0.821 . . . . 54.32 111.047 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.4 mmmt -98.46 146.43 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.329 -0.989 . . . . 54.049999999999997 108.329 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 234' ' ' VAL . 23.9 p -90.73 164.9 13.95 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.341 -0.614 . . . . 72.049999999999997 109.341 176.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.66 -38.28 81.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.9 0.381 . . . . 74.430000000000007 110.674 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.19 -43.07 96.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.186 -0.915 . . . . 75.420000000000002 109.75 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -75.53 -37.7 59.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.693 0.997 . . . . 62.409999999999997 113.693 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 230' ' ' THR . 41.3 t -69.5 -45.36 78.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 119.806 -0.758 . . . . 72.239999999999995 110.247 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.3 p -58.06 -50.28 74.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.405 -0.518 . . . . 72.010000000000005 111.186 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.52 -39.33 87.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.202 -0.454 . . . . 63.549999999999997 110.922 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.457 ' HG3' HG13 ' A' ' 224' ' ' ILE . 2.4 tmm? -63.52 -47.09 83.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.261 -1.015 . . . . 75.040000000000006 108.261 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.534 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.7 mtm -63.21 -37.6 87.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.739 -0.664 . . . . 71.129999999999995 112.74 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 57.4 t -70.48 -26.49 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-O 121.627 0.727 . . . . 74.109999999999999 109.576 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.42 83.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.527 . . . . 74.219999999999999 110.468 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.43 24.58 10.81 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 109.941 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.9 p -64.35 -18.67 64.86 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.374 1.25 . . . . 72.420000000000002 114.374 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 p -80.29 -21.82 42.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.418 0.628 . . . . 72.120000000000005 111.068 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 162' ' ' ARG . 48.4 t30 -159.54 97.5 1.33 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.176 -1.046 . . . . 63.119999999999997 108.176 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 241' ' ' ASN . 53.0 tp -123.91 134.2 53.58 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.318 0.58 . . . . 64.230000000000004 110.897 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.21 115.38 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.705 -1.591 . . . . 73.140000000000001 106.705 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 52.1 mt -111.54 119.92 60.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 120.087 -0.645 . . . . 64.329999999999998 111.191 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 220' ' ' GLU . 27.2 m -103.09 118.25 36.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.04 -1.096 . . . . 73.030000000000001 108.04 177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.542 HG21 HD22 ' A' ' 212' ' ' LEU . 21.8 m -125.4 168.97 17.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 109.002 -0.74 . . . . 74.129999999999995 109.002 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 250' ' ' LYS . 0.1 OUTLIER -119.63 133.12 23.83 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.121 -1.066 . . . . 64.450000000000003 108.121 173.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 55.2 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 121.328 1.352 . . . . 74.400000000000006 112.629 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -112.9 0.67 15.21 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.532 -1.284 . . . . 71.319999999999993 107.532 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t30 51.57 -84.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.562 1.545 . . . . 73.099999999999994 113.241 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -148.44 109.31 4.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.584 -0.895 . . . . 70.140000000000001 108.584 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.548 ' O ' ' HD2' ' A' ' 255' ' ' ARG 0.299 5.8 ppt_? . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 113.157 0.799 . . . . 62.119999999999997 113.157 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.321 -1.112 . . . . 74.219999999999999 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.7 p -86.1 100.47 12.21 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.262 0.553 . . . . 74.340000000000003 110.889 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 8.3 mmpt? -94.57 81.51 3.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.42 -0.585 . . . . 65.549999999999997 109.42 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -134.05 4.83 3.54 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.652 -0.704 . . . . 74.519999999999996 110.953 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 68.43 112.26 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.009 0.924 . . . . 65.200000000000003 112.26 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.2 113.61 32.52 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.024 -1.102 . . . . 75.109999999999999 108.024 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.48 104.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.198 3.265 . . . . 64.239999999999995 113.875 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.3 m -136.61 1.12 2.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.426 -0.806 . . . . 63.420000000000002 110.666 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.33 95.65 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 110.03 -0.359 . . . . 51.130000000000003 110.03 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.3 p -127.1 140.3 52.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.859 -0.61 . . . . 55.240000000000002 109.903 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.2 pt -107.46 140.75 21.82 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.547 -0.538 . . . . 71.129999999999995 109.547 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.16 165.84 28.9 Favored 'Trans proline' 0 C--O 1.245 0.827 0 C-N-CA 122.703 2.268 . . . . 72.140000000000001 111.941 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -69.94 153.6 43.04 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 108.786 -0.82 . . . . 72.150000000000006 108.786 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.18 123.42 24.44 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.072 0.939 . . . . 74.030000000000001 112.884 -174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -179.61 -37.94 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 103.594 -2.743 . . . . 71.120000000000005 103.594 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -130.91 148.89 52.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 112.51 -2.132 . . . . 63.200000000000003 105.861 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 96.5 m -110.38 150.1 29.29 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.411 -0.959 . . . . 65.040000000000006 108.411 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.4 p -99.09 123.59 51.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.367 0.603 . . . . 72.129999999999995 110.698 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 p -82.0 120.37 25.16 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.79 -1.189 . . . . 55.240000000000002 107.79 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.86 154.22 51.74 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.386 -0.525 . . . . 73.120000000000005 110.281 -174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 34.9 mm -96.76 118.31 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.323 -2.103 . . . . 73.209999999999994 105.323 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 160' ' ' ARG . 33.9 pt -103.79 160.97 4.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.786 -1.165 . . . . 73.409999999999997 110.37 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.45 16.82 10.46 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.222 0.609 . . . . 71.439999999999998 110.642 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.35 -28.99 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.495 1.118 . . . . 44.520000000000003 112.777 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.31 -22.67 63.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.301 0.572 . . . . 71.030000000000001 111.239 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.5 mt -108.94 -40.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.153 0.501 . . . . 51.109999999999999 109.803 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.27 122.26 79.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 113.381 0.882 . . . . 33.310000000000002 113.381 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.86 156.56 34.86 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.55 2.834 . . . . 71.450000000000003 109.424 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.81 -11.65 8.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.075 0.464 . . . . 74.439999999999998 111.993 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.522 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 21.2 p -71.11 -18.38 62.53 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 116.083 -0.508 . . . . 70.319999999999993 110.88 176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -121.26 151.48 39.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.447 -0.575 . . . . 72.209999999999994 109.447 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -140.45 120.5 13.7 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.001 -0.741 . . . . 74.209999999999994 109.001 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 10.0 ptp180 -120.46 125.66 48.45 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.457 0.91 . . . . 64.430000000000007 113.457 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 148' ' ' ILE . 28.3 m -117.05 142.1 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 107.794 -1.187 . . . . 74.400000000000006 107.794 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.49 125.76 52.16 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.92 -0.712 . . . . 75.329999999999998 111.072 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 98.1 mt -91.34 140.82 29.41 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 123.536 0.735 . . . . 73.349999999999994 109.054 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 243' ' ' SER . 12.9 t -134.57 133.65 40.46 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.545 -0.539 . . . . 75.310000000000002 109.545 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -133.84 136.12 44.21 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 109.878 -0.415 . . . . 75.099999999999994 109.878 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -147.39 140.55 25.2 Favored 'General case' 0 C--N 1.275 -2.638 0 O-C-N 124.077 0.86 . . . . 75.200000000000003 109.276 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 87.2 -46.35 3.52 Favored Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.137 -0.554 . . . . 71.150000000000006 112.323 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.7 t -135.46 131.02 35.64 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.864 -0.421 . . . . 62.210000000000001 109.864 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.503 ' OD1' ' HB3' ' A' ' 242' ' ' SER . 34.6 t70 -99.58 86.39 3.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.771 0.796 . . . . 64.430000000000007 109.671 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -94.07 155.66 39.88 Favored Pre-proline 0 C--N 1.277 -2.559 0 CA-C-N 114.655 -1.157 . . . . 74.230000000000004 109.199 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.57 156.26 23.02 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.979 2.453 . . . . 63.109999999999999 112.695 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.4 mp -60.77 159.06 11.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 62.43 109.438 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.84 25.42 4.06 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 120.697 -0.763 . . . . 34.530000000000001 114.524 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 45.6 p90 -162.21 169.46 20.71 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.524 -0.547 . . . . 75.299999999999997 109.524 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -128.19 155.3 44.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.593 -1.632 . . . . 63.240000000000002 106.593 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.0 pt -119.55 159.43 20.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 118.552 0.615 . . . . 72.420000000000002 112.171 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -136.57 178.31 7.17 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.389 -0.823 . . . . 72.120000000000005 109.279 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -111.39 162.82 14.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.887 -0.783 . . . . 71.409999999999997 108.887 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 166.9 -174.35 42.23 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.38 -1.088 . . . . 75.400000000000006 110.38 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.9 p -103.26 133.92 47.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 121.549 0.69 . . . . 63.100000000000001 110.923 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 46.5 t -102.52 153.26 20.24 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.297 -1.372 . . . . 73.099999999999994 107.297 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.77 123.29 58.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.166 0.508 . . . . 54.130000000000003 109.852 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -108.59 129.14 55.32 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.907 -1.146 . . . . 75.299999999999997 107.907 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.3 113.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.331 -0.618 . . . . 74.230000000000004 109.331 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.4 p -120.07 -179.46 3.93 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.498 -0.556 . . . . 32.0 109.498 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.87 -24.25 60.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.171 -0.677 . . . . 64.409999999999997 109.171 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.6 p -82.24 -1.7 50.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.705 -0.68 . . . . 51.229999999999997 111.161 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 110.21 -147.0 17.32 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.845 -0.616 . . . . 74.510000000000005 111.776 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -83.83 128.47 34.56 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.05 0.452 . . . . 52.219999999999999 110.247 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -113.81 143.18 45.09 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.82 -0.627 . . . . 74.239999999999995 111.915 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 191' ' ' LYS . 7.6 mmpt? -96.07 125.89 40.93 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 114.464 -1.244 . . . . 74.200000000000003 108.37 177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 181' ' ' SER . 12.3 pt20 -134.17 151.89 77.32 Favored Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.665 -0.865 . . . . 74.540000000000006 108.665 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.97 124.51 14.6 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 121.967 1.778 . . . . 75.219999999999999 109.629 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.12 159.41 23.05 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 120.49 -0.862 . . . . 51.32 111.415 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 231' ' ' LEU . 34.8 mm -118.43 117.64 55.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.86 -1.533 . . . . 74.040000000000006 106.86 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 47.5 m-85 -110.89 161.64 15.62 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.422 -0.214 . . . . 74.420000000000002 110.422 -174.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.56 132.07 33.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.272 -1.01 . . . . 73.510000000000005 108.272 172.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.5 t -85.14 -49.54 8.16 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.596 -0.52 . . . . 61.030000000000001 109.596 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.95 154.08 12.72 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.918 -0.771 . . . . 64.409999999999997 108.918 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 174' ' ' PHE . 4.6 mm? -93.14 144.37 25.34 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 123.155 0.284 . . . . 72.519999999999996 110.334 175.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.12 118.35 70.27 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 107.768 -1.197 . . . . 61.539999999999999 107.768 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.47 124.97 17.03 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.369 2.046 . . . . 74.219999999999999 110.784 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.94 -15.15 56.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.596 -0.812 . . . . 54.240000000000002 111.655 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.29 52.45 Favored Glycine 0 CA--C 1.497 -1.069 0 N-CA-C 109.894 -1.283 . . . . 61.539999999999999 109.894 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 163' ' ' LEU . 26.8 tp -57.44 -32.54 67.01 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.08 1.141 . . . . 72.439999999999998 114.08 -171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.83 -36.31 62.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.359 0.599 . . . . 40.130000000000003 110.179 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.1 tm-20 -74.64 -42.95 57.63 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.161 -1.052 . . . . 70.230000000000004 108.161 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.0 t -61.37 -39.55 91.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.077 -0.965 . . . . 73.239999999999995 111.217 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.0 t -80.13 -27.77 39.03 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.823 -0.751 . . . . 55.530000000000001 109.916 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 82.77 -3.99 81.14 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.528 0.971 . . . . 74.0 115.528 172.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.625 ' HG ' HD11 ' A' ' 148' ' ' ILE . 3.1 mm? -76.23 -20.45 57.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.391 1.256 . . . . 62.530000000000001 114.391 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 249' ' ' VAL . 46.1 mt -107.05 133.06 52.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.264 -0.974 . . . . 64.400000000000006 109.257 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.53 159.86 16.11 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.606 -0.516 . . . . 74.120000000000005 109.606 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.13 -37.34 61.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 123.474 0.71 . . . . 74.450000000000003 111.959 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -75.58 -23.52 56.52 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 112.692 0.627 . . . . 73.239999999999995 112.692 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 61.7 m-20 -63.47 145.49 55.53 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.722 0.639 . . . . 64.349999999999994 110.5 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 13.1 pt-20 -116.38 148.65 40.44 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.228 -0.442 . . . . 71.439999999999998 110.576 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 249' ' ' VAL . 28.1 m -78.66 143.93 11.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 120.918 0.39 . . . . 74.0 111.38 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 250' ' ' LYS . 48.0 mm -110.65 -50.1 6.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.617 -0.72 . . . . 62.409999999999997 109.639 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.482 ' HG3' HG22 ' A' ' 219' ' ' ILE . 53.4 mt-10 -137.71 147.1 44.5 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 121.329 0.585 . . . . 74.450000000000003 111.996 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.44 104.16 12.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.347 -1.297 . . . . 63.439999999999998 108.414 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.526 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.9 m-20 63.99 9.96 4.98 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.697 0.999 . . . . 73.120000000000005 113.697 -174.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 111.17 -3.69 28.41 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.152 -0.779 . . . . 75.040000000000006 111.152 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.4 111.86 22.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.262 -1.384 . . . . 74.310000000000002 107.262 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.21 134.29 50.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 119.559 -0.856 . . . . 64.430000000000007 109.129 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 219' ' ' ILE . 35.3 m -74.58 -5.92 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 O-C-N 123.913 0.758 . . . . 72.450000000000003 111.035 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.76 122.07 20.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.558 -1.275 . . . . 54.350000000000001 107.558 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 -2.66 68.17 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.59 -0.815 . . . . 72.400000000000006 111.25 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -107.96 147.57 30.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.016 -0.735 . . . . 64.299999999999997 109.016 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 234' ' ' VAL . 36.0 p -95.4 168.54 10.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.55 -0.537 . . . . 51.520000000000003 109.55 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 195' ' ' ILE . 10.2 mp -58.73 -37.32 75.91 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 109.964 -0.384 . . . . 72.150000000000006 109.964 174.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.22 -51.75 65.59 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 124.001 0.813 . . . . 64.400000000000006 109.832 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -72.97 -41.81 64.0 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 113.298 0.851 . . . . 74.420000000000002 113.298 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 230' ' ' THR . 30.1 t -67.64 -44.69 85.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 119.947 -0.701 . . . . 55.420000000000002 110.952 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 40.6 p -60.93 -48.37 82.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.414 -0.514 . . . . 72.129999999999995 110.096 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.37 -41.09 93.0 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.311 -0.858 . . . . 74.030000000000001 111.355 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -65.51 -44.21 87.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.803 -0.814 . . . . 73.329999999999998 108.803 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 172' ' ' LEU . 73.9 mtm -65.17 -44.44 88.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.718 -0.674 . . . . 73.120000000000005 112.803 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.72 -29.82 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 N-CA-C 109.618 -0.512 . . . . 71.140000000000001 109.618 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.75 -39.39 77.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.471 0.708 . . . . 41.310000000000002 111.266 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.56 ' HB2' HD13 ' A' ' 245' ' ' LEU . 30.6 m-80 -100.21 83.96 2.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.746 -1.576 . . . . 65.129999999999995 106.746 177.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 169' ' ' ASP . 15.3 m -78.12 -51.95 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.981 -1.009 . . . . 72.340000000000003 113.2 -170.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 33.2 t -69.98 -34.3 73.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.363 0.875 . . . . 74.439999999999998 113.363 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -151.01 115.44 5.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.661 0.743 . . . . 73.030000000000001 111.105 175.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.7 tp -128.42 134.31 48.76 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.851 -1.068 . . . . 71.439999999999998 109.707 -174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.81 115.01 43.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.326 -0.62 . . . . 70.340000000000003 109.326 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -108.06 119.81 58.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.851 -0.425 . . . . 73.439999999999998 109.851 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.1 m -109.9 119.56 39.71 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.141 -0.689 . . . . 71.150000000000006 109.141 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 218' ' ' VAL . 23.5 m -117.77 170.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.791 -0.818 . . . . 54.329999999999998 108.791 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.487 ' CG ' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -130.58 130.91 23.03 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.517 -0.92 . . . . 72.430000000000007 108.517 169.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.533 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 19.4 Cg_endo -62.85 134.01 44.63 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.198 1.265 . . . . 73.219999999999999 109.428 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 254' ' ' GLN . . . -81.42 -9.48 59.72 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.858 -0.423 . . . . 63.009999999999998 109.858 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 73.45 -39.56 0.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.233 1.413 . . . . 73.209999999999994 110.126 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 252' ' ' ALA . 34.9 tt0 -73.24 94.3 1.97 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.266 -1.383 . . . . 64.409999999999997 107.266 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.999 -1.852 . . . . 74.099999999999994 105.999 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.282 0 N-CA-C 110.676 -0.97 . . . . 71.510000000000005 110.676 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -71.96 118.55 14.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.476 -0.564 . . . . 73.540000000000006 109.476 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -163.36 179.04 7.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 105.633 -1.988 . . . . 73.099999999999994 105.633 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.416 ' H ' ' HG3' ' A' ' 130' ' ' LYS . 48.8 m -52.77 121.81 7.93 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.148 0.499 . . . . 71.109999999999999 110.244 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 112.85 5.22 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.041 -0.981 . . . . 72.109999999999999 112.88 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.88 109.6 59.28 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 107.717 -1.216 . . . . 64.010000000000005 107.717 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.28 -25.73 76.84 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.892 2.395 . . . . 74.099999999999994 111.761 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.6 t 61.59 74.31 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.332 1.053 . . . . 74.409999999999997 111.152 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.1 mt -102.96 101.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 115.107 -0.951 . . . . 74.409999999999997 108.462 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.8 m -108.06 109.63 21.12 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.223 -0.658 . . . . 73.120000000000005 109.223 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.451 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.5 pp -112.11 143.69 29.27 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 116.121 -0.491 . . . . 73.430000000000007 111.437 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.47 119.94 7.52 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.957 1.771 . . . . 73.430000000000007 109.992 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -80.85 83.93 6.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 113.284 0.846 . . . . 74.010000000000005 113.284 -176.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.9 85.71 3.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.506 -1.294 . . . . 72.420000000000002 107.506 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -163.06 149.03 12.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.608 -1.256 . . . . 72.319999999999993 107.608 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -82.75 102.58 11.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.407 -0.917 . . . . 75.340000000000003 109.119 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.1 t -110.88 129.22 55.93 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.318 -1.364 . . . . 61.100000000000001 107.318 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.82 130.73 51.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.418 0.627 . . . . 74.049999999999997 111.392 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 205' ' ' LEU . 72.1 m -77.33 117.72 19.11 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.963 0.887 . . . . 61.100000000000001 109.654 174.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.1 158.46 30.62 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.017 -1.447 . . . . 72.239999999999995 107.199 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 159' ' ' ARG . 33.6 pt -92.3 149.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 C-N-CA 118.897 -1.121 . . . . 74.109999999999999 108.319 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.623 HD13 ' HG2' ' A' ' 162' ' ' ARG . 20.7 pt -132.3 160.07 42.73 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.024 0 CA-C-N 114.54 -1.209 . . . . 73.530000000000001 111.528 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 61.2 23.12 13.36 Favored 'General case' 0 C--O 1.212 -0.895 0 O-C-N 124.773 1.296 . . . . 75.239999999999995 110.003 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.51 -29.59 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 72.329999999999998 112.729 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.73 -24.86 44.62 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.092 0.472 . . . . 71.140000000000001 111.511 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.29 -42.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.415 0.626 . . . . 75.209999999999994 109.819 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG21 ' HD3' ' A' ' 160' ' ' ARG . 75.4 t -85.79 136.66 36.46 Favored Pre-proline 0 C--N 1.299 -1.61 0 CA-C-N 115.284 -0.871 . . . . 70.239999999999995 112.19 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.486 ' O ' HG12 ' A' ' 154' ' ' VAL . 56.1 Cg_endo -73.31 155.66 51.14 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.701 2.267 . . . . 64.319999999999993 109.179 172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.96 -10.93 6.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.173 0.805 . . . . 71.349999999999994 113.173 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.542 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 24.9 p -69.64 -24.94 63.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.196 -0.456 . . . . 74.219999999999999 111.09 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -113.71 141.97 46.6 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.306 -0.627 . . . . 74.439999999999998 109.306 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.577 ' HD2' HG21 ' A' ' 148' ' ' ILE . 12.9 tpp180 -126.9 134.49 50.45 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 63.3 mtp85 -125.81 124.78 41.71 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.247 -0.433 . . . . 70.400000000000006 110.957 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.26 151.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.049 0.452 . . . . 75.140000000000001 111.024 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.623 ' HG2' HD13 ' A' ' 149' ' ' ILE . 25.4 mmt180 -98.83 130.17 45.24 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.703 -1.221 . . . . 72.099999999999994 107.703 175.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 164' ' ' CYS . 5.2 tt -91.43 133.88 35.1 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.295 -1.002 . . . . 71.319999999999993 108.295 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 163' ' ' LEU . 75.1 m -116.07 135.54 53.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.468 -0.568 . . . . 61.310000000000002 109.468 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -86.34 142.76 28.25 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.185 -1.043 . . . . 74.340000000000003 108.185 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -129.95 110.04 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.101 0.408 . . . . 74.329999999999998 112.101 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.49 -73.99 2.43 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 116.088 -0.505 . . . . 72.420000000000002 113.511 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -136.67 176.4 8.73 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.79 -0.448 . . . . 52.109999999999999 109.79 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -77.87 80.34 4.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.636 0.731 . . . . 71.409999999999997 111.888 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -98.4 152.73 38.08 Favored Pre-proline 0 C--N 1.291 -1.938 0 CA-C-N 114.838 -1.074 . . . . 75.230000000000004 110.333 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.31 156.97 15.41 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.701 2.934 . . . . 73.310000000000002 112.412 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.6 mp -60.83 162.17 7.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.392 -0.596 . . . . 60.43 109.392 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -83.14 17.87 20.51 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.3 -0.952 . . . . 64.120000000000005 113.276 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 247' ' ' ILE . 48.2 p90 -155.13 153.92 31.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.92 -0.4 . . . . 74.209999999999994 109.92 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -114.75 161.26 18.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.264 -1.013 . . . . 73.140000000000001 108.264 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.68 159.42 19.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.847 0.356 . . . . 74.5 111.101 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -132.26 177.0 7.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.689 -0.687 . . . . 72.019999999999996 109.539 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.48 162.99 13.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.222 -1.029 . . . . 61.350000000000001 108.222 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.7 39.02 Favored Glycine 0 N--CA 1.407 -3.284 0 N-CA-C 108.242 -1.943 . . . . 53.009999999999998 108.242 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.2 m -126.34 124.27 39.89 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 107.604 -1.258 . . . . 73.430000000000007 107.604 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -109.33 146.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.124 -1.065 . . . . 63.039999999999999 108.124 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.83 129.43 45.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.39 0.614 . . . . 73.340000000000003 110.616 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -122.77 124.55 43.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.301 -1.0 . . . . 75.340000000000003 108.301 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.66 121.35 49.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 120.526 -0.47 . . . . 74.129999999999995 110.871 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 24.5 p -115.5 -178.98 3.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.652 -0.704 . . . . 72.239999999999995 109.884 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.74 65.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 71.25 111.322 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.4 p -81.79 -18.85 42.67 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.984 0.421 . . . . 61.100000000000001 110.901 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.36 -166.86 25.68 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.824 -0.91 . . . . 73.340000000000003 110.824 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.8 pp -82.88 139.98 33.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.927 -0.709 . . . . 71.329999999999998 110.596 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.96 146.26 47.32 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -111.83 125.44 54.01 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.126 -1.065 . . . . 65.409999999999997 108.126 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -133.44 155.28 80.86 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.741 -0.837 . . . . 73.409999999999997 108.741 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.2 108.57 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.822 1.681 . . . . 75.519999999999996 110.109 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -98.24 125.3 8.48 Favored Glycine 0 N--CA 1.414 -2.785 0 N-CA-C 110.554 -1.018 . . . . 45.310000000000002 110.554 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.9 mm -93.85 116.84 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 107.649 -1.241 . . . . 74.219999999999999 107.649 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 51.5 m-85 -112.91 166.67 11.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.121 -1.066 . . . . 72.109999999999999 108.121 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 71.8 mt -77.78 131.39 34.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.557 -0.905 . . . . 74.219999999999999 108.557 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.1 t -90.86 -44.17 9.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.764 -0.585 . . . . 63.439999999999998 111.3 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -164.17 143.96 7.89 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.602 -0.439 . . . . 75.109999999999999 110.206 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.71 144.23 27.55 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.61 0.568 . . . . 74.109999999999999 109.94 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.29 125.51 51.99 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 107.897 -1.149 . . . . 55.240000000000002 107.897 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.09 124.88 15.73 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.896 1.731 . . . . 64.230000000000004 109.613 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.91 8.43 85.84 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.761 -0.936 . . . . 73.420000000000002 110.761 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.25 157.91 29.65 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.802 -1.319 . . . . 64.129999999999995 109.802 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.477 HD11 ' OG ' ' A' ' 146' ' ' SER . 28.4 tp -51.05 -49.95 59.58 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.974 0.909 . . . . 74.140000000000001 113.29 -174.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.62 60.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.875 0.369 . . . . 41.409999999999997 111.819 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.04 -42.42 72.93 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.892 -1.151 . . . . 74.25 107.892 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -63.24 -40.14 96.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.211 -0.904 . . . . 64.439999999999998 110.931 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.3 p -78.15 -33.97 50.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.773 -0.371 . . . . 71.549999999999997 111.726 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.89 26.26 69.94 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.679 -0.568 . . . . 64.5 111.679 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 148' ' ' ILE . 97.2 mt -97.21 -13.5 22.02 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.799 0.333 . . . . 71.129999999999995 111.202 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.02 131.81 16.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.901 -0.59 . . . . 72.519999999999996 110.977 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -125.13 167.06 15.32 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.858 0.863 . . . . 64.430000000000007 111.169 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 27.5 m -46.5 -30.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 115.413 1.634 . . . . 60.009999999999998 115.413 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -78.96 -25.08 43.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.929 -1.108 . . . . 74.230000000000004 112.205 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 52.6 m-20 -70.61 144.18 51.24 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.878 -0.786 . . . . 62.009999999999998 108.878 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -112.74 144.62 41.95 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.468 -0.333 . . . . 61.299999999999997 111.434 -176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 249' ' ' VAL . 27.4 m -80.77 133.51 29.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.137 0.494 . . . . 74.549999999999997 110.667 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.9 mm -104.63 -45.04 9.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.886 -0.597 . . . . 73.319999999999993 110.585 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 219' ' ' ILE . 48.3 mt-10 -145.71 145.59 30.93 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.123 0.487 . . . . 63.25 111.588 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 238' ' ' MET . 29.9 m -133.35 104.9 7.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.571 -0.9 . . . . 70.219999999999999 108.571 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.536 ' OD1' HD12 ' A' ' 245' ' ' LEU . 5.2 m-20 59.32 16.07 4.78 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 114.044 1.127 . . . . 55.119999999999997 114.044 -176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.01 -14.63 19.16 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.052 -1.071 . . . . 61.039999999999999 111.77 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 226' ' ' VAL . 46.4 mm -75.91 122.47 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.421 -1.326 . . . . 73.510000000000005 107.421 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -79.32 2.7 20.52 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.573 0.583 . . . . 62.229999999999997 112.573 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 224' ' ' ILE . 19.3 m 55.39 4.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.235 1.814 . . . . 74.420000000000002 113.783 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.31 122.48 28.5 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.833 -0.432 . . . . 72.010000000000005 109.833 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.5 88.21 Favored Glycine 0 C--N 1.309 -0.969 0 C-N-CA 120.821 -0.704 . . . . 61.039999999999999 111.423 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 226' ' ' VAL . 31.9 mmmt -89.88 148.25 23.27 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.354 -0.98 . . . . 70.319999999999993 108.354 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 41.7 p -92.4 167.99 11.6 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 109.08 -0.711 . . . . 75.230000000000004 109.08 176.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.83 -33.41 74.1 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.833 -0.432 . . . . 64.510000000000005 109.833 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -57.41 -51.1 70.8 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.933 0.77 . . . . 74.010000000000005 109.514 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 237' ' ' MET . 82.2 mm-40 -70.12 -43.0 71.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.388 -0.823 . . . . 62.329999999999998 112.601 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 22.0 t -67.6 -44.29 86.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 119.43 -0.908 . . . . 71.439999999999998 110.947 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.6 p -60.61 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.991 -0.684 . . . . 70.209999999999994 110.472 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.7 -43.44 85.18 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.046 -0.525 . . . . 75.349999999999994 111.011 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 233' ' ' GLN . 2.1 tmm? -64.79 -43.41 93.29 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.411 0.624 . . . . 71.400000000000006 109.422 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.509 ' HB3' HD21 ' A' ' 172' ' ' LEU . 77.6 mtm -68.82 -42.44 77.23 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.974 0.731 . . . . 75.439999999999998 112.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 235' ' ' THR . 64.6 t -67.21 -29.98 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.313 0.578 . . . . 72.319999999999993 109.687 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.72 94.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.729 0.776 . . . . 73.349999999999994 110.336 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.44 ' HB2' HD13 ' A' ' 245' ' ' LEU . 39.6 m-80 -103.93 26.83 8.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.865 -1.061 . . . . 74.510000000000005 111.073 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 p -60.19 -16.37 32.5 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 114.241 1.2 . . . . 54.130000000000003 114.241 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.9 m -76.78 -37.0 56.63 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.15 0.5 . . . . 74.400000000000006 110.548 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.13 97.29 2.42 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.476 1.132 . . . . 64.040000000000006 109.193 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 222' ' ' ASN . 48.3 tp -122.97 133.56 54.37 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.615 -1.175 . . . . 63.149999999999999 109.014 -176.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 149' ' ' ILE . 62.5 mt -102.33 114.9 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 106.882 -1.525 . . . . 74.519999999999996 106.882 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 70.8 mt -108.33 119.07 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 116.057 -0.519 . . . . 74.430000000000007 109.863 -175.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 56.8 m -112.28 117.41 32.44 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 109.405 -0.591 . . . . 71.329999999999998 109.405 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 218' ' ' VAL . 35.6 m -122.79 162.2 23.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.432 -1.322 . . . . 53.329999999999998 107.432 177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' THR 0.26 0.0 OUTLIER -119.83 121.5 29.71 Favored Pre-proline 0 C--N 1.278 -2.53 0 C-N-CA 118.369 -1.332 . . . . 74.310000000000002 109.822 171.23 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.563 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.8 Cg_endo -59.65 134.46 57.87 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.394 2.063 . . . . 71.400000000000006 112.735 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -83.14 -5.28 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.76 -1.109 . . . . 53.25 109.367 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 47.8 t30 76.49 141.39 0.07 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.936 1.294 . . . . 63.509999999999998 110.987 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -76.58 93.96 3.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.763 0.792 . . . . 74.329999999999998 109.718 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? . . . . . 0 C--N 1.298 -1.639 0 CA-C-N 114.982 -1.008 . . . . 63.350000000000001 113.053 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.674 0 N-CA-C 110.892 -0.883 . . . . 35.149999999999999 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.3 p -107.54 172.06 7.04 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.783 -0.451 . . . . 71.319999999999993 109.783 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -88.21 76.77 8.39 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.336 -0.987 . . . . 73.340000000000003 108.336 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.4 m 73.33 -51.67 0.7 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.767 1.227 . . . . 75.329999999999998 109.124 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -140.24 161.35 37.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.979 -1.86 . . . . 62.210000000000001 105.979 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 136' ' ' ILE . . . -89.9 115.18 63.29 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 108.084 -1.08 . . . . 73.430000000000007 108.084 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.57 112.3 1.21 Allowed 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.543 2.162 . . . . 64.319999999999993 111.801 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.0 m 66.01 84.82 0.15 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.738 -1.119 . . . . 75.010000000000005 111.044 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 133' ' ' ALA . 61.4 mt -81.26 100.55 5.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.394 0.616 . . . . 61.530000000000001 109.453 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 92.4 7.74 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.243 -0.89 . . . . 72.010000000000005 110.542 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.3 tt -114.85 140.61 25.67 Favored Pre-proline 0 N--CA 1.421 -1.919 0 N-CA-C 106.823 -1.547 . . . . 45.329999999999998 106.823 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.21 148.52 85.62 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.136 1.891 . . . . 54.509999999999998 110.308 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.82 109.61 2.96 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.086 -0.646 . . . . 73.430000000000007 109.637 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.89 141.8 53.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.228 -0.896 . . . . 74.219999999999999 112.737 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -137.02 -35.82 0.69 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.253 -1.017 . . . . 65.450000000000003 108.253 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 5.7 mpt_? -103.0 146.94 27.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.972 -1.862 . . . . 75.430000000000007 105.972 172.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 166' ' ' HIS . 89.5 m -112.58 151.15 30.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 113.937 1.088 . . . . 64.420000000000002 113.937 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.58 134.55 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.721 -1.127 . . . . 63.140000000000001 109.288 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 p -85.77 127.25 34.49 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.41 -0.959 . . . . 64.0 108.41 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.68 154.33 43.4 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.92 -0.712 . . . . 32.420000000000002 111.414 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 49.5 mm -96.75 104.84 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 106.63 -1.619 . . . . 73.340000000000003 106.63 176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.596 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 30.0 pt -99.99 164.0 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 113.229 0.825 . . . . 73.120000000000005 113.229 -171.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . 0.338 13.0 m-20 41.82 79.04 0.04 OUTLIER 'General case' 0 C--O 1.245 0.835 0 N-CA-C 116.663 2.097 . . . . 63.520000000000003 116.663 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.55 -29.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.262 -1.336 . . . . 62.109999999999999 112.022 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.63 -29.36 45.84 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.002 -0.436 . . . . 75.450000000000003 111.112 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.68 -43.94 46.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.127 -0.488 . . . . 71.310000000000002 110.958 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 158' ' ' HIS . 75.1 t -112.66 127.88 26.28 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 116.399 -0.364 . . . . 64.329999999999998 111.582 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.0 156.25 65.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.603 2.202 . . . . 63.039999999999999 109.614 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.25 -13.67 5.58 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 112.913 0.709 . . . . 64.310000000000002 112.913 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.7 p -64.53 -33.24 75.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 123.141 0.576 . . . . 72.430000000000007 109.942 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.447 ' HB2' HG13 ' A' ' 154' ' ' VAL . 58.0 m170 -113.09 159.14 19.51 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.999 -0.741 . . . . 73.409999999999997 108.999 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 211' ' ' LEU . 19.3 ttm180 -125.27 141.61 51.98 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.332 -0.618 . . . . 65.430000000000007 109.332 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.622 ' HD2' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -124.2 117.12 23.87 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.446 -0.797 . . . . 65.430000000000007 108.909 -174.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -127.7 137.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.032 -0.729 . . . . 60.240000000000002 109.032 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 245' ' ' LEU . 33.4 ttm180 -107.5 141.58 38.72 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.122 -0.631 . . . . 72.420000000000002 112.656 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 37.6 mt -92.29 139.94 30.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.167 -0.924 . . . . 62.409999999999997 110.155 171.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . 35.0 t -129.55 139.16 51.59 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.371 -2.085 . . . . 54.030000000000001 105.371 171.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 169' ' ' ASP . 24.3 ttmm -130.27 120.71 24.85 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 114.131 1.159 . . . . 74.040000000000006 114.131 -174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.632 ' HD2' ' SG ' ' A' ' 144' ' ' CYS . 78.6 m-70 -145.73 130.99 18.5 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.848 -1.069 . . . . 61.229999999999997 108.58 172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.41 -57.67 4.92 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 116.299 -0.409 . . . . 74.329999999999998 112.775 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.5 m -89.33 94.37 9.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.148 0.499 . . . . 51.030000000000001 111.673 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 9.3 p-10 -83.86 19.25 1.76 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 123.963 0.905 . . . . 51.450000000000003 111.535 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -86.22 161.94 47.64 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.708 -0.678 . . . . 70.239999999999995 112.316 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -49.92 159.58 1.62 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 125.083 3.855 . . . . 73.120000000000005 112.515 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.611 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.8 mp -58.54 156.09 11.17 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.926 -0.398 . . . . 63.310000000000002 109.926 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.473 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -82.35 27.55 3.62 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.833 -0.698 . . . . 71.109999999999999 114.528 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -154.42 146.53 23.68 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.068 -0.716 . . . . 72.129999999999995 109.068 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -111.06 163.03 14.27 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.594 -1.262 . . . . 71.140000000000001 107.594 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.5 pt -119.55 156.72 21.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.365 0.602 . . . . 70.019999999999996 111.872 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 26.0 ptt180 -132.62 168.63 17.92 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.949 -1.023 . . . . 74.200000000000003 108.605 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.643 ' HB3' HD11 ' A' ' 231' ' ' LEU . 6.4 p-10 -124.52 152.2 43.72 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 123.28 0.363 . . . . 74.510000000000005 110.075 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 179.72 -154.26 13.4 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.881 -1.288 . . . . 73.230000000000004 109.881 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.454 HG21 ' HE2' ' A' ' 191' ' ' LYS . 24.9 m -120.64 132.78 55.29 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.174 -1.047 . . . . 70.439999999999998 108.174 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -103.9 148.77 25.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.9 -1.148 . . . . 72.340000000000003 107.9 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.8 p -101.22 125.89 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-O 121.545 0.688 . . . . 54.450000000000003 109.361 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.531 ' HG3' HG23 ' A' ' 185' ' ' THR . 28.5 tpt180 -107.71 115.16 29.64 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.799 -0.815 . . . . 74.129999999999995 108.799 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 55.5 t -88.89 113.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.115 -0.698 . . . . 71.140000000000001 109.115 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 183' ' ' ARG . 45.4 p -125.59 -174.42 3.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.898 -0.592 . . . . 71.310000000000002 110.629 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.12 -18.34 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.126 0.488 . . . . 71.439999999999998 110.394 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 m -80.63 -23.5 39.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.388 -0.597 . . . . 64.120000000000005 109.388 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.81 -124.49 4.85 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.655 -1.378 . . . . 71.25 109.655 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.549 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.4 pp -100.32 136.13 40.69 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.372 -0.531 . . . . 50.119999999999997 110.193 176.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.73 133.24 49.53 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.5 -0.926 . . . . 75.010000000000005 108.5 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 180' ' ' THR . 52.9 mtpt -97.69 137.17 37.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.04 -0.726 . . . . 74.310000000000002 109.04 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.1 148.38 51.47 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.421 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -63.17 117.38 4.31 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.217 1.944 . . . . 74.540000000000006 109.604 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -118.79 136.2 11.96 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 119.725 -1.226 . . . . 43.409999999999997 113.055 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.43 117.04 51.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.258 -1.756 . . . . 74.540000000000006 106.258 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 39.3 m-85 -110.91 164.27 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.202 -0.666 . . . . 73.439999999999998 109.202 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 61.6 mt -74.53 131.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.718 -1.216 . . . . 62.119999999999997 107.718 173.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.4 t -93.04 -43.75 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.982 -0.449 . . . . 63.229999999999997 111.812 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -164.62 151.02 10.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.109 -0.33 . . . . 75.040000000000006 110.109 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 206' ' ' ALA . 3.8 mm? -102.0 144.46 30.57 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.743 0.652 . . . . 75.299999999999997 109.915 176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.473 HG22 ' CA ' ' A' ' 173' ' ' GLY . 13.3 m -93.04 145.21 29.68 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 106.895 -1.52 . . . . 62.520000000000003 106.895 173.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.01 124.46 14.48 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.287 1.325 . . . . 73.409999999999997 109.846 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 81.64 13.7 79.47 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.066 -1.064 . . . . 40.229999999999997 112.626 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.05 167.32 52.47 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.855 -0.688 . . . . 71.010000000000005 111.455 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 209' ' ' THR . 32.1 tp -52.09 -53.43 42.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.494 0.664 . . . . 71.329999999999998 111.647 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 200' ' ' LEU . . . -75.33 -30.78 60.39 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.871 -1.058 . . . . 61.25 111.223 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 -51.17 18.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.248 -0.887 . . . . 74.019999999999996 108.612 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -67.92 -36.3 79.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.809 -0.632 . . . . 70.109999999999999 111.945 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 205' ' ' LEU . 11.3 t -88.1 -17.75 30.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 117.952 -1.499 . . . . 63.140000000000001 110.456 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.89 35.03 80.98 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.884 -0.598 . . . . 74.010000000000005 113.812 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.482 ' HB3' HH11 ' A' ' 159' ' ' ARG . 92.8 mt -105.89 -9.9 16.92 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.698 -0.401 . . . . 64.329999999999998 111.99 -176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.432 ' HG ' ' HB1' ' A' ' 206' ' ' ALA . 1.1 pt? -149.23 137.75 20.97 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.959 -0.564 . . . . 71.230000000000004 109.787 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.04 168.09 17.98 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.353 1.061 . . . . 63.32 110.731 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.1 m -46.04 -29.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 115.172 1.545 . . . . 72.319999999999993 115.172 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -77.47 -24.66 50.18 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.403 -0.811 . . . . 71.340000000000003 111.719 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 55.6 m-20 -73.77 144.36 45.66 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.761 -0.829 . . . . 63.039999999999999 108.761 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.66 146.81 42.47 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.184 0.516 . . . . 74.129999999999995 111.684 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 249' ' ' VAL . 34.7 m -81.25 145.23 9.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.758 -0.655 . . . . 62.219999999999999 110.316 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.5 mm -113.56 -53.61 4.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-O 121.154 0.502 . . . . 74.209999999999994 110.683 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -141.69 144.61 34.18 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.962 -0.563 . . . . 73.319999999999993 111.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.427 HG23 ' HB ' ' A' ' 224' ' ' ILE . 30.4 m -112.04 104.1 16.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.278 -1.379 . . . . 72.129999999999995 107.278 173.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 67.51 -72.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.728 1.211 . . . . 73.099999999999994 111.446 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -155.26 7.64 0.3 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.006 -1.238 . . . . 64.120000000000005 110.006 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 221' ' ' VAL . 40.6 mm -97.07 112.63 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.761 -1.2 . . . . 73.319999999999993 107.761 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 137.99 58.37 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.711 -0.848 . . . . 61.350000000000001 108.711 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.2 -7.2 10.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 O-C-N 123.311 0.382 . . . . 62.340000000000003 110.91 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.49 123.33 22.18 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.117 0.484 . . . . 63.210000000000001 111.098 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.73 -6.26 77.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.808 -0.633 . . . . 74.540000000000006 113.073 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.41 159.93 14.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 122.43 -0.453 . . . . 74.549999999999997 110.378 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 234' ' ' VAL . 42.8 p -89.23 164.39 14.98 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.073 -0.651 . . . . 74.310000000000002 109.398 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.6 mp -63.44 -36.26 83.16 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.22 -0.445 . . . . 75.329999999999998 110.6 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.92 -51.25 70.86 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 123.95 0.781 . . . . 63.399999999999999 109.737 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.74 -45.09 91.43 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 112.757 0.651 . . . . 75.349999999999994 112.757 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 230' ' ' THR . 48.9 t -64.75 -47.95 86.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.284 -0.566 . . . . 72.450000000000003 111.454 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 239' ' ' VAL . 35.0 p -61.9 -42.81 99.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.136 -0.626 . . . . 74.030000000000001 111.201 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -62.43 -37.47 85.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.818 -0.628 . . . . 74.420000000000002 110.621 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 240' ' ' ALA . 2.5 tmm? -65.46 -43.34 90.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.65 -1.241 . . . . 72.430000000000007 107.65 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.605 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.9 mtm -67.17 -37.7 84.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.139 -0.937 . . . . 74.329999999999998 112.903 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 235' ' ' THR . 67.9 t -71.42 -27.67 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.41 0.624 . . . . 72.239999999999995 109.321 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 237' ' ' MET . . . -62.35 -41.89 98.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.533 0.682 . . . . 11.109999999999999 111.141 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 245' ' ' LEU . 2.2 m-20 -103.86 23.45 12.83 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.691 -0.686 . . . . 63.039999999999999 110.371 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.438 ' HB2' ' CE ' ' A' ' 165' ' ' LYS . 71.9 p -58.28 -23.36 56.01 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.733 1.383 . . . . 73.519999999999996 114.733 -174.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.3 t -64.8 -38.36 90.72 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.864 -0.421 . . . . 71.040000000000006 109.864 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 6.0 p30 -155.24 96.43 1.81 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.871 0.844 . . . . 72.319999999999993 109.018 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 241' ' ' ASN . 41.4 tp -117.63 128.02 54.53 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.068 -0.969 . . . . 64.140000000000001 110.517 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 149' ' ' ILE . 45.5 mt -99.96 114.8 39.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.305 -1.369 . . . . 74.239999999999995 107.305 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.439 HD12 ' SD ' ' A' ' 238' ' ' MET . 15.0 tt -113.45 126.79 70.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 119.05 -1.06 . . . . 71.409999999999997 110.751 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.0 m -102.45 118.23 36.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.418 -0.81 . . . . 62.210000000000001 109.756 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 218' ' ' VAL . 30.9 m -122.94 158.19 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.633 -0.877 . . . . 62.43 108.633 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -111.58 124.72 31.87 Favored Pre-proline 0 C--N 1.286 -2.192 0 N-CA-C 108.239 -1.022 . . . . 64.349999999999994 108.239 173.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.559 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 57.6 Cg_endo -73.28 134.5 21.06 Favored 'Trans proline' 0 N--CA 1.421 -2.75 0 C-N-CA 120.945 1.097 . . . . 75.230000000000004 111.653 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -95.38 -9.67 32.17 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.286 -1.746 . . . . 54.210000000000001 106.286 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.1 t30 67.99 -107.07 0.09 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.594 -2.094 . . . . 74.540000000000006 111.996 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.64 1.18 0.39 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.183 0.992 . . . . 72.400000000000006 111.541 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 . . . . . 0 N--CA 1.423 -1.79 0 C-N-CA 123.853 0.861 . . . . 74.239999999999995 110.046 -171.799 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 111.575 -0.61 . . . . 42.420000000000002 111.575 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.4 m -101.85 -11.14 19.26 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.181 0.515 . . . . 73.430000000000007 111.153 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -93.41 -13.4 28.04 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.315 0.578 . . . . 73.409999999999997 109.94 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 31.6 p -79.02 132.49 36.66 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.539 -0.755 . . . . 62.130000000000003 110.709 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 136.06 37.17 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.771 -1.196 . . . . 72.049999999999997 107.771 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.11 109.34 63.1 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 112.183 0.438 . . . . 64.120000000000005 112.183 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.99 -0.08 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.162 1.908 . . . . 75.120000000000005 109.796 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m 70.2 -76.95 0.06 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.382 1.473 . . . . 73.120000000000005 112.696 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.8 mt 53.77 71.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 122.332 1.063 . . . . 71.549999999999997 108.723 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 m -144.77 177.37 8.76 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.813 -1.085 . . . . 65.129999999999995 108.82 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.95 116.81 65.64 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.55 -1.648 . . . . 74.329999999999998 106.55 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.45 19.01 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.596 0 C-N-CA 123.094 2.529 . . . . 73.120000000000005 114.06 -173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 72.43 127.9 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.314 1.046 . . . . 73.099999999999994 112.368 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -170.1 153.36 4.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.418 -2.067 . . . . 74.319999999999993 105.418 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.4 -25.77 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.336 -0.616 . . . . 70.310000000000002 109.336 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -131.95 111.49 11.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.081 -0.509 . . . . 65.129999999999995 110.932 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.0 t -111.65 162.26 15.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.214 -1.032 . . . . 61.119999999999997 108.214 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -99.2 125.77 52.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.836 0.827 . . . . 62.399999999999999 111.677 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 205' ' ' LEU . 7.7 p -102.16 117.97 35.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 114.681 -1.145 . . . . 62.539999999999999 109.263 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.07 161.5 42.42 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.635 -0.876 . . . . 75.549999999999997 108.635 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 211' ' ' LEU . 37.6 pt -89.57 149.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.99 -1.084 . . . . 72.420000000000002 108.558 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.15 159.9 38.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 115.218 -0.901 . . . . 60.310000000000002 111.103 -170.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 63.63 14.79 8.41 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.336 1.054 . . . . 75.0 111.509 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.58 -28.45 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.807 0.843 . . . . 64.310000000000002 112.167 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.85 -31.39 69.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.232 0.539 . . . . 74.230000000000004 110.026 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.49 -53.43 8.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.528 -0.76 . . . . 41.539999999999999 110.311 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 155' ' ' PRO . 81.4 t -63.89 136.78 96.88 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.434 -0.803 . . . . 72.519999999999996 111.302 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 154' ' ' VAL . 19.2 Cg_exo -64.47 154.65 70.57 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.153 1.902 . . . . 54.140000000000001 109.178 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -11.3 15.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 113.616 0.969 . . . . 74.209999999999994 113.616 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.567 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 20.7 p -72.65 -15.23 61.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.601 -0.727 . . . . 62.539999999999999 112.644 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.483 ' HB2' ' CG1' ' A' ' 154' ' ' VAL . 31.9 m170 -120.7 149.51 42.4 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.054 -0.404 . . . . 74.340000000000003 110.531 174.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.534 ' NH2' ' HB3' ' A' ' 251' ' ' PRO . 23.4 ttp180 -133.64 128.09 34.35 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.519 0.728 . . . . 64.040000000000006 110.208 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.4 mtp85 -118.98 119.11 33.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.451 -0.795 . . . . 65.129999999999995 111.026 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m -117.03 145.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.406 -0.961 . . . . 71.310000000000002 108.406 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -103.03 134.42 46.49 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.145 -1.022 . . . . 61.210000000000001 110.209 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 50.0 tp -91.16 116.88 29.16 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.689 -1.597 . . . . 62.219999999999999 106.689 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 12.8 t -135.95 167.47 21.15 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.61 -1.256 . . . . 33.539999999999999 107.61 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.735 ' HE2' ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -78.08 142.28 38.24 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.542 1.163 . . . . 72.409999999999997 114.135 -169.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.26 97.76 3.8 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.299 -1.773 . . . . 72.129999999999995 106.253 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.0 -66.58 3.84 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.462 -1.055 . . . . 74.150000000000006 110.462 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.4 m -139.55 -178.01 5.2 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.79 -1.189 . . . . 63.450000000000003 107.79 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.7 -53.41 22.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 109.361 -0.607 . . . . 74.200000000000003 109.361 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 65.56 160.08 0.13 Allowed Pre-proline 0 N--CA 1.478 0.946 0 O-C-N 124.508 1.13 . . . . 73.450000000000003 111.525 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.54 152.02 81.66 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 121.338 1.359 . . . . 73.230000000000004 108.697 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 172' ' ' LEU . 4.4 mp -68.34 138.19 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.314 -0.555 . . . . 72.019999999999996 110.746 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.98 25.49 1.83 Allowed Glycine 0 C--N 1.32 -0.358 0 N-CA-C 115.839 1.096 . . . . 72.230000000000004 115.839 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -151.48 147.52 26.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 117.305 0.552 . . . . 75.129999999999995 109.869 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 88.5 m-85 -105.12 162.89 12.99 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.302 -0.999 . . . . 71.239999999999995 108.302 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 235' ' ' THR . 27.1 pt -122.42 155.41 27.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.215 0.531 . . . . 51.310000000000002 111.864 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.409 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.4 ptt180 -132.52 167.41 20.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.874 0.87 . . . . 75.120000000000005 109.558 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 231' ' ' LEU . 3.9 p30 -111.22 148.94 31.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.018 -0.537 . . . . 72.310000000000002 111.027 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -172.26 -154.42 10.12 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 108.939 -1.664 . . . . 40.009999999999998 108.939 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.0 p -123.0 139.12 54.41 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 117.402 0.601 . . . . 64.420000000000002 110.769 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.5 t -103.2 143.2 32.94 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.581 -0.896 . . . . 74.439999999999998 108.581 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.33 114.72 33.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.676 -1.231 . . . . 75.310000000000002 107.676 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -108.25 119.27 38.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.966 0.412 . . . . 74.519999999999996 110.025 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 13.1 p -93.68 126.41 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.623 -0.717 . . . . 73.349999999999994 110.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 56.1 p -131.51 -179.09 5.16 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.5 -0.773 . . . . 73.329999999999998 109.628 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.71 -16.12 60.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.402 0.62 . . . . 72.439999999999998 109.777 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.1 m -90.73 -4.59 56.59 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.388 -0.824 . . . . 60.329999999999998 110.17 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.59 -156.9 15.47 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.738 -0.945 . . . . 75.400000000000006 110.738 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 189' ' ' LEU . 2.7 pp -100.78 136.88 39.94 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 117.712 0.756 . . . . 62.240000000000002 111.586 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.3 146.39 50.04 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.46 -0.57 . . . . 75.310000000000002 109.46 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -92.07 134.19 35.06 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.908 -0.775 . . . . 75.519999999999996 108.908 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.19 162.76 55.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.887 -1.153 . . . . 74.329999999999998 107.887 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.88 120.2 7.86 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.774 1.649 . . . . 72.200000000000003 109.801 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -110.12 128.51 8.9 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.539 -0.839 . . . . 70.540000000000006 111.037 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -107.35 116.84 51.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.65 -1.611 . . . . 74.439999999999998 106.65 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 49.2 m-85 -111.7 162.13 15.53 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.174 -0.676 . . . . 75.530000000000001 109.174 -175.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.0 mt -72.9 131.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 43.4 t -86.63 -54.5 4.35 Favored 'General case' 0 C--N 1.284 -2.265 0 O-C-N 121.934 -0.479 . . . . 53.200000000000003 111.252 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -163.26 150.16 12.55 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.802 -0.814 . . . . 75.129999999999995 108.802 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 207' ' ' GLU . 3.8 mm? -93.33 142.47 27.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 123.328 0.393 . . . . 50.130000000000003 109.947 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.18 121.0 69.88 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 107.341 -1.355 . . . . 71.340000000000003 107.341 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.87 124.14 15.53 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.69 1.593 . . . . 73.200000000000003 110.222 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.63 -5.39 76.94 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.802 -0.713 . . . . 41.539999999999999 111.448 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.16 164.11 51.07 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.752 -0.939 . . . . 44.240000000000002 110.752 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.523 HD11 ' OG ' ' A' ' 146' ' ' SER . 37.5 tp -64.19 -47.77 78.52 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.471 0.915 . . . . 74.010000000000005 113.471 -173.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.54 66.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.321 0.581 . . . . 54.43 110.934 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' LEU . 1.8 tm-20 -74.9 -48.07 26.65 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.082 -0.963 . . . . 75.230000000000004 108.957 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 t -72.4 -27.37 62.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.145 -0.479 . . . . 51.210000000000001 111.592 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.433 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 21.6 p -74.52 -33.21 62.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.602 -0.439 . . . . 63.329999999999998 110.126 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.45 27.44 72.52 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.001 -0.84 . . . . 51.509999999999998 111.001 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 148' ' ' ILE . 96.1 mt -96.35 -40.92 8.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.624 0.602 . . . . 72.239999999999995 112.624 -175.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 249' ' ' VAL . 21.6 mt -105.49 163.23 12.8 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.479 -0.888 . . . . 75.510000000000005 108.99 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.89 162.53 28.37 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.324 0.107 . . . . 64.310000000000002 110.895 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.72 -29.63 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.423 0.63 . . . . 74.109999999999999 112.601 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.02 -24.96 58.44 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.972 -0.455 . . . . 74.340000000000003 111.273 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 62.9 m-20 -66.75 142.85 57.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.243 -0.651 . . . . 71.129999999999995 109.243 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 14.6 pt-20 -115.63 146.25 41.97 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.313 -0.555 . . . . 73.239999999999995 109.766 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 249' ' ' VAL . 27.0 m -77.77 142.35 14.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.058 -0.519 . . . . 63.119999999999997 110.334 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.534 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.1 mm -111.9 -55.7 4.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.579 -0.737 . . . . 65.530000000000001 110.01 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' HG22 ' A' ' 219' ' ' ILE . 36.3 mt-10 -141.62 146.51 36.3 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.535 -0.757 . . . . 74.439999999999998 111.687 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 238' ' ' MET . 17.5 m -127.36 101.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 114.816 -1.084 . . . . 74.129999999999995 108.316 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.483 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.9 m-20 63.34 29.57 15.69 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 123.606 0.763 . . . . 74.140000000000001 111.779 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 94.56 -6.79 71.08 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.538 -0.839 . . . . 42.210000000000001 112.158 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.9 mm -84.8 106.02 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.081 -1.081 . . . . 72.25 108.081 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.66 138.07 50.38 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 108.303 -0.999 . . . . 75.409999999999997 108.303 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.14 2.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.877 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.85 123.54 26.4 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.353 -0.98 . . . . 72.099999999999994 108.353 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.24 -2.32 74.67 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.686 -0.769 . . . . 61.310000000000002 111.219 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 29.7 mmmt -106.39 147.79 28.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.019 -0.734 . . . . 74.450000000000003 109.019 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 234' ' ' VAL . 46.0 p -94.59 167.65 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.398 -0.594 . . . . 45.109999999999999 109.398 175.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 178' ' ' ASP . 10.1 mp -58.69 -38.26 77.86 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 120.921 -0.312 . . . . 74.239999999999995 110.478 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.44 -50.99 71.73 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.361 -0.836 . . . . 72.450000000000003 110.287 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 229' ' ' LYS . 97.6 mt-30 -65.82 -46.37 78.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.019 -0.537 . . . . 75.329999999999998 111.795 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 230' ' ' THR . 53.3 t -62.6 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 121.091 -0.244 . . . . 62.539999999999999 111.551 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.437 HG23 HD11 ' A' ' 176' ' ' ILE . 27.6 p -57.6 -48.14 80.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.287 -0.565 . . . . 75.219999999999999 110.955 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -62.12 -38.31 88.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.024 -0.535 . . . . 53.549999999999997 111.363 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -63.2 -46.55 86.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.436 -0.95 . . . . 73.430000000000007 108.436 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.415 ' HB3' HD21 ' A' ' 172' ' ' LEU . 76.4 mtm -66.36 -33.05 74.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.01 0.744 . . . . 70.0 113.01 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 58.9 t -74.45 -35.28 38.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 73.219999999999999 109.134 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.66 87.56 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.844 -0.616 . . . . 63.350000000000001 110.694 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 245' ' ' LEU . 18.6 m120 -103.79 27.43 7.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.801 0.667 . . . . 74.010000000000005 112.801 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 69.0 m -55.21 -24.87 29.51 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.066 1.136 . . . . 73.340000000000003 114.066 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.474 ' O ' ' HE3' ' A' ' 165' ' ' LYS . 43.6 p -64.81 -51.56 61.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.679 0.276 . . . . 72.310000000000002 110.956 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -137.53 97.12 3.38 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.058 0.932 . . . . 75.400000000000006 108.677 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 35.9 tp -123.92 121.34 35.05 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.188 -0.914 . . . . 61.130000000000003 109.926 -176.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 61.5 mt -96.32 115.25 35.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 106.465 -1.68 . . . . 64.530000000000001 106.465 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 59.0 mt -106.84 118.9 55.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.738 -0.838 . . . . 70.400000000000006 108.738 -175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.7 m -109.94 117.45 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.645 -0.502 . . . . 75.5 109.645 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 218' ' ' VAL . 28.7 m -122.85 165.47 18.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.72 -0.844 . . . . 75.349999999999994 108.72 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.534 ' CD ' HD11 ' A' ' 219' ' ' ILE . 13.1 ptmm? -115.61 115.56 41.74 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 109.197 -0.668 . . . . 64.25 109.197 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 157' ' ' THR . 18.4 Cg_endo -59.69 134.57 58.42 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.34 2.026 . . . . 73.109999999999999 112.795 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -116.94 12.8 14.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.959 -1.018 . . . . 52.100000000000001 109.034 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 59.1 t30 72.46 138.98 0.05 Allowed 'General case' 0 C--O 1.244 0.793 0 O-C-N 124.817 1.323 . . . . 73.040000000000006 110.672 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -82.11 74.48 9.09 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.545 0.688 . . . . 75.420000000000002 111.268 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.306 1.443 . . . . 60.119999999999997 108.241 178.582 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 110.375 -1.09 . . . . 53.399999999999999 110.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.9 m -81.64 98.01 8.16 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 117.298 0.549 . . . . 74.519999999999996 111.073 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.48 97.26 6.06 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.885 -0.598 . . . . 72.120000000000005 110.853 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.4 m -148.4 88.04 1.62 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.45 0.643 . . . . 65.120000000000005 111.651 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.67 68.81 0.75 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.013 -1.106 . . . . 64.230000000000004 108.013 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.3 113.36 56.47 Favored Pre-proline 0 N--CA 1.417 -2.104 0 CA-C-N 113.942 -1.481 . . . . 41.130000000000003 109.811 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.39 112.09 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 63.210000000000001 110.585 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.4 p -123.83 34.11 5.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 122.22 1.01 . . . . 71.129999999999995 108.629 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.4 mt -77.61 -25.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.106 -1.406 . . . . 72.319999999999993 108.725 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.7 t 70.41 -164.28 0.16 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.571 -1.27 . . . . 43.200000000000003 107.571 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 138' ' ' ILE . 2.0 mp -79.15 115.88 56.03 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 108.731 -0.84 . . . . 75.450000000000003 108.731 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.32 80.31 3.12 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.691 2.26 . . . . 55.43 114.017 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -154.82 136.66 14.5 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 105.67 -1.974 . . . . 72.219999999999999 105.67 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.66 86.47 7.12 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.145 -1.022 . . . . 63.340000000000003 112.017 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -143.87 -51.92 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.053 -1.43 . . . . 74.420000000000002 108.262 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -142.78 142.25 31.86 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.017 -0.992 . . . . 64.450000000000003 109.838 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.2 t -145.68 137.67 25.38 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.588 -0.893 . . . . 65.329999999999998 108.588 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.86 139.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 113.072 0.767 . . . . 75.140000000000001 113.072 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 p -92.75 127.91 38.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.219 -1.03 . . . . 61.039999999999999 108.219 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.32 155.99 48.78 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.71 -0.223 . . . . 74.549999999999997 111.319 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 211' ' ' LEU . 43.0 mm -95.43 113.2 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.354 -1.35 . . . . 73.430000000000007 107.354 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.743 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -104.6 156.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.49 -0.777 . . . . 52.299999999999997 111.225 -175.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 154' ' ' VAL . 5.2 m-20 67.24 11.18 8.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 72.420000000000002 112.435 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -58.54 -28.88 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.205 0.526 . . . . 74.319999999999993 111.472 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -64.66 -32.82 74.65 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 112.205 0.446 . . . . 74.420000000000002 112.205 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.69 -27.88 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.805 0.668 . . . . 61.119999999999997 112.805 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 150' ' ' ASP . 76.3 t -73.9 127.8 87.68 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 116.19 -0.459 . . . . 71.209999999999994 112.032 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.36 156.77 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.856 2.371 . . . . 62.450000000000003 110.474 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.0 -12.38 0.83 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.448 0.699 . . . . 73.519999999999996 112.621 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.523 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 40.2 p -74.42 -23.71 58.98 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 122.774 0.43 . . . . 71.409999999999997 111.264 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 154' ' ' VAL . 40.3 m170 -119.51 151.86 37.91 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.149 0.5 . . . . 73.540000000000006 111.546 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 159' ' ' ARG . 1.8 tpm_? -131.32 140.17 49.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.741 -1.577 . . . . 72.319999999999993 106.741 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 49.5 mtp180 -130.33 129.59 43.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.926 -0.71 . . . . 73.120000000000005 109.53 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.83 137.45 51.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 120.939 0.4 . . . . 64.230000000000004 110.594 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.554 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.1 tmm_? -100.56 120.35 39.89 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.733 -0.84 . . . . 73.430000000000007 108.733 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 205' ' ' LEU . 5.9 tt -105.37 139.85 39.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.943 -1.132 . . . . 72.299999999999997 107.943 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 25.7 p -128.36 166.22 19.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.086 -177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 1.5 tpmt? -79.86 142.22 35.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.341 -0.845 . . . . 70.510000000000005 110.007 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -131.31 160.59 34.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.56 -1.274 . . . . 74.129999999999995 107.56 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.67 62.09 0.47 Allowed Glycine 0 CA--C 1.522 0.479 0 O-C-N 123.934 0.771 . . . . 32.149999999999999 113.126 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.4 t 179.85 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.405 -1.702 . . . . 72.109999999999999 106.405 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.2 85.65 7.17 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.852 0.834 . . . . 72.329999999999998 111.192 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.88 163.13 17.99 Favored Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 114.245 -1.343 . . . . 70.349999999999994 109.823 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -65.37 157.78 56.14 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.02 2.48 . . . . 65.230000000000004 109.317 170.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 238' ' ' MET . 5.5 mp -59.42 159.84 7.57 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.528 -0.469 . . . . 61.140000000000001 110.497 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . -73.94 22.7 1.16 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 115.288 0.875 . . . . 53.329999999999998 115.288 -174.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -162.29 147.89 12.83 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.941 -0.763 . . . . 72.209999999999994 108.941 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -102.95 162.87 12.58 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.207 -1.405 . . . . 75.340000000000003 107.207 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.45 HD11 ' OG1' ' A' ' 235' ' ' THR . 26.8 pt -123.57 151.8 28.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.767 0.794 . . . . 70.319999999999993 112.424 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 13.1 ptt180 -128.21 169.85 13.68 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.591 -1.186 . . . . 74.430000000000007 108.683 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -117.9 163.06 17.11 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 109.301 -0.629 . . . . 75.25 109.301 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.53 -158.16 30.92 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 110.453 -1.059 . . . . 10.44 110.453 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 137.97 54.6 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.863 0.364 . . . . 61.100000000000001 110.588 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.8 t -103.39 138.78 39.67 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.058 -1.09 . . . . 75.099999999999994 108.058 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.35 114.84 35.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.709 -0.848 . . . . 75.340000000000003 108.709 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -108.34 133.38 52.63 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.941 -0.572 . . . . 74.109999999999999 110.038 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.57 119.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 108.833 -0.803 . . . . 74.319999999999993 108.833 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.1 p -118.63 -178.86 3.64 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.992 -0.744 . . . . 71.219999999999999 108.992 176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -75.03 -15.35 60.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.326 0.584 . . . . 55.140000000000001 110.196 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.9 m -85.79 -23.1 27.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.489 -0.778 . . . . 31.129999999999999 110.214 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.85 -137.21 9.08 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 110.93 -0.868 . . . . 62.109999999999999 110.93 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 189' ' ' LEU . 61.8 mt -101.45 143.21 31.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 113.123 0.786 . . . . 72.25 113.123 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -137.41 140.15 41.15 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 114.794 -1.094 . . . . 72.109999999999999 108.795 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -113.64 125.78 54.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 119.923 -0.711 . . . . 70.099999999999994 110.219 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.07 141.0 37.26 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.292 -0.867 . . . . 45.520000000000003 109.882 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.66 119.63 6.91 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.09 1.86 . . . . 72.549999999999997 110.419 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -126.68 157.92 20.57 Favored Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 120.829 -0.701 . . . . 72.319999999999993 111.717 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 231' ' ' LEU . 25.6 mm -108.54 117.35 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.218 -1.401 . . . . 74.140000000000001 107.218 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 84.5 m-85 -111.07 161.94 15.4 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 110.16 -0.311 . . . . 65.510000000000005 110.16 -174.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -72.9 131.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.413 -0.958 . . . . 74.140000000000001 108.413 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 47.5 t -87.05 -48.63 7.93 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.824 -0.547 . . . . 63.240000000000002 111.068 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -165.21 154.7 12.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.652 -0.87 . . . . 75.439999999999998 108.652 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.49 141.88 28.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.814 0.34 . . . . 65.140000000000001 110.605 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 59.0 t -96.14 124.8 50.46 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 107.597 -1.26 . . . . 61.32 107.597 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.57 124.81 17.2 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.494 2.13 . . . . 51.420000000000002 111.836 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.52 81.91 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.691 -0.686 . . . . 53.140000000000001 111.641 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -84.59 165.08 40.2 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 121.153 -0.546 . . . . 34.210000000000001 112.262 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 163' ' ' LEU . 29.4 tp -52.78 -52.74 55.51 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.623 0.971 . . . . 75.319999999999993 113.623 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.76 -28.16 58.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.057 0.456 . . . . 63.130000000000003 111.331 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 -49.02 28.11 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.307 -0.861 . . . . 73.040000000000006 108.748 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.7 t -63.78 -36.59 84.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.659 -0.7 . . . . 73.140000000000001 110.857 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.528 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 45.9 p -82.31 -33.73 28.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.399 -0.52 . . . . 74.200000000000003 110.869 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.37 22.42 71.16 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.117 -0.793 . . . . 62.310000000000002 111.117 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 148' ' ' ILE . 97.0 mt -88.4 -20.12 25.68 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 111.914 0.339 . . . . 75.120000000000005 111.914 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 249' ' ' VAL . 27.0 mt -125.49 149.38 48.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.231 -1.025 . . . . 52.439999999999998 108.231 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.15 164.04 15.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.098 0.249 . . . . 24.25 110.957 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.89 -31.91 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.667 0.787 . . . . 72.530000000000001 112.118 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.97 -26.32 59.5 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.504 -0.878 . . . . 74.099999999999994 112.635 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 68.4 m-20 -65.4 144.64 56.94 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.483 0.489 . . . . 72.430000000000007 111.074 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 12.7 pt-20 -111.53 148.61 32.84 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 110.457 -177.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 249' ' ' VAL . 35.6 m -86.32 134.26 27.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.797 -0.638 . . . . 64.010000000000005 109.432 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.428 HG22 ' HG3' ' A' ' 220' ' ' GLU . 49.2 mm -102.09 -41.61 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.01 0.433 . . . . 71.430000000000007 110.544 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' A' ' 219' ' ' ILE . 44.0 mt-10 -143.75 156.47 44.52 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.343 0.592 . . . . 71.340000000000003 111.246 -176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.33 101.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.304 -1.316 . . . . 63.229999999999997 108.216 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.599 ' OD1' HD12 ' A' ' 245' ' ' LEU . 4.2 m-20 67.16 11.46 8.4 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.709 1.204 . . . . 73.209999999999994 113.475 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.22 -11.33 24.31 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 110.426 -1.069 . . . . 64.230000000000004 110.426 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.07 109.93 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.419 -1.326 . . . . 73.349999999999994 107.419 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.2 135.8 57.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 109.255 -0.646 . . . . 70.299999999999997 109.255 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 219' ' ' ILE . 33.6 m -79.57 -1.39 4.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.795 -0.638 . . . . 74.010000000000005 111.0 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.3 122.61 19.24 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.887 -0.782 . . . . 75.25 108.887 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.98 55.06 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.922 -0.656 . . . . 74.400000000000006 112.811 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.56 152.46 24.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 234' ' ' VAL . 18.0 p -91.69 162.07 14.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.206 -0.664 . . . . 71.019999999999996 109.206 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 195' ' ' ILE . 9.7 mp -55.46 -42.97 75.05 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 118.066 0.394 . . . . 60.119999999999997 110.802 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -57.08 -41.77 79.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.983 -0.553 . . . . 60.140000000000001 110.413 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.44 -44.2 45.59 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 113.296 0.85 . . . . 71.340000000000003 113.296 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 230' ' ' THR . 47.3 t -64.94 -47.55 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 121.005 -0.278 . . . . 74.430000000000007 111.252 -178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.45 ' OG1' HD11 ' A' ' 176' ' ' ILE . 3.8 m -66.4 -42.21 88.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.061 -0.718 . . . . 53.409999999999997 109.061 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.83 -39.02 92.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.492 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -60.3 -42.29 95.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.205 -1.406 . . . . 63.32 107.205 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.529 ' HB3' HD21 ' A' ' 172' ' ' LEU . 71.8 mtm -62.67 -48.73 78.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.797 -1.092 . . . . 65.049999999999997 113.106 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 45.0 t -66.74 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 121.413 0.625 . . . . 74.310000000000002 109.643 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.6 81.22 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.669 0.788 . . . . 53.43 110.721 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 245' ' ' LEU . 0.9 OUTLIER -102.13 30.22 4.62 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.512 -0.767 . . . . 75.109999999999999 111.699 -178.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 39.3 t -59.47 -16.5 24.41 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.458 -0.337 . . . . 65.540000000000006 111.535 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 20.5 p -64.28 -52.99 55.89 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 110.178 177.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -150.1 102.21 3.08 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.911 -1.144 . . . . 61.25 107.911 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 222' ' ' ASN . 49.3 tp -120.89 129.71 53.61 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.048 -0.978 . . . . 61.109999999999999 109.601 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 149' ' ' ILE . 68.6 mt -112.52 115.16 49.07 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.61 0 N-CA-C 107.944 -1.132 . . . . 63.420000000000002 107.944 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 4.2 mp -106.94 122.51 61.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.526 -0.47 . . . . 70.030000000000001 110.47 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.2 m -97.95 126.11 43.2 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.699 -1.223 . . . . 71.140000000000001 107.699 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.595 HG21 HD22 ' A' ' 212' ' ' LEU . 28.2 m -129.03 166.35 26.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.72 -0.845 . . . . 74.310000000000002 108.72 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -125.09 137.33 29.51 Favored Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 106.176 -1.787 . . . . 75.239999999999995 106.176 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 33.5 Cg_endo -66.95 133.07 29.99 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 CA-C-N 119.255 0.77 . . . . 73.109999999999999 110.427 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -93.99 -2.76 52.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.212 -1.033 . . . . 71.310000000000002 108.212 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -87.71 80.1 8.02 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.519 -1.218 . . . . 62.350000000000001 108.37 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -119.63 89.53 3.15 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.316 -1.311 . . . . 75.450000000000003 108.564 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 104.877 -2.268 . . . . 74.239999999999995 104.877 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.755 -0.938 . . . . 61.43 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 m -87.55 -35.29 18.23 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.903 0.352 . . . . 75.510000000000005 110.23 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 58.72 82.42 0.14 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.979 -1.009 . . . . 74.409999999999997 108.871 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.3 t -73.25 103.41 3.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.97 0.891 . . . . 54.450000000000003 111.873 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 5.9 mmpt? -102.31 -19.71 14.9 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.371 -0.831 . . . . 55.399999999999999 109.976 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.94 109.29 14.41 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 109.163 -0.68 . . . . 72.120000000000005 109.163 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 55.5 Cg_endo -75.71 139.73 22.81 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.45 2.1 . . . . 64.420000000000002 111.729 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 p -78.75 -19.95 51.08 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.501 0.667 . . . . 50.119999999999997 109.981 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.66 100.21 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.268 -0.878 . . . . 61.439999999999998 110.427 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.3 t -153.04 122.53 6.75 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.412 -1.699 . . . . 73.209999999999994 106.412 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.4 pp -79.84 143.57 58.31 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 112.776 0.658 . . . . 61.009999999999998 112.776 -175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.65 110.25 0.7 Allowed 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.844 2.363 . . . . 74.219999999999999 111.504 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -134.24 19.81 3.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.826 -0.624 . . . . 63.32 110.862 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.17 71.8 4.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.959 0.885 . . . . 72.519999999999996 111.062 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.74 -24.97 14.83 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.732 -1.951 . . . . 75.109999999999999 105.732 171.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -116.88 148.59 41.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.36 -1.746 . . . . 71.109999999999999 106.468 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 4.0 t -109.35 128.43 55.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 104.189 -2.523 . . . . 64.219999999999999 104.189 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.96 127.76 67.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 114.527 1.306 . . . . 34.219999999999999 114.527 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.9 p -98.97 122.09 41.78 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.463 -1.244 . . . . 74.400000000000006 107.95 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.52 156.57 42.62 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.84 0.087 . . . . 44.009999999999998 110.873 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 211' ' ' LEU . 29.7 mm -95.06 103.73 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.703 -1.592 . . . . 53.340000000000003 106.703 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -99.43 151.75 4.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.119 -0.946 . . . . 72.319999999999993 111.582 -173.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 64.36 25.06 13.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.155 0.982 . . . . 74.230000000000004 108.687 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.18 -28.78 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 72.400000000000006 111.796 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -74.83 -20.85 59.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.362 0.601 . . . . 64.340000000000003 109.857 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.02 -56.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.457 -0.792 . . . . 75.209999999999994 111.047 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 8.6 p -69.31 141.0 90.72 Favored Pre-proline 0 N--CA 1.424 -1.74 0 CA-C-N 115.93 -0.577 . . . . 63.299999999999997 112.418 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 6.1 Cg_exo -75.35 155.82 41.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.886 2.391 . . . . 42.219999999999999 110.279 174.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.33 -11.81 53.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.637 0.606 . . . . 70.200000000000003 112.637 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.543 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 13.1 p -75.94 -1.56 26.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.453 0.644 . . . . 73.209999999999994 110.872 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -127.32 152.23 47.73 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.29 1.036 . . . . 74.310000000000002 108.439 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 248' ' ' THR . 19.5 tpp180 -125.56 130.65 52.13 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.502 -1.666 . . . . 73.319999999999993 106.502 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 65.1 mtp85 -122.8 117.34 25.43 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.623 -0.431 . . . . 75.019999999999996 110.075 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.48 135.05 60.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.828 -0.434 . . . . 63.450000000000003 109.828 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.2 tmm_? -100.14 119.83 38.93 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.16 -1.422 . . . . 74.219999999999999 107.16 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 172' ' ' LEU . 6.1 tt -97.64 139.14 33.98 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.966 -1.124 . . . . 73.439999999999998 107.966 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 162' ' ' ARG . 26.5 p -129.9 162.61 28.2 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.36 -0.382 . . . . 70.420000000000002 110.994 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 242' ' ' SER . 33.7 mmtp -118.15 138.72 52.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 121.505 0.669 . . . . 74.430000000000007 111.56 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -146.46 96.84 2.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.692 -1.596 . . . . 73.439999999999998 106.692 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.29 -31.69 7.44 Favored Glycine 0 C--N 1.295 -1.71 0 N-CA-C 107.677 -2.169 . . . . 44.140000000000001 107.677 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.3 m 62.37 175.55 0.14 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 115.092 1.515 . . . . 71.019999999999996 115.092 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.274 3.4 m-20 64.53 -0.21 0.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.784 1.772 . . . . 63.509999999999998 115.784 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.3 tttt -78.67 128.57 76.78 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 108.727 -0.842 . . . . 75.349999999999994 108.727 175.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 52.8 Cg_exo -57.27 155.46 29.64 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.131 2.554 . . . . 64.430000000000007 111.601 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 238' ' ' MET . 4.5 mp -69.26 153.12 44.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.594 -0.442 . . . . 62.420000000000002 109.908 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -76.33 27.91 1.48 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.839 1.096 . . . . 52.219999999999999 115.839 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CZ ' HG12 ' A' ' 247' ' ' ILE . 51.0 p90 -162.28 147.89 12.86 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 117.433 0.617 . . . . 74.430000000000007 110.288 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.48 161.08 15.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.219 -1.4 . . . . 63.439999999999998 107.219 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.5 159.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 118.201 0.455 . . . . 74.430000000000007 111.793 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 196' ' ' PHE . 25.1 ptt180 -138.04 160.26 39.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.571 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.5 162.63 13.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.912 -1.04 . . . . 74.099999999999994 110.171 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 165.82 -162.37 35.84 Favored Glycine 0 C--N 1.29 -2.02 0 N-CA-C 108.961 -1.656 . . . . 43.229999999999997 108.961 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.2 p -123.66 140.1 53.33 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 117.553 0.677 . . . . 61.310000000000002 111.99 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t -103.43 146.17 28.9 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.497 -1.297 . . . . 40.049999999999997 107.497 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.5 123.82 61.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 110.143 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.523 ' HB2' ' OE1' ' A' ' 192' ' ' GLN . 30.4 tpt180 -112.51 128.84 56.46 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.498 -0.556 . . . . 73.25 109.498 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.62 113.39 29.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.068 -0.716 . . . . 75.329999999999998 109.068 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 47.6 p -119.86 -177.34 3.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.03 -0.73 . . . . 75.209999999999994 109.03 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.28 -15.33 61.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.331 0.586 . . . . 71.420000000000002 109.871 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -82.23 -14.6 55.28 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.597 -0.728 . . . . 71.340000000000003 109.465 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.59 -147.95 17.69 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 109.975 -1.25 . . . . 52.140000000000001 109.975 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.7 pp -97.58 124.24 41.76 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.794 0.797 . . . . 74.120000000000005 110.191 176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.5 146.62 47.94 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.821 -0.627 . . . . 62.130000000000003 110.888 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.37 137.2 37.42 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.974 -0.557 . . . . 71.329999999999998 110.978 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.523 ' OE1' ' HB2' ' A' ' 183' ' ' ARG . 46.5 mt-30 -121.6 153.58 59.54 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 107.599 -1.26 . . . . 73.219999999999999 107.599 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.19 113.24 3.01 Favored 'Trans proline' 0 C--O 1.242 0.683 0 N-CA-C 107.855 -1.633 . . . . 63.109999999999999 107.855 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -107.75 137.33 13.97 Favored Glycine 0 CA--C 1.481 -2.036 0 C-N-CA 120.024 -1.084 . . . . 75.319999999999993 113.077 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.61 117.79 54.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.01 -1.478 . . . . 74.400000000000006 107.01 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 217' ' ' GLU . 57.4 m-85 -114.51 166.37 11.77 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.368 -0.604 . . . . 52.009999999999998 109.368 -176.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.96 132.87 32.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.49 -1.3 . . . . 74.540000000000006 107.49 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 32.5 t -92.31 -46.55 7.64 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.418 -0.513 . . . . 62.539999999999999 110.957 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -164.38 154.67 14.58 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.1 -1.444 . . . . 74.310000000000002 107.1 -172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.02 143.82 36.19 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.159 -0.616 . . . . 74.329999999999998 111.435 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.72 123.21 72.73 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 108.254 -1.017 . . . . 74.329999999999998 108.254 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.29 125.24 18.49 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.369 2.046 . . . . 75.329999999999998 110.636 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.6 12.13 80.68 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.863 -0.684 . . . . 53.100000000000001 111.918 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -92.5 163.36 27.37 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.072 -0.811 . . . . 21.440000000000001 111.072 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 54.5 tp -48.72 -51.1 30.57 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.496 0.924 . . . . 61.310000000000002 113.496 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 212' ' ' LEU . . . -74.02 -30.7 62.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.915 0.388 . . . . 54.049999999999997 111.463 -175.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -47.95 25.83 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.574 -0.739 . . . . 75.530000000000001 109.039 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 62.4 m -66.01 -32.59 74.16 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.547 0.573 . . . . 71.219999999999999 112.547 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 41.8 p -86.0 -32.87 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.605 -0.438 . . . . 74.129999999999995 111.222 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.26 22.58 76.26 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.326 -0.709 . . . . 42.219999999999999 111.326 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 148' ' ' ILE . 91.2 mt -97.65 -4.47 37.35 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.075 0.464 . . . . 62.210000000000001 111.466 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 2.5 mp -132.45 133.41 43.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.557 -1.646 . . . . 63.329999999999998 106.557 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.78 162.03 13.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.61 0.243 . . . . 71.129999999999995 110.385 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.54 -31.36 46.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 C-N-CA 123.449 0.699 . . . . 74.420000000000002 112.187 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 254' ' ' GLN . 0.8 OUTLIER -80.14 -21.89 42.65 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 113.476 0.917 . . . . 64.409999999999997 113.476 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 82.9 m-20 -61.77 144.46 54.69 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.044 0.926 . . . . 74.019999999999996 112.397 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 196' ' ' PHE . 37.0 tt0 -99.86 139.9 34.86 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.243 -1.344 . . . . 74.430000000000007 109.061 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 249' ' ' VAL . 19.4 m -89.11 139.9 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 120.219 -0.593 . . . . 74.239999999999995 109.438 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 226' ' ' VAL . 48.0 mm -106.13 -52.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.451 0.643 . . . . 72.510000000000005 110.623 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -139.3 145.43 39.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 115.659 -0.7 . . . . 61.350000000000001 112.378 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.67 107.35 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-N 114.601 -1.181 . . . . 51.140000000000001 108.632 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 66.4 t30 72.97 -70.61 0.16 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.123 2.169 . . . . 75.209999999999994 109.939 -173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 107.981 -2.048 . . . . 44.100000000000001 107.981 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.0 mm -115.07 123.26 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 107.082 -1.451 . . . . 73.239999999999995 107.082 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -68.79 134.62 49.99 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.127 -0.694 . . . . 65.219999999999999 109.127 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 218' ' ' VAL . 31.3 m -84.86 -13.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 120.947 -0.301 . . . . 73.510000000000005 110.827 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -65.23 122.57 17.41 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 123.779 0.674 . . . . 34.130000000000003 110.817 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 -16.91 59.1 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-N 115.347 -0.842 . . . . 73.549999999999997 112.979 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -95.3 158.32 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 117.397 0.599 . . . . 72.140000000000001 110.465 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.4 p -82.83 166.34 19.07 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.604 -0.439 . . . . 73.349999999999994 110.256 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.09 -37.6 83.3 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.693 0.282 . . . . 65.450000000000003 110.792 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.411 -0.813 . . . . 73.409999999999997 110.02 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.11 -34.99 64.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 113.215 0.821 . . . . 72.540000000000006 113.215 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 230' ' ' THR . 56.2 t -68.26 -46.5 80.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.689 -0.804 . . . . 73.319999999999993 109.759 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.6 p -61.2 -44.68 96.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.05 -0.66 . . . . 44.200000000000003 111.209 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -53.7 -45.13 70.28 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.087 0.555 . . . . 61.020000000000003 111.159 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.49 -46.46 82.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.086 -0.709 . . . . 74.200000000000003 109.086 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.456 ' HB3' HD21 ' A' ' 172' ' ' LEU . 74.8 mtm -63.62 -41.35 98.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.556 -0.747 . . . . 72.409999999999997 112.918 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.407 ' HA ' ' HB3' ' A' ' 242' ' ' SER . 98.8 t -68.78 -31.91 52.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.3 0.572 . . . . 44.219999999999999 109.77 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.96 99.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.804 -0.634 . . . . 65.510000000000005 110.957 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 241' ' ' ASN . 0.7 OUTLIER -103.01 21.56 15.51 Favored 'General case' 0 C--O 1.201 -1.459 0 CA-C-N 115.872 -0.604 . . . . 71.420000000000002 109.69 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 81.1 p -56.87 -29.89 63.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.345 1.609 . . . . 73.510000000000005 115.345 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 164' ' ' CYS . 19.3 p -71.61 -30.76 66.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.682 0.623 . . . . 75.329999999999998 112.682 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -143.31 95.26 2.73 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.154 -1.054 . . . . 73.140000000000001 108.154 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 241' ' ' ASN . 65.1 tp -130.08 134.8 47.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.028 -0.533 . . . . 72.239999999999995 111.342 -175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 149' ' ' ILE . 85.3 mt -104.08 116.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 N-CA-C 108.422 -0.955 . . . . 61.43 108.422 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG12 ' CZ ' ' A' ' 174' ' ' PHE . 3.3 mp -106.04 119.85 56.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.446 -0.902 . . . . 74.239999999999995 109.051 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.0 m -110.36 117.05 32.58 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 218' ' ' VAL . 22.9 m -123.95 171.93 12.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.657 -0.868 . . . . 55.009999999999998 108.657 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -126.73 128.25 24.31 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.709 -0.478 . . . . 74.219999999999999 109.709 172.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 157' ' ' THR . 19.0 Cg_endo -59.67 134.68 59.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.374 2.05 . . . . 53.409999999999997 111.556 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.07 -11.47 43.98 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.383 -0.826 . . . . 71.109999999999999 110.569 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 53.25 45.3 28.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.835 -0.802 . . . . 75.420000000000002 108.835 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 215' ' ' ASN . 14.3 pt20 -44.43 101.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 117.524 2.416 . . . . 71.099999999999994 117.524 -171.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 254' ' ' GLN . 15.8 ttm180 . . . . . 0 CA--C 1.511 -0.546 0 C-N-CA 125.485 1.514 . . . . 75.120000000000005 108.655 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.771 0 N-CA-C 111.486 -0.646 . . . . 54.310000000000002 111.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -77.47 138.74 39.41 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 111.766 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -105.23 -37.88 6.73 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.742 -0.663 . . . . 73.420000000000002 109.304 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.8 m 71.9 -33.5 0.27 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.617 1.167 . . . . 71.310000000000002 112.363 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.593 ' N ' ' HE3' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -64.05 145.17 56.37 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 110.137 -0.32 . . . . 64.540000000000006 110.137 176.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.49 109.32 56.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 108.223 -1.029 . . . . 72.230000000000004 108.223 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 103.38 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.46 2.774 . . . . 61.25 113.935 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 m -152.67 93.08 1.73 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.564 -1.272 . . . . 74.150000000000006 107.564 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.9 mt -119.2 117.0 52.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.869 -0.605 . . . . 65.209999999999994 110.39 -176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.0 m -74.78 106.11 6.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.661 -0.866 . . . . 60.539999999999999 108.661 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 138' ' ' ILE . 2.4 pp -103.3 143.87 27.49 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 113.62 0.97 . . . . 70.349999999999994 113.62 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.4 138.34 38.62 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.573 2.182 . . . . 73.450000000000003 109.854 170.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . 0.268 16.3 p-80 -81.48 61.62 5.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 115.466 1.654 . . . . 63.310000000000002 115.466 -173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -179.01 89.78 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 123.834 0.854 . . . . 73.010000000000005 111.928 171.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -131.15 102.9 6.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.209 -0.905 . . . . 75.209999999999994 109.789 171.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -88.2 102.91 15.27 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.051 -1.833 . . . . 74.519999999999996 106.051 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 3.3 p -113.6 162.11 16.61 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 114.375 1.25 . . . . 63.509999999999998 114.375 -168.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.57 142.16 16.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.263 -1.335 . . . . 45.25 108.432 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 161' ' ' VAL . 9.0 m -70.88 139.64 50.84 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.236 0.541 . . . . 74.340000000000003 109.842 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.58 153.53 20.0 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.731 -0.84 . . . . 72.239999999999995 108.731 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 40.3 mm -95.59 112.7 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.024 -1.473 . . . . 74.099999999999994 107.024 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.691 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -105.83 170.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.233 -0.439 . . . . 61.450000000000003 110.643 -177.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 60.78 24.63 14.52 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.941 0.775 . . . . 74.510000000000005 111.806 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.51 -29.73 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.381 0.882 . . . . 72.530000000000001 113.381 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.67 -24.61 56.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.925 0.393 . . . . 62.329999999999998 110.589 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.4 mm -99.02 -48.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.04 -0.527 . . . . 74.329999999999998 110.899 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.2 122.71 65.46 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 114.434 1.272 . . . . 75.109999999999999 114.434 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.03 156.3 30.27 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.428 2.752 . . . . 72.409999999999997 109.736 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.98 -26.32 10.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 124.26 1.024 . . . . 72.409999999999997 113.308 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 3.3 t -74.85 -16.14 60.7 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.976 -0.556 . . . . 55.420000000000002 112.325 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 25.6 m170 -113.34 160.87 17.91 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.629 -0.669 . . . . 62.149999999999999 110.644 176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 211' ' ' LEU . 22.1 ttp180 -144.18 118.63 9.67 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.888 -0.597 . . . . 74.439999999999998 110.42 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 91.3 mtt180 -112.39 125.58 54.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.897 -0.592 . . . . 73.319999999999993 112.152 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 212' ' ' LEU . 17.7 m -118.59 141.48 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.483 -0.781 . . . . 63.340000000000003 109.33 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -102.16 134.08 45.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.196 -0.668 . . . . 71.329999999999998 109.196 -176.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.578 HD22 HD23 ' A' ' 172' ' ' LEU . 46.6 tp -90.87 134.93 34.07 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.623 0.769 . . . . 53.149999999999999 109.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.14 152.48 33.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.961 -1.018 . . . . 60.149999999999999 110.042 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 1.2 tpmt? -86.31 121.27 28.64 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.664 0.616 . . . . 73.439999999999998 112.664 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.419 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 29.7 t-80 -110.64 146.72 35.68 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.822 -2.288 . . . . 74.430000000000007 104.822 168.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.12 64.49 2.38 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.783 -0.723 . . . . 71.030000000000001 112.519 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 26.4 m -148.79 112.15 4.98 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.517 -0.92 . . . . 65.109999999999999 108.517 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.71 81.62 8.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.182 0.991 . . . . 70.420000000000002 109.564 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 171' ' ' PRO . 67.9 mttm -135.58 167.3 22.95 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 113.87 -1.514 . . . . 75.409999999999997 107.117 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 170' ' ' LYS . 8.0 Cg_endo -52.28 154.79 10.43 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.556 2.171 . . . . 65.209999999999994 111.636 175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 163' ' ' LEU . 4.7 mp -59.98 -51.27 70.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.909 -0.587 . . . . 42.240000000000002 111.904 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 204' ' ' GLY . . . 156.4 5.59 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.451 -1.357 . . . . 60.340000000000003 114.312 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -145.98 147.87 32.15 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.144 0.472 . . . . 75.200000000000003 110.784 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' VAL . 91.5 m-85 -98.81 149.28 23.04 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.567 -1.271 . . . . 75.439999999999998 107.567 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 24.7 pt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.026 0.441 . . . . 60.299999999999997 111.223 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -130.13 177.55 7.22 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.298 -0.864 . . . . 72.239999999999995 108.669 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 231' ' ' LEU . 4.7 p-10 -113.88 162.17 16.69 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.774 -0.824 . . . . 64.430000000000007 108.774 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.15 -151.7 10.9 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.165 -1.574 . . . . 34.240000000000002 109.165 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.2 p -124.23 128.7 49.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 117.579 0.69 . . . . 75.439999999999998 112.102 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.8 t -103.73 145.37 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.883 -1.154 . . . . 75.299999999999997 107.883 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.19 129.33 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 121.558 0.694 . . . . 72.329999999999998 110.205 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.558 ' HG3' HG23 ' A' ' 185' ' ' THR . 30.5 tpt180 -117.65 131.62 56.62 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.441 -0.8 . . . . 72.010000000000005 109.909 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.91 113.81 30.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 108.312 -0.996 . . . . 71.439999999999998 108.312 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 183' ' ' ARG . 24.4 p -118.79 -175.31 2.87 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.539 -0.3 . . . . 61.109999999999999 111.406 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.96 -20.02 61.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.979 0.419 . . . . 52.149999999999999 110.638 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -89.64 -9.15 50.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.062 -0.517 . . . . 54.219999999999999 111.128 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.53 -135.05 9.65 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 111.58 -0.608 . . . . 53.229999999999997 111.58 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 189' ' ' LEU . 60.7 mt -100.51 134.26 43.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 121.448 0.642 . . . . 63.310000000000002 112.139 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -129.41 138.52 51.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.771 -1.104 . . . . 74.439999999999998 109.587 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -113.21 134.62 54.49 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.617 -0.512 . . . . 64.040000000000006 109.617 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.31 163.71 49.15 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.534 -0.757 . . . . 52.130000000000003 109.286 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.94 109.18 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.224 1.949 . . . . 62.329999999999998 110.098 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -103.4 145.75 16.29 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.034 -0.826 . . . . 72.209999999999994 111.034 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.8 mm -106.21 117.93 52.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.08 -1.452 . . . . 64.040000000000006 107.08 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 217' ' ' GLU . 69.0 m-85 -113.14 158.62 20.17 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.025 -0.361 . . . . 71.400000000000006 110.025 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 66.1 mt -72.42 133.11 32.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.589 -1.263 . . . . 75.430000000000007 107.589 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 33.6 t -96.22 -46.01 6.61 Favored 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.823 -0.548 . . . . 72.329999999999998 110.728 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -165.74 156.38 13.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.771 -0.825 . . . . 71.209999999999994 108.771 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.25 143.88 26.19 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.708 0.29 . . . . 74.450000000000003 110.438 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.487 HG22 ' CZ ' ' A' ' 175' ' ' TYR . 67.8 t -89.38 118.76 69.39 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 108.009 -1.108 . . . . 72.409999999999997 108.009 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.3 124.39 14.01 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 122.9 2.4 . . . . 60.450000000000003 112.268 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.97 -2.3 87.03 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.955 -0.566 . . . . 42.340000000000003 112.517 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 173' ' ' GLY . . . -80.32 169.05 52.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 111.679 -0.568 . . . . 64.209999999999994 111.679 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 163' ' ' LEU . 26.4 tp -50.34 -53.15 31.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.96 0.726 . . . . 75.25 112.96 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.21 59.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.145 -0.48 . . . . 70.430000000000007 111.893 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -73.6 -39.79 64.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 34.2 t -72.65 -35.83 67.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.589 -0.732 . . . . 54.340000000000003 111.557 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.6 t -90.76 -26.74 19.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 120.093 -0.643 . . . . 61.130000000000003 111.606 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.77 93.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.596 -0.335 . . . . 64.439999999999998 113.135 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 159' ' ' ARG . 87.3 mt -115.42 2.52 13.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.334 0.494 . . . . 70.239999999999995 112.334 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 161' ' ' VAL . 1.2 mm? -129.55 145.71 51.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.524 -1.287 . . . . 64.239999999999995 107.524 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -95.07 156.37 16.34 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.362 -0.607 . . . . 62.409999999999997 109.362 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.16 -30.92 51.39 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-O 122.119 0.961 . . . . 53.200000000000003 109.928 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.07 -22.08 45.83 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 114.445 1.276 . . . . 71.239999999999995 114.445 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 69.4 m-20 -61.29 145.15 52.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.618 0.723 . . . . 62.329999999999998 111.976 -172.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 10.9 pt-20 -108.3 133.98 51.76 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.002 -0.999 . . . . 64.450000000000003 110.6 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 249' ' ' VAL . 30.0 m -76.6 131.77 34.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.159 0.504 . . . . 64.530000000000001 111.038 -177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 220' ' ' GLU . 46.9 mm -101.16 -49.06 11.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.926 -0.579 . . . . 73.420000000000002 109.804 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.476 ' HG3' HG22 ' A' ' 219' ' ' ILE . 51.8 mt-10 -139.78 145.59 38.41 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.562 -0.745 . . . . 73.099999999999994 111.231 -178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.76 109.06 25.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 114.757 -1.11 . . . . 63.450000000000003 108.854 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.408 ' HB2' HD12 ' A' ' 245' ' ' LEU . 65.8 t30 76.86 -53.1 0.57 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 127.402 2.281 . . . . 73.340000000000003 109.858 -175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.446 ' H ' ' H ' ' A' ' 224' ' ' ILE . . . 171.06 21.34 0.02 OUTLIER Glycine 0 C--N 1.283 -2.407 0 N-CA-C 107.89 -2.084 . . . . 62.439999999999998 107.89 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.446 ' H ' ' H ' ' A' ' 223' ' ' GLY . 42.8 mm -111.56 125.24 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 107.072 -1.455 . . . . 71.120000000000005 107.072 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.55 146.41 53.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.098 0.475 . . . . 64.549999999999997 110.31 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.16 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.503 -0.771 . . . . 75.319999999999993 110.557 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.48 21.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.907 -0.588 . . . . 75.439999999999998 110.325 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.53 -10.04 64.75 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.907 -0.663 . . . . 43.340000000000003 111.683 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -102.05 149.85 23.83 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.264 0.555 . . . . 60.229999999999997 112.088 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 234' ' ' VAL . 21.4 p -87.33 169.17 12.51 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.04 -0.982 . . . . 55.310000000000002 108.932 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 178' ' ' ASP . 9.1 mp -62.02 -32.03 72.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.62 -0.264 . . . . 65.129999999999995 110.617 176.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -61.17 -49.83 75.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.413 -0.588 . . . . 61.329999999999998 109.413 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 12.5 mm-40 -67.32 -41.43 85.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.589 -0.732 . . . . 63.43 112.062 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 230' ' ' THR . 44.4 t -68.42 -45.91 81.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 120.435 -0.506 . . . . 71.299999999999997 111.214 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.8 p -58.8 -45.95 88.72 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.243 -0.583 . . . . 64.430000000000007 110.781 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.77 -42.16 78.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.836 -0.62 . . . . 73.420000000000002 111.607 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -64.96 -44.59 88.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.603 -0.888 . . . . 74.540000000000006 108.603 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.492 ' HG2' HD21 ' A' ' 245' ' ' LEU . 75.9 mtm -68.06 -35.32 78.02 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.776 0.658 . . . . 72.230000000000004 112.776 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.43 -25.9 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.203 0.525 . . . . 64.329999999999998 109.623 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.34 -42.27 93.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.422 0.629 . . . . 52.039999999999999 109.653 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' HD13 ' A' ' 245' ' ' LEU . 84.9 m-20 -103.18 35.47 2.54 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.874 . . . . 73.140000000000001 111.055 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 61.3 p -64.15 -16.03 61.04 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.286 0.847 . . . . 63.240000000000002 113.286 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.4 m -78.0 -54.25 6.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.952 0.406 . . . . 74.109999999999999 110.265 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.28 106.05 5.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.96 -0.756 . . . . 75.140000000000001 108.96 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 238' ' ' MET . 49.9 tp -129.23 135.84 49.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.399 -0.364 . . . . 75.430000000000007 110.504 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 62.5 mt -96.9 114.98 35.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.881 -1.525 . . . . 70.209999999999994 106.881 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.3 mp -106.95 121.33 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.943 -1.098 . . . . 74.319999999999993 109.899 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 26.1 m -106.6 117.71 34.77 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.306 -0.628 . . . . 61.420000000000002 109.306 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 218' ' ' VAL . 31.5 m -122.0 164.69 18.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.894 -1.15 . . . . 64.109999999999999 107.894 175.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -134.96 132.94 20.59 Favored Pre-proline 0 C--N 1.28 -2.45 0 N-CA-C 108.87 -0.789 . . . . 70.340000000000003 108.87 169.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.537 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 12.0 Cg_endo -55.93 134.52 64.58 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 121.954 1.769 . . . . 60.439999999999998 111.32 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -91.34 0.37 57.53 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.36 -0.837 . . . . 73.439999999999998 110.404 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t30 66.06 16.16 10.35 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.265 1.031 . . . . 75.019999999999996 109.326 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 59.54 88.47 0.07 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.272 -1.331 . . . . 64.409999999999997 111.612 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.674 -0.862 . . . . 74.409999999999997 108.674 -179.24 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.23 -1.148 . . . . 75.099999999999994 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.1 m -95.23 157.04 16.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.735 -0.468 . . . . 71.310000000000002 109.735 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -86.35 82.62 7.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.449 0.642 . . . . 42.140000000000001 110.29 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.3 p -137.04 171.33 14.66 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.982 -1.008 . . . . 65.049999999999997 108.799 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -134.06 128.35 34.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.988 0.423 . . . . 74.150000000000006 110.387 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.09 108.77 59.02 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.149 -1.056 . . . . 71.209999999999994 108.149 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.49 -25.06 48.45 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.87 2.38 . . . . 73.319999999999993 113.058 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.5 t 63.45 25.51 14.54 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.697 0.76 . . . . 71.540000000000006 110.319 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.6 pt -82.09 24.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 113.71 1.004 . . . . 72.349999999999994 113.71 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.7 t -130.92 113.83 14.51 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.234 -1.395 . . . . 72.299999999999997 107.234 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.5 pp -114.46 142.37 28.04 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 113.025 0.75 . . . . 75.030000000000001 113.025 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 138' ' ' ILE . 39.7 Cg_exo -62.0 112.99 1.68 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.486 2.124 . . . . 62.119999999999997 111.037 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -130.22 -21.98 2.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.776 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 142' ' ' PHE . 16.3 t70 59.59 -159.78 0.29 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.724 0.81 . . . . 72.129999999999995 109.56 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.454 ' H ' ' CG ' ' A' ' 141' ' ' ASP . 64.9 m-85 -98.48 -45.28 6.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.725 -0.842 . . . . 73.219999999999999 108.725 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -94.53 142.16 27.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.334 -0.848 . . . . 72.099999999999994 110.725 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 14.0 p -146.78 163.21 36.72 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.973 -0.558 . . . . 70.439999999999998 111.021 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.45 139.63 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.38 -0.6 . . . . 73.209999999999994 109.38 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.9 p -77.11 136.25 38.62 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.033 -0.728 . . . . 75.200000000000003 109.033 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.29 156.61 43.48 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 121.087 -0.245 . . . . 73.109999999999999 111.641 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 160' ' ' ARG . 45.6 mm -94.13 103.08 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.422 -1.696 . . . . 73.019999999999996 106.422 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.75 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -100.46 154.59 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.594 -0.73 . . . . 75.310000000000002 111.026 -176.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 68.84 15.52 8.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 64.150000000000006 110.334 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.6 p -60.66 -30.66 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.571 0.748 . . . . 53.119999999999997 112.785 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.66 -29.94 36.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.469 0.652 . . . . 62.329999999999998 110.25 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.84 -58.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.356 -0.838 . . . . 53.25 110.711 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 155' ' ' PRO . 6.2 p -68.36 144.92 97.03 Favored Pre-proline 0 N--CA 1.426 -1.639 0 C-N-CA 123.3 0.64 . . . . 62.130000000000003 110.133 -175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 154' ' ' VAL . 17.3 Cg_exo -67.62 155.85 68.44 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.756 2.304 . . . . 62.119999999999997 110.661 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.38 -11.6 34.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.181 0.437 . . . . 75.409999999999997 112.181 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 25.8 p -71.92 -21.0 61.68 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 123.098 0.559 . . . . 74.409999999999997 111.053 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -119.59 141.72 49.03 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 120.86 0.362 . . . . 64.299999999999997 110.054 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -125.57 135.58 52.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.815 -0.809 . . . . 74.209999999999994 108.815 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 58.7 mtp85 -121.94 123.91 42.81 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 111.242 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.1 m -116.26 137.59 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 109.378 -0.601 . . . . 72.409999999999997 109.378 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.558 ' HB2' HD12 ' A' ' 149' ' ' ILE . 28.0 ttt180 -100.82 125.43 47.33 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.267 0.556 . . . . 73.239999999999995 111.874 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 40.9 tp -91.91 136.26 33.29 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.706 -1.133 . . . . 64.430000000000007 108.231 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.1 p -127.97 143.45 51.09 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.976 -1.491 . . . . 75.409999999999997 106.976 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 243' ' ' SER . 39.8 ttmt -79.6 121.18 24.95 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.257 0.551 . . . . 75.140000000000001 110.896 -174.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.4 110.04 21.87 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.464 -0.789 . . . . 62.219999999999999 111.199 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.49 -85.01 0.85 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 116.263 -0.426 . . . . 54.439999999999998 112.959 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -116.28 164.77 14.02 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.648 -0.871 . . . . 62.210000000000001 108.648 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.1 77.43 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.824 1.297 . . . . 71.310000000000002 111.063 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -86.95 154.91 55.57 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 113.69 -1.595 . . . . 64.230000000000004 110.061 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.3 149.89 89.07 Favored 'Trans proline' 0 C--O 1.258 1.478 0 C-N-CA 122.532 2.155 . . . . 64.230000000000004 112.052 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 172' ' ' LEU . 3.7 mp -67.35 143.22 56.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.301 -1.0 . . . . 61.399999999999999 108.301 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.575 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -81.17 38.69 2.42 Favored Glycine 0 CA--C 1.499 -0.968 0 N-CA-C 116.175 1.23 . . . . 64.230000000000004 116.175 -174.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -151.86 146.14 25.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.623 -0.88 . . . . 74.019999999999996 108.623 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 198' ' ' SER . 93.0 m-85 -112.36 159.34 18.78 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.155 -1.424 . . . . 72.040000000000006 107.155 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.444 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -122.58 162.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.751 0.786 . . . . 74.400000000000006 111.877 177.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -141.4 167.37 22.33 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 114.906 -1.043 . . . . 63.439999999999998 109.323 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -110.31 146.08 36.33 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 108.271 -1.011 . . . . 64.5 108.271 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.33 -166.22 26.05 Favored Glycine 0 C--N 1.281 -2.509 0 N-CA-C 109.67 -1.372 . . . . 61.32 109.67 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.0 m -113.25 126.36 55.32 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.002 -0.74 . . . . 71.129999999999995 109.002 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.6 t -103.51 136.75 42.65 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.237 -1.023 . . . . 50.009999999999998 108.237 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.95 117.47 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.442 0.639 . . . . 74.299999999999997 110.059 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -114.09 132.1 56.16 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.702 -0.851 . . . . 71.010000000000005 108.702 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.23 113.17 32.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.483 -0.932 . . . . 73.310000000000002 108.483 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.0 p -115.75 -174.68 2.57 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.687 -0.486 . . . . 72.310000000000002 109.687 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.53 64.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.374 0.607 . . . . 73.200000000000003 109.495 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.3 m -80.68 -12.25 59.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.436 -0.802 . . . . 73.340000000000003 109.649 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.29 -164.76 12.1 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.139 -0.553 . . . . 63.43 111.857 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.12 126.83 30.93 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.937 -0.764 . . . . 74.329999999999998 108.937 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -129.26 124.54 34.73 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.635 0.731 . . . . 74.140000000000001 110.282 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -104.4 126.71 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.087 -0.961 . . . . 73.209999999999994 108.498 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -147.5 159.69 40.88 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.21 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -55.47 120.24 7.89 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.955 2.437 . . . . 64.409999999999997 112.16 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -128.66 147.68 17.65 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.358 -1.097 . . . . 44.43 110.358 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.2 mm -96.48 117.46 40.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.075 -1.083 . . . . 71.430000000000007 108.075 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -110.86 164.61 12.61 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.664 -0.865 . . . . 75.209999999999994 108.664 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.496 ' CD1' HD23 ' A' ' 212' ' ' LEU . 54.8 mt -76.91 133.08 31.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.856 -0.794 . . . . 53.409999999999997 108.856 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 41.9 t -85.97 -61.42 1.75 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 122.052 -0.405 . . . . 44.149999999999999 110.92 -177.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -158.14 154.96 28.3 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.275 -1.009 . . . . 74.340000000000003 108.275 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 59.6 mt -110.93 144.78 39.46 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 110.187 -0.301 . . . . 73.109999999999999 110.187 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.575 HG22 ' CA ' ' A' ' 173' ' ' GLY . 22.2 m -85.5 140.73 36.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 108.358 -0.978 . . . . 51.039999999999999 108.358 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.64 124.24 14.64 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 121.582 1.522 . . . . 62.229999999999997 110.148 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.58 5.67 81.54 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.484 -0.865 . . . . 53.509999999999998 112.167 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.68 163.48 51.35 Favored Glycine 0 C--O 1.217 -0.933 0 N-CA-C 111.537 -0.625 . . . . 63.039999999999999 111.537 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.12 -50.8 35.58 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.742 0.817 . . . . 71.510000000000005 112.624 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.402 ' HB1' HD22 ' A' ' 212' ' ' LEU . . . -74.61 -35.89 62.95 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.031 0.443 . . . . 74.209999999999994 111.491 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -41.38 70.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.059 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -71.82 -39.61 69.7 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.848 -0.615 . . . . 71.310000000000002 111.021 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.456 ' HB ' ' HG ' ' A' ' 211' ' ' LEU . 46.3 p -78.99 -34.64 43.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.184 -0.606 . . . . 74.239999999999995 112.358 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.9 18.35 70.5 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.091 -0.804 . . . . 75.109999999999999 111.091 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 148' ' ' ILE . 91.4 mt -84.53 -20.47 31.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.477 -0.362 . . . . 61.43 111.839 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.496 HD23 ' CD1' ' A' ' 197' ' ' ILE . 0.0 OUTLIER -148.93 145.49 27.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.267 -0.424 . . . . 64.230000000000004 110.337 177.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -116.5 164.93 13.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.816 0.341 . . . . 73.310000000000002 111.524 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 27.7 m -52.14 -30.72 13.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 114.647 1.351 . . . . 72.439999999999998 114.647 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.613 ' HB2' ' HG2' ' A' ' 254' ' ' GLN . 55.3 m-80 -76.33 -24.07 54.27 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.365 -0.835 . . . . 72.209999999999994 113.016 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.612 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 71.5 m-20 -63.75 145.18 56.25 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.567 0.698 . . . . 72.230000000000004 111.455 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.77 137.84 39.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.141 -0.936 . . . . 70.140000000000001 109.664 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 249' ' ' VAL . 29.6 m -84.56 143.21 12.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.454 -0.573 . . . . 62.539999999999999 109.454 -178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.486 HG22 ' HG3' ' A' ' 220' ' ' GLU . 48.6 mm -108.36 -53.82 6.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.401 0.619 . . . . 73.349999999999994 110.78 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.486 ' HG3' HG22 ' A' ' 219' ' ' ILE . 34.7 mt-10 -145.35 150.26 36.27 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 115.485 -0.779 . . . . 74.329999999999998 111.493 -175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.34 108.12 24.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 106.823 -1.547 . . . . 74.209999999999994 106.823 171.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.537 ' OD1' HD12 ' A' ' 245' ' ' LEU . 6.0 m-20 68.61 -77.07 0.05 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.403 1.081 . . . . 62.340000000000003 110.834 -169.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.48 12.63 0.67 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.673 -1.371 . . . . 63.229999999999997 109.673 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 43.7 mm -97.44 111.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.189 -1.041 . . . . 65.439999999999998 108.189 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 220' ' ' GLU . 39.5 tt0 -69.01 130.58 43.18 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.895 -0.78 . . . . 72.230000000000004 108.895 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 218' ' ' VAL . 34.6 m -71.51 -22.75 22.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 112.234 0.457 . . . . 62.340000000000003 112.234 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 225' ' ' GLU . . . -67.85 127.91 34.55 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.015 -0.539 . . . . 71.109999999999999 110.247 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.96 -7.27 62.62 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 111.372 -0.691 . . . . 40.509999999999998 111.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.86 160.04 16.05 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 122.91 -0.171 . . . . 74.019999999999996 110.582 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 234' ' ' VAL . 40.7 p -88.63 168.12 12.8 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.892 -0.781 . . . . 64.219999999999999 108.892 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -29.0 66.26 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.41 -40.35 95.61 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.182 -0.673 . . . . 62.130000000000003 109.182 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 84.4 mm-40 -72.2 -45.16 61.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.973 -0.558 . . . . 74.519999999999996 111.676 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 230' ' ' THR . 61.8 t -63.92 -46.11 95.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.499 -0.48 . . . . 64.340000000000003 111.077 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.407 HG23 HD11 ' A' ' 176' ' ' ILE . 28.2 p -57.82 -49.0 78.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.478 -0.489 . . . . 72.310000000000002 110.683 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.38 -46.34 76.54 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.756 -0.656 . . . . 73.340000000000003 111.752 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -60.71 -42.33 97.02 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.489 0.662 . . . . 70.120000000000005 109.914 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 76.2 mtm -70.69 -41.15 72.4 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.426 -0.806 . . . . 73.530000000000001 112.537 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' HA ' ' OG ' ' A' ' 242' ' ' SER . 83.4 t -69.58 -32.72 53.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 120.242 -0.583 . . . . 70.299999999999997 109.717 177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.9 82.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.538 0.685 . . . . 73.239999999999995 110.415 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 245' ' ' LEU . 40.0 m-80 -104.81 20.81 18.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.185 -0.916 . . . . 70.530000000000001 112.685 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 239' ' ' VAL . 73.7 m -57.97 -16.88 13.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.28 1.585 . . . . 72.099999999999994 115.28 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 51.0 m -66.19 -44.76 83.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.409 -0.517 . . . . 73.349999999999994 110.24 177.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -150.88 97.74 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.349 -1.352 . . . . 74.439999999999998 107.349 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.537 HD12 ' OD1' ' A' ' 222' ' ' ASN . 47.6 tp -125.65 134.92 51.7 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.22 -0.445 . . . . 73.209999999999994 111.626 -173.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 149' ' ' ILE . 67.2 mt -99.84 120.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.119 -0.697 . . . . 71.420000000000002 109.119 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.0 mp -106.33 119.53 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.207 -1.035 . . . . 72.409999999999997 108.207 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 160' ' ' ARG . 63.1 m -105.51 117.57 34.35 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.697 -0.483 . . . . 72.450000000000003 109.697 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 218' ' ' VAL . 18.8 m -125.68 169.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.42 -0.956 . . . . 74.439999999999998 108.42 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.402 ' CD ' HD11 ' A' ' 219' ' ' ILE . 12.9 ptmm? -129.51 143.25 48.18 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 107.636 -1.246 . . . . 71.129999999999995 107.636 170.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 18.9 Cg_endo -60.63 134.38 54.0 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 N-CA-C 108.517 -1.378 . . . . 63.420000000000002 108.517 174.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -90.15 0.1 57.34 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.469 -0.493 . . . . 62.310000000000002 110.589 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 60.45 78.13 0.29 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.16 -1.422 . . . . 62.350000000000001 107.16 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.613 ' HG2' ' HB2' ' A' ' 215' ' ' ASN . 45.2 mt-30 -52.34 114.87 1.49 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.167 -1.378 . . . . 73.319999999999993 112.601 -171.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 114.376 -1.283 . . . . 73.200000000000003 110.968 -177.136 . . . . . . . . 2 2 . 1 stop_ save_